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Abstract 
A state of chronic metabolic inflammation and activation of the cell stress 
response in organs such as liver and adipose tissue are important 
pathogenic adaptations with the onset of obesity and the metabolic 
syndrome. The extent to which these processes are modulated by the 
early life nutritional experience is not well established, especially in large 
animal models. The overall aim of this thesis was to identify whether 
nutritional programming during prenatal and postnatal development 
enhances metabolic inflammation and cell stress response of obesity. A 
nutritional model of fetal growth restriction achieved by maternal nutrient 
restriction (NR) to 60% of requirements during late gestation (110 days 
to term at 147 days) in twin bearing sheep was used. Combination of 
prenatal and postnatal nutritional interventions were studied with the 
following three study protocols:  
1. Offspring of twin bearing sheep born to mothers nutrient restricted or 
fed to appetite were separated after weaning at 3 months of age and 
then exposed to either restricted physical activity leading to obesity or to 
unrestricted activity and remained lean. 
2. Following maternal NR, both twins or only one twin were reared on 
their mother’s milk during suckling period in order to achieve a relatively 
faster growth rate in the latter.  
3. Twin offspring of sheep randomised to NR or feeding to requirement 
during late gestation were separated after birth and randomised to either 
formula feeding or being fed by the mother until weaning followed by 
obesogenic rearing.   
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Total body weight of sheep in the obese group was raised by ~30% and 
was unaffected by any intervention. Obesity led to an increased insulin 
response to the glucose tolerance test, together with hepatic triglyceride 
deposition, and adipocyte hypertrophy with macrophage infiltration in 
omental adipose tissue. NR exacerbated obesity associated hepatic 
triglyceride deposition and upregulated gene expression of hepatic 
autophagy and omental unfolded protein response. Formula feeding of 
sheep offspring following NR was associated with slower weight gain and 
decreased gene expression for MTOR. Sheep offspring fed by mother as 
singleton gained weight at faster rate during suckling period as compared 
to offspring fed by their mothers as twins. Neither postnatal interventions 
exacerbated the state of obesity associated metabolic inflammation and 
cell stress response. It is possible that the increased hepatic autophagic 
gene expression is a reflection of defective autophagy and future work 
should include study of markers of autophagic function. Possible 
mechanisms of upregulated omental adipose UPR in offspring of sheep 
undergoing NR could include a programmed decrease in adipocyte 
number or selective survival of preadipocytes with effective ER stress 
response. Such adaptations followed by obesity would predispose the 
adipocytes to initiate inflammation and cell death pathways.   
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1. Introduction 
1.1 The metabolic syndrome, insulin and insulin 
resistance 
Metabolic syndrome (MetSyn) is a term used to describe a cluster of 
conditions which occur together and predispose an individual to the 
development of type 2 diabetes and cardiovascular disease. These conditions 
are raised blood pressure, dyslipidaemia (raised triglycerides and lowered 
high-density lipoprotein cholesterol), raised fasting glucose, and central 
obesity (defined as Body Mass Index (BMI) of >30kg/m2). The congregation 
of these conditions is a recognised phenomenon [1] and is known to be 
independently associated with cardiovascular events and death. This was 
confirmed in a meta-analysis [2] of 43 cohorts of adults (n=17573) which 
demonstrated the increased relative risk (RR=1.78) of cardiovascular events 
and death in the presence of the MetSyn. The relative risk remained high 
(RR=1.54) even after adjusting for common cardiovascular risk factors. The 
MetSyn is associated with a five-fold increased risk of type 2 diabetes [3] 
and predicts diabetes, independently of glucose intolerance.  
The worldwide prevalence of the MetSyn is difficult to estimate due to 
multiple clinical definitions and diagnostic criteria used in such studies [1]. 
Irrespective of the diagnostic criteria, MetSyn is highly prevalent in 
developed [4] and developing countries [5]. In the United States and 
Europe, 20—25% of the adult population and, in South East Asia, 
approximately 20% of the adult population have been reported to be 
affected [5]. Such a high prevalence of the MetSyn and its consequent 
effects on health is now a global public health problem which has been 
described as a worldwide pandemic [6, 7]. 
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Insulin is a hormone secreted by pancreatic beta cells in a regulated manner 
and is important for regulation of body’s carbohydrate and fat metabolism. 
The term insulin resistance describes a state when the cells in the body fail 
to respond to presence of insulin, thereby adversely affecting the control of 
normal metabolic processes. The body responds by increasing insulin 
secretion, resulting hyperinsulinemia occurs and this often precedes the 
development of type 2 diabetes mellitus which is characterised by presence 
of hyperglycaemia in presence of insulin.  
Insulin resistance is a common feature of the MetSyn and contributes to the 
pathogenesis of its components [8]. Obesity [9, 10] and, more specifically, 
fat deposition in the body’s truncal region [11] (central adiposity) has been 
long known to be strongly associated with the development of insulin 
resistance, whilst weight loss has been demonstrated to improve insulin 
resistance [12]. The establishment of insulin resistance is considered central 
to pathogenesis of the adverse cardiovascular and metabolic outcomes of the 
MetSyn [13].  
1.2 The multiple modifiable risk factors for development 
of the MetSyn 
Obesity is a major component of the MetSyn and according to the estimates 
of the World Health Organisation (WHO) in 2008, out of the estimated 6.8 
billion world-wide population [14], 1.5 billion (35% of adults) aged 20 years 
and over were overweight and, of these, at least 200 million men and nearly 
300 million women were obese [15]. The high prevalence of obesity is not 
limited to the developed world or to adulthood as it is increasing in the 
developing world [16] and the prevalence of childhood obesity has tripled in 
the past 30 years [17]. 
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Whilst obesity is a major risk factor for development of the MetSyn [18-20], 
other mutually interacting factors including ethnicity, low birth weight, 
nutrition during early life, gender and postmenopausal state, smoking and 
diet also contribute to the development of the MetSyn and its associated 
morbidities [7]. A state of subacute inflammation is considered to be one 
such risk factor [21]. This concept is supported by the increased incidence of 
the MetSyn and type 2 diabetes in individuals with clinical conditions of 
chronic inflammatory state such as hepatitis C [22], HIV [23] and 
rheumatoid arthritis [24]. The modifiable risk factors preceding the 
development of the MetSyn provide a vital opportunity for preventative and 
therapeutic measures which have the potential to result in major public 
health benefits [7].  
1.3 The concept of cell stress response 
All the living cells in a body are regularly exposed to stimuli with the 
potential of causing cellular damage or cell death. Such stimuli can originate 
intrinsic to the cell, for example, malfolded protein structure, accumulation 
of toxic metabolites, DNA damage, energy deficit and activation of 
inflammatory pathways or can be of extrinsic origin such as pathogen 
infestation, excess metabolites, osmotic load, excess heat or cold. The 
response mounted by the cell to these stimuli is dependent on several 
factors including [25]: 
 type and level of insult 
 type of organ/cell 
 the adaptive capacity of the cell 
Cell stress response pathways play a significant role in the physiological and 
pathological processes of development, ageing and disease [26]. 
Developmentally, the cell stress response pathways are important 
component of embryogenesis, implantation and organ development. [27]. 
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Innate cellular mechanisms collectively act to correct the insult, limit or 
reverse the damage to the macromolecules, organelle or cell structure and 
are collectively called the cell stress response (Figure 1.1). On activation, the 
cell stress response eventually leads to intact cell survival or cell death [25]. 
The elaborate pathways that act to try to restore cell’s survival ability are 
still being discovered and updated but are already known to have 
considerable overlap. The different interlinked primarily pro-survival 
pathways are: 
 unfolded protein response (UPR) 
 heat shock response 
 antioxidant response 
 DNA damage response 
 autophagy 
If the pro-survival response is unsuccessful, cell death programmes are 
activated. These are: 
 apoptosis 
 autophagy 
 necrosis 
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The DNA damage response is initiated by exposure to chemotherapeutic 
agents, irradiation and environmental toxins. Known regulators of the heat 
shock response include environmental factors (heat shock, drugs, oxidative 
stress, toxic chemicals, heavy metals etc), pathological conditions (fever, 
inflammation, ischemia and reperfusion) and diseases (such as Alzheimer’s 
Disease and Huntington’s Chorea) [28]. These will not be considered in this 
study. In contrast, the cell stress response pathways, which are known to be 
activated in nutritional deprivation or obesity include autophagy (Section 
1.4.2.2) and unfolded protein response (Section 1.4.2.1), form an important 
focus of this study. 
1.4 Adipose tissue in pathogenesis of the MetSyn 
The main storage site for fat in the body, adipose tissues, are distributed in 
specific locations referred to as adipose tissue depots. In humans, adipose 
tissue depots are primarily described beneath the skin (subcutaneous fat), 
around internal organs (visceral fat), in bone marrow (yellow bone marrow) 
and in breast tissue.  
Figure 1.1 Schematic diagram illustrating the role of cell stress response in cell 
survival or cell death.  
Depending upon the type and severity of insult, a cell responds with activation of the 
cell stress response which either attempts to promote cell survival or directs the cell 
towards programmed cell death pathways 
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Visceral fat or abdominal fat is packed in between organs such as between 
stomach, liver, intestines and kidneys, and is composed of several depots 
including mesenteric, epididymal white adipose tissue (EWAT) and perirenal 
depots. An excess of visceral fat is known as central obesity. There is a 
strong correlation between central obesity, insulin resistance and type 2 
diabetes [29, 30].  
Although adipose tissue exists both as white (WAT) and brown adipose 
tissue (BAT) in mammals, only WAT increases significantly with obesity 
whilst BAT decreases [31]. Whilst WAT is mainly storing energy, BAT 
releases energy from glucose and free fatty acids as heat by activating its 
unique protein, uncoupling protein 1 (UCP1) [32]. Adult humans still have 
small depots of brown adipocytes in the supraclavicular region and UCP1-
positive cells are also found interspersed in WAT [32]. Whilst the role of BAT 
is increasingly being characterised, the focus of studies described in this 
thesis will be on depots of WAT. Unless otherwise stated, the use of term 
adipose tissue in this thesis represents white adipose tissue.   
Adipose tissue consists of several cell types, with the highest percentage of 
cells being adipocytes which store lipids. Other cell types include fibroblasts, 
macrophages, and endothelial cells and many small blood vessels. 
Adipocytes are derived from multi-potent mesenchymal stem cells that 
become committed to adipocyte cell lineage in tightly controlled processes 
[33]. With increasing fat deposition, adipose tissue mass increases by either 
adipocyte hypertrophy or hyperplasia. The dynamics of fat cell turnover have 
been under considerable scrutiny. It has been proposed that the number of 
fat cells in an individual are set during early life and, whilst 10% of the fat 
cells are renewed annually, the total number of adipocytes in adulthood 
remains largely constant [34]. In obesity, such restrictions on the total 
number of adipocytes means that excess fat storage would be dependent on 
adipocyte hypertrophy. Adipocyte hypertrophy is known to lead to 
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inflammatory cytokine expression [35] and may potentially put the cell’s 
metabolic pathways under a state of stress and cellular dysfunction [36]. 
The role of inflammation in adipose tissue in the pathogenesis of metabolic 
derangements and insulin resistance seen in the MetSyn is described in 
detail in the sections that follow.   
1.4.1 Obesity and metabolic inflammation in adipose tissue 
The presence of low grade chronic inflammation in obese individuals has 
been demonstrated in several animal and human studies [37]. Biomarkers of 
inflammation (such as C-reactive proteins, interleukin-6 and soluble 
intracellular adhesion molecules) are present at increased concentrations in 
individuals who are insulin resistant and obese [38].   
This obesity-associated inflammation is distinct from the well described acute 
phase response inflammation to trauma or infection. This moderate, chronic 
process is orchestrated by metabolic cells [39], has a largely local action and 
leads to modification of the tissue environment as reflected in immune cell 
infiltration and tissue remodelling in adipose tissue. The term 
metaflammation [39] has been proposed for this type of inflammation in a 
tissue with a primarily metabolic role.  
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There are several proposed mechanisms that link the state of nutrient 
excess, limited fat storage capacity of adipocytes, inflammation and the 
development of insulin resistance. The pathways which interact, promoting a 
state of cell stress and metabolic inflammation (Figure 1.2), are: 
 adipokine-induced inflammation 
 free fatty acid and lipid induced inflammatory processes 
 macrophage activation 
 endoplasmic reticulum (ER) stress and activation of the UPR  
 
 
  
Figure 1.2 Mutually interacting processes in adipose tissue in response to obesity 
which contribute to metabolic inflammation.  
Adipose tissue releases adipokines and cytokines which promote macrophage 
infiltration, affect metabolism and activate proinflammatory intracellular pathways 
via c-Jun N-terminal kinase (JNK) and inhibitor of nuclear factor kappa-B kinase 
(IKK). Excess free fatty acids, activation of endoplasmic reticulum (ER) stress and 
macrophage mediated inflammation are other mechanisms of this inflammation.  
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1.4.1.1 Adipokines in metabolic inflammation 
As early as 1993, it had been identified that adipose tissue from obese 
individuals also secrete proinflammatory cytokines (e.g. tumour necrosis 
factor-α (TNFα)) which were capable of inhibiting insulin signalling [40, 41]. 
TNFα is a cytokine secreted primarily, but not exclusively, by macrophages 
and influences host defence and whole body lipid and glucose metabolism. 
Increased adipose tissue expression of TNFα messenger RNA (mRNA) and 
protein (local and systemic) has been demonstrated in four different rodent 
models of obesity and diabetes [40]. In further studies in murine genetic 
models, lack of TNFα bestows protection from the development of insulin 
resistance secondary to obesity, demonstrating the definitive role of 
adipokine-mediated inflammation in the pathogenesis of insulin resistance 
following obesity [42]. Such substances which have the potential to modify 
cell signalling and are secreted by adipose tissues are called adipokines. 
Leptin, the first adipokine to be described in detail [43], is the product of the 
obese (ob) gene and is synthesised and secreted by adipose tissue in 
response to change in body fat and nutritional status. Circulating levels of 
leptin are increased in obesity in proportion to the body mass index (BMI) 
[44]. The primary function of leptin is stimulation of anorexigenic pathways 
through its action on hypothalamus [45]. Leptin’s other actions include an 
insulin sensitising action in myocytes, hepatocytes and pancreatic β-cells 
where it also reduces the intracellular lipid content [46]. However, elevated 
leptin concentrations in obesity are, paradoxically, associated with insulin 
resistance and direct correlate with the severity of metabolic dysfunction 
[47]. This complex phenomenon has been attributed to leptin resistance and 
has not yet been fully explained [47].  
Leptin has also been demonstrated to affect both innate and adaptive 
immune responses [48, 49], through a multitude of mechanisms including 
macrophage cytokine induction, activation of antigen presenting cells, 
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neutrophils and selective activation of Th1 immune cells. Children with 
congenital leptin deficiency manifest a reduced number of circulating CD4(+) 
T cells, impaired T cell proliferation and decreased cytokine release which 
are all reversed following administration of leptin [46]. Indeed, with 
increasing evidence of leptin’s proinflammatory role a therapeutic role for 
recombinant leptin is now being proposed [50]. 
Out of the several isoforms of the leptin receptor (ObR), isoform b (ObRb) 
has the predominant role in leptin’s intracellular action, whereas other 
isoforms bind, and inactivate, free leptin. The multiple pathways downstream 
of ObRb activation by leptin include IRS(1/2) phosphorylation, increased 
transcription of suppressor of cytokine signalling (SOCS) and components of 
activator protein 1 (AP1) transcription factors [49]. The downstream 
outcomes of these disparate outcomes include anti- and pro-inflammatory 
outcomes and also promoting insulin sensitivity and resistance. Whilst the 
specific pathways establishing leptin’s role in obesity related inflammation 
and adverse metabolic outcomes have not been definitively distinguished 
[51], there is a consensus that the proinflammatory outcome of excess 
leptin in obesity contributes to the development of metabolic dysfunction and 
insulin resistance in obesity [52].   
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The concept of fat as a producer of important cytokines has evolved with 
identification of numerous other adipokines with pro and anti-inflammatory 
properties [53, 54] (Table 1.1). 
Adipokines with pro-inflammatory properties 
Leptin 
Resistin 
Retinol binding protein 4 
Lipocalin 2 
Angiopoietin-like protein 2 
Tumour Necrosis Factor 
Interleukin-6 
Interleukin-18 
CC chemokine ligand -2 
CXC-chemokine ligand 5 
Nicotinamide phosphoribosyltransferase 
Adipokines with anti-inflammatory properties 
Adiponectin 
Secreted frizzled-related protein 5 
 
In adipocyte cell cultures, gene expression of proinflammatory adipokines 
can occur in response to adipocyte hyperplasia [35]. These adipokines are 
known to act through proinflammatory pathways including c-Jun N-terminal 
kinase (JNK) and Inhibitor of nuclear factor kappa-B (IKK) (NF-κB) (as 
described in Section 1.4.3), macrophage chemotaxis and activation and 
modulation of the unfolded protein response [53].  
 
  
Table 1.1 Adipokines known to have pro- and anti-inflammatory properties 
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1.4.1.2 Free fatty acid and lipid induced inflammatory processes 
Plasma free fatty acids are elevated in obesity [55] and can contribute to 
development of inflammation and insulin resistance through activation of 
pathogen sensing receptors [56] known as pattern recognition receptors 
(PRR) which recognise pathogen-associated molecular patterns (PAMP). 
PAMP are molecules that are broadly shared by pathogens but 
distinguishable from host molecules such as bacterial lipopolysaccharides. 
Primarily part of the innate immune response, PRR are also present on the 
metabolic cells (liver, adipose tissue and myocytes) of the body and are 
capable of initiating inflammation and cell stress response. Toll-like receptors 
(TLR) are membrane bound PRR known to be present in adipose tissue and 
liver and are a key element of innate and adaptive immunity capable of 
activating intracellular inflammatory pathways (JNK) and stimulating release 
of cytokines [57]. Adipose tissue expresses the subtypes TLR4 and TLR2. 
Fatty acids of nutritional origin have been demonstrated to activate 
adipocyte and macrophage TLR4 and this activation contributes to the 
resulting insulin resistance [58] in mice. In the same experimental study of 
fatty acid infusion in TLR4 knockout mice, insulin signalling was not 
suppressed and insulin resistance did not occur. In mice, high fat diet (HFD) 
feeding also caused an increase in TLR4 expression along with increased 
expression of mediators of inflammation, IKK complex and c-JNK activity 
[59]. All these features were blunted in mouse model of genetic loss of TLR4 
function [59] and cell specific deletion model of TLR4 [60]. This 
demonstrated that TLR4 function is essential for activation of inflammatory 
response and insulin resistance in response to abundant fatty acids and in 
the high fat diet mouse model. 
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Activation of TLR also has been demonstrated to be linked with activation of 
responses in the ER. Activation of mouse macrophages with TLR4 agonists 
including lipopolysaccharide or tunicamycin leads to upregulation of 
components of the ER stress response [61] and cytokine release from the 
macrophages. PAMP activation in presence of excess fatty acids, therefore, 
can lead to upregulation of metabolic inflammation via direct activation of 
inflammatory pathways and indirectly via activation of the ER stress 
response.  
Another pathogen sensing receptor, double-stranded RNA-dependent protein 
kinase (PKR) is also significantly activated (by phosphorylation [62]) in the 
liver of the classic mouse model of severe insulin resistance resulting from 
leptin deficiency (ob/ob mice) and in the white adipose tissue and liver of 
mice on high fat diets as compared to their controls [63]. This was also 
replicated in a mice model of lipid infusion [63] while inhibitors of PKR lead 
to improve insulin sensitivity in obese diabetic mice [64]. PKR’s primary 
function is considered to be as sensor for double stranded RNA, an indicator 
of viral invasion of the cell. PKR acts to regulate the activity of inflammatory 
kinases like JNK to regulate insulin action  [39]. PKR has also been proposed 
to act in a way similar to the TLR molecules in regulation of inflammation in 
response to fatty acids [63]. PRRs, including TLR4 and PKR, therefore, play a 
key role in activation of metabolic inflammation in response to activation by 
free fatty acids (Figure 1.3). 
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1.4.1.3 Adipose tissue macrophages 
Weisberg et. al. [65] identified increased accumulation of macrophages in 
adipose tissue from obese, as compared to non-obese, mice. They also 
demonstrated that adipose tissue macrophages are of bone marrow origin 
and are responsible for almost all adipose tissue TNF-α expression and 
significant amounts of inducible nitric oxide synthase (iNOS) and interleukin 
(IL)-6 expression, a finding that has been confirmed in mice models and in 
humans [65]. The adipose tissue macrophage accumulation in obesity tends 
to occur in clusters surrounding necrotic adipocytes. Such appearances of 
macrophage accumulation have been called “crown-like structures” (CLS, 
Figure 1.4) and have been reported in mouse, sheep and human obese 
subjects [66-68]. Another pattern of macrophage accumulation, unique to 
omental adipose tissues, is as milky spots [69-71]. Milky spots, considered 
to be a lymphoid tissue of the omentum, develops during the late pregnancy 
in humans and sheep, is developmentally different from other lymphoid 
Figure 1.3 Schematic diagram showing pathways of fatty acid induced metabolic 
inflammation.  
Free fatty acids, activate pattern recognition receptors such as toll-like receptors 
(TLR) and double-stranded RNA-dependent protein kinase (PKR) which stimulate 
intracellular proinflammatory pathways and ER stress response contributing to 
metabolic inflammation in obesity. 
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tissue which can be identified as early as 13 weeks gestation in humans 
[72]. These milky spots are considered to be an important source of 
macrophages in peritoneal immune responses [71]. 
 
Adipose tissue macrophages are key to obesity-associated metabolic 
inflammation. In microarray gene expression analysis of mouse white 
adipose tissue, Xu et. al. [21] identified highly specific upregulation of 
macrophage-associated inflammatory genes in adipose tissue of mouse 
models of genetic and high-fat diet-induced obesity as compared to lean 
mice. In this experimental study, 59% of the upregulated (more than 2 fold 
change) genes were inflammatory genes. These findings were confirmed in 
specific genes of interest by real-time PCR. Furthermore, with increasing 
obesity, gene expression of inflammatory genes was upregulated and 
preceded an increase in circulating insulin concentrations. 
An association between macrophage activation and obesity has been 
demonstrated in human subjects. In a study of obese subjects undergoing 
gastric bypass surgery [67], adipose tissue samples from before, and 3 
Figure 1.4 Diagram summarising characteristic features of adipose tissue 
macrophage infiltration.  
Macrophages present in adipose tissue increase in number and activation state in 
response to obesity and are associated with upregulated inflammatory gene 
expression. Obesity also leads to increased numbers of crown-like structures 
characterised by necrotic adipocytes surrounded by macrophages.  
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months after, surgery were investigated and compared with adipose tissue 
from lean subjects. The adipose tissue of obese subjects had more crown-
like structures, stained positive for cluster of differentiation 68 (CD68, a 
marker of phagocyte activity) and HAM56 (human macrophage 56, a mature 
macrophage marker) and had increased expression of genes involved in 
inflammatory or immune processes (as assessed by microarray gene 
expression). Weight loss following bariatric surgery lead to a decrease in 
macrophage number with remaining macrophages staining positive for the 
anti-inflammatory protein, IL-10. A significant decrease in plasma 
concentrations of leptin, insulin, and C-reactive peptide (CRP), as well as two 
acute-phase proteins, serum amyloid A and orosomucoid, were observed to 
be associated with weight loss after gastric bypass surgery.   
Macrophages in adipose tissue can exist in one of two activation states [73]. 
The classically activated, M1 activation, pattern is induced by 
proinflammatory factors and such macrophages display increased 
inflammatory gene expression with enhanced reactivity to fatty acids and 
lipopolysaccharides (LPS). The alternatively activated, M2 macrophages 
display low levels of inflammatory gene expression, secrete high levels of 
antiinflammatory factors, such as IL-10 and IL-4, and are poorly activated 
by fatty acids. 
In a human study [74] of subcutaneous adipose tissue from non-diabetic 
patients undergoing plastic surgery and of omental adipose tissue from 
organ donors [74], macrophage activation state were characterised. The 
surface markers on adipose tissue macrophages were compared with 
peripheral blood monocytes which had been differentiated in vitro to M1 and 
M2 lineages. Adipose tissue macrophages expressed a surface marker 
phenotype similar to the M2 lineage and, accordingly, secreted high amounts 
of IL-10 and IL-1 receptor antagonists. Upon activation, the macrophages 
were capable of secreting a large amount of proinflammatory cytokines 
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(TNF-α, IL-6, IL-1, MCP-1 and MIP-1α) at levels significantly higher than the 
comparative M1 macrophages. However, this adipocyte macrophage M2 
activation is in contrast to findings of another study comparing omental and 
subcutaneous adipose tissue [75] where macrophages with M1 surface 
markers were significantly increased in omental as compared to 
subcutaneous tissue in obese women and also in subcutaneous adipose 
tissue of obese women as compared to lean women. After weight loss, M2 
surface markers were significantly increased in subcutaneous tissues as 
compared to the pre weight loss. 
In conclusion, obesity leads to macrophage accumulation in the adipose 
tissue and this response is more pronounced in visceral than subcutaneous 
adipose tissue. Rodent models demonstrate M1 activation pattern in adipose 
tissue macrophages. However, the evidence regarding activation states of 
the adipose tissue (M1 or M2 activation states) in humans and large 
mammals is not yet clear. 
1.4.1.4 Role of glucocorticoids in adipose inflammation 
Glucocorticoids (GC) are known to regulate adipokines secretion. Leptin 
expression is known to increase in response to GC[76]. In line with the 
known anti-inflammatory actions, GCs decrease inflammatory cytokines, 
namely IL-6, IL-8, and TNF in intact samples of adipose tissues [77, 78]. 
Accordingly, dexamethasone administration in humans significantly 
suppresses inflammatory response [79].  Intracellular cortisol levels are 
regulated by the enzyme hydroxysteroid dehydrogenase (HSD) isoforms 1 
and 2. HSD1, a NADPH dependent enzyme, is expressed in many tissues, 
including liver and adipose tissue, and acts predominantly as a reductase, 
generating cortisol in vivo [80]. HSD2, highly expressed in kidney and colon, 
inactivates cortisol to cortisone. A positive correlation has been 
demonstrated between adipose HSD1 mRNA with both BMI and adipocyte 
size [80, 81]. In addition, in vitro analyses of HSD1 activity from adipose 
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tissues demonstrate increased HSD1 activity from tissues from obese 
individuals [82]. 
The action of GCs on target cells is thought to be mediated by the type 2 
glucocorticoid receptor (GCR), a member of the nuclear receptor superfamily 
that is expressed in virtually all tissues.  Activation of GCR is known to 
promote macrophage accumulation[83], and differential expression of GCR 
has been proposed to have role in depot specific differences in macrophage 
accumulation[80]. In addition, cytokines such as TNFα are known to 
differentially affect expression of specific isoforms of GCR in adipose tissues 
[84]. This is particularly important as activation of GCR directly interacts 
with NF-κB (discussed in Section 1.4.3) to lead to repression of inflammatory 
cytokines [85]. 
1.4.2 Adipose tissue cell stress response in obesity 
Cell stress response pathways known to be activated in nutritional 
deprivation or obesity include autophagy and unfolded protein response 
which form an important focus of this study. 
1.4.2.1 Unfolded protein response 
Endoplasmic reticulum (ER) is an organelle inside cellular cytoplasm which 
appears like a network of flattened sacs composed of membrane in 
continuation with the nuclear membrane. The organelle broadly consists of 
two components: smooth endoplasmic reticulum, which is the site for lipid 
and carbohydrate metabolism and rough endoplasmic reticulum, so called as 
it is coated with ribosomes and is the main site for cellular protein synthesis. 
The ER plays a key role in quality control during steps of protein synthesis, 
which comprise of tightly controlled processes of translation from mRNA as 
polypeptide chains, folding into secondary structures and post-translational 
modification.  
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1.4.2.1.1 Normal protein folding and quality control processes in the 
ER 
Protein synthesis and quality control is a tightly regulated multi step process 
(Figure 1.5) and the ER is a key organelle responsible for this process. 
Following production, a polypeptide chain rapidly folds upon itself into a 
secondary structure called nascent protein. The conformation of this 
secondary structure depends upon the thermodynamic and kinetic properties 
of the polypeptide components and its environment [26]. As a result, the 
hydrophobic and non-polar aspects of the chain are concentrated in the 
centre of the protein, whilst the hydrophilic aspects form the exposed 
surface. Such a conformation protects the hydrophobic sections of protein 
from damaging interaction with other proteins present in the highly 
concentrated composition of the ER lumen [86].  
Proteins also undergo post-translational modification in the ER. Out of the 
numerous possible processes, only disulphide bond formation and N-linked 
glycosylation are linked to the UPR [26]. Both these processes modify the 
topology and the composition of the protein structure by modifying the 
hydrophobic (disulphide) and hydrophilic (glycosylated) areas of the 
polypeptide chain.   
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During the process of folding and post-translational modification, a 
proportion of proteins are not able to attain a stable state. Such malfolded or 
unfolded proteins are functionally redundant and structurally unstable due to 
Figure 1.5 Schematic diagram demonstrating protein folding and quality control 
processes in the ER.  
Following translation, polypeptide chains rapidly fold and attain a stable nascent form 
with hydrophobic core. The exposed hydrophobic areas 78 kDa glucose-regulated 
protein 78 (GRP78) binds to exposed hydrophobic areas of malfolded proteins. In 
addition, UDP-glucose:glycoprotein glucosyltransferase (UGGT) binds to malfolded 
glycoproteins and attempts to refold such proteins. Remaining malfolded proteins are 
bound to ER stress degradation enhancer molecule (EDEM) and marked for ER-
associated protein degradation (ERAD). 
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their interaction with surrounding protein structures. Two main quality 
control processes that monitor the ER contents for malfolded protein, 
attempt to correct the malfolded protein by unfolding and refolding the 
protein and, if unsuccessful, direct the protein to cytosolic destruction by 
labelling with ER stress degradation enhancer molecule (EDEM) [87]. 
 78 kDa glucose-regulated protein (GRP78) 
 UDP-glucose:glycoprotein glucosyltransferase (UGGT) 
GRP78 is also known as binding immunoglobulin protein (BiP) or heat shock 
70 kDa protein 5 (HSPA5). As a molecular chaperone, GRP78 binds to 
exposed hydrophobic areas of malfolded proteins, preventing their 
interaction with other surrounding proteins. Bound and activated GRP78 
facilitates disulfide reduction, rearrangement, and reoxidation of the 
polypeptide chain until the correct protein conformation is achieved [88].  
UGGT is another enzyme resident in the ER and monitors misfolded 
glycoproteins within the ER lumen. Upon identification, UGGT glycosylates 
such glycoproteins, which are then bound to the resident molecular 
chaperones, calnexin and calreticulin, and are redirected to process of re-
folding [89]. 
Normally folded proteins are then transferred to Golgi apparatus for further 
processing or transportation. However, protein chains that remain 
uncorrected despite the above quality control measures or which 
quantitatively exceed the ER’s ability to monitor and correct are directed to 
degradation pathways called endoplasmic-reticulum-associated protein 
degradation (ERAD). In this process, such proteins are labelled with a 
protein called ER degradation enhancing α-mannosidase-like molecule 
(EDEM) and directed to cytosolic degradation [87]. 
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1.4.2.1.2   ER stress and the unfolded protein response 
If the influx of unfolded polypeptides exceeds the processing capacity of the 
ER, the physiological milieu of the organelle is unsettled. ER stress is the 
term used to describe this state of imbalance between protein folding 
capacity and protein load. The ER actively monitors the load of its unfolded 
protein cargo and, when this is excessive, a coordinated set of pathways is 
activated aimed at restoration of the normal ER state. However, if the ER 
stress stimulus is overwhelming, the same set of pathways lead to activation 
of cell death processes. The process of activation of such pathways is called 
the unfolded protein response (UPR) [26]. The cellular processes initiated 
during the UPR to limit the organelle damage and maintain cellular 
homeostasis [26] include (Figure 1.6): 
 decreased transcription of genes encoding secretory proteins 
 decreased translation 
 increased folding capacity of the ER by increase in chaperones 
including GRP78 and C/EBP-homologous protein (CHOP)  
 clearance of slowly folding proteins through ERAD 
 increased size of the ER 
It is believed that, once the ER stress exceeds the pro-survival processing 
capacity of the UPR, the process of redirection to programmed cell death 
involves activation of the pathways of apoptosis and autophagy [90-92].  
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1.4.2.1.3 The canonical pathways of UPR 
The ER membrane bears three distinct transmembrane proteins that monitor 
the levels of unfolded proteins in the ER lumen and can activate pathways 
named after them. These proteins are: 
 Inositol Requiring Enzyme 1 (IRE1) 
 PKR-like eukaryotic initiation factor 2α kinase (PERK) 
 Activating Transcription Factor 6 (ATF6)     
Figure 1.6 Schematic diagram demonstrating the multiple outcomes of activation of 
the unfolded protein response (UPR) in the endoplasmic reticulum (ER).  
UPR activation attempts to decrease ER protein load by decreasing synthesis of 
ribonucleic acids (RNA) and proteins and increasing synthesis of protein folding and 
quality control components including increasing the size of the ER. Remaining 
malfolded protein is directed towards ER-associated-degradation (ERAD). UPR 
activation is also known to interact with and activate cell death pathways of 
autophagy and apoptosis.  
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In the absence of ER stress, these proteins are maintained in inactivated 
state bound to protein chaperones like GRP78. On accumulation of unfolded 
protein within the ER lumen, GRP78 is recruited away from the 
transmembrane proteins leading to activation of the three well described 
canonical pathways (Figure 1.7). 
  
  
Figure 1.7 Canonical pathways of the unfolded protein response (UPR) 
Upon accumulation of excessive amounts of malfolded protein inside the ER (ER 
stress), molecular chaperones like GRP78 get removed from ER membrane proteins 
ATF6, IRE1 and PERK and preferentially bind to malfolded proteins. The unbound ER 
membrane proteins, ATF6, IRE1 and PERK activate a sequence of downstream steps, 
called UPR pathways which collectively upregulate genes and proteins aimed at 
resolution of the ER stress by decreasing generalised transcription and protein 
translation, increasing UPR components and ER size and if unsuccessful at resolving 
ER stress, activation of programmed cell death pathways. ER, endoplasmic reticulum; 
UPR, unfolded protein response; GRP78, glucose regulated protein-78; ATF6, 
activating transcription factor-6; IRE1, inositol requiring enzyme-1; PERK, PKR-like 
eukaryotic initiation factor 2α kinase; XBP1, X-box binding protein-1; EDEM1, ER 
degradation enhancing α-mannosidase-like molecule; CHOP, C/EBP-homologous 
protein; eiF2α, eukaryotic initiation factor-2α; ATF4, activating transcription factor-
4.         
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1) IRE1 Pathway.  
Upon separation of GRP78 from its binding site on IRE1, the latter undergoes 
oligomerisation and activation of its ribonuclease domain. The substrate for 
this domain in mammals is X-box binding protein 1 (XBP-1) mRNA. In a 
unique mechanism, the activated IRE1 catalyses the excision of 26 
nucleotide segment (unconventional intron) causing a frame shift mutation 
in the mRNA [93]. As a result of this splicing, the protein product of the 
spliced XBP1 (XBP-1s) mRNA is a 371 amino acid isoform instead of the 261 
amino acid isoform produced by the unspliced XBP1 (XBP-1u) mRNA.  
XBP-1s is a basic leucine zipper (bZIP) domain containing transcription factor 
and it activates expression of multiple downstream UPR components 
including ER chaperones, transcriptional increase in EDEM, modulation of 
inflammation and activation of apoptosis [26](Table 1.2). 
Canonical 
pathway 
Process Outcome 
Effect on organ 
system 
IRE 1 
pathway 
XBP1 
splicing 
Increased transcription of chaperones like 
GRP78 and proteins involved in ER 
biogenesis 
Upregulated  UPR 
and ER synthesis 
Transcriptional increase in EDEM [87] Upregulated ERAD 
 
Recruitment of TNF alpha receptor 
associated factor 2 (TRAF2) leading to 
activation of  
 c-Jun N-terminal Kinase (JNK) 
 NF-κB pathway 
 
Inflammation 
modulation 
 
Stimulation of Bcl2 proteins BAX and BAK 
Recruitment of Apoptosis signalling kinase1 
(ASK1) 
Apoptosis 
  
Table 1.2 Summary of the outcome of activation the IRE1 pathway of unfolded protein 
response.  
IRE1 pathway activation catalyses splicing of transcription factor XBP1 which 
upregulates transcription of ER stress response components including chaperones, 
EDEM. Other outcomes of this pathway activation include activation of 
proinflammatory JNK and NF-κB pathways and components of apoptosis. IRE1, 
inositol requiring enzyme 1; XBP1, X-box binding protein 1; GRP78, glucose regulated 
protein-78; JNK, c-Jun N-terminal kinase; ERAD, ER-associated-degradation; EDEM, 
ER degradation enhancing α-mannosidase-like molecule; NF-κB, nuclear factor 
kappa-light-chain-enhancer of activated B cells; Bcl2, apoptosis regulator b cell 
lymphoma 2; BAX, Bcl-2-like protein 4; BAK, Bcl-2 homologous antagonist/killer. 
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2) PERK pathway.  
Activation of the PERK pathway leads to downstream phosphorylation of the 
alpha subunit (eIF2A) of protein eukaryotic initiation factor-2 (eIF2). This 
phosphorylated subunit competitively reduces the function of eIF2B leading 
to reduced global protein synthesis and reduced workload of the ER. This 
pathway also interacts with NF-κB (described in Section 1.4.3.2) and 
modulates inflammation. 
Canonical 
pathway 
Process Outcome Effect on organ system 
PERK 
pathway 
Phosphoryl-
ation of 
eIF2α 
Repression of protein 
translation 
Decreased ER load 
Decreased synthesis of IκB 
leading to activation of NF-
κB 
Modulation of inflammation 
and apoptosis 
Preferential translation of 
ATF4 [94] 
Autophagy [95] and 
apoptotic cell death [90] 
ATF4 mediated inhibition of 
hepatic Akt/ PKB and 
increased PPARϒ 
Hepatic lipid accumulation 
and decreased insulin 
sensitivity 
PERK pathway interacts with cell death pathways at multiple locations 
through increase in translation of activating transcription factor 4 (ATF4) 
[94], which in association with C/EBP homologous protein induces cell death 
[90]. The ATF4 activation through this pathway has been demonstrated to 
be essential to autophagy activation and cell death [95]. 
In addition, UPR activation can have direct effects on cellular metabolic 
functioning. This is particularly relevant for the liver as ATF4 and CHOP 
affect cellular insulin sensitivity by leading to inhibition of Akt, an insulin 
sensitising kinase [96, 97] or increasing expression of genes that regulate 
Table 1.3 Table summarising the outcome of activation of PERK pathway of UPR.  
Inactivating phosphorylation of eIF2α leads to repression of secretory protein 
synthesis attempting to decrease ER load, proinflammatory pathway NF-κB activation 
and autophagic and apoptotic cell death pathways mediated by activation of 
transcription factor, ATF4. PERK pathway also plays a role in hepatic lipid metabolism 
by promoting insulin resistance and hepatic steatosis via inhibition of Akt and 
increased PPARϒ respectively. PERK, PKR-like eukaryotic initiation factor 2α kinase; 
ATF4, activating transcription factor 4; eIF2α, eukaryotic initiation factor 2 α subunit; 
NF-κB, nuclear factor kappa-light-chain-enhancer of activated B cells; IκB, inhibitor 
of kappa B; Akt/PKB, Protein Kinase B; PPARϒ, peroxisomal proliferation activated 
receptor ϒ 
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lipogenesis (peroxisomal proliferation activated receptor ϒ, PPARϒ) [98]. The 
multiple outcomes of PERK pathway activation are summarised in Table 1.3.  
3) ATF6 Pathway 
Upon release from nuclear membrane, ATF6 translocates to the Golgi 
complex where through proteolytic steps, the cytosolic bZIP domain is 
released. The activated ATF6 then translocates into the nucleus and 
activates transcription. Along with upregulation of the expression for ER 
chaperones and EDEM, this pathway also decreases cholesterol synthesis 
through transcriptional repression of low-density lipoprotein receptor [26] 
(Table 1.4). 
Canonical 
pathway 
Process Outcome 
Effect on organ 
system 
ATF6 
pathway 
Activation by 
proteolysis and 
translocation to 
nucleus; 
Binding to 
SREBP2 
Increased transcription of 
chaperone GRP78 
Upregulated UPR 
Stimulation of EDEM  
Upregulated of 
ERAD 
Transcriptional repression of LDLR 
Decreased 
cholesterol 
synthesis 
 
1.4.2.1.4 Role of UPR in adipose tissue in obesity 
During a state of obesity, adipose tissue homeostasis is affected by factors 
including energy availability, increased synthetic demand and activation of 
inflammatory pathways all of which are known to activate the ER stress 
response [91].The direct evidence of obesity-related activation of ER stress 
response in liver and adipose tissue came from studies in HFD mice. In 
comparison to lean animals, HFD feeding led to activation of PERK and IRE1α 
and this was associated with increased JNK activity [99]. This response was 
Table 1.4 Table summarising the outcome of activation of ATF6 pathway of UPR.  
UPR, unfolded protein response, ATF6, activating transcription factor 6; GRP78, 
glucose regulated protein-78, ERAD, endoplasmic reticulum associated degradation,  
EDEM, ER degradation enhancing α-mannosidase-like molecule; NF-κB, nuclear factor 
kappa-light-chain-enhancer of activated B cells; LDLR, low-density lipoprotein 
receptor; SREBP, Sterol regulatory element-binding protein. 
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also seen in ob/ob mouse model (genetic obesity resulting from leptin 
deficiency) in both adipose tissue and liver [99]. In cell culture of mouse 
embryo fibroblasts (MEFs) derived from XBP-1–/– mice, the cultured cells had 
impaired ER responses and insulin signalling. 
Genetic engineering techniques in rodent models have bolstered the 
evidence of role of UPR in systemic glucose and lipid homeostasis. Some 
such experiments have been summarised in Table 1.5. 
Target of 
genetic 
engineering 
Role of target in 
ER stress 
Intervention Outcome 
ER chaperone 
protein: 
ORP150  
[100] 
 
ORP150 deficiency 
leads to increased 
cell susceptibility 
to ER stress 
ORP overexpression 
in the liver of obese 
diabetic mice (obese 
diabetic C57BL/KsJ-
db/db mice) 
Decreased ER stress markers, 
improved insulin resistance and 
glucose tolerance 
Expression of 
antisense ORP150 in 
the liver of normal 
mice (C57BL6) 
Impaired glucose tolerance and 
decreased insulin receptor 
signalling through phosphorylation 
of IRS1 
ER chaperone 
GRP78 [101] 
 
ob/ob mice 
overexpressing 
GRP78 using an 
adenoviral vector 
Decreased lipogenic gene 
expression and hepatic steatosis 
and increased insulin sensitivity. 
NCK [102] 
Nck1, shown to 
modulate the UPR 
obese Nck1−/− and 
Nck1+/+ mice and 
HepG2 cell culture 
In vivo improved glucose disposal 
and in vitro enhanced insulin 
signalling in NCK-/- mice and 
HepG2 cells 
 
These have been confirmed in human studies. In a study of abdominal 
subcutaneous adipocytes from obese and lean individuals, ER stress markers 
(calnexin, GRP78, IRE1α, PERK), measured using Western blotting, were 
significantly increased in adipocytes from obese individuals [103]. 
Furthermore, treatment of cultured human adipocytes with 
lipopolysaccharide, high glucose and saturated fatty acids increased gene 
expression of UPR components, a response absent when the treatment was 
combined in the presence of anti-inflammatory compound salicylate [104]. 
This finding was confirmed in a study of proteomic, Western blotting and RT-
Table 1.5 Studies of genetically engineered rodent models demonstrating the role of 
adipose tissue ER stress response in insulin resistance. 
GRP78, glucose regulated protein 78; IRS1, insulin receptor substrate 1; NCK, 
Noncatalytic region of tyrosine kinase; ORP150, oxygen-regulated protein 150 
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PCR analyses of subcutaneous adipose tissue biopsies from lean-insulin 
sensitive and obese-insulin resistant non-diabetic individuals which 
demonstrated selective upregulation of UPR components [103]. In another 
human study, subcutaneous adipose tissue of obese subjects was sampled 
before, and 1 year after, weight-reducing bariatric surgery.  Mean weight 
loss of 39% in the obese subjects led to decreased gene expression for 
GRP78 and of alternatively spliced XBP-1 associated with decreased adipose 
tissue protein expression of eiF2α and cJNK [105]. This has been confirmed 
in another study of human subcutaneous adipose tissue, demonstrating that 
the increased gene expression for ER stress markers associated with obesity 
decreases with weight loss in obese non-diabetic individuals, but not in 
obese diabetics  [106].  
These human studies have been performed using subcutaneous adipose 
tissue. So far, no human or large animal experiments have demonstrated 
visceral adipose tissue activation of UPR in response to obesity. This study 
intends to describe the characteristics of the UPR state in a large animal 
model of obesity in comparison to lean counterparts.   
1.4.2.2 Autophagy 
Cell death pathways are constitutive to various relevant physiological 
processes including adipocyte development [107], hepatic development 
[108], adipose tissue remodelling [109],  lipid metabolism [107], formation 
of crown-like structures, response to ER stress and inflammation [90]. The 
various pathways of metabolic inflammation in obesity interact with these 
cell death pathways and, collectively, are part of the cell stress response. 
Any study of obesity associated cell stress response should, therefore, 
include exploration of the state of metabolic inflammation and the state of 
the cell death pathways.   
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Using morphological criteria, cell death pathways can be classified as either 
programmed cell death pathways or necrosis [110].  Programmed cell death 
describes pathways which are intrinsic to the cell and are mediated by a 
regulated intracellular pathways. In contrast, necrosis is the death of a cell 
caused by external factors. Out of the two main pathways of programmed 
cell death, autophagy and apoptosis, the former is particularly important as 
it is known to contribute not just to cell death but also to lipid metabolism, 
adipocyte development and metabolic inflammation [107]. 
The multiple possible pathways of adipose tissue inflammation and cell stress 
described above have the potential of initiating processes of programmed 
cell death [25, 111]. The crown-like structures in adipose tissue have a dead 
adipocyte in the centre surrounded by inflammatory infiltrate [66]. The ER 
stress pathways interact at multiple levels with autophagy and apoptosis 
pathways and free fatty acids induced inflammation also has the potential of 
inducing cell death [112].  
1.4.2.2.1 Autophagy: pathway and regulation 
The literal translation of the term autophagy in Greek language is “self-
eating”. This was initially described as an evolutionary-conserved process 
wherein, faced with persistent starvation, a cell consumes its own non-
essential components to promote survival. However, it is now known that, 
depending upon the severity and type of the precipitating stress, this tightly-
regulated process can progress to the death of the cell [111]. Autophagy is 
also a constitutive component of several physiological processes including 
cell and organ development, cell growth and organ adaptive response to 
stress [113]. 
The classical process of autophagy (macroautophagy) involves formation of 
double membrane vesicles called autophagosomes around the cytoplasmic 
target (organelles, proteins, pathogens) (Figure 1.8). The autophagosome 
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then fuses with the cellular lysosomes to form autolysosome where the 
process of enzymatic degradation of the contents begins. The sequestered 
contents are, thereafter, degraded within the lysosome allowing the cell to 
either eliminate damaged or harmful constituents or recycle components, 
thereby contributing to nutrient and energy homeostasis [113].  
 
 
The formation of the phospholipid double membrane autophagosome is the 
outcome of a highly regulated engagement of pathways involving several 
autophagy related genes (ATG), eighteen of which have been recognised in 
eukaryotes. The products of these genes act together, either as complexes, 
or as the outcome of conjugation pathways, to promote autophagosome 
formation and functioning [114].  
The process begins with initiation and nucleation steps which involve 
association of two complexes, Unc-51 like kinase (ULK) complex and class III 
Figure 1.8 Schematic diagram depicting overview of the autophagic process. 
Initiation and nucleation steps lead to formation of a phospholipid bilayer which 
enlarges to engulf cytoplasmic content until the ends of expanding phospholipid 
membrane close to form an enclosed autophagosome. The autophagosome fuses with 
lysosome to form autolysosome to enable enzymatic degradation of the contents.   
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phosphotidyl inositol 3-kinase (PI3K) complex. Beclin 1 is a component of 
the PI3K complex and is key to the regulation of this initiation. Following the 
initiation step, forming a phospholipid membrane, two important ubiquitin-
like conjugation systems are activated which eventually result in coating of 
the phospholipid bilayer with specialised ubiquitin like molecules ATG12 and 
microtubule-associated protein 1A/1B-light chain 3 (LC3). As the expanding 
phospholipid bilayer engulfs cytoplasmic content and organelles, the proteins 
like ATG12 and LC3 coat the autophagosome and mark it as a target for 
lysosomal degradation [114] (Figure 1.9). The process continues until the 
two ends of the expanding bilayer meet and fuse to form an 
autophagosome.  
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1.4.2.2.2 Regulation of autophagy 
Several physiological processes including development, differentiation, cell 
survival and homeostasis require effective cellular autophagic functioning.  
Insulin action, ER stress and energy sensing are three known regulators of 
autophagy in a cell.  
Insulin. The protein mammalian target of rapamycin (mTOR) is a nodal 
component of the processes regulating autophagy. mTOR is part of a 
Figure 1.9 Schematic diagram depicting the key pathways conjugation systems 
required for autophagosome formation. 
A phospholipid bilayer is formed following initiation and nucleation steps which 
require association of two complexes, Unc-51 like kinase (ULK) complex and class III 
phosphotidyl inositol 3-kinase (PI3K) complex. Beclin 1 is a component of the PI3K 
complex. The expanding bilayer is then coated with specialised ubiquitin like 
molecules: product of autophagy related gene 12 (ATG12) and microtubule-
associated protein 1A/1B-light chain 3 (LC3) which facilitate eventual fusion with 
lysosomes. 
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complex mTORC1 which prevents autophagy activation by its binding to the 
ULK complex and the dissociation of the two leads to activation of autophagy 
[115]. Insulin receptor activation leads to inhibition of autophagy by 
activating mTOR (Figure 1.10). This is executed through mediators 
downstream of insulin receptor. Pi3K is a signalling molecule which upon 
activation of insulin receptor activates Akt/PKB (protein kinase B) pathway 
[113]. A consequence of this pathway activation is prevention of the 
Tuberous Sclerosis 1/2 (TSC1/2) complex formation. TSC1/2 normally 
inhibits mTOR [115, 116]. Therefore, insulin action via its receptor leads to 
activation of mTOR and inhibition of autophagy in a cell [117].  
 
Figure 1.10 Schematic diagram depicting regulation of autophagy by insulin. Insulin 
receptor activation leads to eventual activation of mTOR leading to inhibition of 
autophagy.  
PI3K, Phosphatidylinositol-4,5-bisphosphate 3-kinase; PKB, protein kinase-B, TSC, 
tuberous sclerosis complex; mTOR, mammalian target of rapamycin; ULK, Unc-51 like 
kinase; ATG12, autophagy related gene 12; LC3, microtubule-associated protein 
1A/1B-light chain 3 
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ER stress. Several studies have reported that ER stress can induce 
autophagy. UPR activation leads to phosphorylation of eiF2α, which is 
mediated by PERK (Section 1.4.2.1.3) leading to conversion of LC3-I to LC3-
II and to increased ATG12 expression [118]. The transcription factor ATF4 is 
also known to increase production of ATG8 and ATG5 expression. Other 
mechanisms that have been proposed include inhibition of PKB-mTOR 
pathway and increase in intracellular levels of calcium leading to AMPK 
activation (Figure 1.11).  
 
 
Figure 1.11 Regulation of autophagy by ER stress response activation.  
Activation of PERK pathway of ER stress response leads to transcriptional increase in 
components of autophagic pathway including LC3, ATG proteins. ER stress associated 
increase in intracellular calcium leads to inhibition of mTOR leading to activation of 
autophagy. ER, endoplasmic reticulum; PERK PKR-like eukaryotic initiation factor 2α 
kinase; ATF4, activating transcription factor 4; eIF2α, eukaryotic initiation factor 2 α 
subunit; AMPK, 5' adenosine monophosphate-activated protein kinase; PI3K, 
Phosphatidylinositol-4,5-bisphosphate 3-kinase; TSC,  tuberous sclerosis complex; 
mTOR, mammalian target of rapamycin; ULK, Unc-51 like kinase; ATG12, autophagy 
related gene 12; LC3, microtubule-associated protein 1A/1B-light  chain 3 
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Energy sensing. There are two different well described regulators of 
autophagy in response to nutrient depletion: adenosine monophosphate-
activated protein kinase (AMPK) and sirtuin 1 (Figure 1.12). 
 Nutrient depletion state is conveyed to mTOR through the nutrient sensor 
AMPK. Decreased ATP production in a state of energy depletion increases 
AMP:ATP ratio and activates AMPK. AMPK activation leads to inhibition of 
mTORC1 inhibition by activating phosphorylation of the tuberous sclerosis 
complex-2 (TSC2) [119] and inactivating phosphorylation of the regulatory 
associated protein of mTOR (RAPTOR) [120]. AMPK is also known to directly 
activate ULK1 by phosphorylation [121, 122]. 
Another important enzyme Sirtuin, product of gene SIRT1, a NAD dependent 
deacetylase, induces autophagy in response to environmental stress. Cell 
culture studies of various rat tissues have demonstrated that calorie 
restriction upregulates SIRT1 expression in brain, kidney, liver, WAT, and 
skeletal muscle [123]. It has also been demonstrated that SIRT1 is required 
for autophagy induction by starvation [124]. The components of autophagy 
pathway ATG5, ATG7 and LC3 are known de-acetylation substrates of 
Sirtuin1 [124]. Sirtuin1 also activates the transcription factor forkhead box 
O3a (FOXO3a) [125] which translocates to the nucleus and upregulates 
multiple autophagy related genes such as ULK2, BECN1, ATG12 and LC3 
[126]. Therefore, nutrient depletion states can activate autophagy through 
various mechanisms including Sirtuin1 and inhibition of mTOR. 
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Figure 1.12 Schematic diagram depicting regulatory role of energy sensing in 
autophagy activation.  
Nutrient depletion, via activation of AMPK leads to inhibition of mTOR and direct 
activation of ULK leading to activation of autophagic pathway. Nutrient depletion also 
leads to increase in Sirtuin which directly activates components of autophagic 
pathway and also activates transcription factor FoxO3a leading to upregulation of 
autophagy. AMP, 5' adenosine monophosphate; ATP, 5' adenosine triphosphate; 
AMPK, AMP activated protein kinase; PI3K, Phosphatidylinositol-4,5-bisphosphate 3-
kinase; TSC, tuberous sclerosis complex; mTOR, mammalian target of rapamycin; 
ULK, Unc-51 like kinase; ATG12, autophagy related gene 12; LC3, microtubule-
associated protein 1A/1B-light chain 3; FoxO3a, forkhead box O3a transcription 
factor. 
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1.4.2.2.3 Autophagy in adipose tissues and insulin resistance 
In the adipose tissue, autophagy has been identified as a key factor in 
various physiological functions including lipid metabolism, adipocyte 
development, modulation of inflammation and insulin sensitivity [127].  
Autophagy of lipid droplets (lipophagy) has been identified in hepatocytes 
[128] as one mechanism contributing to formation [129] and breakdown of 
intracellular lipid droplets [130]. In contrast, pharmacological inhibition of 
adipocyte autophagy leads to development of a phenotype resembling brown 
fat cells characterised by increased mitochondria and small multilocular lipid 
droplets [131]. Furthermore, adipose tissue-specific disruption of ATG7 in 
mice reveals that autophagy contributes to regulation of proportion of white 
and brown fat and determination of the final adipose tissue mass [132]. On 
a background of the increased autophagy activity that is known to occur 
during pre-adipocyte adipogenesis [133], autophagy appears to play an 
important role in adipogenesis. 
Autophagy in obesity has been investigated in four main studies of human 
adipose tissue, consistently demonstrating its upregulation with obesity 
[106, 134-136].   In a study comparing omental and subcutaneous adipose 
tissue depots from obese and lean individuals undergoing elective surgery 
[134], increased autophagy was identified in omental fat as compared to the 
subcutaneous depot and in obese individuals as compared to lean. This was 
characterised by increased protein abundance of ATG5, LC3 and ATG12-
ATG5 complex, increased mRNA expression for LC3 and ATG5, more 
autophagosomes identified by immunohistochemistry and increased 
autophagic flux.  Analysis following collagenase digestion demonstrated that 
increased autophagy gene expression was present in adipocytes as well as 
the stromal vascular fraction. In addition, a subgroup of individuals 
exhibiting insulin resistance demonstrated a relatively increased gene 
expression for autophagy markers. The findings of this study are consistent 
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with other previous human studies identifying increased autophagy in 
adipocytes from adipose tissue from patients with type 2 diabetes [135, 
137]. In studies of weight loss induced by bariatric surgery, gene expression 
for BECN and autophagosome formation [106] in adipose tissue were 
decreased after weight loss as compared to pre-bariatric surgery levels.  
Whilst human studies have consistently shown increased adipose tissue 
autophagy with obesity, high fat diet mice studies have not been consistent 
with studies reporting obesity-induced decreases [138], or increases, in 
autophagy [106, 107]. Whilst this highlights the potential limitation of small 
animal experimental models and the impact of possible variation in 
experimental conditions, such experimental models are, nevertheless, 
necessary for experimental studies of pathways and regulation. It has been 
proposed that obesity itself alters the regulation of autophagy in adipose 
tissue [106]. This was identified in a study of 40% caloric restriction in a 
mouse model of HFD as compared to lean mice fed a standard chow diet. In 
this model, caloric restriction in HFD mice was associated with an increase in 
markers of autophagy (increased Beclin and p62 protein). However, whilst 
Beclin and p62 decreased in HFD animals following caloric restriction for 15 
days, it led to an increase of the same autophagy markers in the adipose 
tissue of mice on chow. In the same study, mTOR protein expression 
decreased following caloric restriction in HFD mice and increased in mice on 
the standard chow diet.  
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1.4.2.3 Apoptotic cell death 
The term apoptosis was first used to describe a morphologically distinct form 
of cell death [139] which involves shrinkage and blebbing of cells, nuclear 
fragmentation with condensation of chromatin and phagocytosis of cell 
fragments without accompanying inflammatory responses.  
Various types of cellular stress stimuli have been shown to trigger apoptosis, 
including chemotherapeutic agents, irradiation, oxidative stress and ER 
stress [140]. Apoptosis can be commenced by any of various initiation 
pathways which all converge onto activation of enzymes called caspases. 
Synthesised and present constitutively as inactive proenzymes, upon 
activation caspases cleave various substrates in the cytoplasm and nucleus, 
eventually leading to the morphological features of apoptosis in the cell 
[141].  
Apoptotic cell death is an outcome of various preceding cellular or 
extracellular processes including ER stress [140, 142] (Section 1.4.2.1.3), 
inflammation and autophagy [141, 143]. This is due to modulation of the 
components of the various apoptosis initiation pathways through increased 
transcription or activation of pro- or anti-apoptotic constituents of a cell 
(Table 1.6). 
Apoptosis is known to play a major role in embryonic development and 
ageing. Whilst apoptosis is known to contribute to development of type 1 
diabetes by causing cell death of insulin secreting beta cells in pancreas, its 
role in the pathogenesis of metabolic disease is yet to be explained in detail. 
Apoptosis has been proposed to be relevant to adipose tissue remodelling 
[109, 144], fat cell turnover [34] and obesity associated liver disease [145, 
146]. Indeed, in parallel to increased ER stress and autophagy, consistently 
increased apoptosis markers have been found obese animal models. Any 
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modulation to the constitutive apoptosis mechanisms of body has the 
potential to programme the susceptibility of an individual to adverse 
metabolic outcomes.  
 
Mechanism of 
apoptosis activation 
Molecular pathway 
Interaction with other cell 
stress and inflammation 
pathways 
TNF receptor 
activation (Extrinsic 
pathway) 
TNF receptors: Fas 
stimulation 
Inflammation and TNF release 
Mitochondrial 
pathway (Intrinsic 
pathway) 
Mitochondrial release of  
Cyt-C, AIF and other 
factors 
Oxidative stress: release of Cyt-
C 
ER stress: upregulation of 
mitochondrial pathway [142], 
increase in intracellular Calcium 
Ratio of anti-
apoptotic and 
proapoptotic Bcl-2 
family proteins 
[147] 
Anti-apoptotic: Bcl-2, Bcl-
XL, and Mcl-1 
 
Pro-apoptotic: Bax, Bak, 
and BH3 domain only 
molecules 
UPR leads to CHOP induction and 
increase in proapoptotic factors 
[148]. 
JNK pathway activates 
proapoptotic factors [149] 
NF-κB, regulate inhibitor of 
apoptosis (IAP) [150] 
  
 
Table 1.6 Interaction of molecular pathways with apoptosis activation.  
Initiation of apoptosis depends upon balance between anti-apoptotic and pro-
apoptotic factors which are affected by several extrinsic mechanisms including 
inflammatory state, ER stress, oxidative stress and cytokines. 
TNF, tumour necrosis factor; ER, endoplasmic reticulum, UPR, unfolded protein 
response; JNK, c-Jun N-terminal kinase; NF-κB, nuclear factor kappa-B; Cyt-C, 
cytochrome C; AIF, apoptosis inducing factor; Bcl-2, B-cell lymphoma 2 
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1.4.2.4 Necrosis 
The morphological features of necrotic cell death are secondary to the loss of 
control of ionic balance leading to intracellular uptake of water, swelling of 
the cell and organelles and plasma membrane rupture leading to cellular 
lysis [151]. This lysis releases many intracellular constituents, attracting 
immune cells and provoking an inflammatory response. In the past, this 
process was considered to be unregulated. However, it is now known that 
necrosis is also regulated by signalling pathways. Death domain receptors 
including tumour necrosis factor receptor (TNFR1) and toll-like receptors 
trigger necrosis, in particular in the presence of caspase inhibitors 
[152].Other relevant mediators responsible for necrosis pathway initiation 
and propagation include reactive oxygen species (ROS) and increases in 
intracellular calcium.  
In obesity, the adipocyte cell death, which is considered to be the primary 
stimulus leading to macrophage localisation and activation [66] to regions 
described as crown-like structures (CLS), is considered to be the outcome of 
necrotic cell death. The precipitating processes that lead to adipocyte 
necrosis associated with CLS remain the focus of ongoing research [109, 
153].  
  
  43 
1.4.3 Interactions between inflammation, cell stress response and 
insulin action  
Insulin action is mediated through its transmembrane receptor which 
belongs to tyrosine kinase family. Amongst the large number of intracellular 
substrates of insulin receptor, tyrosine phosphorylation of insulin receptor 
substrate (IRS) proteins is a crucial step in mediation of insulin action. 
Multiple regulatory mechanisms involve inactivation of these IRS proteins as 
a means of decreasing the downstream effects of insulin action and thereby 
generating insulin resistance. Examples of such pathways relevant to 
metabolic inflammation include c-Jun N-terminal kinase (JNK), IKK (inhibitor 
of nuclear factor kappa-B (NF-κB) kinase) [73], PKC, TNFα activation and 
suppressor of cytokine signalling (SOCS).  Both JNK and IKKβ can be 
activated by exposure to cytokines such as TNFα [154], free fatty acids [58] 
(Section 1.4.3) and ER stress [155] 
1.4.3.1 JNK 
JNK is a stress activated kinase which belongs to the mitogen-activated 
protein kinase (MAPK) family. There are ten known isoforms and splice 
variants of JNK which are all derived from three genes JNK1, JNK2 and JNK3. 
Three different downstream outcomes of JNK activation with potential roles 
in inflammation and insulin resistance have been described (Figure 1.13). 
Activated JNKs cause inactivation of IRS by serine phosphorylation rendering 
the cell resistant to downstream action of insulin receptor activation [156]. 
Obesity in the HFD mice model leads to elevated JNK activity [157] and an 
absence of JNK1 results in decreased adiposity, significantly improved insulin 
sensitivity and enhanced insulin receptor signalling capacity. These results 
were also replicated in the ob/ob mice model [157]. Activation of JNK also 
transcriptionally controls cytokine release and multiple cellular processes like 
apoptosis, differentiation and proliferation through transcription factors 
including activating transcription factor 2 (ATF2) and activator protein 1 
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(AP1). This release of proinflammatory cytokines in response to JNK 
activation has been demonstrated in adipose tissue macrophages [158] and 
hepatic Kupffer cells [159].  
 
1.4.3.2 IKK 
In almost all animal cell types, a protein complex called NF-κB (nuclear 
factor kappa-light-chain-enhancer of activated B cells) controls transcription 
of multiple genes propagating cellular inflammation. In an unstimulated cell, 
NF-κB is an inactivated dimeric state bound to protein complexes called 
Inhibitor of κB (IκB). The dissociation of this IκB from NF-κB is brought 
about by an enzyme called IκB kinase (IKK). IKKβ is one of two catalytic 
subunits of the IKK complex.  
Figure 1.13 Depiction of the central role of JNK in development of insulin resistance 
and propagation of inflammation.  
Upon activation, JNK causes inactivating phosphorylation of IRS and activation of 
transcription factors ATF2 and AP1 lead to increased gene expression of various 
proinflammatory and proapoptotic genes. ER, endoplasmic reticulum; PRR, pattern 
recognition receptors; JNK, c-Jun N-terminal kinase; IRS, insulin receptor substrate; 
ATF2, activating transcription factor 2; AP1, activator protein 1  
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In cultured cells, activation of IKKβ attenuates insulin signalling, whereas 
IKKβ inhibition reverses insulin resistance [160]. As molecular mechanism 
for the development of this insulin resistance, cell culture experiments have 
identified that IKK activation leads to inactivating phosphorylation of IRS as 
a direct substrate [161, 162]. However, in comparison to JNK, the evidence 
of its in vivo physiological effects through this mechanism is less strong [39].   
As molecular mechanism of the development of this insulin resistance, 
inactivating phosphorylation of IRS as a consequence of direct substrate of 
IKK has been identified in cell culture experiments 
The primary mechanism of insulin resistance following IKKβ activation 
appears to be through induction of proinflammatory cytokines via the 
upregulation of expression of inflammatory components by NF- κB.  IKKβ 
over-expression in hepatocytes causes local and systemic induction of 
proinflammatory cytokines and systemic insulin resistance in absence of 
obesity [163]. Interestingly, IKKβ induced insulin resistance was fully 
reversed with neutralising antibodies against IL6 [163], implying a central 
role of the cytokine in the development of insulin resistance. Targeted 
disruption of hepatocyte IKKβ genes in mice led to decreased hepatic 
inflammatory cytokine expression and improved insulin action in liver tissue 
without improvement in systemic insulin sensitivity [164]. The above studies 
demonstrate that, whilst IKKβ is an important contributor to the 
development of obesity associated insulin resistance, inflammation 
modulation is the primary mechanism underlying its role (Figure 1.14). 
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JNK and IKK activation, therefore, promote development of insulin resistance 
in cells exposed to the metabolic and inflammatory stress of obesity by 
inhibiting intracellular pathways beyond insulin receptor activation and also 
by further exacerbating the proinflammatory state of the cell and its 
environment. 
1.4.3.3 Cluster of Differentiation 95 
Cluster of differentiation (CD95), also known as Fas, is a member of the TNF 
receptor family.  The primary role of this receptor is considered to be the 
regulation of programmed cell death through apoptosis. However, activation 
of CD95 receptor can also induce non-apoptotic signalling pathways including 
those of inflammation [165]. CD95 is known to be expressed in 
Figure 1.14 Schematic diagram demonstrating mechanisms of inflammation 
propagation and proposed mechanism of development of insulin resistance in 
response to IKK stimulation.  
Activated IKK catalyses removal of inhibitory IκB from NF-κB and the latter controls 
transcription of several inflammatory genes. IKK is also proposed to directly inhibit 
IRS. ER, endoplasmic reticulum; PRR, pattern recognition receptors; IRS, insulin 
receptor substrate; NF-κB, nuclear factor kappa-light-chain-enhancer of activated B 
cells; IκB , Inhibitor of κB; IKK, IκB kinase.  
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preadipocytes and adipocytes [166]. Intracellularly, CD95 is predominantly 
localized in the golgi complex and translocates to cell surface upon 
stimulation [167]. NF-κB directly regulates CD95 expression by binding to 
position 295 to 286 of CD95 gene promoter [168]. 
CD95 expression is markedly increased in the adipocytes from ob/ob and 
db/db mice as compared to controls and in the adipose tissue of obese and 
type 2 diabetic patients [169, 170]. In addition, CD95 deficient and 
adipocyte-specific CD95 knock out mice have both been shown to be 
protected from developing insulin resistance secondary to high fat diet 
feeding [170]. This was associated with reduced adipose tissue expression 
for inflammatory mediators such as IL6, TNFα, MCP1 and decreased plasma 
IL6 concentrations. 
In addition, adipose tissue CD95 has been shown to affect pathogenesis of 
hepatic steatosis. High fat diet in mice with adipocyte specific CD-95 
knockout demonstrate decreased steatosis, decreased liver ceramides and 
reduced activation of NF-κB [170]. In addition to promoting inflammation, 
the proapoptotic function of CD95 is considered significant in pathogenesis of 
NASH as a mediator of cytotoxicity in response to excess circulating free 
fatty acids [171]. CD95, therefore, is considered to be an important nodal 
point for interaction of cell stress pathways and inflammation with role in 
development of insulin resistance. 
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1.4.4 Summary of role of adipose tissue in obesity associated 
metabolic dysfunction 
The evidence presented so far demonstrates that adipose tissue is a dynamic 
organ and, in addition to its role as a store of excess fat in the body, it is a 
seat of multiple mutually interacting processes which regulate the state of 
metabolic inflammation and cell death. In the state of obesity, these 
pathways both influence the metabolic function of adipose tissue and 
promote a state of insulin resistance as witnessed in the MetSyn 
(Figure1.15). In order to study the developmental mechanisms of obesity 
associated metabolic dysfunction, it is important to examine the cell stress 
response pathways in the adipose tissue depots.  
 
  
Figure 1.15 Diagram summarising interaction of multiple cell stress pathways 
activated in adipose tissue during obesity and their collective effect on development 
of the metabolic syndrome and insulin resistance. 
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1.5 The liver 
The liver, the largest gland in the body, is central to the body’s metabolism 
of major substrates: carbohydrates, proteins, amino acids and lipids. 
Following absorption from the intestine, nutrients are delivered to the liver 
via the portal vein and, depending upon the state of the body’s energy 
levels, these nutrients are allocated to breakdown, storage, processing or 
distribution. A healthy and well-functioning liver is, therefore, important for 
maintenance of the entire body’s state of metabolic health by maintaining a 
balance between catabolic and anabolic processes. However, this mechanism 
is disrupted in disease states such as the MetSyn [172].  
The majority of cells (60-80%) in the liver tissue are hepatocytes which 
perform the metabolic functions of the liver including storage of triglycerides. 
The other cell types present in the liver tissue include Kupffer cells (resident 
macrophages), natural killer cells, T cells, sinusoidal cells and stellate cells.  
1.5.1 Non-alcoholic fatty liver disease 
Non-alcoholic fatty liver disease (NAFLD) is a term used to describe the 
accumulation of fat within the liver in absence of excessive alcohol use. 
Whilst there are other rare causes of its occurrence (such as amiodarone, 
Reye’s syndrome and corticosteroids), it is strongly associated with obesity 
and the MetSyn [173].First described in 1980 [174], NAFLD covers a 
spectrum of severity, ranging from asymptomatic accumulation of fat in the 
liver (hepatic steatosis), hepatic fat accumulation with features of 
inflammation (non-alcoholic steatohepatitis (NASH)) to the extreme of 
irreversible hepatic fibrosis and loss of liver function (cirrhosis). 
There is a large variation in the reported prevalence of NAFLD primarily 
owing to its asymptomatic nature and poor sensitivity of the diagnostic 
radiological tests, especially in mild cases [175].  In Western populations, 
the incidence has been reported at 20-30% of adults [176, 177]. The 
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prevalence and severity of the condition also varies with ethnicity, age and 
gender [177]. This is similar to known ethnic differences in other 
complications of overnutrition such as insulin resistance, diabetes and the 
MetSyn and it has been proposed that, like them, NAFLD is an outcome of 
interaction between a susceptible host and the environment of positive 
energy balance [178] . 
1.5.2 Relationship between NAFLD and insulin resistance 
Accumulation of fat in the liver, the hallmark of NAFLD, is strongly 
associated with all the components of the MetSyn [173]. Indeed, some 
authors have proposed that the presence of NAFLD should be included in the 
diagnostic criterion for the MetSyn [179]. NAFLD is present in 50-75% of 
people with type 2 diabetes and 76% of obese people and has been shown 
to predict insulin resistance independently from presence of obesity [180].  
Insulin resistance has been proposed to promote hepatic triglyceride (TAG) 
accumulation. The two main sources for hepatic TAG are dietary TAG, 
transported to the liver via chylomicrons, or as the outcome of intrahepatic 
synthesis using glycerol and fatty acids (Figure 1.16). The fatty acids 
required for this synthesis are either sourced from plasma as non-esterified 
fatty acids (NEFA) or newly synthesised within the hepatocyte by de novo 
lipogenesis (DNL). Whilst the hepatic uptake of NEFA is not regulated and is 
directly related to plasma NEFA concentrations, de novo lipogenesis is a 
precisely regulated process. Quantification studies in hepatic TAG 
accumulation in NAFLD have demonstrated that NEFA accounts for 59% of 
hepatic TAG, 26% from DNL and 15% from dietary sources [181].  
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Two molecular mediators of lipid metabolism, namely, sterol regulatory 
element-binding protein isoform 1c (SREBP1c) and carbohydrate response 
element-binding protein (ChREBP) are important in the regulation of 
hepatocyte lipogenesis. SREBP1-c, upon activation and transcription 
upregulation secondary to insulin action [182], transcriptionally upregulates 
most genes involved in DNL and TAG synthesis and decreases breakdown of 
fatty acids (β oxidation) [183, 184]. Therefore, through activation of SREBP-
1c, normal insulin action in hepatocytes leads to fatty acid build up, 
providing increased substrate for triglyceride synthesis. ChREBP is activated 
in hyperglycaemia [185] and, apart from upregulating production of 
enzymes of DNL, upregulates pathways of glycolysis (the process of glucose 
metabolism to pyruvate) and, thereby through the Kreb’s cycle, provides 
building blocks for fatty acid synthesis [186]. Hyperglycaemia, therefore, 
stimulates both glycolysis and lipogenesis by facilitating conversion of 
glucose to fatty acids in condition of energy excess.  
In the state of insulin resistance, the associated hyperglycaemia and the 
reactive increase in insulin concentrations lead to an unrestricted activation 
of ChREBP and SREBP respectively (Figure 1.17). This promotes DNL and 
Figure 1.16 Schematic diagram depicting regulation of hepatocyte lipid metabolism 
in response to blood glucose concentrations and insulin action. 
NEFA, non esterified fatty acids; ChREBP, carbohydrate response element-binding 
protein; SREBP, Sterol regulatory element-binding protein isoform 1c; VLDL, very low 
density lipoprotein. 
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inhibits β oxidation within hepatocytes and, hence, promotes the 
accumulation of triglycerides within the cell [187].Furthermore, increased 
plasma concentrations of NEFA, due to absence of insulin mediated 
suppression of hormone sensitive lipase in adipocytes, also leads to increase 
FA availability in the hepatocyte. Insulin resistance, therefore, promotes 
intrahepatic accumulation of triglycerides and development of hepatic 
steatosis.  
 
Accumulation of lipids within the liver has also been proposed to cause 
insulin resistance (Table 1.7). Inherited or acquired lipodystrophy [188, 
189], a condition characterised by loss or absence of adipose tissue resulting 
in redistribution of lipids to liver and skeletal muscles, is known to lead to 
insulin resistance [189].  Hepatic lipidomic analyses of human NAFLD 
patients have identified selective accumulation of free cholesterol, 
proinflammatory eicosanoids, diacylglycerides (DAG) and ceramides 
increasing with NAFLD progression [190]. Hepatic accumulation of DAG, an 
intermediate of TAG synthesis, strongly correlates with insulin resistance 
Figure 1.17 Lipid metabolism in hepatocytes in the state of insulin resistance. 
Insulin resistance leads to increase in hepatocyte triglyceride synthesis through 
increased delivery of NEFA and activation of ChREBP and SREP1c mediators. NEFA, 
non esterified fatty acids; ChREBP, carbohydrate response element-binding protein; 
SREBP1c, Sterol regulatory element-binding protein isoform 1c; VLDL, very low 
density lipoprotein. 
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[191], and has been investigated as a mediator of insulin resistance 
development [192]. Increased intracellular DAG leads to activation of 
hepatocyte protein kinase C (PKC) isoform ξ leading to inactivation of serine 
phosphorylation of IRS [193]. Furthermore, DAG upregulates inflammatory 
pathways via JNK and IKK (reviewed in [194]). Findings from several genetic 
studies with transgenic and knockout mice [193, 195-198] support these 
mechanisms.   
Lipid induced insulin resistance- Proposed mechanisms 
Steatosis     hepatic DAG activated PKCξ    inactivation of IRS 
Steatosis     hepatic DAG                          activation of JNK and IKK 
Steatosis  hepatic Ceramides                  inhibition of Akt/PKB 
Steatosis    hepatic Ceramides                        activation of JNK and 
IKK 
Steatosis  hepatic cholesterol, LPA, long chain fatty acyl-CoA 
Ceramides are a family of lipid molecules composed of sphingosine and a 
fatty acid. As a component of sphingomyelin, ceramides are found in all cell 
membranes. Increased accumulation of hepatic ceramides during hepatic 
steatosis is considered to be secondary to its upregulated de novo synthesis 
and salvage processes secondary to increased saturated fats [199], oxidative 
stress [200] or inflammatory stress [201]. Increased availability of NEFA to 
hepatocytes also increases the ceramide load to the cell. Apart from being 
structural components of the cell membrane, ceramides are also known to 
take part in lipid signalling. Studies in skeletal muscles have consistently 
demonstrated Akt/PKB inhibition as the mechanism of promotion on insulin 
resistance secondary to ceramides [202]. This is supported by in vitro 
experiments in cultured hepatocytes [203] and by in vivo experiments of 
inhibition [204] or promotion [205] of hepatic ceramide synthesis. 
Table 1.7 Table listing some of proposed mechanisms for development of hepatic 
insulin resistance in NAFLD.  
Hepatic DAG, ceramides, cholesterol and long chain fatty acyl-CoA accumulation in 
NAFLD have all been proposed to cause insulin resistance through inactivation of IRS 
or activation of inflammation. DAG, diacylglycerides; PKCξ , protein kinase C isoform 
ξ; JNK, c-Jun N-terminal kinase; IKK, Inhibitor of κB kinase; Akt/PKB, protein kinase 
B; LPA, lysophosphatidic acid. 
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Furthermore, ceramide accumulation promotes inflammatory cascades 
activation via JNK and IKK pathways [206].  
Other potential mediators of lipid induced hepatic insulin resistance are 
cholesterol, lysophosphatidic acid (LPA) and long chain fatty acyl-CoA [207].  
Experimental and epidemiological evidence, therefore, demonstrate that the 
presence of insulin resistance and NAFLD foster the development and 
progression of each other, thereby, advancing the metabolic derangements 
present in the state of obesity.  
1.5.3 Hepatic inflammation in obesity associated metabolic 
dysfunction. 
With advancing NAFLD, the histological features within hepatic tissue 
progress from lipid accumulation (steatotis) to cellular inflammatory 
changes, cellular infiltration, fibrosis and associated hepatocellular 
degenerative changes which have been called non alcoholic steatohepatitis 
(NASH). There are multiple operational criterion for histological diagnosis of 
NASH [178]. It is generally accepted that along with presence of 
inflammatory infiltrate, steatosis and ballooning degeneration of hepatocytes 
should be histologically demonstrated for a diagnosis of NASH [208].  
The inflammation seen in NASH has been demonstrated to be the outcome 
of multiple pathways extrinsic or intrinsic to the liver (Figure 1.18). Adipose 
tissues are key source of mediators contributing to hepatic inflammation.  
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1.5.3.1 Adipose tissue derived factors in hepatic inflammation 
Adipose tissue, particularly visceral adipose tissue, has been extensively 
studied as the source of hepatic inflammation.  Intra-abdominal fat is an 
established risk factor for development of metabolic derangements [209] 
and NAFLD [210]. Fat transplantation of tissue of subcutaneous origin to an 
intra-abdominal site in rodents has been shown to improve glucose 
homeostasis [211]. As described in Section 1.4, adipose tissue is capable of 
initiating a multifaceted inflammatory response in obesity. A time course 
study in HFD mice given a cholesterol-enriched diet for 6, 16 and 26 weeks 
duration demonstrated that macrophage and cytokine transcripts were 
upregulated in adipose tissue at 6-16 weeks before their appearance in the 
liver from 16-26 weeks after the start of the HFD and this was associated 
with macrophage infiltration within the liver at 16 and 26 weeks [212]. In a 
Figure 1.18  Sources of inflammatory processes witnessed in non alcoholic fatty liver 
disease.  
Adipokines and free fatty acids from adipose tissues in obesity are extrinsic sources 
of inflammation whilst processes intrinsic to liver including ER stress response, 
cytokines, oxidative stress and autophagy have all been demonstrated to collectively 
contribute to the activation and progression of hepatic inflammation.  
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study of obese human individuals (BMI>35kg/m2) undergoing gastric 
surgery, histological analysis from omental adipose tissue and liver 
demonstrated a significant association between omental macrophage 
accumulation and hepatic fibroinflammatory lesions.  
Adipose tissues are also capable of secreting a variety of substances capable 
of promoting hepatic inflammation. Dietary [213] and transgenic [214, 215] 
animal models have consistently confirmed the association of increased 
plasma free fatty acids with hepatic lipid accumulation. As discussed in 
Section 1.4.3, free fatty acids activate intracellular inflammatory cascades 
through activation of pattern recognition receptors including TLR4 and can 
also promote activation of ER stress. In addition, the effect of adipokines on 
liver has been extensively investigated. Leptin administration is associated 
with reversal of NAFLD and abnormal liver function in ob/ob mice [216], 
db/db mice [217] and humans with lipoatrophic diseases [218] following 
leptin administration [219].  However, studies of correlation of NAFLD with 
circulating leptin concentrations in humans have produced conflicting results 
[220-222]. In obese NAFLD patients, increased leptin concentrations have 
also been shown to correlate with the severity of hepatic steatosis, a 
phenomenon that has been attributed to leptin resistance [223-225]. The 
specific role and the mechanism of this adipokine action in hepatic 
inflammation and insulin resistance is, therefore, not yet fully elucidated 
[225]. Leptin’s role in NAFLD progression has been proposed to be the 
outcome of its multiple actions including its effects on innate and adaptive 
immunity [226], profibrogenic role [227] and decreased insulin sensitivity 
secondary to leptin resistance. 
Other adipokines, including adiponectin, resistin, TNFα and IL6, have also 
been proposed to contribute to the hepatic lipid deposition and inflammation 
seen in NAFLD (reviewed in [225]) 
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1.5.3.2 Interaction of hepatic inflammation and hepatic cell 
stress response 
1.5.3.2.1 Hepatic ER stress response and inflammation 
The hepatocyte ER is the main site for multiple simultaneous metabolic 
processes including synthesis and secretion of proteins, lipoproteins, very 
low density lipoprotein (VLDL) and cholesterol [108]. The hepatocyte ER 
stress response has been extensively studied in the context of NAFLD, its 
associated inflammation and insulin resistance [99, 228]. The studies 
investigating the directionality of the cause and effect relationship between 
NAFLD and ER stress response are summarised below.  
HFD and ob/ob mouse models of obesity exhibit upregulation of ER stress 
markers [99] along with features of insulin resistance and type 2 diabetes. 
In HFD mice, obesity and the induced ER stress response have been shown 
to precede JNK activation. Chromium picolinate is used as a dietary 
supplement by diabetics and acts by decreasing lipid uptake by hepatic cells. 
Administration of chromium to mice reduced hepatic lipid accumulation and 
decreased markers of ER stress associated with amelioration of insulin 
resistance in ob/ob mice. In human studies, hepatic GRP78 and p-eIF2α are 
decreased following weight loss after gastric bypass surgery [105].  
The above studies suggest ER stress response activation is the outcome of 
hepatic lipid accumulation.   
ER stress activation has also been demonstrated to promote hepatic lipid 
accumulation through several mechanisms. As discussed in Section 1.5.2, 
the aggregate liver lipid is the outcome of balance between lipid deposition 
and secretion from the hepatocytes. Activation of UPR leads to increased 
lipogenesis due to increased activation of SREBP and can override cholesterol 
mediated inhibition of SREBP.  Decreased protein abundance, a consequence 
of a decrease in generalised protein translation results in decreased ER 
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content of inhibitory protein product of insulin-induced gene 1 (Insig1) 
[229]. Due to its short half-life, the amount of Insig1 within ER decreases 
rapidly leading to activation of SREBP1 [230]. Hepatic lipogenesis is also 
increased due to increased PPARϒ with eif2α activation [98] (PERK pathway), 
decreased insulin sensitivity due to inhibition of Akt/PKB via the ATF4 (PERK 
pathway) [97], JNK mediated IRS inhibition (Section 1.4.3.1). Furthermore, 
attenuated global translation and ERAD also leads to decreased 
Apolipoprotein B synthesis. This contributes to hepatic steatosis due to 
decrease in VLDL secretion [231]. 
The above mechanisms have been tested in experimental models. 
Overexpression of GRP78 in cultured primary hepatocytes and ob/ob mice 
led to amelioration of ER stress, inhibition of SREBP1c activation and reduced 
steatosis [232]. This result is similar to treatment of ob/ob mice with 
chemical chaperones (4-phenylbutyric acid and taurine-conjugated 
ursodeoxycholic acid) which presumably improve protein folding which led to 
decreased ER stress response, improved insulin sensitivity and resolution of 
fatty liver [233].  Inhibition of eIF2α arm of UPR also improves steatosis and 
glucose tolerance [98]. 
The relationship between NAFLD and ER stress is bidirectional and the 
reciprocal fostering of each other promotes metabolic inflammation and 
derangement of cellular function. ER stress response, therefore, plays an 
important role in NAFLD and associated metabolic dysfunction. 
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1.5.3.2.2 Autophagy in the liver  
The process of autophagy has been identified as key to hepatic metabolism 
and its role in the development of NAFLD and metabolic diseases of obesity 
has been extensively investigated [234, 235].  
Autophagy contributes to normal hepatocyte lipid metabolism and it has also 
been proposed that lipid accumulation leads to a defect in the intracellular 
autophagic processes. Shibata et. al. demonstrated that a normal lipid 
droplet membrane contains several components of autophagic LC3 
conjugation system [129], a finding confirmed in subsequent studies [131] 
which also identified that starvation leads to transfer of lipid content from 
lipid droplets to autophagosomes and lysosomes. This autophagy of lipids 
has been termed lipophagy.  Defective lipophagy, secondary to ATG5 
knockdown or pharmacological inhibition, leads to excessive lipid 
accumulation within hepatocytes [236]. The presence of increased 
autophagic vesicles within a cell does not necessarily imply increased 
autophagic activity and may reflect a defect in autophagic processing and 
consensus criterion have been devised to differentiate one from another 
[237]. It has been proposed that hepatic lipid accumulation in HFD mice, by 
itself, leads to defective autophagic function contributing to decreased 
mobilisation of lipids into autophagic compartments in HFD mice facing food 
withdrawal [130]. Similar defective autophagy has also been demonstrated 
in other experiments of genetic (ob/ob) and dietary models of murine 
obesity [234]. 
Defective autophagy has also been demonstrated in association with 
increased hepatic lipid and glycogen deposition in the offspring of Wistar rats 
that underwent gestational nutrient restriction to 35% of metabolic 
requirements during late gestation (day 14 until birth) [238]. Intra uterine 
growth restriction (IUGR) secondary to prenatal nutrient restriction in this 
model was associated with decrease in hepatic autophagic vacuoles and a 
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decrease in the autophagic protein markers. When fed a high-fat diet until 
22 weeks, offspring of control rats showed enhanced autophagic activity in 
liver, whereas, the IUGR rats maintained lower levels of Atg7 and LC3B II 
and developed insulin resistance, liver steatosis and ER stress [238]. 
Normal functioning of cellular autophagic pathways is required for 
maintenance of cellular insulin sensitivity. In HFD mice, decreased Atg7 
expression precedes (16 weeks) the development of insulin resistance (22 
weeks) [234]. Suppression of autophagy in atg7-/-  mice model resulted in 
upregulation of ER stress and insulin resistance, whereas overexpression of 
atg7, achieved with an adenoviral delivery to the liver of ob/ob mice, led to 
improved glucose homeostasis, insulin action and amelioration of ER stress 
markers [234]. In addition, normal autophagic function, through its 
modulating role in immune system and apoptotic cell death pathways 
(Section 1.5.2.2) can affect hepatic functioning and insulin sensitivity.  
1.5.3.2.3 Intrinsic hepatic factors: cytokines, inflammation and 
oxidative stress 
Hepatic lipid accumulation by itself can promote inflammation by NF-κB 
activation and cytokine production as demonstrated by Cai and colleagues 
[239] in a HFD mouse model which had hepatic inflammatory cytokine 
profile similar to a transgenic mouse model of subacute hepatic inflammation 
produced by low level activation of NF-κB. Both these mice models had 
activation of NF-κB and its transcriptional targets along with increased 
hepatic insulin resistance as compared to lean and wild type controls. These 
effects were reversed in both models by repression of hepatic IκBα 
demonstrating that liver lipid accumulation leads to subacute hepatic 
inflammation through NF-κB activation and downstream cytokine production. 
The role of specific lipid intermediates such as ceramides and DAG has been 
discussed in Section 1.5.2.  
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The presence of oxidative stress in livers of patients with NASH has been 
identified with presence of oxidised lipids, proteins and DNA [240-242]. 
There are multiple possible sources of this oxidative stress including release 
of reactive oxygen species from uncoupled oxidative phosphorylation in 
mitochondria [243], peroxisomes [240] and inflammatory cells [244]. 
However, the role of oxidative stress as primary inducer of hepatocellular 
injury and dysfunction has not been convincingly demonstrated and 
antioxidants such as Vitamin E have been tried with limited improvement in 
the progression of established NASH [245]. It is believed that oxidative 
stress and/or cytokines are not likely to be the initiators of liver 
inflammation in NASH. However, it may have roles in insulin resistance and 
perpetuation of inflammation [246].   
In conclusion, hepatic inflammation in NAFLD is brought on by mechanisms 
originating in adipose tissue and by processes intrinsic to liver. Such obesity-
induced mechanisms interact with each other to propagate the inflammatory 
response, cause hepatocellular damage and dysfunction leading to 
development of the MetSyn and insulin resistance. In turn, insulin resistance 
also propagates the hepatic lipid accumulation and cellular damage of NAFLD 
causing a vicious cycle of disease progression. The cellular stress response of 
liver and adipose tissues is, therefore, central to the pathogenesis of the 
MetSyn. Modulation of this cell stress response through developmental, 
dietary or therapeutic means has the potential of altering an individual’s 
susceptibility to the MetSyn and this may be of great public health or clinical 
significance.  
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1.6 Developmental programming of insulin resistance and 
the MetSyn 
1.6.1 The concept of developmental programming 
Environmental conditions during the development of an organism can modify 
the evolution of a single genotype to many diverse structures, physical 
states and behaviours. Some of these environment-induced changes during 
early life (conception, fetal life, infancy and early childhood) can have a long 
term impact on later health and disease risk. Often such changes have 
graded and subtle effects which, by themselves, do not induce disease but 
can affect the predisposition to disorders including cardiovascular diseases, 
obesity, type 2 diabetes and osteoporosis [247]. This process by which 
changes in the genetic, epigenetic or phenotypic make-up of an individual 
are brought about as a response to environmental influences in early life is 
called developmental programming.  
The developmental origin of health and disease (DOHAD) concept focuses on 
the contribution of the environment during the earliest stages of human 
development to the pathogenesis of adult conditions. Following its 
introduction as the ‘fetal origin of adult diseases’ (FOAD) hypothesis by Hales 
and Barker in 1992 [248], this concept has evolved and has been supported 
by numerous epidemiological and experimental studies [68, 249-252]. 
Furthermore, it has become increasingly apparent that, along with the 
severity of the environmental stimulus, the outcome of the extent of this 
adaptation is dependent upon the timing of the stimulus with reference to 
the developmental stage, that is, there are critical windows of development 
of the organism [253]. 
It has been proposed that a developing organism makes physiologic 
adaptations in response to the environmental cues prevalent during such 
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critical windows of development. If the environmental conditions persist in 
later life, such adaptations, which have been called ‘predictive adaptive 
response’, would provide physiologic advantage to the individual. However, 
in case of a mismatch between adaptations made and the environmental 
factors existing during later life, such adaptations may prove to be 
detrimental for the individual and add to the predisposition to pathologic 
conditions.  
Evidence based on epidemiological studies, such as the Dutch famine cohort, 
has its own limitations. Health outcomes are typically multifactorial and may 
be influenced by interaction with the prevailing environmental conditions at 
the time of the study. Furthermore, the cohort also has progressively 
increasing loss to follow-up from 84% enrolment at initiation [254] to low of 
28% at the follow up in studies done in 2005 [255] increasing the risk of 
survivor bias. In addition, the timing of nutrient restriction during pregnancy 
was based on date of birth assuming a 40 weeks gestation of all 
pregnancies. This approach, along with retrospectively maternal 
undernutrition into trimesters increases the likelihood of improper 
classification of timing of undernutrition. It is known that IUGR is associated 
with preterm delivery and it is therefore likely that a proportion of newborns 
deemed IUGR at 40 weeks gestation were late preterm AGA infants. The 
statistical power of large epidemiological studies hopes to account for bias 
such as these. It is therefore important to attempt to replicate findings of 
epidemiological studies to well designed experimental studies of appropriate 
animal models.   
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1.6.2 The critical windows of development and nutritional 
programming 
1.6.2.1 Suboptimal nutrition during pregnancy 
Birth weight became the focus of investigations following the demonstration 
of a strong association between low birth weight and predisposition to the 
MetSyn and type 2 diabetes in several longitudinal studies [248, 256]. 
However, there are several factors that interact together to determine birth 
weight, such as placental efficiency, genetics, environment and maternal 
nutrition. Of these, the role of maternal nutrition during specific stages of 
fetal development, its contribution to birth weight [257] and the onset of the 
MetSyn became apparent from the follow up studies of survivors of the 
Dutch famine.  
During the German occupation of the Netherlands during the Second World 
War in 1944-45, there was an extreme shortage of food supplies in the 
western part of the country. This was due to a railway embargo on food 
supplies and made worse by inability to resume supplies due to frozen 
waterways during an unusually severe winter. As a consequence, the 
average food intake for pregnant women during this period was 
approximately 800-1000 kcal/d [258] in comparison to the recommended 
energy intake of 2,140 kcal/d [259, 260]. The offspring of these pregnant 
women were traced in their later life as part of the Dutch Famine cohort 
studies.  The unique nature and period (Nov 1943 to Jan 1945) of the calorie 
restriction during pregnancy enabled researchers to study the effect of 
suboptimal nutrition during each of the three trimesters of the pregnancy. 
The control groups for these studies were Dutch individuals born before the 
famine and individuals who were conceived after the famine (born between 
December 1945 and Feb 1947).  
In comparison to the control groups, offspring of mothers exposed to famine 
during their final trimester in utero had a reduced birthweight, whereas the 
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mean birthweight of the offspring of mothers exposed in their first or second 
trimester in utero was not reduced [258, 261]. In analyses performed at 50 
years of age, children born after exposure to the famine during the first 
trimester went on to have a higher rate of coronary heart disease and 
increased plasma lipids [262]. At the same age, offspring of the pregnant 
women exposed to famine during late gestation had impaired glucose 
tolerance [258]. This unique epidemiological study, therefore, identified the 
distinct impact of undernutrition during specific critical windows of 
gestational development on the offspring health.  
Another epidemiological study of developmental programming potential of 
decreased perinatal nutrition is that of the 1959-1961 Chinese famine. The 
‘giant leap forward’ campaign, initiated by the Chinese government in 1958, 
was an economic and social campaign aimed to rapidly transform the 
agrarian economy into a communist society through rapid industrialisation 
and collectivisation. However, during execution of the widespread changes, 
there was a sudden and severe fall in food grain production leading to severe 
famine. Follow up studies of children born during the periods during, and 
after, the famine identified that surviving adults affected by gestational 
undernutrition had a 3.1 times higher risk of developing the MetSyn [263] at 
the mean age of 44 years. This study, however, was unable to delineate the 
effects of exposure during specific gestational periods/ critical windows. 
The role of gestational undernutrition in developmental programming has 
been further explored in experimental studies. Offspring of pregnant sheep 
receiving 70% of recommended calorie intake during late gestation, and 
then exposed to a restricted, obesogenic environment, demonstrated insulin 
resistance identified by increased area under the curve during glucose 
tolerance tests (GTT) along with alteration of plasma lipid and protein 
profiles [264]. The findings are consistent with results of similar experiments 
in a small animal model [265]. Late gestation is the period of fetal 
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development characterised by rapid fetal weight gain and when endocrine 
functions linked to hypothalamic maturation are established [7].  Late 
gestational undernutrition in the sheep model has been identified to have a 
significant impact on the birth weight [266], control of energy metabolism 
[267] and, more specifically, on the development of adipose tissue in the 
offspring [268].  
Programming of adipose tissues in response to maternal undernutrition has 
also been investigated. In rats, moderate (50%) and severe (70%) prenatal 
caloric restriction programmes the offspring to greater fat deposition when 
presented with hypercaloric diet [269]. There is also evidence that a protein-
restricted diet during gestation also programmes susceptibility to obesity and 
alterations to glucose metabolism in adult rats and mice [270, 271]. In 
sheep, maternal nutrient restriction during the early period of gestation (28-
80 days gestation) increases adiposity and mRNA expression of UCP1 and 
peroxisome proliferator-activated receptor α (PPARα) alpha in the offspring 
at term [272].  In contrast, nutrient restriction during late gestation (115 
days gestation until term,~145 days) led to reduced fetal fat deposition and 
UCP1 expression in the offspring sampled near term (143 days gestation) 
[273]. By one year of age, however, the offspring had increased fat mass 
and were more likely to become glucose intolerant [274]. The variation in 
adipose depot size in response to nutrition during fetal and early postnatal 
growth demonstrates the susceptibility of adipose tissue to development 
programming during this period. Further experimental studies in offspring of 
sheep exposed to late gestational nutrient restriction have demonstrated 
altered adipose tissue inflammatory profiles [275]. 
The liver is also known to be vulnerable to developmental programming 
during early life. Among 50 human infants matched for gestational age, 
those born small-for-gestational-age (SGA) were found to have reduced liver 
and kidney (but not spleen) dimensions, as measured by ultrasonography at 
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birth [276]. The British Women’s Heart and Health study reported a small 
but consistent linear association between decreasing birthweight and adult 
age adjusted levels of markers of liver damage (alanine aminotransferase 
(ALT), gamma glutamyltransferase (GGT) and alkaline phosphatase (ALP)) 
[277].  
Animal experiments of nutritional manipulation with a low protein, isocaloric 
diet during late gestation in rats have shown that this induces structural and 
functional changes in the liver [278]. Maternal macronutrient restriction 
during mid-gestation followed by a postnatal obesogenic environment has 
also been demonstrated to promote hepatic lipid deposition and increased 
gene expression for hepatic PPARγ in sheep as early as one year of age 
[279].  
Existing human and animal studies, therefore, indicate that developmental 
programming during gestation, and more specifically during late gestation, 
could play a significant role in the long term metabolic health of an 
individual. Adipose tissue and liver have both been demonstrated to be 
susceptible to such programming through nutrient availability during this 
critical window of development.   
1.6.2.2 Early postnatal growth  
The association between the rate of infant growth with eventual glucose 
tolerance and obesity has long been recognised [280]. The growth 
acceleration hypothesis [281], formulated in 2004, proposed that the 
increased risk of adult metabolic and cardiovascular morbidity associated 
with being born small for gestational age (SGA) is a consequence of 
accelerated early growth.  
Early infant growth is determined by several factors including genetic, 
environmental and nutritional influences [282, 283]. However, during the 
first 30 days of infancy, the genetic contribution to growth is considered to 
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be minimal [283] whilst nutrition and the postnatal environment are more 
important. As a target of public health and clinical interventions for the 
prevention of long term adverse metabolic and cardiovascular consequences, 
nutritional interventions could, therefore, be used to modulate early growth. 
1.6.2.2.1 Epidemiological evidence 
The epidemiological studies describing the association between early growth 
rate and long term outcome are heterogeneous in their study subjects 
(preterm, growth restricted or term appropriate for gestational age (AGA) 
babies) and also in the duration of growth measurements [284-288]. A 
recent meta-analysis [289] of cohort studies (n=47661) addressed this by 
performing individual level analysis adjusting for sex, age and birth weight. 
For each 1 unit increase in weight standard deviation (SD) scores of the 
infant between 0 and 1 year age, the adjusted risk of childhood obesity was 
increased nearly twofold (odds ratio=1.97 [95% confidence interval (CI) 
1.83, 2.12]). The increase in adjusted risk for adult obesity for the same 1 
unit increase in infant weight SD scores was 23% (odds ratio=1.23 [1.16, 
1.30]). However, this is in conflict with more recently published Medical 
Research Council (MRC) retrospective cohort study of 64 year old surviving 
adults which concluded that greater weight gain in infancy and early 
childhood (birth to 2 years age) was associated with higher lean mass 
whereas greater weight gain in late childhood was associated with higher fat 
mass [290].   
A prospective birth cohort study [285] of 851 children measured fasting 
insulin sensitivity (homeostatic model, HOMA) and insulin secretion post oral 
glucose tolerance test at age 8 years. In this study, greater weight gain 
between birth to 3 years of age predicted lower insulin sensitivity and higher 
BMI and waist circumference.  
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Epidemiological studies, which can only demonstrate associations, are prone 
to bias and cannot exclude reverse causality. For example, reverse causality 
would mean that an obese individual was always predetermined to have 
higher weight gain and as a result have a larger appetite and more rapid 
weight gain even from birth. In order to address factors such as these, 
experimental studies are required. 
1.6.2.2.2 Experimental evidence 
Exclusive breast feeding and late weaning are both known to lead to slower 
weight gain as compared to formula fed infants or infants weaned earlier 
[291]. Identification of such different growth trajectories between breast and 
formula fed infants has led to development of new growth charts by the 
World Health Organization (WHO) to reflect their very different growth 
patterns [292].  
In this setting, the relative contribution of the type of feed offered and the 
early growth rate achieved was studied in a randomised controlled trials of 
preterm children [286] exploring the impact of type of feeding and early 
growth on  insulin resistance in adolescence. The study was divided into two 
trial arms. In the first, high energy preterm formula was compared with 
breast milk (banked breast milk donated by lactating women) and in the 
second, the milk feeds or supplements were randomised to high energy 
containing preterm formula or relatively low energy term formula. Fasting 
32-33 split proinsulin was used as a marker of insulin resistance and 
measured at adolescence. These trials demonstrated that the concentration 
of the fasting split proinsulin was lower in adolescence in those children 
receiving lower nutrition as compared to those children receiving a nutrient 
enriched diet. This indicates that the relative growth rate in early life was a 
risk factor for later insulin resistance in both breast milk and formula milk 
fed infants. In another prospective randomised controlled trial of infants born 
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SGA, faster weight gain in infancy was associated with greater fat mass in 
childhood [293]. 
Animal experiments using rodent models have used different approaches to 
alter the energy consumption during the early growth period. These 
interventions have included the use of maternal diet rich in lard through the 
suckling period [294] or by decreasing litter size soon after birth (typically to 
4-6 pups from 10-14 pups) leading to increased milk availability per pup for 
the offspring and thus faster early growth [295, 296]. These studies 
demonstrated predisposition in adult offspring to worse cardio metabolic 
outcomes such as raised systolic blood pressure associated with 
hyperinsulinaemia [294] and increased adiposity [296]. In another 
experimental study, manipulation of rat litter size to produce faster weight 
gain resulted in decreased insulin stimulated glucose uptake in adipose 
tissue accompanied by reduced intracellular insulin signalling (reduced 
GLUT-4, IRS-1 and PI3K expression, and Akt activity) [136]. These studies 
show that, in rats, early postnatal growth can modulate aspects of insulin 
sensitivity predisposing an individual to insulin resistance.  
It is, however, unclear whether this mechanism is an effect of developmental 
programming on insulin sensitivity or an indirect effect of increased 
predisposition to obesity.  
Rodent development is also significantly different from humans and other 
large mammals. The main differences between rodents and large mammals 
is the former have large litter sizes and differ in fetal organ growth rate and 
metabolic rate [297]. Importantly, the hypothalamic pituitary adrenal axis is 
immature at birth in rodents [298]. There have been very few large animal 
model experiments demonstrating the presence of metabolic consequences 
of nutritionally altered early growth and its impact on metabolic outcome in 
the adult. 
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1.6.2.3  Formula feeding and developmental programming 
A number of epidemiological cohort studies have explored associations 
between type of feed consumed by an infant and its long term programming 
impact on obesity, the MetSyn and type 2 diabetes. However, such 
population based studies comparing breast and formula feeding are difficult 
to interpret due to the inevitable presence of confounding factors of differing 
socio-economic background. There is also a likelihood of publication bias with 
studies showing no beneficial effect being less likely to be published. 
Formula feeding has been proposed to programme the development of 
obesity. A recent systematic review [299] analysed 61 studies comparing 
breast feeding to formula feeding and risk of later obesity. Of these, 28 
studies provided unadjusted odds ratio and 6 studies provided odds ratio 
adjusted for parental obesity, maternal smoking, and social class. The 
analysis reported that breastfed subjects were less likely to be defined as 
obese as compared to formula fed subjects (odds ratio: 0.87; 95% 
confidence interval [CI]: 0.85–0.89). The results remained significant in sub 
analysis of 6 studies with adjustment for confounding factors. These findings 
were similar to other published meta-analyses from different authors [300, 
301]. Another meta analysis which demonstrated a linear inverse 
relationship between the duration of breastfeeding and later offspring risk of 
overweight, that is, the longer an infant was breastfed, the lower was 
his/her risk of overweight status during childhood and adult [302], also 
suggests a protective role of breastfeeding against later obesity.  
There are no published studies investigating the association between formula 
feeding and MetSyn as a clinical definition. However, some studies have 
been published on the long term effects of breastfeeding on single 
components of the MetSyn. These studies differ in not just the inclusion 
criteria, but also in their methodologies. The WHO publication in 2007 [303] 
chose not to correct for current body weight as it considered that a modest 
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decrease in adult weight is unlikely to have an impact on the serum 
cholesterol levels of the individual. In contrast, the previously published 
meta analysis [304] included current weight along with BMI or ponderal 
index. Notwithstanding the methodological differences, both studies reported 
absence of a consistent association between feeding type and components of 
the MetSyn except a modest decrease in adult mean total cholesterol levels 
by around 0.18 mmol/L (95% CI: 0.06 to 0.30 mmol/L) in the breast fed 
group as compared to the formula fed group [304]. This decrease represents 
3.2% of the median adult cholesterol reported in the study (5.7 mmol/L).  
Few studies have evaluated the relationship between breastfeeding duration 
and later onset of type 2 diabetes [301]. Although breastfed subjects may 
be less likely to present with type 2 diabetes (pooled odds ratio: 0.63; 95% 
CI: 0.45–0.89)[305], other studies have reported no association between a 
surrogate marker of insulin resistance the homeostatic model (HOMA) index 
and breastfeeding duration [306].   
Differences in composition of breast milk and commercial formula milk have 
also been proposed to affect the later metabolic outcome of the infant. 
Factors such as milk cholesterol content, reduced milk protein 
concentrations, increased long-chain polyunsaturated fatty acids [307] and 
presence of hormones such as leptin, adiponectin and ghrelin [308] in breast 
milk have been investigated for their effect on long term appetite signalling 
and body composition of the adult individual.  
Nobili et. al. performed a retrospective analysis in 191 biopsy proven cases 
of children (3-18 years old) with NAFLD and demonstrated that, following 
correction for age, waist circumference, gestational age and neonatal weight, 
the odds of non-alcoholic steatohepatitis (OR: 0.04, 95% CI 0.01 to 0.10) 
and fibrosis (OR: 0.32, 95% CI 0.16 to 0.65) were lower in breastfed versus 
not breastfed infants [309]. However, another prospective study comparing 
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intrahepatocellular lipid content quantified through use of using magnetic 
resonance spectroscopy did not demonstrate any difference in hepatic lipid 
deposition between breast fed or formula fed infants measured at time 
points of median age of 13 days and between 6-12 weeks [310]. The same 
study also demonstrated absence of difference in adiposity between the two 
groups. However, with a small sample size of 7 subjects across 3 groups, 
this observational cohort study may not be sufficiently powered to detect the 
absence of a difference. Whilst various potential mechanisms have been 
proposed, there have not been any previous published experimental studies 
in a large animal model investigating the impact of formula feeding on the 
programming of the cell stress response and metabolic inflammation of the 
individual.   
1.7 Programming of the hepatic and adipose cell stress 
and inflammation response 
Whilst cell stress and inflammation have been widely studied as mechanisms 
for obesity-induced insulin resistance, the role of developmental 
programming in modulating cell stress responses has only been recently 
explored systematically. Sharkey et al. demonstrated in the sheep model, 
that early gestational nutrient restriction in the sheep model differentially 
alters ER stress response and inflammation in visceral (perirenal) adipose 
tissue and kidney [68]. The increased gene expression for ER stress was 
associated with raised inflammation and presence of CLS in the adipose 
tissue. This was also associated with increased pJNK in the adipose tissue. In 
another study [275], late gestation nutrient restriction led to increased CD68 
mRNA coupled with increased TLR4 gene expression.  
Nutrition during early life and its effect on early growth is a modifiable risk 
factor with great public health implications. Small animal models 
investigating programming of inflammation and the immune system have 
concentrated on maternal obesity [311]. Furthermore, studies investigating 
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nutritional programming have focussed primarily on brown fat development, 
hepatic growth factors, insulin sensitivity and ontogeny [312, 313]. 
Defective autophagy has also been demonstrated in association with 
increased hepatic lipid and glycogen deposition in the offspring of Wistar rats 
that underwent, gestational nutrient restriction to 35% of metabolic 
requirements during late gestation (day 14 until birth) [238]. There have 
been no other published large animal studies that have explored nutritionally 
mediated developmental programming of pathways of metabolic 
inflammation and cell stress response in omental adipose tissue and the 
liver. The experimental studies performed as part of this thesis explore the 
nutritional programming of this cell stress response to obesity in omental 
adipose tissue and the liver (Figure 1.19). 
 
  
Figure 1.19 Schematic diagram illustrating the proposed interaction of nutritionally 
mediated developmental programming stimulus in the pathogenesis of obesity 
induced metabolic syndrome and insulin resistance. 
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1.7.1 Experimental approach 
A robust experimental model, which permits controlled nutritional 
intervention during pregnancy and early life, allows ongoing monitoring of 
weight gain and physiological parameters, mimics human organ 
development and physiology and has precedence of experimental studies in 
hepatic and adipose tissues is required to optimally study the potential 
nutritional programming of the obesity-induced cell stress response and 
inflammation.  
1.7.1.1 The sheep as an experimental model for programming 
Randomised controlled studies which can control for confounding factors 
such as genetic predispositions and social status, designed to control for 
other risk factors such as parity, number of fetuses and gender are best 
placed to validate findings of epidemiological studies. However, since it is not 
possible to subject humans to highly invasive physiological or experimental 
procedures, it would not also be possible to elucidate the molecular biological 
mechanisms behind the outcome of the interventions. With use of animal 
models, it is possible to perform interventions in a targeted and controlled 
fashion and study the effects of these interventions. The outcome of these 
experimental studies has the potential to be translated to human 
applications through a step-wise process.  
In order to evaluate the mechanisms behind developmental programming, 
rodent, pig and sheep models have been extensively used. The sheep has 
many advantages as an experimental model.  At birth, the size of the 
offspring and the relative weight of the fetus to the mother are comparable 
in sheep. The ovine pregnancy is of longer gestation as compared to rodent 
models and the organogenesis and maturation stages of the fetus have 
largely been characterised [314].  The relatively longer gestation of sheep 
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pregnancy allows researchers to target specific stages of organ growth and 
development for nutrient manipulation. Furthermore, the gestational stages 
in sheep are comparable to humans and the late gestational period (110 
days to 148 days gestation) is similar to human third trimester of pregnancy 
and coincident with maximal fetal growth. The specific organ growth rate 
and fetal metabolic rate are very similar in sheep and humans and very 
different to rodents [297]. Importantly, the hypothalamic pituitary adrenal 
axis maturity is similar in sheep and humans through the late gestation and 
at the time of birth [298] which is not the case with rodent models. 
Experimental studies of maternal undernutrition during pregnancy performed 
in the sheep model have demonstrated effects on the fetus comparable to 
human IUGR with identifiable programming effects on insulin sensitivity 
[315]  and cardiovascular system [316] in later life.  
The ovine model also has some disadvantages. Unlike the rodent model, 
which has shorter gestation (21 days) and large litter size enabling a high 
turnover and generational studies, performance of such generational studies 
in sheep models would require extensive logistical and financial resources. 
Sheep have a cotyledonary placenta as compared to the discoid placenta in 
humans. Being a ruminant animal, the sheep uses volatile fatty acids (VFA) 
as main energy source as compared to glucose in humans. The VFAs (acetic 
acid, propionic acid and butyric acid) are metabolised differently in the liver. 
Propionic acid is the major source of hepatic gluconeogenesis, whilst acetic 
acid and butyric acid are utilised throughout the body as energy sources. 
Despite these differences, credible models of ovine obesity have been 
developed using programmes of manipulation in maternal diet, postnatal 
feeding and post-weaning activity [68, 267, 279]. The development of 
obesity observed in these models shows increased visceral adiposity which is 
believed to contribute to the development of a low grade chronic 
inflammatory state and obesity mediated metabolic comorbidities.  
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1.7.1.2 Omental adipose tissue characteristics 
An excess of visceral adipose tissue deposition is known to be associated 
with central obesity, insulin resistance and type 2 diabetes [29, 30].  Ovine 
omental adipose tissue is a major proportion of the visceral adipose tissue 
depot and is known to rapidly expands soon after birth, a characteristic, 
which could increase its succeptibility to nutritional programming influences. 
Macrophage cells have been identified in ovine fetal omentum as early as 72 
days of gestation whereas T cells have been identified at 140 days of 
gestation spots’ [69]. Adipocyte hypertrophy in omental, but not 
subcutaneous depot, in obese women was independently associated with 
dyslipidemia [317]. The numbers of CLS in omentum correlate with the 
severity of hepatic fibroinflammatory lesions [318] and liver fat content 
[319] as well as insulin sensitivity [320]). Several chemotactic cytokines are 
expressed at higher levels in omentum [321]. Omental adipose tissue 
possess distinct characteristics that make it an important subject for 
investigations into developmental programming of adult disease. 
1.7.1.3 Development of sheep omentum and liver 
Like humans, the sheep omentum is derived from cells of mesodermal origin 
(dorsal mesogastrium) in the early fetal period. During this period, it 
consists of a gelatinous membrane with evolving blood vessels and no 
differentiated adipose tissue [322]. However, the cells of immune origin can 
be identified as early as 72 days of gestation and these rapidly evolve into 
aggregates known as ‘milky spots’ [69]. These cells have been identified as 
macrophages. Adipocytes and T cells start appearing at around 125 days of 
gestation. At birth, the omentum measures approximately 230 x 90mm [69] 
and, following birth, the weight of the omental adipose tissue depot rapidly 
expands to 3 g/kg body weight by the age of 7 days and 10 g/kg body 
weight by the age of 28 days [323].  
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The earliest identifiable embryonic hepatic structure originates as a ventral 
outgrowth from the gut endoderm around the seventeenth day of ovine 
gestation and is called the hepatic diverticulum [324]. Hepatocytes, the 
principal cell type in the liver, and biliary epithelial cells are derived from the 
embryonic endoderm, whilst stromal cells, stellate cells, Kupffer cells and 
blood vessels, are of mesodermal origin and are incorporated as the 
diverticulum expands into the surrounding mesoderm. With rapid 
proliferation and differentiation, hepatic lobes are evident by the twenty first 
day and hepatic lobules with identifiable structures and endothelial cells are 
present by the thirtieth day. During fetal development, the liver assumes 
haematopoietic function until the last 2 months of gestation. The increase in 
liver size during the pregnancy follows a linear pattern all through the 
gestation until birth [325].   
1.7.1.4 Experimental approach  
The sheep model of obesity and nutritional intervention in early life permits 
measurement of maternal and offspring physical and constitutional 
characteristics, measurement of physical activity, assay of plasma 
metabolites and hormones, post-mortem adipose tissue depot size through 
Dual-energy X-ray absorptiometry (DXA) scan and direct weighing 
respectively, and genetic and molecular analysis of hepatic and adipose 
tissue. Such a comprehensive approach permits scrutiny of the physio-
pathological response to experimental intervention throughout the 
experimental study. The role of each study in the establishment of the 
experimental model is summarised in Table 1.8. 
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Process under investigation Physiological parameter 
Establishment of model of 
maternal undernutrition 
during late gestation, 
offspring nutrition during 
suckling period and post 
weaning obesity 
Maternal weight gain 
Mid intervention maternal paired plasma 
glucose, insulin, triglycerides and NEFA 
Offspring weight 
Relative weight gain during early infancy 
Physical activity measurement 
Offspring postweaning weight gain 
Absolute and relative organ weight 
Offspring metabolic outcome 
of experimental intervention 
Glucose tolerance test with timed glucose and 
insulin assay 
Plasma triglycerides, NEFA, cortisol and leptin 
assay 
State of adipose tissue 
metabolism and distribution 
Plasma leptin, triglyceride and NEFA 
measurement 
Dual-energy X-ray absorptiometry of adipose 
depots 
Adipose tissue depot weight 
Adipose tissue inflammatory 
response 
Plasma leptin assay 
Histological analysis for adipocyte hypertrophy, 
crown-like structure abundance, macrophage 
infiltration 
Immunohistological analysis for GRP78 (ER 
stress), IBA1 (macrophage markers) and 
phosphorylated JNK staining 
Gene expression studies 
Hepatic structural and 
metabolic outcome of 
experimental intervention 
Absolute and relative organ weight 
Hepatic triglyceride assay 
Hepatic thiobarbituric acid reactive substances 
assay for oxidative stress  
Histological analysis for features of steatosis 
and NAFLD 
Hepatic inflammatory 
response 
Histological analysis for features of NASH 
Gene expression analysis 
  
Table 1.8 Overview of experimental approach for study of hepatic and adipose tissue 
cell stress and inflammatory response to obesity and nutritional programming. 
NEFA, non esterified fatty acids; NAFLD, non alcoholic fatty liver disease; NASH, non 
alcoholic steatohepatitis; GRP78, 78kDA glucose regulated protein; JNK, c-Jun N-
terminal kinase. 
  80 
1.7.1.4.1 Gene expression 
In selecting the genes of interest for exploration of the cell stress response 
and metabolic inflammation, transcriptionally regulated genes relevant to the 
pathway were identified and experiments were performed only when the 
primers and the experimental products confirmed to the strict quality control 
criterion described in Chapter 2. Given above constraints, the following gene 
expression experiments were performed to investigate the effect of obesity 
and nutritionally mediated developmental programming in sheep liver and 
omental adipose tissues (Table 1.9):  
Process under 
investigation 
 Gene of interest 
Modulators and 
effectors of 
metabolic 
inflammation 
 CD95  
TLR4 
Leptin receptor (liver) 
Leptin (adipose) 
Adiponectin (adipose) 
Cell stress 
response 
Autophagy: components 
and regulators 
BECN1 
ATG12 
AMPK 
mTOR 
ER stress and UPR GRP78 
EDEM 
ATF4 
ATF6 
 
  
 
Table 1.9 Genes involved in regulation of development of insulin resistance by 
activation of cell stress response and metabolic inflammation 
CD95, cluster of differentiation 95; TLR4, toll-like receptor 4; BECN1, gene encoding 
Beclin1; ATG12, autophagy related gene 12; AMPK, 5' adenosine monophosphate 
activated protein kinase; mTOR, mammalian target of rapamycin; ATF4, activating 
transcription factor-4; ATF6, activating transcription factor-6; EDEM1- ER stress 
degradation enhancer molecule-1; GRP78, glucose-regulated protein 78. 
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1.8 Aims and hypothesis 
Experimental evidence from current research has demonstrated that the 
hepatic and adipose cell stress response and metabolic inflammation are 
important mechanisms in pathogenesis of obesity associated insulin 
resistance and the MetSyn. Research involving a large animal model 
describing the state of omental adipose and hepatic cell stress response in 
obesity related insulin resistance is lacking. 
Recent evidence also shows that the cell stress response and metabolic 
inflammation are susceptible to developmental programing. The potential 
roles of cell stress response and metabolic inflammation as mechanisms of 
developmental programming secondary to nutritional interventions in early 
life have also not previously been investigated. The studies described in the 
thesis aim to demonstrate the presence of activation of cell stress response 
in association with metabolic inflammation in important metabolic organs 
(liver and adipose tissue) and also to identify modulation of the cell stress 
response and metabolic inflammation in the presence of programming 
stimuli during critical periods of development.  
This thesis will investigate the following hypotheses: 
1. that the development of obesity in an ovine model will lead to 
activation of the cell stress response and metabolic inflammation in 
the liver and adipose tissue. 
2. that early life nutritional interventions during late gestation and the 
suckling period of infancy will independently programme the adaptive 
capacity of hepatic and omental adipose tissue cells making them 
susceptible to the cell stress response and metabolic inflammation, 
predisposing the individual to insulin resistance. 
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2 Materials and methods 
2.1 Experimental study design 
The Early Nutrition Programming Project (EARNEST, FP62007, #FOOD-CT-
2005-007036) is a large multidisciplinary investigation into long-term 
consequences of early nutrition on the metabolic health of an individual 
[326]. The experiments described in this thesis were performed on sheep as 
a component of the overall EARNEST programme. The animal experiments 
were done at the joint animal breeding unit, Sutton Bonington campus of the 
University of Nottingham (Nottingham, UK), by Dr S. Sebert under 
supervision of Professor M.E. Symonds and Dr D Gardner. All experiments 
were performed in accordance with the UK Home Office and the UK Animals 
(Scientific Procedures) Act (1986) and under licence and ethical approval 
from the University of Nottingham (Nottingham, UK).  
The nutritional intervention in sheep was performed across two generations: 
pregnant ewes and the offspring and the outcome variables were studied in 
the latter. The experimental treatments were undertaken in three stages: 
Fetal growth Nutritional intervention in twin bearing pregnant eves 
during late gestation (110 days until the birth of twin 
offspring at term) 
Early growth Early growth modulation of the offspring during the 
suckling period (birth to 90 days)  
Obesity  Post weaning environment of rearing of the offspring 
(age 90 days until 17 months).   
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2.1.1 Nutritional intervention in twin bearing pregnant ewes during 
late gestation 
Following ultrasound confirmation of twin bearing gestation at 75 days of 
gestation (dGA), 39 Bluefaced Leicester cross Swaledale ewes of similar 
body weights and age were selected for this study.  The energy 
requirements of the pregnant ewes was calculated as per the guidelines of 
Agricultural and Food Research Council (AFRC) published in the manual of 
energy and protein requirements in ruminants [2] which takes into account 
the body weight, gestational age and the expected energy utilisation for 
basal metabolism and fetal growth. All ewes were fed 40% concentrated 
pellets and 60% straw nuts (Manor Farm Feeds, Oakham, UK) and had 
unrestricted access to a mineral block to ensure adequate micronutrient 
supply. The ewes were randomised to one of three treatment groups which 
determined the amount of calories offered to them in the late gestation 
(110dGA to term; normal ovine term gestation period is 145±2 days) see 
Figure 2.1 
The ewes in the nutrient restricted (N) group received 60% of their 
calculated metabolic requirements (0.46 MJ/kg0.75 body weight at 110 dGA 
and 0.72 MJ/kg0.75 body weight at 140 dGA) for pregnant sheep during this 
period. The second group of ewes were given 100% of their metabolic 
requirements (R) and the third group were offered feed amounting to 50% 
more energy consumption than specified by the AFRC manual of the energy 
and protein requirements and hence consumed 150% of their metabolic 
requirements (1.15 MJ/kg0.75 body weight at 110 dGA and 1.80 MJ/kg0.75 
body weight at 140 dGA) which was the amount determined from previous 
experiments [266] with the same model of sheep allowed to feed to their 
appetite (A). 
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The feed consumption was monitored by daily weighing the leftover feed and 
ewes were weighed weekly before feeding and dietary requirements adjusted 
accordingly. On 130dGA, blood samples were taken from the jugular vein 
after an overnight fast (≥18h) and collected into 10 ml lithium heparin (LiH) 
and 10 ml ethylenediaminetetraacetic acid (EDTA) coated tubes. Plasma was 
separated by immediate centrifugation (10 min, 4000 g, 4°C) of the LiH 
tubes and all samples were stored in-80°C freezer.  
 
  
Figure 2.1Flowchart depicting prenatal nutritional intervention in the studies.   
Twin bearing pregnant ewes were fed a diet according to their metabolic 
requirements until 110 days of gestation following which they were randomly 
assigned to one of three diets until term (145 days). Nutrient restricted diet (N) 
meeting 60% of caloric requirements. Sheep fed to requirement (R) were offered 
100% metabolic requirements and calorie consumption was measured for sheep fed 
to appetite (A) who consumed 150% of the metabolic requirements.  Blood sample 
was taken to measure metabolic and physiological indices at 130 days of gestation. 
After birth the offspring were randomised to experimental conditions described in 
Section 2.1.3 
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2.1.2 Modulation of early growth of the offspring during the suckling 
period 
 
At birth the twin offspring were weighed and randomised to one of three 
groups (Figure 2.2). The first group consisted of twin offspring, both fed by 
their mothers thereby achieving a standard (St) growth rate for a twin 
during the suckling period. The offspring from the remaining ewes were 
raised separate from each other and were further randomised to one of two 
groups. One offspring from the twin pair was raised by their mother as a 
singleton without any competition for the mother’s feed from the twin, hence 
achieving a relatively accelerated (Ac – Accelerated growth; M- mother’s 
milk) rate of early growth whilst the twin of this offspring was fed with the 
standard formula feed Lamlac™ (Volac international, Royston. UK) giving the 
phenotype of formula (F) feeding during the early growth period. The 
constituents of the formula includes whey protein, vegetable oil and is 
supplemented with Vitamin A (50,000iu/L), Vitamin D3(6,000 iu/L), Vitamin 
E (100 iu/L), DL-metheionine and calcium carbonate. The details of the 
macronutrient composition of the formula milk are given in Table 2.1. The 
lambs were kept with their mothers for the first 48h to allow them to receive 
Figure 2.2: Schematic representation of experimental intervention during the 
suckling period.  
Following nutritional interventions to diet of twin bearing pregnant ewes (described 
in Section 2.1.1), the twin offspring were either both fed by their mothers achieving 
a standard rate of growth for a twin (St) or separated with only one of the twins 
reared with the mother with no competition for feed achieving an accelerated rate of 
early growth (Ac- Accelerated growth/M – mother fed) whilst the other twin 
randomised to be fed with the standard formula feed (F). 
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colostrum and reduce their risk of death. Once separated from their mothers 
to a barn, hand feeding with a bottle was initiated 4 times a day until they 
were able to use the feeder (Volac ewe 2™, Volac international, Royston, 
UK). The offspring of nutrient restricted and fed to requirement ewes were 
kept in separate barns. The shared Volac feeding system contained milk 
calculated for shared maximum intake of 1L/day/lamb. All offspring were 
weighed twice every week during the first month after birth and then weekly 
until the end of lactation at 3 months of age. 
 Ewe milk* Formula milk# 
Protein (%) ~5 4.8 
Fat (%) ~6 4.8 
Carbohydrate (%) ~4.8 4.1 
Energetic value (MJ/kg) 4.5 4.1 
2.1.3 Post weaning environment of rearing until early adulthood 
(age 90 days until 17 months) 
At 90 days of age, the offspring raised by their mother as twins were 
randomised to one of the two customised environments of rearing with an 
aim to alter the amount of physical activity and consequent development of 
the obesity phenotype. One group of offspring were allocated to an 
obesogenic (O) environment in a restricted barn with a stocking rate of 6 
sheep per 19m2. The other group offspring were raised in a field with a 
stocking rate of 6 sheep per 1125 m2 allowing unrestrained physical activity 
leading to development of a relatively lean (L) phenotype (Figure 2.3). The 
animals raised in the field for L phenotype were fed by foraging on grass and 
were given micronutrient supplementation. The animals in the restricted 
environment were given feed based on a mix of low (3kg/d straw nuts; 8.5 
MJ/kg) and high (800 g/d of concentrate pellets; 12.5 MJ/kg) energy dense 
food.  At age 15 months, their physical activity measurements were 
Table 2.1 Macronutrient content of ewe and formula milk.  
*, values as quoted by Park et. al and Dove et. al  [327 , 328] ; #, as quoted by 
company analysis (Volac International Ltd, Royston, UK). The formula milk is 
comprised of whey protein powder (as protein source), vegetable oil (as fat source), 
wheat gluten and lactose (as carbohydrate source) with added vitamins and minerals.  
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performed using a uniaxial accelerometer. Animals were weighed once a 
month and blood samples taken at 7 and 16 months of age. 
 
  
Figure 2.3: Schematic representation of post weaning environment of rearing until 17 
months of age.  
Following weaning at 90 days of age, the offspring were randomised to one of two 
experimental groups. Randomisation to a barn with a stocking rate of 6 sheep per 
19m2 restricted physical activity leading to an obesogenic environment (O) or 
randomisation to a field with a stocking rate of 6 sheep per 1125 m2 allowing 
unrestrained physical activity leading to development of a relatively lean (L) 
phenotype.  
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2.1.4 Overview of the factorial experimental designs 
The randomisation of the animals was performed into groups in such a way 
so as to maintain equity of gender distribution. The experimental animals 
were exposed to a combination of two of the three experimental treatments 
described above in order to study the interaction and the relative 
contribution of interventions in these developmental periods (2X2 factorial 
design experiment). Notably, out of 77 offspring, 6 offspring died of natural 
causes. Further details of the specific age and cause of death is not 
available. The animal deaths were not concentrated to a specific 
experimental group and is less than overall 10% animal death rate in 
previous studies [329, 330]. An overview of the factorial design is given in 
Table 2.2 with a flow chart depiction in Figure 2.4  
Maternal 
nutrition 
Early growth 
Post 
weaning 
environment 
Factorial study design 
Nutrient 
restriction/  
Fed to 
appetite 
 
 
Obesogenic/ 
Lean 
Prenatal nutrient restriction and the 
post weaning environment of 
rearing. 
Control group: fed to appetite and 
rearing in lean environment 
(Study 1, Chapter 3) 
Nutrient 
restriction/ 
Fed to 
requirement 
Suckling as 
singleton/ 
Being formula 
fed 
 
Prenatal nutrient restriction and the 
effect of formula feeding during 
early growth. 
Control group: Fed to requirement 
and feeding on mother’s milk. 
(Study 3, Chapter 4) 
Nutrient 
restriction 
Suckling as 
twin/ Suckling 
as singleton  
 
Rate of early growth during 
suckling following late gestation 
nutrient restriction. 
Control group: Suckling as twin. 
(Study 2, Chapter 5) 
  
Table 2.2: Table demonstrating interaction of prenatal and postnatal experimental 
conditions used in the factorial design of the experiments 
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Figure 2.4 Schematic representation of the sequential experimental intervention 
evolving into the three different experimental studies. 
Study 1; During the late gestation (110dGA to term) twin bearing ewes were fed to 
appetite (A) and following the suckling period (age 90 days) twin offspring were 
separated to either rearing in an environment restricting physical activity leading to 
obesity (A-O) or allowing physical activity where they remained lean (A-L). Twin 
bearing ewes were nutrient restricted to 60% of their caloric requirements during 
late gestation (N) and after weaning at 90 days age one of the twin offspring twin 
was reared in an environment restricting physical activity leading to obesity (N-O) or 
allowing physical activity where they remained lean (N-L). During the suckling period, 
the offspring were reared together with their mother in all groups. 
Study 2; Twin offspring of ewes restricted to 60% nutrient restriction (N) during late 
gestation were either separated and only one offspring fed to mother’s milk without 
competition achieving an accelerated rate of growth (Ac) or were both fed by the 
ewes achieving a standard rate of growth for a twin (St). All offspring were raised in 
obesogenic environment of restricted activity. 
Study 3; During the late gestation (110dGA to term) twin bearing ewes were fed a 
diet meeting 100% caloric requirements (R) and during the suckling period (birth to 
90 days) one twin was formula fed (R-F) while the other was fed by the mother (R-
M). Twin bearing ewes were nutrient restricted to 60% of their caloric requirements 
(N) and during the suckling period one twin was formula fed (N-F) while the other 
was fed by the mother (N-M). Following weaning, all offspring were reared in 
restricted obesogenic environment. 
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2.2 Blood sampling 
Blood sampling was performed in the pregnant ewes at 130 dGA and in the 
offspring at age of 7 and 16 months. A jugular intravenous catheter was 
surgically implanted under local analgesia and glucose tolerance test (GTT) 
was performed 24 hours after this. The blood samples were transferred to 
labelled EDTA and LiH tubes. Both heparin and EDTA samples were rapidly 
centrifuged at 2500g for 10 minutes at 4°C to obtain plasma samples that 
were then stored at -80°C until analysis. Two days after the glucose 
tolerance test, another 5ml blood sample was taken and transferred to LiH 
tubes for determination of plasma leptin and cortisol. The blood sampling 
and GTT was performed by Dr Sylvain Sebert. The results presented in this 
thesis were derived from analysis of raw data by the author.  
2.3 Tests for glucose tolerance and insulin resistance  
The term insulin resistance describes a state of decreased uptake of glucose 
by skeletal muscles and adipose tissues and also decreased inhibition of 
hepatic glucose production despite the presence of circulating insulin in the 
blood at physiological levels. A variety of experimental methods are 
employed to assess the insulin resistance and glucose tolerance levels in 
animal and human experiments.  
The hyperinsulinaemic euglycaemic glucose clamp test involves continuous 
infusion of a high dose of insulin (hyperinsulianemia) with an aim to achieve 
a steady state insulin level by suppressing the body’s endogenous insulin 
response. This is followed by infusion of a variable rate of glucose in order to 
estimate the amount needed to maintain (clamp) the blood glucose within 
the normal range (euglycaemia). A direct estimation of glucose disposal 
ability of the body performed by this method is labour intensive, time 
consuming and expensive [331] and the analysis performed at a 
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hyperinsulinaemic state is also not considered to accurately reflect the 
glucose and insulin dynamics in the physiological state [331].  
The second option is performing a glucose tolerance test by administering a 
glucose load through oral, intravenous or intraperitoneal routes and taking 
blood samples for plasma glucose and insulin at regular intervals. This test 
analyses an individual’s ability to initiate an insulin production response to a 
glucose load and the insulin resistant state of the tissues by measuring the 
rate of decline of the plasma glucose in response to this insulin surge [332, 
333]. As a marker of insulin sensitivity, GTT has been demonstrated to 
correlate well with the hyperinsulinaemic euglycaemic glucose clamp [331, 
333].  
A commonly used surrogate marker of insulin resistance is the calculation of 
the homeostatic model of insulin resistance (HOMA-IR) by using the values 
of fasting plasma glucose and insulin levels[334]: 
  HOMA-IR = glucose (
mmol
L
)  X insulin (
µg
L
) 
In human experiments, the outcome of HOMA-IR is normalised with a 
denominator of 22.5 which represented the expected normal insulin level for 
a normal fasting plasma glucose thus giving a value of 1 for an individual 
with normal insulin sensitivity. Both HOMA-IR [334] and GTT [331, 333] 
have been demonstrated to have a good correlation with the 
hyperinsulinaemic euglycaemic glucose clamp making the latter labour 
intensive, time consuming and expensive method superfluous [331] if the 
desired outcome is determination of relative insulin resistance.   
  
Equation 2.1: Equation for calculation of homeostasic model of insulin resistance 
(HOMA-IR) 
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2.3.1 Glucose tolerance test procedure and analysis 
This was performed in the offspring at the age of 7 and 16 months, 24 hours 
after surgical implantation of a jugular intravenous catheter. After overnight 
fast (≥ 18 hours), a baseline blood sample was taken and transferred to 
EDTA and LiH tubes. Following this a 0.5g/kg intravenous glucose bolus was 
administered to the sheep via the catheter and 5ml blood samples were each 
collected at 10, 20, 30, 60, 90, 120 minutes after the glucose bolus and 
transferred to labelled LiH and EDTA tubes, centrifuged and stored as 
described in Section 2.2.  
2.4 Plasma analyses 
2.4.1 Plasma glucose analysis 
Randox RX Imola auto-analyser (Randox laboratories, Crumlin, UK) and 
reagents were used to perform the plasma glucose quantification. 2 µl of 
plasma was mixed with 200µl of reagent containing glucose oxidase, 4-
aminophenazone, phenol and peroxidase and incubated at room temperature 
for 25 minutes. The optical density of the coloured complex was measured 
on a plate reader at 500 ηm. Results were compared to a single standard of 
5.49 mmol/L in a linear relationship. All the samples and standards were run 
in duplicate and the samples with a coefficient of variation <5% between 
experimental replicates were included. The analysis was performed by Dr 
Dellschaft and Dr Bloor at the School of Veterinary Medicine and Science, 
Sutton Bonington Campus, University of Nottingham. The results presented 
in this thesis were derived from analysis of raw data by the author. 
2.4.2 Insulin assay 
2.4.2.1 Enzyme Linked Immuno-Sorbent Assay (ELISA) 
ELISA is an immunoassay used to determine the quantity of a specific target 
protein in a plasma sample. A well plate is coated with antibody that 
specifically binds to the protein of interest. On addition of plasma to the well 
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plate, this capture antibody binds to the protein and retains the protein when 
the rest of plasma is washed off using a wash buffer. Non-specific binding to 
the well plate surface is prevented by its prior coating with another blocking 
protein which does not bind to the antibody. A second detection antibody, 
conjugated with biotin and specific to a different sequence present on the 
same antigen of interest (protein) is added to the well to form an antigen 
antibody complex with the protein of interest (see Figure 2.5). The biotin 
bound to the second antibody can forms a strong bond with streptavidin-
horseradish peroxidase complex. Following subsequent washing off with 
buffered saline solution, the amount of horseradish peroxidase remaining in 
the well is proportional to the antigen-antibody complex. The quantity of 
such residual horseradish peroxidase can be calculated by colorimetric 
assessment of the blue product when tetramethylbenzidine (TMB) is added 
to the wells which react with horseradish peroxidase. After a fixed incubation 
period, the reaction is stopped by addition of sulphuric acid and 
quantification performed by colorimetry. 
 
The Sheep Insulin ELISA kit (Mercodia, Uppsala, Sweden) contains 96-well 
plates in the kit which are coated with antibodies raised against sheep insulin 
Figure 2.5 Schematic diagram demonstrating the steps in sandwich enzyme linked 
immunosorbent assay (ELISA) 
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(capture antibodies). The reported detection range for the kit is between 
0.05 -3 ng/ml as specified in the product information sheet. To each well of 
the ELISA kit, 25 µl of plasma sample was added followed by addition of 50µl 
reagent containing detection antibody along with streptavidin-conjugated 
enzyme and incubated on orbital shaker for 2 hours. The plate was washed 
thoroughly using buffered saline and this was repeated 6 times following 
which the excess fluid was removed from the well plate by gently tapping it 
on absorbent paper. 200ul of TMB solution was added to each well and the 
reaction was stopped after 15 minute incubation with the addition of 50µl 
sulphuric acid (0.5mol/L). The optical density was measured on a μQuant 
plate reader (Bio-tek Instruments Inc., Potton, UK) at 450nm wavelength. 
The results were corrected in comparison to a blank (all reagents with 
distilled water as sample) and all samples were performed in duplicate and 
compared to standard dilution of the standard provided in the kit (0.1 – 2.5 
µg/L).  
2.4.3 Plasma lipid analysis 
The metabolic profile of all the animals was developed by quantifying the 
levels of plasma triglycerides and non-esterified fatty acids (NEFA).  
2.4.3.1 Plasma triglyceride and NEFA quantification procedure 
The plasma triglyceride and NEFA quantification procedures were performed 
on a Randox RX Imola auto-analyser (Randox Laboratories, County Antrim, 
UK) and using reagents provided by Randox. The plasma samples were 
thawed gently on ice and loaded into the auto analyser. The auto analyser 
completed a calibration before measuring each metabolite and all samples 
were analysed in duplicate. For samples with coefficient of variation higher 
than 5% between the duplicates, the analyses were repeated. The plasma 
triglyceride and NEFA quantification was performed by Dr Ian Bloor and Dr 
  95 
Neele Dellschaft. The results presented in this thesis were derived from 
analysis of raw data by the author. 
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2.4.4 Cortisol Assay 
2.4.4.1 Competition radioimmunoassay procedure 
The reagents which include antibody coated tubes, 125I labelled cortisol 
solution, standard solution containing 0, 1, 5, 10, 20, 50 nM concentration of 
cortisol were part of the Coat-A-Count Cortisol In-vitro Diagnostic Test Kit 
(Diagnostics products corporation, Siemens, Camberley, UK). The reported 
minimal level of detection of this kit is 5.5 nmol/L (information from product 
manual). 25µl of plasma or standards and 1ml of the kit solution containing 
125I labelled cortisol were mixed in each coated tube and incubated on a 
shaker at 37°C for 45 minutes. One extra tube without an antibody coating 
was also simultaneously treated with the kit solution to determine the 
background binding of the antibody to the plastic of the tube.  All the fluid 
was then aspirated without disturbing the coated inner surface of the tubes. 
The radioactive decay in tubes was measured for one minute in a gamma 64 
counter (Wizard 1470 automatic gamma counter, Perkin Elmer, Waltham, 
MA, USA). After correcting for the readings from the background binding 
tube, the counts per minute were plotted on the standard curve extrapolated 
from the log-linear graph derived from the standard dilution to determine to 
cortisol concentration in plasma. The measurement of the standard dilutions 
was carried out in duplicates and coefficient of variation of <10% was 
considered acceptable.  
2.4.5 Plasma leptin 
Plasma leptin concentration quantification was performed by the laboratory 
of Professor Keisler at the Department of Animal Science of the University of 
Missouri using the radioimmunoassay method developed by Delavaud [335].  
The principle behind this radioimmunoassay procedure is same as the one 
described in Section 2.4.4. The presence of plasma leptin and 125I isotope 
labelled leptin in the same solution leads to their competition for binding to 
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the leptin antibody in a ratio relative to their respective concentration. The 
heavier antigen antibody complex can be precipitated using polyethylene 
glycol and after removal of the unbound radiolabelled leptin, the radioactivity 
in the precipitated complexes in the tube can be measured using the gamma 
counter. The reported minimum level of detection limit for this assay is 0.3 
ng/ml. 
100µl of plasma or 50µl of standards (at concentrations of 1.7, 2.5, 5, 8, 15, 
40, 50, 80 ng/ml, in triplicates) were mixed with 50 μl primary rabbit anti-
ovine leptin antibody (1:1500, raised to establish this assay). The solution 
was brought to 400 μl with incubation buffer and incubated at 4°C for 24 
hours. 125I labelled leptin (100µl at 20,000 cpm) was added to this mixture 
and further incubated for 20 hours at 4°C followed by addition of 100μl ram 
anti-rabbit secondary antibody and further incubated for 1h. Addition of 2 ml 
4.4% polyethylene glycol 6000 (BDH Prolabo, VWR, Radnor, PA, USA) 
caused precipitation of the antigen-antibody complexes following which the 
unbound leptin in the solution was removed by aspiration. The radioactivity 
in the precipitate on the tube was measured using a Cobra II gamma 
counter (Packard Inc, Downers Grove, Australia) and concentration of leptin 
calculated by extrapolation from the log-linear graph made from the 
standard dilution.  
2.5 Physical activity measurement 
In order to study the impact of the environment of rearing and also of the 
programming influence of the experimental interventions, an accelerometer 
was used to measure the spontaneous physical activity of the animals to 
reflect both the occurrence and intensity of movements [336] and used as a 
proxy for energy expenditure by bodily movements as previously described 
[337].  
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2.5.1.1 Uniaxial accelerometer  
Actiwatch (Actiwatch, Linton instrumentation, Diss, UK; now Camntech Ltd., 
Cambridge, UK) is a piezo-electric accelerometer which records intensity, 
amount and duration of movement in all directions. The actiwatch 
accelerometer was attached around the neck of each sheep using a collar 
and care was taken to avoid causing pain or distress that could otherwise 
affect their movement. The sheep were returned to their allocated 
experimental environment to resume their daily routine. The measurements 
were made in the offspring at age 45 days and again at age 15 months over 
a continuous period of minimum 48 hours. In order to rule out any potential 
impact of handling on the physical activity, data from a 24 hour period from 
the day 2 of the experiment was used (see Figure 2.6). 
 
  
Figure 2.6: An actogram demonstrating graphical representation of the physical 
activity data over a period of 48 hours. The data from day 2 of the recording (indicated 
by the red box in the figure) were analysed to rule out any potential impact of 
handling on the physical activity recordings. 
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2.5.1.2 Physical activity data analysis 
The data analysis was performed by me in collaboration with Dr. Charlotte 
Burton, a BMed Sci student who worked under my direct supervision The 
actiwatch data was downloaded and analysed using the activity and sleep 
analysis 7 software (CamNtech ltd, version 7.43). The intensity of activity 
was measured in a unit called counts and at a sampling frequency of 32 Hz, 
the actiwatch measured any movement greater than 0.5g and the maximum 
value was recorded as the count for that second. An epoch is a period 
defined by the user for purpose of logging the activity data. Thee individual 
counts from every second during that epoch were totalled and gave a value 
for the activity score. An epoch length of one minute was chosen and data 
generated for a continuous 24 hour period. The data of physical activity for 
every minute over the 24 hour period was thus used to calculate three main 
variables to describe the physical activity phenotype:  
 mean activity over 24 hour period 
 peak activity over 24 hour period 
 duration of mobility over 24 hour period 
2.6 Postnatal growth and adipose depots analysis 
Body weight measurements were taken using standard weighing scales 
every 3 days during the first month including birth weight and then every 
seven days up until 90 days of age and monthly thereafter until the 
completion of the study. 
Dual X-ray absorptiometry (DXA) scan was performed at 16 months of age 
in sedated sheep (intravenous ketamine and xylazine) and scanned for 15 
minutes using Lunar DPX-L bone densitometer (Lunar, Florida, USA). DXA 
analysis provided the measurements of overall bone densitometry, fat mass 
and fat free mass in the body. Whole carcass chemical analysis in 14 
representative animals was also performed following tissue sampling to 
validate the DXA findings. Following DXA scanning, half carcasses were 
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macerated and dried. Nitrogen content and fat percentage analysis was 
performed on 250g of homogenised tissue from the carcass using a 
FlashEA1112® nitrogen analyser (Thermo Scientific, Massachusetts, USA) 
and Gerhardt Soxtherm 406 fat analyser (Wolflabs, York, UK). These 
experiments and measurements were carried out by Dr Sylvain Sebert. The 
results presented in this thesis were derived from analysis of raw data by the 
author.    
2.7 Euthanasia and tissue sampling  
At 17 months of age, all offspring were fasted overnight and humanely 
euthanased in the morning by electrical stunning and exsanguination. All 
major tissues, glands, adipose depots and organs were immediately 
dissected from the animal, weighed and ‘snap’ frozen in liquid nitrogen 
before storage at -80°C. In addition, a sample of the omental adipose tissue 
was fixed in 10% formalin for histological analysis. 
2.8 Tissue analysis 
All chemicals, reagents and laboratory procedures were assessed and 
implemented in compliance with the UK Health and Safety Executive’s 
Control of Substances Hazardous to Health (COSHH, SI No. 1657, 1988) and 
Risk Assessment guidelines. Unless otherwise specified, all laboratory-based 
techniques and protocols were conducted within the Department of Academic 
Child Health, School of Clinical Sciences, Division of Human Development, 
University of Nottingham and the School of Veterinary Medicine and Science, 
Sutton Bonington Campus, University of Nottingham. 
All samples were kept stored in –80°C freezers to preserve sample integrity 
and kept on dry ice whenever in transit for sampling or processing. The 
tissues from all experimental groups were kept in separate doubly labelled 
bags. The chopped pieces of tissues were allocated random numbers and the 
experimenter was blinded to the experimental groups whilst performing the 
  101 
tissue processing to avoid any bias during analysis.  In order to eliminate 
chances of contamination, all the experimental work was performed using 
autoclaved or sterile equipment, including filter pipette tips, whilst wearing 
gloves. The work benches and equipment were cleaned with ribonuclease 
(RNase) Zap® (Ambion, California, USA) and 70% denatured ethanol 
(Ecolabs, Surrey, UK). Sterile nuclease free water (Ambion, Inc UK) was 
used for all the gene expression quantification experiments. 
2.8.1 Triglyceride analysis 
This procedure was performed in two mains stages, lipid extraction and then 
triglyceride analysis. Folch’s method of lipid extraction [338] is a commonly 
used procedure to separate the lipid content of a tissue from the non-lipid 
cellular component. As the tissues are homogenised in presence of a 
chloroform-methanol solvent, the lipid component dissolves into the 
chloroform and can then be separated from the cellular debris by process of 
filtration. Addition of 0.9% saline to this solvent to give a ratio of 8:4:3 of 
chloroform: methanol: saline leads to separation of the liquid into 2 phases 
with the lipids at the bottom phase and non-lipid organic (hydrophilic) 
molecules in the upper phase. After siphoning off the upper phase, the lipids 
in the lower phase can be precipitated by evaporating the solvents under air 
stream. 
Triglyceride form 98% of the lipid contents. The Randox triglyceride analysis 
kit uses colourimetric reaction with a principle similar to the plasma 
triglyceride analysis described in Section 2.4.3. The enzymatic reactions first 
use lipases to break down triglycerides to glycerol and fatty acids. The 
glycerol is then converted to glycerol-3 phosphate using the enzyme glycerol 
kinase in presence of ATP. Upon oxidation of the glycerol-3-phosphate, 
hydrogen peroxide is formed which can be used to create quinoneimine, a 
coloured chromogen.  
  102 
2.8.1.1 Triglyceride extraction and analysis procedure. 
150mg of liver from each animal was kept on ice in a 2ml of 2:1 Chloroform: 
methanol mixture and quickly homogenised using Dispomix homogeniser 
(Medic Tools, Zurich, Switzerland) for 40 seconds. This was then centrifuged 
at 550g for one minute at room temperature followed by gentle agitation for 
20 minutes using an orbital shaker at room temperature to ensure adequate 
exposure of homogenised tissue to the chloroform in the solvent.  The 
cellular debris was removed by passing the homogenate through 24 cm filter 
paper (Whatman Ltd., Banbury, UK) under gravity and filtrate collected into 
a 15ml tube.  The tubes and the filter paper were washed with 8 ml 
chloroform to dissolve any remaining lipids. This was followed by 
centrifugation of the filtrate at 800 g for 10 minutes after adding 2ml 0.9% 
saline for separation of the lipids into the bottom phase. After removal of the 
upper aqueous phase by pipetting, 2ml of the bottom lipid phase was 
transferred to 2ml eppendorf tubes and the liquid evaporated using nitrogen 
stream from Driblock DB-3 (Techne). The evaporated samples were re-
dissolved in 100µl of (60:40 v/v) tert-butanol -Triton X-100 (BDH). 
The triglyceride analysis was performed using Randox trigyceride assay kit 
using a method adapted from the manufacturer’s instructions. The analysis 
was performed in duplicate and results with more than 5% coefficient of 
variance repeated. In a 96 well plate (Grenier Bio-one, Gloucestershire, UK), 
200µl of the enzyme reagent was added to 2µl of sample, standard or 
negative control and incubated at room temperature for 5 minutes for colour 
development. The spectrophotometry analysis was performed on µQuant 
plate reader at 500nm. The results were expressed as triglyceride in 
micrograms per milligram of the liver tissue. 
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2.8.2 Thiobarbituric acid reactive substances (TBARS) 
Oxidative stress in tissues is difficult to measure directly especially because 
reactive oxygen species (ROS) have very short half-life [339].   The free 
radicals (superoxide O2 – or hydroxyperoxyl HO2.) combine with a hydrogen 
atom from the fatty acid chain to make water and a fatty acid radical. These 
fatty acid radicals react with oxygen and form peroxide radical. The peroxide 
radical creates more fatty acid radicals and forms lipid peroxide in the 
process (Figure 2.7) Some of these fatty acids are sourced from cell 
membranes and hence damage the membrane integrity.   
 
  
Figure 2.7: Mechanism of lipid peroxidation 
Free radicals combine with a hydrogen atom from the fatty acid chain to make water 
and a lipid radical. These lipid radicals react with oxygen and form peroxide radical. 
The peroxide radical reacts with another hydrogen atom form a fatty acid and in the 
process creates more fatty acid radicals and forms lipid peroxide. 
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TBARS such as malondialdehyde (MDA) are formed as a stable byproduct of 
this lipid peroxidation which also cause DNA damage. The TBARS react with 
thiobarbituric acid to give a fluorescent red derivative that can be assayed 
spectrophotometrically [340]. The method is commonly used as an analysis 
for lipid peroxidation [341] and has been used as a marker for liver oxidative 
stress [342] in models of non alcoholic fatty liver disease (NAFLD) [343]. 
The assay principle is based on an adduct formation after the reaction 
between MDA and thiobarbituric acid (TBA). The MDA-TBA adduct formed 
from the reaction of MDA in samples with TBA can be measured 
colorimetrically [344]. 
2.8.2.1 TBARS procedure 
This was performed using OxiSelectTM TBARS assay kit [344] (Cell Biolabs, 
California, USA), which included the MDA standards used to prepare dilutions 
ranging from 0-195 mg/dl . Liver tissue weighing approximately 100mg was 
sampled from the frozen tissue and care was taken to prevent thawing by 
keeping on dry ice and transferring to ice before homogenisation in 1ml of 
1X butylated hydrotoluene (BHT) kit reagent and phosphate buffered saline 
(PBS). The samples were centrifuged for 1 minute at 2000g and the 
supernatant transferred to 1.5ml labelled eppendorf tubes. To ensure 
complete removal of cell debris, this was followed by repeat centrifugation at 
10000g for 5 minutes at 4°C.The supernatant was stored at -20°C until 
further use for protein quantification or TBARS assay. 
For TBARS quantification, 100µl of the supernatant, MDA standards or 
negative control (distilled water) was added to a fresh 1.5ml eppendorf tube 
and 100μl of sodium dodecyl sulphate (SDS) lysis solution was added to 
each tube and incubated at room temperature for 5 minutes. This was 
followed by addition of 250μl of TBA and the tubes were incubated in a water 
bath at 95°C for 60 minutes, after which samples were removed and cooled 
on ice for a further 5 minutes. The tubes were centrifuged at 1200g for 15 
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minutes and 300μl of supernatant transferred to a fresh eppendorf tube. 
300μl of n-butanol was next added to the samples and vortexed for 2 
minutes and centrifuged for 5 minutes at 10000g at room temperature to 
allow for phase separation. The top layer containing n-butanol was pipetted 
to another eppendorf tube. In a 96 well plate, 200µl of samples and 
standards were pipetted and spectrophotometric analysis done at 
wavelength 532nm using µQuant plate reader. The sample concentrations 
were calculated from the standard curve prepared from MDA standards 
provided in the kit and normalised against total protein concentration 
calculated using bicinchonic acid (BCA) method and expressed as TBARS μM 
/total protein concentration (μg/μl).  
2.8.2.2 Bicinchonic acid (BCA) total protein determination 
The BCA assay for determination of total protein concentration in a solution 
[345] involves reaction between proteins, BCA and copper sulphate. In a 
temperature dependent reaction, the peptide bonds in a protein reduce 
Cupric (Cu2+) to Cuprous (Cu+) ions. The amount of Cu+ ion is proportional 
to the amount of protein present in the solution which can be quantified by 
the colour of the product of reaction between BCA and Cu+.  
2.8.2.3 BCA assay procedure 
In distilled water, a w/v solution of 1% bicinchonic acid, 2% sodium 
carbonate, 0.16% sodium tartrate and 0.4% sodium hydroxide was 
prepared. The pH was brought to 11.25 with 10% sodium bicarbonate and 
this was labelled as reagent A. Reagent B consisting of 4% (w/v) copper 
sulphate solution in distilled water was freshly prepared. Reagent C was 
prepared by mixing reagents A and B in a ration 50:1 and stored at 4°C until 
needed. 
The reference standards were prepared by making serial dilutions of bovine 
serum albumin (BSA) in 0.9% saline ranging from 0 to 1.0mg/ml. Aliquots of 
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the supernatant stored at -20°C during TBARS quantification (Section 
2.8.2.2) containing protein was diluted 1:20 in 0.9% saline. In a 96 well 
plate, 200µl of reagent C was pipetted and to this 10µl of each sample, 
standards and negative control were added in duplicate. This was incubated 
on an orbital shaker at 37°C for 30 minutes for colour development and 
spectrophotometric absorbance was measured at 562nm. Samples were 
repeated if the coefficient of variance was more that 5%.   
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2.9 Gene expression analysis 
2.9.1 Ribonucleic acid (RNA) extraction 
Prior to RNA extraction from biological tissues, steps of tissue lysis and 
homogenisation were performed in a guanidine-isothiocyanate containing 
buffer, which ensures intact RNA through immediate inactivation of RNases 
and also dissolves all proteins in the homogenised tissue. This method is 
adapted from the published and widely used single step acidified phenol-
chloroform homogenisation method [346, 347].  Addition of chloroform to 
the homogenised tissue in the buffer followed by centrifugation leads to 
formation of three phase layers. The RNA is dissolved in the top aqueous 
phase followed by the DNA interphase. The bottom organic phase holds the 
dissolved proteins. Purified RNA can be extracted from the top aqueous 
phase after ensuring elimination of genomic DNA (gDNA) by passing the top 
aqueous phase through a gDNA eliminator spin column. 
2.9.1.1 RNA extraction procedure 
Tissue samples (weighing between 100 – 150 mg for liver tissue and 450-
525 mg for adipose tissue) were added to labelled containers containing 1 ml 
TRI® reagent (Sigma Chemical Co. Poole, UK). The samples were 
homogenised using a Dispomix homogeniser (Medic Tools, Zurich, 
Switzerland) at 300rpm for 40 seconds and then centrifuged at 550g for 1 
minute to ensure the homogenate settled to the bottom of the tubes.  
An additional lipid removal step was incorporated for adipose tissue at this 
stage. The dispomix tubes containing the homogenised adipose tissue was 
incubated for 2 minutes in a water bath at 37°C to break down the lipid 
content and again centrifuged at 1800 g for 1 minute. Following this, the 
supernatant from the adipose tissue or the complete homogenate from the 
liver tissue was transferred to 2ml eppendorf tubes. To this tube, 200μl of 
analytical-grade chloroform (Fisher Scientific, Leicestershire, UK) was added, 
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mixed by vortexing and then incubated for 15 minutes at room temperature 
to allow phase separation following which, this was subject to centrifugation 
at 12000g for 15 minutes at 4°C and the top aqueous phase was used for 
next steps of RNA purification and extraction. 
RNA purification and extraction were performed using RNeasy Plus mini 
extraction kit (Qiagen, West Sussex, UK). The top aqueous phase was 
transferred to a gDNA Eliminator spin column from the RNeasy plus kit and 
centrifuged at 8000g for 30 seconds. An equal volume of 70% ethanol was 
added to the flow-through liquid to provide appropriate binding conditions to 
the RNA centrifuge column. All of the mixture was transferred to an RNAeasy 
spin mini column and centrifuged at 8000g for 15 seconds at room 
temperature. The flow through was discarded and to each column , 700μl of 
RW1 buffer (containing guanidine isothiocyanate and 70% ethanol) was 
added and centrifuged for 15 seconds at 8000g followed by addition of buffer 
RPE (500μl) and another centrifugation for 15 seconds. In order to eliminate 
any buffer carryover, the column was transferred to another sterile collection 
tube followed by centrifugation for 1 minute.  
To elute RNA from the columns, the column was transferred to a new 
labelled sterile 1.5ml eppendorf tube. This was followed by pipetting of 50 µl 
of RNase free water to the centre of the membrane of the column. To elute 
the RNA, this was then centrifuged at 8000g for 1 minute. 
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2.9.2 RNA quantitation and quality control  
Quality control of isolated RNA is an essential step not just to determine the 
concentrations of the extracted RNA but also to ensure absence of 
contamination (by genomic DNA or chemicals used during extraction) or 
degradation of the RNA. Various methods performing this include, 
performing gel electrophoresis [348, 349] and the newer methods of 
spectrophotometry [350] or calculation of RNA integrity number (RIN) [351]. 
For the RNA extracted from liver tissue, spectrophotometery using Nanodrop 
ND1100 (NanoDrop, Wilmington, DE, USA) was followed by performing non 
denaturing agarose gel electrophoresis. The RNA extracted from adipose 
tissue was also quantified using Nanodrop and the integrity analysis was 
performed using Agilent 2100 bioanalyser (Agilent Technologies, Danbury, 
CT, USA). This additional investigation into RNA integrity was performed 
before performing the PCR as some of the RNA extracted from the adipose 
tissue had been kept in -80°C storage for about 18 months. 
2.9.2.1 RNA gel electrophoresis 
The procedure of separating RNA according to its mass (and consequently 
the chain length) depends upon agarose gel acting as sieve to selectively 
impede the migration of the negatively charged RNA towards the anode on 
application of electric current [349]. After electrophoresis, RNA can be 
visualised using the dye ethidium bromide which intercalates between 
nucleic acids and fluoresces under ultraviolet light. The RNA identified this 
way is present in clusters (bands) of RNA organised according to their length 
which can be identified by comparing with a ladder. Any genomic DNA 
contamination would appear as a smear of fluorescence next to the well 
(poor migration owing to the large size). Presence of two distinct bands of 
28s and 18s RNA where the 28 band appears approximately twice as intense 
as the 18s RNA indicates intact RNA whereas a smear instead of these 
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distinct bands through the far end of the gel would indicate RNA degradation 
into small fragments. 
Non denaturing gel electrophoresis was performed on the RNA extracted 
from the liver tissue samples. In contrast, the denaturing gel electrophoresis 
uses one or a combination of heat, urea, formaldehyde or formamide to 
cause the breakage of hydrogen bonds making the RNA linear (denatured) 
and hence more uniform in migration rate according to its length. Denaturing 
gel electrophoresis is more important when the objective is precise 
measurement of RNA molecular weight which was not the objective of this 
experiment. The procedure also requires use of either complicated laboratory 
instrumentation or toxic, carcinogenic, or expensive chemicals [352]. The 
findings of RNA integrity and purity were confirmed by either 
spectrophotometry or by calculating the RNA integrity (RIN) number 
(Section 2.9.2.4).  
 
2.9.2.2 Non denaturing gel electrophoresis of RNA procedure 
1% w/v agarose gel was made in TAE buffer (2M Tris (hydroxymethyl 
amino-methane, 0.2% (w/v) SDS, 1 M glacial acetic acid, 0.5M Na2EDTA 
ph8, distilled water up to 1000ml) by heating. After a short cooling period 
0.5µl/ml of solution of 0.1% ethydium bromide was added. The solution was 
allowed to cool in a gel cast with specific combs inserted to form wells inside 
the gel. Once the gel was set after a period of 30 - 45 minutes, it was then 
transferred to an electrophoresis chamber. 2µg of RNA, diluted to a volume 
of 10µl using nuclease free water, was mixed with 5µl gel loading buffer (v/v 
saturated bromophenol blue, 0.15% (w/v) EDTA, 20% v/v glycerol) and 
loaded into the wells of the gel. Axygen bioscientific ™ 300bb-1Kb DNA 
ladder (Axygen Inc, CA, USA) was loaded in the wells on the sides. 80 volts 
of electric current was applied using BioRad power pac (Bio-Rad laboratories, 
Hemel Hempstead, UK) for 50 minutes - the time the fastest dye had 
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travelled 2/3 of the gel width. The gel was visualised under a UV trans-
illuminator CCD camera (Fuji film luminescent image analyser LAS-1000 
v1.01) and a digital image of the gel was saved for records and analysis (see 
Figure 2.8) 
 
2.9.2.3 Spectrophotometry using Nanodrop 
RNA concentrations and purity measurements were determined using a 
Nanodrop® ND-1000 (Nanodrop Technologies, Wilmington, USA) 
spectrophotometer.  The nucleic acid concentration was calculated according 
to Beer-Lambert equation [353, 354] which uses the absorbance of the 
Nucleic acids at a set wavelength to calculate their concentration using 
known constant values of extinction coefficients. For calculation of sample 
purity, the purity ratio was calculated. Nucleic acids have maximal 
absorbance at 260ηm which declines appreciably as wavelength increases 
and at a wavelength of 280ηm, the absorbance is 1.8 times lower for pure 
DNA and is halved for pure RNA. A ratio of absorbance at 260nm/280nm of 
1.8 – 2.1 indicates suitability of the RNA for downstream application of 
interest (PCR). Any significant deviation from this ratio of absorbance at 260 
Figure 2.8: Image of non denaturing agarose gel electrophoresis of RNA.  
RNA electrophoresis was performed in 1% agarose gel containing ethydium bromide 
run parallel with 1kB DNA ladder. DNA ladder was used in absence of suitable RNA 
ladder and equivalent nucleotide size was ascertained by retrospective comparison 
of DNA and RNA ladder images from published data. Presence of two distinct bands 
of 28s and 18s RNA where the 28 band appears approximately twice as intense as the 
18s RNA indicates intact RNA. A genomic DNA contamination would have 
demonstrated a smear of large nucleotide size at the top close to the well whereas a 
denatured RNA shows up as a smear of small nucleotide size at the bottom end of the 
gel.   
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and 280ηm is an indicator of contamination. The potential contaminants 
from the RNA extraction steps can be identified according to the shape of the 
absorbance spectrum of the solution with the nucleic acid (Figure 2.9). If the 
RNA concentration is higher than the detection range of the 
spectrophotometer, an aliquot from the RNA extract was diluted using Tris 
buffer at pH 8 as the pH of the solution can affect the absorbance spectrum 
of the RNA [355].  
 
 
2.9.2.4 RNA integrity number (RIN) determination using Agilent 
2100 bioanalyser 
The Agilent 2100 bioanalyser uses microfluidics technology to perform 
electrophoretic migration of RNA through polymer gel in thin glass tubes. 
This procedure is similar to performing a slab gel electrophoresis described 
above but is performed on a much smaller scale in a controlled and 
standardised setting. The glass tubes are part of a standard chip (see Figure 
Figure 2.9: Graph of absorbance at different wavelengths made using Nanodrop 
ND1100 demonstrating evidence of RNA purity, integrity and concentration of a 
representative sample.  
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2.10) which is first loaded with the polymer gel mixed with fluorescent dye. 
The fluorescent dye molecules intercalate into RNA strands which can be 
detected using laser induced fluorescence. On each chip, 12 RNA samples 
and one ladder with marker can be loaded in individual wells. The 
bioanalyser electrodes provide controlled electrical power to each of these 
wells causing migration of the negatively charged RNA towards the anode 
and separation of the RNA molecules according to their size where the 
smaller fragments migrate faster and are identified as they pass a detector 
in the bioanalyser at different speeds. The data are translated to gel like 
images (bands) and an electropherogram (peaks). The RNA data can be 
compared to the RNA ladder which contains six fragments of known 
concentration and ranging in size from 0.2 to 6 kb.  
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For intact RNA, the bioanalyser electropherogram shows two distinct large 
peaks for 18S and 28S RNA and smaller peaks for other smaller RNA. The 
software calculates a RNA Integrity Number (RIN) [351]  using the 
electropherogram data based on a numbered scale ranging from 1 to 10 with 
1 being the most degraded and 10 being the most intact. A RIN of 5 or 
above is considered an indicator of suitability of the RNA for the PCR 
experiments [356].  The RIN is considered as a reliable and informative 
method and is the current gold standard for analysis of RNA integrity [357, 
358] before performing of PCR. 
  
Figure 2.10: Agilent bioanalyser use for RIN determination.  
A) RNA Nano chip used to load RNA ladder and RNA into the analyser. The chip is first 
primed with gel mixed with fluorescent dye. RNA and ladder are loaded into individual 
wells and electric current applied leading to migration of RNA through the gel. B)  A 
gel like image formed from the data. The extreme left well shows the gel like image 
of the ladder whilst the remaining bands demonstrate a gel equivalent picture of the 
RNA. C) An electropherogram of the RNA ladder d) An electropherogram of the RNA 
gel demonstrating large peaks for the marker, 18s and 28s bands. 
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2.9.2.5 RNA handling and storage 
To minimise freeze-thawing of the stock RNA which is attributed to RNA 
degradation, 10μl aliquots of each extracted RNA stock were further diluted 
(1μg/μl for liver and 0.3 μg/μl for adipose tissue) to normalise samples 
ready for quantitative RT-PCR. All extracted RNA samples were stored at      
-80°C until further use. 
2.9.3 Reverse transcription 
This is the process of transcribing single stranded RNA into double stranded 
complimentary DNA (cDNA) using a DNA primer and reverse transcriptase 
enzyme. The expression of any gene of interest can then be quantified from 
this cDNA using the technique of quantitative PCR (qPCR).  
The main components of the reagents used in this technique are the enzyme 
reverse transcriptase, random hexamer primers, oligo dT primers and 
deoxyribonucleotide triphosphate (dNTP) mix. Reverse transcriptase is a 
DNA polymerase enzyme which transcribes single-stranded RNA into single-
stranded DNA. dNTP Mix is a premixed solution containing sodium salts of 
dATP, dCTP, dGTP and dTTP, each at 10mM in water which provide the 
building blocks for the cDNA production. When incubated with the reverse 
transcriptase at 37°C, the cDNA strand is synthesised using the 
deoxyribonucleotides from the dNTP mix.  
2.9.3.1 Reverse transcription procedure 
This was performed using High Capacity RNA to cDNA Kit™ (Applied 
Biosystems, Warrington, UK). The kit contains maloney murine leukemia 
virus reverse transcriptase and buffer mix containing dNTP. The 
procedure was performed using labelled 0.2ml eppendorf tubes.  In a 
20µl reaction containing 2µl of diluted mRNA (1μg/μl for liver and 0.3 
μg/μl for adipose tissue), 10µl of RT buffer, 1µl of enzyme mix and RNase 
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free water were added. After brief centrifugation the reaction mix was 
incubated at 37°C for 60 minutes and the reaction was stopped by 
heating to 95°C for 5 minutes using the Techne Touchgene Gradient 
thermal cycler (Techne Incorporated, New Jersey, USA). Simultaneous 
control experiments containing no reverse transcriptase enzyme were 
also performed to ensure transcription efficiency. After reverse 
transcription the cDNA samples were stored at -20°C. 
2.9.4 Oligonucleotide primers for PCR 
Quantification of a specific gene of interest depends on the ability to make 
its copies in an efficient and reliable (with high specificity) reaction. Primers 
are small sequences of nucleic acids(oligonucleotide) which bind to the cDNA 
and act as markers for starting and finishing points for the process of 
imprinting of the new DNA sequence (copies). The enzyme DNA polymerase 
starts replication at the 3‘end of the primer, and then copies the opposite 
strand.  
An optimum primer should have several qualities. It should be highly specific 
and make copies of only the gene of interest on the genome and not to any 
other unintended genes [359]. The process of ensuring specificity of a 
primer includes finding the appropriate gene sequence. The open access 
annotated GenBank gene sequence databases 
(http://www.ncbi.nlm.nih.gov/gene) of National Center for Biotechnology 
Information (NCBI) or Ensembl (http://www.ensembl.org/index.html) were 
searched to find the appropriate gene sequence. When the appropriate gene 
sequence of Ovis Aries (sheep) was not available, primers to closely related 
species (Bos taurus) for which the genome has been more widely described 
were designed and tested for specificity and efficiency against ovine 
samples. An ideal primer pair would span across an intron on the genomic 
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sequence to ensure absence of amplification of any possible genomic DNA 
contaminant in the reaction mix. 
An ideal primer would perform efficiently which would mean doubling the 
number of cDNA copies after every cycle of the polymerase chain reaction 
(100% efficiency). In order to ensure high efficiency of primers, optimum 
primer parameters have been designated and published [359]. Both the 
primers should have a similar melting temperature (Tm). This is important 
as the annealing to the DNA occurs for both primers at the same time. A 
significant difference between temperatures may result in an incorrect 
sequence of DNA or failure to extend at all. In addition, a correct Tm avoids 
the unintended consequence of the primers annealing with other primers 
during the reaction, producing primer-dimers. The melting temperature of 
the primer is dependent on primer length and the percentage of nucleotides 
guanine (G) and cytosine(C) components of the primer. A primer of around 
20 (±4 base pair length) and 40-60% guanine/cytosine (GC) content is 
optimum. The sequence in the primer bases should not be complementary to 
each other (to avoid primer-dimer formation) or to the bases present on 
itself (to avoid hairpin structure formation). Several open access websites 
(Primer 3 and NCBI primer blast) and commercially available software 
packages (Beacon Designer software® Premier Biosoft, Palo Alto, USA) can 
be used to design optimum primers. 
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2.9.4.1 Primer design for PCR procedure 
The primers used in the experimental protocols were sourced from two 
different sources. The primers acquired from Sigma Aldrich (Table 2.3 and 
Table 2.4) were designed in house by myself or by Dr S Sebert, Dr M Hyatt, 
Dr D Sharkey and Mr M Pope. Some customised primers were also sourced 
from PrimerDesign Ltd. (Table 2.5). These primers were designed to order 
by the company in a manner analogous to that above and after supply were 
tested by myself by agarose gel electrophoresis to ensure the band size 
matched to the size of the gene of interest and also by matching the primer 
sequence to the mRNA sequence. 
Gene  Primer sequence Species 
NCBI 
accession 
number 
Source 
RPO, 
Large ribosomal 
protein  
Forward  
5' - 3' 
CAACCCTGAAGTGCTTGACAT 
Bos 
taurus 
NM_00101268
2 
Robinson  
et al. [360] Reverse  
5'-3' 
AGGCAGATGGATCAGCCA 
YHWAZ, 
tyrosine 3-
monooxygenase
/ tryptophan 5-
monooxygenase 
activation 
protein  
Forward  
5' - 3' 
TGTAGGAGCCCGTAGGTCAT
CT 
Ovis 
aries  
NM_174814 
Garcia-
Crespo et al. 
[361] Reverse  
5'-3' 
TTCTCTGTATTCTCGAGCCAT
CT 
RPL19, 
L19 Ribosomal 
protein 
Forward  
5' - 3' 
CCGGGAATGGACAGTCACA 
Ovis 
aries 
XM_012141899 
Garcia-
Crespo et al. 
[361] Reverse  
5'-3' 
CAACTCCCGCCAGCAGAT 
  
Table 2.3 Details of the genes, accession numbers and primer sequences for primers 
for genes used as reference genes for PCR 
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Gene  Primer sequence Species 
NCBI accession 
number 
Source 
AMPK, 
5' AMP-activated 
protein kinase 
Forward 
5'-3' 
GCTGGATTTTGAATGGAAGG 
Ovis aries NM_001112816 
Sebert 
et al.[267] Reverse 
5'-3' 
CAGCACCTCATCATCAATGC 
Adiponectin 
Forward 
5'-3' 
ATCAAACTCTGGAACCTCCTATCTAC 
Bos 
taurus 
BC140488 
Muhlhausler  
et al.[362] Reverse 
5'-3' 
TTGCATTGCAGGCTCAAG 
ATF4, 
activating 
transcription 
factor-4 
Forward 
5'-3' 
AGATGACCTGGAAACCATGC 
Ovis aries  NM_001142518 
Sharkey 
 et al. [363] Reverse 
5'-3' 
AGGGGGAAGAGGTTGAAAGA 
ATF6, 
activating 
transcription 
factor-6 
Forward 
5'-3' 
AACCAGTCCTTGCTGTTGCT 
Ovis aries  AY942654 
Sharkey 
et al.[363] Reverse 
5'-3' 
CTTCTTCTTGCGGGACTGAC 
CD68, 
cluster of 
differentiation 
68 
Forward 
5'-3' 
GTCCTGCTACCACCACCAGT 
Ovis aries XM_012122595 
Sharkey 
et al.[363] Reverse 
5'-3' 
GCTGGGAACCATTACTCCAA 
CD95, 
cluster of 
differentiation 
95 
Forward 
5'-3' 
CGGGATCTGGGTTCACTTGTC 
Ovis aries NM_001123003  
Reverse 
5'-3' 
AACAGGTGCTCACGATATAGGC 
GRP78, 
glucose-
regulated 
protein 78kDa 
Forward 
5'-3' 
TGAAACTGTGGGAGGTGTCA 
Bos 
taurus  
NM_001075148    
Reverse 
5'-3' 
TCGAAAGTTCCCAGAAGGTG 
Leptin 
Forward 
5'-3' 
GGGTCACTGGTTTGGACTTCA 
Ovis aries NM_173928.2 
Bloor et al. 
[364] Reverse 
5'-3' 
ACTGGCGAGGATCTGTTGGTA 
mTOR, 
mammalian 
target of 
rapamycin 
Forward 
5'-3' 
GCCTTCCGACCTTCTGCCTTC 
Ovis aries  NM_001145455    
Reverse 
5'-3' 
CCGCTGTCCGTTCCTTCTCC 
ObR, 
leptin receptor 
Forward 
5'-3' 
TGAAACCACTGCCTCCATCC 
Ovis aries  NM_001009763 
  
  Reverse 
5'-3' 
TCCACTTAAACCATAGCGAATCTG 
TLR4, 
Toll like receptor 
4 
Forward 
5'-3' 
TGCTGGCTGCAAAAAGTATG 
Ovis aries  NM_001135930 
Sharkey 
et al. [275] Reverse 
5'-3' 
CCCTGTAGTGAAGGCAGAGC 
GCR, 
glucocorticoid 
receptor 
Forward 
5'-3' 
ACTGCCCCAAGTGAAAACAGA 
Ovis aries  >NM_001114186 
Williams 
 et al. [365] Reverse 
5'-3' 
ATGAACAGAAATGGCAGACATT 
  
Table 2.4 Details of the genes, accession numbers and primer sequences for PCR 
primers designed in-house 
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The design for primers was based on the mRNA sequences published on 
NCBI online database (http://www.ncbi.nih.gov). The primers were first 
designed using the open access Primer3 software 
(http://frodo.wi.mit.edu/primer3/) specifically for PCR with the above 
described specifications. The primer sequences were then tested using online 
software Netprimer (http://www.premierbiosoft.com) to rule out presence of 
hairpin structures and primer dimers. To ensure that the primer sequences 
would not cross hybridise with other sequences within the genome, the 
target sequence was tested using the BLAST search engine from the NCBI 
(http://www.ncbi.nlm.nih.gov/BLAST).   Once finalised, the primers were 
ordered from Sigma Aldrich as desalt purification, dry format primers at 
0.05µmol format. 
Gene  Primer sequence Species 
NCBI accession 
number 
ATG12, 
autophagy related gene 12 
Forward  
5' - 3' 
CATTCTGCTAAAGGCTGTAGGA 
Bos taurus NM_001076982 
Reverse  
5'-3' 
GTTCTGAAGCCACAAGTTTAAGG 
BECN1,  
gene encoding Beclin1 
Forward  
5' - 3' 
CCAGGAGGAAGAGGCTAACT 
Bos taurus NM_001033627 
Reverse  
5'-3' 
AAGCTGTTGGCACTTTCTGT 
EDEM 1, 
ER degradation enhancer, 
mannosidase alpha-like 1 
 
Forward  
5' - 3' 
GTCTGGAAAAGTACACAAAAGTCA 
Bos taurus NM_001103092 
Reverse  
5'-3' 
AGCAGATACAGGTATTTACAGGTC 
2.9.5 Polymerase Chain Reaction (PCR) 
Polymerase chain reaction (PCR) is a method for performing exponential 
amplification of short DNA sequences within a longer double stranded DNA 
molecule. PCR entails the use of a pair of primers complementary to a 
defined sequence on each of the two strands of the DNA. These primers are 
extended by a DNA polymerase so that a copy is made of the designated 
sequence. This process can then be repeated over several cycles resulting in 
Table 2.5 Details of the genes, accession numbers and primer sequences for primers 
sourced from PrimerDesign® company 
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exponential amplification of the sequence. The same primers can be used 
again, not only to make another copy of the input DNA strand but also of the 
short copy made in the first round of synthesis. During the reaction, the 
temperature of the reaction needs to be raised to allow separation of the two 
strands of the DNA. However, the raised temperature was a hindrance to 
exponential amplification as it led to denaturation of the enzyme DNA-
polymerase. The exponential amplification without the need for adding new 
polymerase after every round of amplification was made possible by the 
isolation of enzyme Taq polymerase from the bacteria Thermus aquaticus 
[366] which is stable at high temperatures.  
Each cycle of PCR goes through a sequence of steps. The first step is the 
initiation step. This step consists of heating the reaction to a temperature of 
94–96 °C which leads to activation of the DNA polymerase enzyme (hot-start 
PCR). The next step is the denaturation step involving splitting of the 
hydrogen bonds between DNA strands leading to formation of single 
stranded DNA. The reaction temperature is then lowered to 60°C leading to 
annealing of the primers to the individual strands of the DNA template. 
Typically the annealing temperature is about 3-5°C below the Tm of the 
primers used. The primer extension step at temp 72°C leads to new strand 
synthesis by the enzyme DNA polymerase. This process, over several cycles, 
leads to exponential amplification of the DNA template (Figure 2.11).
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Figure 2.11 Schematic representation the principle of exponential amplification during first few PCR cycles 
A) Two parallel long polymer nucleotide chains in a DNA are attached to each other through hydrogen bonds between complementary 
nucleic acids. B1) Denaturation step: Heating of the PCR reaction to 95°C causes disruption of the hydrogen bonds leading to separation 
of the DNA strands yielding single stranded DNA. B2) Annealing step upon lowering of the reaction temperature to 60°C, primers form 
hydrogen bonds to their complementary nucleotides on the single stranded DNA. B3) Elongation step results in formation of complementary 
strand of DNA resulting in the doubling of the DNA quantity after one cycle. C) Repetition of the Steps B1, B2 and B3 results in 4 times 
amplification of DNA content after 2 cycles and D) 8 times amplification after 3 cycles. The exponential increase continues and after n 
cycles 2^n times amplification occurs.
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2.9.5.1 Classical PCR procedure 
By performing classical PCR, copies of a specific gene can be amplified 
from the cDNA product of reverse transcription using specific primers. 
These cDNA copies can then be isolated and extracted by performing 
agarose gel electrophoresis and visualisation. 
The reaction mix varied depending upon the source of the primers and is 
given in Table 2.6. The reaction was performed in a 20µl reaction in 200µL 
eppendorf tubes using Thermo start PCR master mix (Abgene Epsom, UK) 
containing the enzyme Taq polymerase, dNTPs, Mg2+, and buffer. 2µl of 
cDNA product from the reverse transcription was added to 10µl of the 
mastermix and specific volumes of primers were added to this reaction 
mixture (1µl each of forward and reverse primers sourced from Sigma and 
0.5µl of combined Primerdesign primers). The total volume was brought to 
20µl using nuclease free water. 
 
Primers from  
Sigma Aldrich 
Primers from 
PrimerDesign 
Thermostart PCR  
master mix 
10µl 10µl 
Primer 
1µl each of forward and 
reverse 
0.5µl of combined 
primers 
Nuclease free water 6µl 7.5µl 
cDNA 2µl 2µl 
  Table 2.6 The components and volume used for reaction of classical PCR. 
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The reaction was done in duplicate and negative controls for each gene 
containing no cDNA were run concurrently to ensure integrity of PCR. The 
tubes were centrifuged for 1 minute at 3000g and loaded into a Techne 
thermal cycler (Bibby Scientific Limited, Staffordshire) and run on the PCR 
program for 45 cycles. The program steps are given in the Table 2.7. 
 Process 
Temperature 
(°C) 
Duration (mins) 
Step 1 Initiation 105 4 
Step 2 Enzyme activation 96 15 
45 cycles of steps 3-5 
Step 3 Denaturing cDNA strands 94 0.5 
Step 4 Annealing 60 0.5 
Step 5 Extension 72 1 
Single final step 
Step 6 Final Extension 72 7 
Final hold Hold 4 
Until moved to 
storage at -20°C 
2.9.5.2 Agarose gel electrophoresis and DNA extraction  
Negatively charged DNA molecules can be separated with the process of 
electrophoresis. On application of electric field, DNA fragments migrate 
towards the positive electrode. The small fragments travel faster and 
farther in the gel which can then be visualised by staining with ethydium 
bromide. The dye intercalates between bases of DNA and can then be 
visualised under ultra violet (UV) light.  A positive control DNA fragment 
“ladder” is used to identify the size of the unknown bands. The DNA band 
of interest can then be extracted from the gel using commercial gel 
extraction kits. 
  
Table 2.7 The stages and program conditions for classical PCR. The steps 3-5 are 
repeated over 45 cycles before moving to step 6. 
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2.9.5.3 Agarose gel electrophoresis and DNA extraction 
procedure 
Agarose gel was made by dissolving 3% w/v agarose in hot TAE buffer 
(described in Section 2.9.2) and after a short cooling period, 0.5µl/ml of 
0.1% ethyidium bromide was added to this. The solution was allowed to 
cool in a gel cast with specific combs inserted to make wells inside the gel. 
Once the gel was set after a period of 30 - 45 minutes, it was then 
transferred to an electrophoresis chamber which can be connected to 
electrodes providing customisable electrical field. The 20µl PCR product 
was mixed with 5µl gel loading buffer (v/v saturated bromophenol blue, 
0.15% (w/v) EDTA, 20% v/v glycerol) and loaded into the wells of the gel. 
For comparison, DNA ladder was added to parallel wells (Generuler™ ultra 
low range DNA ladder 10-300 bp or Axygen bioscientific ™ 300bp-10000 
bp DNA ladder). An electric current was applied at 100 volts for 50 
minutes using BIORAd power pac 300(Bio-Rad Laboratories Ltd., Hemel 
Hempstead, UK). The PCR products were visualized under a UV trans-
illuminator CCD camera (Fuji film luminescent image analyser LAS-1000 
v1.01).  
Fluorescent gel bands identified and located at the specific size for the 
primer product were cut out of the gel, weighed and extraction and 
purification of the PCR products was performed using the QIAquick® gel 
extraction kit (Qiagen). In 2ml eppendorf tubes containing the cut gel, 600 
ml per 100mg agarose gel of buffer QG (Qiagen), which consists of 5.5 M 
guanidine thiocyanate and 20 mM Tris hydrochloride, was added and 
incubated at 50°C for 10 minutes leading to the dissolution of the gel. 
Addition of 100µl of isopropranol per 100µg of gel to this dissolved solution 
aids precipitation of the DNA. This solution was then pipetted into a 
QIAquick spin column and centrifuged at 10000g for 1 minute. The flow-
through was discarded and another 500µl of buffer QG added to ensure 
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elimination of agarose followed by centrifugation and discarding of the flow 
through. The next step was addition of 700μl of PE buffer containing 
ethanol to the spin column. This was allowed to stand for 5 minutes and 
centrifuged at 10000g for 1 minute and the flow through liquid was 
discarded. The column was transferred to another collection tube (supplied 
as part of the kit) and centrifuged at 10000g for 1 minute to eliminate any 
traces of the PE buffer. To elute the cDNA from the column, it was 
transferred to another sterile 1.5ml eppendorf tube and 50µl elution buffer 
added to the center of the column. This was allowed to stand for 1 minute 
and then centrifuged at 10000g for 1 minute leading to elution of the cDNA 
to the eppendorf tube. The cDNA was quantified using a Nanodrop 
spectrophotometer as described in Section 2.9.2. For the primers sourced 
from Sigma Aldrich, the extracted cDNA was sent for sequencing within the 
University of Nottingham’s Centre for Genetics and Genomics and cross 
referenced with the NCBI online database. The cDNA product of the 
custom primers from PrimerDesign was not sequenced as the product had 
been sequenced at the manufacturing site.  
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2.9.6 Quantitative real time polymerase chain reaction (qPCR)  
Quantitative real time polymerase chain reaction (qPCR) also called real 
time PCR is a technique used to quantify a targeted DNA molecule. This 
procedure is based on a fluorogenic dye called SYBR green which 
preferentially binds to the double stranded DNA during the amplification 
process of PCR and the intensity of its fluorescent signal correlates to the 
amount of DNA present in the reaction (Figure 2.12).  
 
Along with the dye, the other important components of the reaction mix 
include Taq DNA polymerase, Uracil-DNA Glycosylase (UDG), a passive 
reference dye, dNTPs, and buffer components. UDG prevents the 
reamplification of carryover PCR products by removing any uracil 
incorporated into single- or double stranded products [367]. In order to 
adjust for differences in product due to minor pipetting errors, the passive 
reference dye provides an internal reference to which the product signal 
can be normalised during data analysis.  
Figure 2.12: Amplification plot of a PCR reaction demonstrating increasing signal 
from serial dilution of standards and the samples.  
The X axis on the plot contains the cycle number and the Y axis demonstrates 
increasing fluorescent signals. 
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The standard method of defining the unit of signal from the exponentially 
increasing fluorescence data is by identifying the number of cycles taken 
to reach a fixed value of fluorescence threshold called the cycle threshold 
(Ct) [368].  
To quantify the relative quantity of the gene of interest, a serial dilution is 
prepared from a fixed amount of cDNA prepared during classical PCR as 
described in Section 2.9.5. A linear graph (standard curve) is obtained 
after plotting Ct values of the serial dilution of the cDNA against the log of 
the concentration (semi-log scale; Figure 2.13). The relative quantities can 
then be calculated by extrapolating this standard curve.  
In an ideal reaction, the amount of cDNA target doubles in each cycle. 
However, the efficiency of the amplification is often variable among 
primers and templates. The efficiency of the experiment is calculated by 
calculating the slope of the standard curve. Therefore, in an efficiency 
graph where Log (concentration) is plotted on the x-axis and the Ct is on 
the y axis, the slope of a standard curve with ideal efficiency of 100% with 
doubling of the PCR product (amplification factor=2) in every cycle would 
be 3.322.  
Amplification factor = 10(1/slope) 
If slope = 3.322 
Amplification factor = 10(1/3.322) = 2 
The correlation coefficient (R2) of the reaction is also calculated to ensure 
linearity of the standard curve.  
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Another quality control measure in PCR procedure is the melting curve 
test. This is performed to rule out presence of undesired products of PCR 
reaction like primer dimers or unintended products of PCR reaction by 
measuring the fluorescence of the PCR products across a range of 
temperature following completion of PCR cycles. The temperature of 
denaturation (splitting of two DNA strands) is dependent on the length and 
the base composition of the DNA. In a pure solution containing only one 
cDNA, the fluorescence emitted by the SYBR green suddenly drops after 
this temperature is reached. The rate of change in fluorescence can be 
plotted and shows a peak at the temperature of denaturation. If there are 
unintended products of a different length other than the gene of interest, 
they will have a separate peak in this melting curve plot. The presence of a 
single peak of the melting curve plot is therefore used to rule out 
unintended products in the PCR (Figure 2.14). 
Figure 2.13:  A representative graph of standard curve derived by plotting the cycle 
threshold value (Ct) on the y axis against the serial dilution plotted in semi-
logarithamic scale on the X axis. 
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2.9.6.1 Reference gene and relative quantification of the gene 
of interest 
A reference gene (previously known as a housekeeping gene) is a gene 
expressed constitutively in all the cells at a high level and is not affected 
by the experimental conditions in question. The expression of this gene 
can be used to normalise for any variation in RNA abundance at the start 
of reverse transcription which could be present as a consequence of 
difference in the amount of tissue used for RNA extraction, variation in 
enzymatic efficiencies and also difference in overall transcriptional activity 
in the cell or tissue. The expression of reference gene(s) was measured 
from all the samples and was used to quantify the expression of the gene 
of interest.  
2.9.6.2 Choosing the most stable reference genes 
A good reference gene by definition should have very little variation in 
expression throughout sample sets and be expressed relatively higher than 
any genes of interest. The choice of reference gene can be very specific to 
Figure 2.14: Melting curve graph following a qPCR cycle demonstrating presence of 
a single peak thereby confirming absence of any unintended products at the end of 
the qPCR 
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the tissue and the experimental protocol. As numerous studies have 
reported that housekeeping gene expression can vary considerably [369, 
370], identification of most stable reference genes followed by using more 
than one reference genes [371] is becoming standard practice.  The 
GeNormTM visual basic application incorporated in the Microsoft Excel 
software developed by Vandesompele et. al [370] uses the premise that 
expression of good reference genes should be similar in all samples. The 
calculation of the standard deviation of the log transformed values of the 
gene expression as a measure of the stability of reference genes can be 
used to calculate a value which reflects average pairwise variation between 
a particular gene and all other genes. This value is called M value. 
Stepwise exclusion of genes with higher M values (reflecting higher 
pairwise variation) can be performed and a combination of reference genes 
with least M values selected for data analysis [372]. 
2.9.6.3 Calculating relative gene expression 
The Ct values obtained from the qPCR experiment can be used to calculate 
the value of gene expression relative to another sample on the same plate. 
For example, for a twofold change in concentrations between two samples, 
the difference in the Ct values would be one as the sample with half the 
concentration would reach the threshold for Ct value during the next cycle, 
similarly a fourfold change would have a difference of two cycles. This 
difference in the Ct values between the two samples is called delta Ct 
(∆Ct) [368]. Relative concentration between any two samples can thus be 
calculated by the equation. 
  Relative concentration= Efficiency∆Ct 
Relative quantification of the unknown sample requires correction for 
technical sample specific variation (such as differences in total amount of 
cDNA) and identifying samples with genuine variation in gene expression. 
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The use of the GeNorm method performs this by calculation of a 
normalisation factor for all the individual samples (unknowns) in the 
dataset from the reference genes. This normalization factor is the 
geometric mean of the calculated relative concentrations of the reference 
genes. The relative concentration calculated from the PCR run using the 
formula (Relative concentration= Efficiency∆Ct) was then corrected by 
dividing this normalisation factor and the corrected values were then used 
for comparison.  
It is well accepted that for calculation of a measure of central tendency, 
geometric mean is a better value than arithmetic mean especially when 
the range of values are not on the same scale. For example, in order to 
calculate the best measure of central tendency from two different results 
with scales of 1-100 and 1-5, the results from the range 1-100 will get 
more weightage and any small percentage change in it will make a bigger 
impact on arithmetic mean.  Similarly the geometric mean also controls for 
outlying values better than the arithmetic mean [370]. Instead of 
calculating the gene expression relative to all the reference genes and then 
calculating the geometric mean of the outcomes, GeNorm method 
determines the normalisation factor by calculating the geometric mean of 
the reference genes which is then used as a denominator for the relative 
concentration. 
For liver gene expression experiments, previously validated genes [373] 
for liver large ribosomal protein (RPO),  tyrosine-3 monoxygenase/ 
tryptophan-3 monoxygenase activation protein (YWHAZ) and 18S 
ribosomal RNA were evaluated using the GeNorm™ algorithm [370]. Using 
the M values as indicator of gene stability, RPO and YHWAZ were identified 
as the most stable reference genes and used for the normalisation of gene 
expression. For adipose tissue, in absence of any known published 
literature of validated ovine or bovine reference genes, a combination of 
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reference genes studied in human experiments were tested. Importin 8 
(IPO8), 60S ribosomal protein L19 (RPL19) and RPO, were evaluated for 
the gene stability and RPL19 and RPO were identified to be the most stable 
genes and used for normalisation. 
2.9.6.4 qPCR procedure 
qPCR was performed using Applied Biosystems Step one plus ™ real time 
PCR system. This PCR instrument is capable of analysing 96 different 
samples in individual wells on a PCR plate. The PCR reaction was 
performed in a 96 well plate (Abgene) to which 3µl of cDNA (1:10 dilution) 
of samples, serial dilutions (standards), or nuclease free ,5µl SYBR® green 
Taq polymerase master mix (Thermo Scientific, Leicestershire, UK) and 
primers (1µl each of 1:40 forward and reverse primers from Sigma or 
0.5µl of stock primer mix from PrimerDesign) were added to each well. 
The volume was brought to 10µl for the reactions containing PrimerDesign 
primers using nuclease free water (see Table 2.8). All the samples and 
negative controls were performed in duplicates while the standard dilution 
was performed in triplicates to obtain a reliable correlation coefficient (R2) 
and samples with coefficient of variation > 5% were excluded from the 
analysis. 
 
Reaction for primers 
sourced from Sigma 
Aldrich 
Reaction for primers 
sourced from 
PrimerDesign 
Fast SYBR® Green 
Master Mix 
5µl 5µl 
Primer 
1µl each of 1:40 forward 
and reverse primer 
0.5µl of stock primer mix 
cDNA 3µl 3µl 
Nuclease free water 0µl 1.5µl 
Table 2.8 The components and volume of the PCR reaction mix for each reaction. 
The volume of the individual components varied depending on the source of the 
primer used. 
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Once prepared, the well plate was sealed using adhesive seals and 
centrifuged for 1 minute at 600g and placed in the Step one plus ™ real 
time PCR system. The qPCR program steps are shown in the Table 2.9 
 
Process Temperature (°C) Duration 
Number of 
cycles 
Activation of 
AmpliTaq® Fast 
DNA 
polymerase 
95 20sec Hold 
Denature 95 3sec 
40 cycles 
Anneal/extend 60 30sec 
Melting curve 
65 to 90 in 1°C 
increments 
15 minutes 
Incremental 
increase 
 
The qPCR output was measured using the software package StepOne™ 
v2.2 (Applied Biosystems). Experiments with R2 values > .995 and 
amplification factor of 2± 0.05 were considered acceptable. The raw gene 
expression data containing the Ct values was processed and analysed 
using the GeNorm™ software package as described in Section 2.9.6.3. 
2.10 Histology 
Visualisation of the tissue structure and the location of specific protein at a 
microscopic level requires use of histological techniques. However, 
specialised tissue processing is required before a tissue can be visualised 
histologically.  
2.10.1 Tissue processing and microtomy 
Tissue processing steps ensure maintenance of cell structure and prevents 
cell damage [374] while the cells are sliced into thin sections. The steps 
include fixation, dehydration, clearing and embedding. The process of 
fixation maintains clear and consistent morphology of the cellular and 
Table 2.9 The steps in the QPCR protocol including the melting curve stage 
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extracellular structures by minimising loss of enzymatic destruction and 
also destruction from microorganisms [375]. Formalin is an aqueous 
solution of formaldehyde which is commonly used for fixation of tissues. 
Pure formaldehyde is a vapour which when completely dissolved in water 
forms a solution containing 37% formaldehyde. The commonest used 
dilution of 10% formalin contains approximately 3.6% (v/v) formaldehyde 
[374]. Formalin acts by binding to amino acids in tissues to prevent their 
destruction. 
The next tissue processing step of dehydration involves exposing the 
tissues to increasing concentration hydrophilic reagents like methanol or 
isopropyl alcohol. This process removes the fixative and water from the 
tissues. Reagents like xylene, toluene or chloroform are used to clear the 
tissues of the dehydrating solution and prepare the tissue to receive the 
infiltrating medium.  
The step of infiltration and embedding uses a medium that permeates the 
tissue and provides it with an internal and external support (embedding) 
which then solidifies. Paraffin wax is commonly used to infiltrate and 
embed the tissues. The embedded tissue is then sliced in uniform 
thickness sections by the process of microtomy and mounted on slides.  
2.10.1.1 Tissue processing procedure 
A selected amount of the omental adipose tissues was fixed in 10% formal 
saline (10% v/v formaldehyde on 0.9% (v/v) sodium chloride) at the time 
of dissection. For the liver, the tissue samples kept in - 80°C freezer 
following snap freezing in liquid nitrogen as described in Section 2.7 were 
cut and representative samples of approximate size 1cm diameter and 3-4 
mm thickness were taken and kept on dry ice. Care was taken to avoid 
areas of large blood vessels or portal system vessels during this process. 
These samples were gradually thawed over 36 hours by first keeping them 
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in a -20°C freezer for 24 hours and then at -4°C for the next 12 hours as 
described by Sebert et. al. [267]. The samples were then fixed in 10% 
formalin for 3 days and then transferred to 70% IMS until further 
processing was performed.  
The tissues were placed in 5mm Histosette II (Simport, Quebec, Canada) 
plastic cassettes and were processed using a Shandon Escelsior™ tissue 
processor (Thermo Scientific, Anatomical Instruments Company, 
Massachusetts, USA). The reagents used included industrial methylated 
spirit (IMS) (Sigma-Aldrich, Gillingham, UK), xylene (Fisher Scientific) and 
paraffin wax (Tissue Tek® II, Sakura finetek, Alphen aan den Rijn, 
Netherlands). The steps of dehydration, clearing and infiltration were 
performed sequentially as described in Table 2.10. 
 
Step Reagent 
Concentration (%, 
v/v) 
Time (minutes) Temperature (°C) 
Dehydration 
IMS 75 60 30 
IMS 90 60 30 
IMS 95 60 30 
IMS 100 60 30 
IMS 100 60 30 
IMS 100 60 30 
Clearing 
Xylene 100 60 30 
Xylene 100 60 30 
Xylene 100 60 30 
Infiltration 
Paraffin wax 100 80 60 
Paraffin wax 100 80 60 
Paraffin wax 100 80 60 
The processed tissues were embedded in paraffin wax using a Tissue Tex 
blocking machine (Tissue Tek III®, Sakura finetek,).  
Table 2.10: Tissue processing steps performed using a Shandon Escelsior™ tissue 
processor 
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2.10.1.2 Microtomy procedure  
The microtomy for liver tissues was performed using sledge microtome 
(Anglia Scientific, Cambridge, UK, type 200) and Accu-edge low profile 
blades (Feather Safety Razor Co, Medical division, Osaka, Japan) and 5 µm 
sections were prepared. For adipose tissue, 6 µm sections were prepared 
using rotary microtome. The sections were rinsed in 70% ethanol and 
floated in prewarmed waterbath set at 45°C and mounted on Superfrost® 
plus electrostatic slides (Thermo Scientific, Massachusetts, USA). The 
slides were then dried on a heat rack for 15 minutes. These slides were 
baked in an oven at 37°C for 24 hours.   
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2.10.2 Histochemistry 
During microscopy, the ability to differentiate the structural components of 
the tissue can be enhanced by performing staining of the tissue with 
certain dyes. The stains have differential affinity to the components of a 
tissue or cell and provide a contrast for the section under examination.  
2.10.2.1 Haematoxylin and eosin staining. 
Haematoxylin is an alkaline stain used to bind to acidic structures in the 
nucleic acids and demonstrate the nuclei in a slide. Upon oxidation, 
haematoxylin produces hematein which is a blue coloured dye. Harris’s 
haematoxylin is a commonly used preparation and is used as a regressive 
dye [376] which reduces in intensity by progressive washing with a weal 
alkali until the optimum blue stain is produced. Eosin is an acidic dye used 
to demonstrate the general histological architecture of a tissue.  
2.10.2.2 Haematoxylin and Eosin staining procedure 
One slide from each sample was placed in slide rack. These were dewaxed 
by sequential immersion in two xylene troughs for 3 minutes each followed 
by rehydration through immersion in two troughs containing 100 % IMS 
for 3 and 2 minutes and then followed by 3 minute immersion in 70% 
IMS/distilled water. They were finally washed in distilled water trough for 3 
minutes before staining. The nuclear staining was performed by immersion 
in Harris’ haematoxylin (VWR International Ltd., Lutterworth, UK) and then 
rinsed in tap water for 5 minutes to remove excess dye. The slides were 
then immersed for 5 seconds in acid alcohol solution made by adding 1% 
hydrochloric acid (Fisher Scientific) made up in 70% IMS, rinsed in tap 
water and then blued off by immersion for 5 minutes in Scott’s tap water 
(0.2% sodium bicarbonate and 2% magnesium sulphate solution in 
distilled water). A representative slide was quickly checked under light 
microscope to ensure adequate staining of the nuclei and the slide rack 
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was then stained using 0.1% eosin (VWR, as before) for 3 minutes which 
was then washed off under running tap water for 90 seconds. The sections 
were then dehydrated by two immersions of 100% ethanol for 2 minutes 
each and then ethanol cleared during two 3 minute immersions of xylene. 
Sections were mounted with coverslips (VWR) using DPX mounting 
medium (Fisher Scientific), and left to dry overnight. The staining was 
performed by myself and by Dr Paul Andrzejoweski, a BMedSci student 
under my direct supervision. 
2.10.2.3 Masson’s Trichrome staining 
Masson’s Trichrome stain is a tree colour stain protocol used to identify 
connective tissue in relation to cells. The nuclei are stained blue or black 
using haematoxylin, connective tissue can be stained blue or green, 
muscle fibre and keratin takes up a red colour and cytoplasm appears light 
pink. The presence of connective tissue highlighted this way can 
demonstrate the amount and location of fibrosis in pathological processes 
like advanced non-alcoholic fatty liver disease [208] 
2.10.2.4 Masson’s Trichrome procedure 
One slide each from the liver tissue were placed in a slide rack and 
dewaxed and rehydrated as described in Section 2.10.1.1. Fresh Weigert’s 
haematoxylin was prepared by mixing equal measures of Weigert’s 
solution A and solution B (Raymond A. Lamb, Eastbourne, UK) and the 
slides were immersed in the prepared haematoxylin for 10 minutes 
followed by washing off the excess stain under running tap water for 5 
minutes. Similar to Haematoxylin and Eosin (H&E) staining, the slides were 
immersed in acid alcohol (1% hydrochloric acid in 70% IMS), washed in 
tap water and blued off in Scott’s tap water (0.2% sodium bicarbonate and 
2% magnesium sulphate solution in distilled water).  After a wash under 
running tap water, one of the slides was checked for adequate nuclear 
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staining. The slides were then immersed for 2.5 minutes in Solution A 
containing 0.5% Acid fuchsin (Nustain – Pathology Dept., University 
Hospital, Nottingham, UK), 0.5% glacial ethanoic acid (Fisher) in distilled 
water and excess stain was washed under running tap water. This was 
followed by a 10 minute immersion in freshly made solution B containing 
1% phosphomolybdic acid (Raymond A. Lamb, Eastbourne, UK) and then 
another 10 minutes in solution C containing 2.5% aniline blue (Nustain), 
1% glacial ethanoic acid in distilled water. The sections were then 
dehydrated by two immersions of 100% ethanol for 2 minutes each and 
then ethanol cleared during two 3 minute immersions of xylene.  As 
before, sections were mounted with coverslips using DPX mounting 
medium and left to dry overnight. The staining was performed by myself 
along with Dr Paul Andrzejoweski, a BMedSci student who worked under 
my direct supervision. 
2.10.3 Histochemical analysis of hepatic tissue 
The primary purpose of examination of hepatic tissue was to identify and 
attempt to quantify [208, 377] features of hepatic steatosis and NAFLD in 
the samples in a blinded fashion. Images were obtained from 10 randomly 
selected areas of hepatic sections at 10X and 20X magnification using 
Volocity version 5.2.0 (Perkin Elmer, Washington, USA). The images of 
histological sections stained with H&E and Masson’s Trichrome stain were 
assessed qualitatively for features of hepatic steatosis represented by 
presence of large lipid droplets in hepatocytes and of progressive NAFLD 
constituting inflammatory infiltrate and pericellular and periportal fibrosis 
(Figure 2.15). Following assessment, the images were deemed non 
homogenously stained for reliable quantification of fibrosis severity 
permitting quantitatve assessment of only portal triad size. This was 
performed using Volocity software by Dr Paul Andrzejoweski, a BMedSci 
student under my supervision.   
  141 
 
 
 
Figure 2.15 Representative images of liver tissue stained with H&E  (A) and 
Masson’s Trichrome (B) stain visualised at 20X magnification. 
The figures demonstrate differential staining of hepatic lobules. Fibrotic tissue 
preferentially stains with Masson’s Trichrome stain as seen in periportal area in the 
image B (blue arrows). 
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2.10.4 Immunohistochemistry 
Whilst histochemistry is useful in giving general detail of the structural 
composition of a tissue, when a detailed examination of specific processes 
at a microscopic level is required, immunohistochemical techniques can be 
used. These techniques use the antigenic property of the target protein by 
using special antibodies generated to the target. Once bound to the 
antigen in the tissue section, these antibodies called primary antibodies 
are labelled to a variety of signalling markers which can be made to 
produce a colour signal (immune staining) or a fluorescent signal 
(immunofluorescence) by further processing. 
2.10.4.1 Primary and secondary antibodies used in 
immunohistochemistry 
The antibodies used to identify the antigen of interest are produced in an 
animal of species different than the species of experiment (commonly 
rabbit, goat, pig, horse or guinea pigs). Such antibodies can be either 
polyclonal or monoclonal. Polyclonal antibodies are produced through 
immune response stimulation after injecting animals with the whole or a 
component of the antigen protein. The antibodies thus generated are then 
isolated from the plasma by affinity chromatography. In polyclonal 
antibodies, whilst each antibody is able to bind to a specific area of the 
antigen called as epitope, several types of antibodies produced through 
this method are able to recognise several epitopes of the same protein. 
In contrast, monoclonal antibodies are produced by a different process. 
After generating an immune response by injecting animals (commonly 
mice) with the antigen, B lymphocytes are harvested from the spleen or 
lymph nodes of these animals and are fused with myeloma cells. Such 
fused cells gain longevity in culture medium and retain their antibody 
producing ability. These cells are then transplanted to peritoneal cavity of 
a syngeneic animal and antibodies are harvested from the peritoneal fluid. 
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Monoclonal antibodies are considered more specific to the target antigen 
than polyclonal antibodies since they are specific for a single epitope. 
In direct immunohistochemistry (IHC) technique, the antibody used to 
identify the antigen is labelled with a chemical which can be made to 
generate colour or fluorescence by further processing. The procedure has 
the advantage of being rapid without the need of additional steps. 
However, industrial manufacturing of such specific antibodies make them 
expensive and due to no further signal amplification, such as with the 
alternative indirect method, this method is less sensitive. 
The indirect immunohistochemistry procedure uses an unlabelled primary 
antibody that binds to the target antigen and a labelled secondary 
antibody capable of binding to the primary antibody. The secondary 
antibodies have been raised against immunoglobulins of the primary 
antibody species, isolated and then conjugated with the enzyme or the 
fluorophore. These bind to the antigen-antibody complexes and produce a 
colour producing reaction (for example in immunoperoxidase staining) or 
can be detected using a fluorescence microscope (immunofluorescence). 
The resulting colour change or fluoresence can be used for calculating the 
differential expression of such protein in the tissues. The primary 
antibodies used for indirect immunohistochemistry in this study have been 
listed in Table 2.11. 
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Antibody Source Type Dilution 
Anti glucose-
regulated protein 78 
(Anti-GRP78) 
SPA-826; Stressgen, 
now Enzo life sciences, 
Exeter, UK 
Rabbit 
polyclonal 
against mouse 
GRP78 
1:200 
Anti-phosphorylated 
c-Jun N-terminal 
kinase (anti-pJNK) 
SC6254;  
Santa Cruz 
Biotechnology, Santa 
Cruz, USA 
Mouse 
monoclonal 
against human 
pJNK 
 
1:75 
Anti ionised calcium 
binding adapter 
molecule1            
(anti-IBA-1) 
019-19741 
Wako Chemicals 
GmbH, Neuss, 
Germany 
Rabbit 
polyclonal 
against human 
Iba1 
1:240 
2.10.4.2 Slide preparation for immunohistochemistry staining 
A common enzyme system used for labelling antibodies is horseradish 
peroxidase (HRP) and its substrate of 3,3 diaminobenzidine (DAB). The 
enzyme can react with hydrogen peroxide and release atomic oxygen. The 
free oxygen oxidises DAB and produces an insoluble brown end product 
which precipitates to leave a stain on the tissue. 
However some cells and tissues have endogenous enzymes capable of 
catalysing the reaction in ways similar to HRP. Such enzymes need to be 
inactivated prior to the addition of the secondary antibodies by a 
procedure called quenching which uses the mechanism of enzyme 
inhibition in presence of excess substrate to form a catalytically inactive 
product. Hydrogen peroxide is thus used to inactivate the endogenous HRP 
like activity of tissues. 
Another step necessary for effective staining involves the unmasking of the 
antigen so that it is identified by the antibody (epitope retrieval). This is 
important for formalin fixed paraffin embedded tissues as during the 
process of fixation, formalin can cause formation of cross linkages of 
Table 2.11: Details of the antibodies used for immunohistochemistry using DAB 
staining 
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unrelated proteins leading to the loss of immunoreactivity [378]. The latter 
can be restored by one of several epitope retrieval processes [379] which 
include enzymatic digestion using proteases, microwave heating with 
citrate buffer, or a combination of both.  
Appropriate controls for the reagent and tissues are necessary for the 
validation of the IHC results. In order to ensure specificity of the staining 
using the primary antibody, an appropriate negative control is used with all 
the reagent steps and exclusion of application of the primary antibody. 
Such a procedure will ensure ruling out of falsely positive results due to 
inherent peroxidase activity or nonspecific staining due to the binding of 
the secondary antibody. 
2.10.4.3 Staining in immunohistochemistry 
In order to visually identify the location and quantity of the target antigen, 
the antigen antibody complex requires a reporter. The reporters that 
generate colour are called chromogenic reporters. These are generally 
enzyme labels attached to the antibody which facilitates reactions between 
substrates to yield a coloured product visible under light microscopy. 
Following appropriate slide preparation with the processes of quenching 
and epitope retrieval, the antibody attached to the chromogenic reporter, 
HRP produces a brown precipitate in the presence of DAB. The brown 
precipitate marks the location of the antibody on the slide which can then 
be visually identified (Figure 2.16). 
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2.10.4.4 Immunohistochemistry procedure 
The Leica BondMax™ automated IHC slide processor (Leica biosystems) 
which is run with the automated software program Bond version 3.4A 
(Vision Biosystems) was used for performing the IHC staining using Bond 
polymer refine detection reagents (Leica). The slides can be stained in 
batches of 30 after labelling them with a random identifier. This batch 
processing ensures uniformity of the staining protocol and identical 
staining on the slides. Optimisation of staining intensity can be performed 
by configuring the system protocol.  
All slides were dewaxed and hydrated using xylene and ethanol washes for 
one minute each. The slides were incubated in Bond ™ epitope retrieval 1 
solution containing citric acid, buffer and surfactant and heated to 95°C. 
The duration of the next step of immersion in 3% hydrogen peroxide for 
quenching was determined by performing tests in a series of experiments 
during which 45 minutes quenching was identified to be ideal. This was 
followed by wash with Bond wash solution™ and distilled water which were 
Figure 2.16: Schematic diagram demonstrating the principle of diaminobenzidine 
(DAB) staining in immunohistochemistry. 
Following binding of a primary antibody to the target antigen, a secondary antibody 
tagged to horseradish peroxidase (HRP) enzyme complex in binds to the primary 
antibody. On addition of diaminobenzidine (DAB), the HRP enzyme complex 
converts into a brown precipitate which stains the cell surface at the location of the 
target antigen. 
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also used for all the subsequent washes mentioned below. All the samples 
except the negative control were exposed to 150µl of the optimised 
concentration of the primary antibody dilution as detailed in the Table 2.11 
for 15 minutes. The antibody dilutions were prepared in Bond™ primary 
antibody diluent containing Tris-buffered saline and protein stabiliser. This 
was washed off and followed by exposure to 150µl of the secondary anti-
mouse and anti-rabbit polymer conjugated to HRP. The DAB refine ™ 
reagent was then added for 10 minutes to stain the antigen antibody 
complexes with brown colour.  The background staining was then 
performed using 0.02% haematoxylin for 5 minutes. The sections were 
then dehydrated by two immersions of 100% ethanol for 2 minutes each 
and then ethanol cleared during two 3 minute immersions of xylene.  
Sections were mounted with coverslips (VWR) using DPX mounting 
medium (Fisher), and left to dry overnight. The steps of DAB staining and 
haematoxylin staining were excluded in one slide each to be used as 
source images for colour vector calculation. 
The slides were visualised using Nikon Eclipse 90i microscope equipped 
with Micropublisher 3.3RTV high-speed colour CCD camera (QImaging, 
Surrey, BC, Canada). Randomly selected images at 10X and 20X 
magnification for both liver and adipose tissues were captured and saved 
using Volocity software version 6. (Improvision Ltd., Coventry, UK). 
Separate images of the brightfield (no slide in the light path) and darkfield 
(light path completely occluded with the diaphragm) were also saved for 
performing background correction. 
Serial antibody dilutions were performed for each antibody to determine 
the appropriate optimum dilution. The recognised method of identifying 
the optimum antibody dilution [380] as the one that produces good 
staining whilst the next dilution has a sudden drop in staining intensity. 
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2.10.5 Quantification of adipocyte size 
With increasing evidence indicating the importance of adipocyte size in 
metabolic inflammation and cell stress response [35, 36], accurate 
determination of adipocyte size gains importance [381]. Several methods 
of adipocyte size determination have been described, each with their 
advantages and disadvantages. The indirect methods include measuring 
the triglyceride and DNA content and the adipocyte size expressed as the 
ratio of triglyceride content per unit DNA content. However, the measured 
DNA content invariably will include the contribution from the stromal 
vascular fraction of the adipose tissue and hence will not only 
underestimate the adipocyte size, but also be affected by variation in the 
stromal vascular component seen in inflammation related to obesity. 
Another method includes estimation of osmium fixed fat cells derived from 
a known wet weight of adipose tissue [382, 383]. In this method, osmium 
fixed adipocytes are counted individually using an electronic counter and 
this cell number is used to divide the lipid weight measured from a 
comparable sample. The disadvantages of this method include the 
possibility of osmium causing the swelling of the cell [384], toxicity of 
osmium tetraoxide and non-availability of an electronic counter. A method 
of measurement of adipocytes size after collagenase digestion has also 
been used. However, in this method the free adipocytes are distorted to a 
uniform circular shape and this method is also known to cause lysis of 
large adipocytes introducing error [384].  
Direct measurement of adipocyte size from microscopic examination has 
been frequently reported. This can be performed using measured 
adipocyte diameter [385] or by measuring the adipocyte area [68]. Using 
the adipocyte diameter to calculate the volume is tedious and also 
assumes regular-spherical shape of the adipocyte. Using adipocyte area 
calculated from microscopy provides a better estimate of cell volume and 
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has been recently used and validated in comparison to other available 
methods [68, 386]. Automated methods using commercial [386] and 
public domain [387] software have been published and validated. 
ImageJ is a public domain, Java-based image processing program 
developed at the National Institutes of Health [388, 389] and is widely 
used for image analysis and quantification of adipocyte size and DAB stain 
intensity [387, 390-392]. The plugins used in conjunction with the 
software are listed in Table 2.12 and their use described in individual 
sections. 
Plugin Name Author Role 
Calculator plus 
Wayne Rasband 
[393] 
(nih.gov) 
Performs calculation on RGB 
images. Used here to perform 
background correction of 
images 
Color 
Deconvolution 
Gabriel Landini [394] 
(bham.ac.uk) 
Performs stain separation in a 
digital images resulting in 
separate images of individual 
stain location 
Auto 
Thresholding 
Gabriel Landini [395] 
(bham.ac.uk) 
Process of identifying and 
applying a threshold point of 
hue in an image. The areas of 
image below this threshold are 
excluded as background 
staining. 
  
Table 2.12: Details of the plugins used with ImageJ software for the process of 
quantification of the DAB staining in digital images. 
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2.10.5.1 Adipocyte size quantification procedure 
The images were acquired from random areas of the slides and the 
samples had been given random numbers to keep the acquisition free of 
bias. Calibration of the images was performed using stage micrometers 
and constant exposure time and brightness settings were kept for every 
image for an experiment during the image acquisition and digital storage 
using the Volocity 6 software (Improvision Ltd, Coventry, UK). Image 
acquisition was performed at 20X magnification and the calibrated images 
were then converted to tagged image file format (TIFF) for further analysis 
using ImageJ software. This format is widely used for scientific imaging 
and maintains the advanced image data across various software platforms 
(Volocity, Microsoft paint and ImageJ). ImageJ software is also 
customisable to perform specific image processing tasks with the use of 
plugins. The images were manually studied in the Microsoft paint version 
6.1 software (Microsoft Corp., USA) and areas of large blood vessels and 
partially imaged cells at the edge or artefacts were cropped out to exclude 
them. A minimum of 500 cells per sample were tagged manually using the 
paintbrush application of Windows paint application and the number 
counted using the magic-wand tool of the Volocity software. The total area 
of the image was calculated using the Volocity software and divided by the 
number of cells counted. 
This method was devised in house and permitted an accurate and prompt 
measurement of mean adipocyte surface area by including a large number 
of adipocytes in analysis. Previously published methods [68, 396] using 
Volocity software involve manual measurement of individual adipocyte size 
making the process tedious leading to inclusion of fewer (approx. 100) 
adipocytes in the analysis. The in-house method permitted a prompt 
assessment of a mean 750 cells and demonstrated a high correlation with 
the previously published methods in 25 randomly selected images (Figure 
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2.17). Blinded analysis of mean area measured by two individual assessors 
also demonstrated minimal inter individual variation (Pearson correlation 
coefficient r= 0.97).  
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Figure 2.17 Graph demonstrating strong correlation of two different quantification 
methods of adipocyte size measurement.  
The method developed in-house performed adipocyte size measurement as the 
value obtained by dividing the total surface area visible on a calibrated image from 
stained adipose tissue section by the total number of adipocytes in the field. The 
previously used and published method [68] involved manual measurement of 
individual adipocyte area in the image from stained adipose tissue slide. The 
correlation was performed in data obtained from 25 randomly selected images. 
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2.10.6 Quantitative assessment of DAB staining 
Immunohistochemical staining is being increasingly used not just as a 
stain but as a precise, quantifiable immunoassay. A correlation between 
staining with immunohistochemical stain and protein levels have been 
demonstrated using Western blotting [397] and enzyme immunoassays 
[398]. Several automated protocols [390] for quantification of DAB 
staining are available and standardised computerised image analysis has 
been shown to be superior to manual methods in several comparative 
studies [399-401].   
Quantification of images using computers involves transforming 
components of images to quantifiable numbers. A digital image is formed 
by combination of pixels where each pixel represents the smallest point 
with individual characteristics. Two of the models used to describe these 
pixels are intensity with RGB model and colour density with optical density 
(OD) models.   
RGB stands for the initials of the three primary colours red, green and 
blue. Every colour in the spectrum can be represented by intensity of the 
red, green and blue components of that colour. In computerised digital 
images, every pixel of a coloured image has a RGB value and these 
intensity values often range from 0 to 255, the range that a single byte 
consisting of 8 bits can offer. For example, pure red pixel in the RGB 
model can be represented by RGB values of 255, 0, 0 where there is 0 
intensity of green and blue colour. Using this colour model, standardised 
mathematical modifications to all the experimental images can be 
performed. One such example of a standardised mathematical modification 
of an image is whilst performing background correction. 
A background correction needs to be performed on digital images of 
microscopic slides to exclude artefacts from the image present due to 
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variation in background illumination intensity, colour temperature of the 
light source and also artefacts from the camera (hot pixels) or the light 
path [402]. A priori correction of the background images uses images of 
brightfield (with no slide) and darkfield (blocking the light path) captured 
at the time of image acquisition (Equation 2.2). In the ImageJ software, 
this process can be done by performing the calculations given in the 
Equation 2.2 with the use of an open source plugin called Calculator plus 
published by Rasband [393]. 
Corrected image= 
Specimen - darkfield
Brightfield - darkfield
 
The corrected image obtained as a result is free from artefacts and 
variations in image present due to variance in illumination, light path or 
camera (Figure 2.18).  
 
Equation 2.2: Principal equation used in performing background correction using 
the plugin Calculator plus and the ImageJ software [402].  
A brightfield image is taken with the same light source and illumination with no 
slide and darkfield image is taken with the same settings but an opaque obstruction 
in the light path. The RGB values of the images are calculated using ImageJ 
software and following calculation using the equation, the resulting RGB values of 
each pixel is used to redraw a corrected image. 
Figure 2.18 A series of representative images demonstrating the process of 
background correction.  
A) Uncorrected images with artefacts (red arrows) and variation in light path (blue 
arrows) B) Brightfield image with no slide in the light path demonstrating the same 
artefacts and variance in light path as visible in image A. C) Same image following 
removal of artefact and variation in illumination after background correction.  
  154 
Another method of representation of colour intensity is through the OD 
model where the optical density represents the absorbance of the light by 
that colour. This model is used for colour differentiation. The process of 
differentiating one stain from another in an image of a slide has to 
overcome the challenge of co-localisation of the stains, such as staining of 
the nucleus by both, haematoxyin and DAB stains. Many techniques of 
colour separation have been developed with good success reviewed by 
Bray et. al [390]. The commonly used and validated [403] technique for 
colour deconvolution [404] was first introduced by Ruifrok et. al. The 
process requires determining the relative RGB characteristics of the DAB 
and the haematoxylin stain. For this, samples stained with DAB only and 
also samples stained with haematoxylin only are first used to determine 
the RGB and OD values in absence of the other stain. These values can be 
mathematically normalised after representing them in an orthogonal 
matrix equation where each row represents the stain and each column 
represents the optical density values of the RGB components of each stain 
(Equation 2.3). 
 
The normalised optical densities of the counterstain (eosin in the case of 
immunohistochemistry with DAB) can be subtracted from the DAB OD 
values and the resultant values used to construct an image with just the 
outcome of the above calculations (Equation 2.3). The reconstructed 
Equation 2.3: Orthogonal matrix equation. Each row represents a stain and each 
column represents the optical density of the RGB components of each stain 
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image with just DAB can then be used to quantify the area of DAB 
staining. The dimensions were not adjusted for shrinkage of tissue. 
This software required for this process has been constructed as an open 
source plugin called Colour Deconvolution© Dr G Landini [394]. This free 
software license plugin can be included into the ImageJ software package 
and the optical density vectors of the DAB staining particular to the lab can 
be calculated and used to construct an image with DAB stain only (Figure 
2.19) 
 
The next step is quantification of the DAB stain. Before this can be 
performed, the step of thresholding is performed. This step ensures that 
nonspecific staining seen in negative control is accounted for. The images 
are quantifying after removing the background stain by the process of 
Figure 2.19: Colour deconvolution of DAB and haematoxylin stain using the ImageJ 
software plugin called ColorDeconvolution [394].  
Using custom optical density matrices calculated from slides stained with only 
haematoxylin and only DAB respectively, a DAB stained digital image (A) can be 
separated into separate images which pick out the brown stain of the DAB (B), blue 
stain of the haematoxylin (C) and the background staining (D). The image B can be 
further processed to quantify the DAB staining. 
  156 
thresholding [130]. The thresholds were standard for each experiment and 
were identified from a series of thresholding procedures available in the 
auto_threshold.jar plugin [395]. The chosen threshold showed minimal 
staining of the negative control slide (with no antibody; Figure 2.20). The 
same thresholding procedure was applied to all the sample images and the 
data obtained in pixels converted to µm2 using the calibration values 
obtained by the graticules during the image acquisition. 
 
2.10.6.1 Quantification of DAB staining in adipocytes 
The image acquisition using Volocity 6 software (Improvision Ltd, 
Coventry, UK) for the slides stained with TNFα , pJNK and GRP78 
antibodies was performed at 20 X magnification. For slides stained with 
Figure 2.20 : Images demonstrating thresholding procedure on a representative 
negative control and sample.  
A) A 10X image of a negative control tissue slide demonstrating residual 
background staining similar to DAB B) Same image as B following automatic 
threshold correction demonstrating minimal false positive uptake of the DAB stain. 
The amount of false positive uptake was corrected for by using the watershed tool. 
C) 10X image of a representative sample following colour deconvolution 
demonstrating DAB staining D) The outcome of thresholding step on image C 
demonstrating DAB staining isolation. 
A B 
C D 
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Iba1antibody, 10X magnification was used so as to cover a larger surface 
permitting analysis of infrequently occurring crown like structures in the 
tissue. The calibrated images (as described in 2.9.4.1) were then 
converted to tagged image file format (TIFF) for further analysis using 
ImageJ software. All the commands described hereafter in this section are 
summarised in Table 2.13. After performing the background correction 
using the calculator plus plugin and the tools of the ImageJ software, the 
images were cropped and surface area of adipocytes was calculated as 
described above. Images of slides stained without haematoxylin and 
without DAB were used to calculate vectors for colour deconvolution using 
the plugin (Commands: Plugins>Colour deconvolution> From ROI, show 
matrices> save log). The vectors thus generated were used to modify the 
java plugin and new vectors were saved with customised name UON DAB. 
The new vectors were then used to perform the colour deconvolution step 
in all the images. The colour deconvoluted image containing the DAB stain 
thus generated was processed by automated thresholding to exclude 
contribution of nonspecific staining. The thresholded images were 
quantified for the number and area of the stain (Analyse> analyse 
particles). The data were saved and used for statistical analysis. Notable, 
in the adipocyte the cytoplasm and the cell organelles were located as a 
thin rim on the periphery while the lipid formed the majority of the cellular 
content.  As a result the stain in the adipocyte in tissues from obese 
animals was either spread thinly along the wall or was concentrated in 
pockets of perinuclear cytoplasmic content. In order to avoid 
underestimation  introduced by increasing lipid fraction of the adipocyte 
area and in keeping with published methods [68], the immunohistological 
output was expressed as stained area per adipocyte.  
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2.11 Statistical analyses 
All animal work presented in this thesis was performed by my colleagues 
at the University of Nottingham. The intention of this thesis was to 
investigate the nutritional programming of the cell stress in the omental 
adipose tissue and liver during different early life developmental periods. 
Whilst it is important to minimise the number of animals investigated, it is 
important to ensure that the available number of liver and adipose tissue 
samples were sufficient to provide adequate sensitivity to statistical result, 
necessitating the calculation of statistical power.  
2.11.1 Statistical power and sample size 
The power of a study is defined as the probability of rejecting a null 
hypothesis when the null is false [405]. An adequately powered study will, 
therefore obtain a statistically significant result when a difference exists, 
whereas, an underpowered study may fail to demonstrate a statistical 
significance when a difference between the experimental groups exists 
Table 2.13:  Table listing the commands used in ImageJ software for quantification 
of the DAB staining in digital images. The individual steps were automated using 
the Macro functionality of the ImageJ software. The matrix for the UON DAB 
command was calculated in-house from images of slides containing no DAB and no 
haematoxylin respectively.  
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(type II error). Conventionally the power of a study is kept at 80% which 
would mean that the maximum probability of a type 2 error is 80% and 
the value of α, the probability that null hypothesis is rejected when the null 
is true (the experimental observation occurred by chance) is set at less 
than 5% (significance criterion of p<0.05).   
Ideally, for any experimental study, the sample size calculation is 
performed prospectively and requires the knowledge of the following 
variables: 
 Standard deviation in the population (s) 
 The expected effect size 
 The desired values of α (conventionally <0.05) 
 The desired power of the study (conventionally accepted at 80%) 
However, there are several factors that preclude a priori sample size 
estimation for studies such as this. Firstly, each of the multiple 
downstream experiments including physiological parameters, proteomics 
and gene expression analysis would have their own individual standard 
deviation and effect size and inclusion of each of these in sample size 
calculation is not possible. Furthermore, there is absence of a direct 
relationship between statistical effect size and clinically significant effect. 
For example, identification of a statistically significant fold change in gene 
expression, by itself, does not correspond to clinically significant outcome. 
It is therefore not possible to designate a target effect size of biological 
studies such as this. 
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Several approaches have been used to overcome the absence of a priori 
power calculation. These include: 
 prospectively calculated sample size for standardised values 
 retrospective power calculation 
 pattern recognition by analysis of biological pathways through multiple 
experiments 
For calculation of sample size and statistical power, several propriety 
software packages and online resources are available [406, 407]. However 
it is important to understand the relationship between observed effect size 
in an experiment and standardised effect size used to prospectively 
calculate sample size and power of study. In an experiment involving 
comparison of continuous variables, the sample size can be calculated 
using Snedecor and Cochran equation [407] (Equation 2.4 below)  
 
The value of C is constant for an experiment and can be obtained from 
statistical resources [407, 408]. For example, in a study design with a 
statistical power of ≥80% and a significant result of p<0.05, the value of C 
in the equation is 7.5.  
The effect size in statistics means the strength of change in a 
phenomenon. Simplistically it is represented by the difference between the 
mean values of two experimental groups (mean difference). When the 
Equation 2.4 Snedecor and Cochran equation used to calculate sample size in 
randomised experiments involving comparison between two groups of continuous 
variables. 
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standard deviation of the two groups is taken to account, it can be 
standardised to standardised mean difference (Cohen’s d). After 
completion of an experiment or in a pilot study, this can be calculated 
using the observed means and standard deviations [409, 410]. However, 
for prospective sample size calculations, in absence of observed effect size, 
standardised values are used for small, medium, or large effect size and 
are represented by accepted values of Cohen’s d as 0.2d, 0.5d and 0.8d 
respectively [409]. 
Therefore, using the Snedecor equation, the recommended sample size for 
an experiment with 10% standard deviation designed to study a 
standardised mean difference of 20% would be >4.5 in each group. Even 
after accounting for losses due to death of offspring, the minimum sample 
size in the study groups is 7 animals. This study therefore permits 
experiments to be performed with minimum power of 80% and statistical 
significance of 0.05 as for experiments where the ratio between the 
standard deviation and the standardised mean difference is >1.53.  
In absence of prospective power calculation, retrospective power 
calculations (observed power) can be performed using SPSS. However, the 
appropriateness of such an approach has been disputed [405, 406, 411]. 
The opponents of such practice state that whilst the effect size and 
standard deviations from an experiment can be useful tools for planning a 
future experiment, in the absence of a non-significant result, a 
retrospective analysis  of observed power is a 1:1 function of the p value 
[411] and in absence of statistical significance, the calculated power 
cannot be interpreted. The supporters of retrospective power analysis 
[405] have argued that identification of high value of observed power in 
retrospective analysis is helpful as it demonstrates that non significance 
occurred due to absence of phenomenon. However, a low value of 
observed power on retrospective analysis is not able to differentiate 
  162 
whether the non-significance is the outcome of a type II error or a genuine 
absence of phenomenon.  
The third strategy used to minimise error in correlation between statistical 
result and clinical phenomenon involves investigation of multiple 
components of same biological pathway through various means including 
laboratory assays, gene expression and proteomics study. Findings of such 
descriptive experiments inform further detailed analysis and also provide 
valuable statistical data for prospective sample size calculation.  
2.11.2 Choice of statistical tests 
The statistical analysis was performed using IBM SPSS Statistics version 
22 software (IBM Corp©). For analysing continuous variables orginating 
from distinct groups such as those in this study, the choice of statistical 
test depend the distribution of the data around the mean. The data can 
thus be normally distributed around the mean or have a skewed 
distribution. During statistical analysis, Shapiro-Wilks test analysis was 
performed to determine the distribution of data. The relevant parametric 
test was performed for data found to be normally distributed around the 
mean. For data demonstrated to have a non-normal distribution, retesting 
was performed following logarithamic transformation. If the transformed 
data were also not normally distributed, appropriate non parametric test 
was performed as described below. 
2.11.2.1 Comparison of variables originating from two groups 
Data analysis typically involves comparison of means of dependant 
variables from comparable experimental groups. If the experimental study 
compares two independent groups (Chapter 4), and data meet the 
assumptions of homogeneity of variance and normal distribution, the 
independent t-test was performed. IBM SPSS automatically carries out the 
Levene’s test of homogeneity of variance during such testing and if the 
  163 
homogeneity of variance was deemed to be unequal (Levene’s p<0.05) the 
outcome of adjusted t statistic was used. 
If the data were not normally distributed despite log10 transformation of 
data, Mann Whitney U test was used for statistical analysis of the 
continuous data. 
2.11.2.2 Data analysis in factorial study design 
Continuous data originating from more than two independent groups (as is 
the case in Chapters 3 and 5) cannot be compared using multiple t testing 
as such a procedure would increase the probability that any significant 
finding is a type I error (called familywise error). This is because as more 
tests are conducted, the likelihood that one or more are significant just 
due to chance increases. Such data are therefore first analysed using an 
omnibus test like ANOVA which first attempts to identify overall 
experimental effect, a finding which is then confirmed by comparison 
between individual groups.  
A factorial study design analyses for interaction between two or more 
variables. For example the experiment to determine the effect of late 
gestational nutrient restriction (N) and obesogenic environment (O) on the 
gene expression for CD68, analyses combinations of two different 
independent variables (nutrient restriction and obesogenic environment). 
This experiment is designed not just to study the impact of these 
independent variables but also their interaction with each other. The 
output of the omnibus test used in such studies– independent design 
factorial ANOVA will demonstrate the individual impact of N and O (output 
described as main effect) on the gene expression of CD68 and also if any 
interaction is present between N and O (output described as interaction 
effect) that impact this gene expression. Such an interaction could be 
ordinal interaction – for example if CD68 gene expression had increased 
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with obesity but in the nutrient restricted group, the increase was 
significantly more, exaggerating the value of the outcome variable (Figure 
2.21) . In contrast, disordinal interaction would mean that the two 
variables interact to oppose each other’s direction of change. Thus a 
statistically significant outcome of factorial ANOVA indicates presence of 
overall difference in the means under comparison and the presence of an 
interaction. However, it does not provide details of the direction or the 
extent of the difference between individual groups in the experiment for 
which further testing is required.  
  
In the presence of a significant outcome of factorial ANOVA, indicating 
either presence of main effects or that of an interaction between the 
factors under investigation, a hypothesis driven simple main effects 
analysis can be performed to perform sub group analysis. This pairwise 
comparison between combinations of the treatment groups ensures that 
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Figure 2.21 Representative graphical examples demonstrating ordinal (A) and 
disordinal (B) interaction between two variables with dotted arrows denoting the 
direction of the change.  
In Figure A, the direction of change in gene expression in response to the two 
variables (obesity with groups lean and obese and nutrient restriction with groups 
fed to appetine (A) and nutrient restricted (N)) is same which would be an ordinal 
interaction between the two variables. Figure B demonstrates disordinal interaction 
where the direction of change in gene expression with the two variables is opposite. 
The gene expression increases with obesity, whereas it is decreasing with nutrient 
restriction.  
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the familywise error rate is less than the commonly accepted value of 
0.05. If the number of sub-groups in a factorial analysis are three or 
greater, a post hoc test such as Bonferroni needs to be performed. 
However, in a two by two comparison, such post hoc testing is neither 
required nor possible [412, 413]. In SPSS, a simple effects sub-group 
analysis is not available using custom tools. This was performed using 
Syntax. The syntax for a representative example of simple effects analysis 
is demonstrated in Figure 2.22.  
 
For data which did not confirm to a normal distribution, the 2 way ANOVA 
is considered a robust test for analyses of data which are of non-normal 
distribution [414]. However, in keeping with established practise, 
independent samples Kruskal-Wallis test followed by Mann Whiney was 
performed to confirm the findings of ANOVA testing and results were 
reported as significant only when confirmed by the non-parametric tests. 
However, there is no current method to perform the equivalent of simple 
effect analysis of subgroups in the event of a statistically significant 
Kruscall-Wallis test. It was necessary to deduce likely difference by 
inspection of the medians followed by performance of Mann Whitney U test 
between the identified sub-groups. For sake of uniformity of presentation 
and in keeping with standard practice, data were expressed as mean and 
Figure 2.22 Representative example of Syntax used for simple main effects analysis 
performed following identification of a significant effect or interaction in two-way 
ANOVA procedure. 
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standard error of the mean for all the experimental output irrespective of 
the type of distribution of the data. 
2.11.2.3 Analysis of data involving repeated measures 
Statistical analysis of a series of data collected over time for the same 
subject need to account for the repeated measures to prevent occurrence 
of a type I error. For studies with factorial designs and repeated measures, 
the purpose of the statistical test is to understand group differences over 
time where groups are formed by the combination of between-subjects 
factors. In such a scenario, time is included as an independent factor that 
is common to the subject (within-subject factor) in addition to the 
experimental conditions, which differ between the subjects (between-
subject factors). 
A two-way mixed ANOVA is the choice of statistical test if the design 
consists of a combination of one within-subject factor and one between-
subject factor. For example, a study where animals were fed either 
formula milk of mother’s milk (type of feed is the between-subject factor) 
have body weight measurements recorded every 2 weeks for 8 weeks 
(serial body weight measurements are the within subject factors).  
If the study design has one within-subject factor in addition to two 
between-subject factors, the analysis is performed using a three-way 
mixed ANOVA. For example, three-way mixed ANOVA is used in an study 
where body weight is measured every 2 weeks for 8 weeks (within-subject 
factor) in animals that differ in combination of two different variables such 
as type of feed and mother’s nutrition (between-subject factors).  
Mixed ANOVA testing identifies interaction amongst the variables as an 
omnibus test and, by itself, does not specify which specific groups within 
each factor were significantly different from each other. In the presence of 
an interaction between experimental factors, additional testing is the 
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required to identify specifics of differences between groups. When this 
additional testing explores effect of combinations of experimental factors, 
it is called simple effects analysis and when this analysis explores the 
effect of the experimental interventions they are called main effects 
analysis. For example, the main effect analysis for the three way study 
design described above would explore the effect of type of feed 
irrespective of maternal nutrition whereas a simple effect analysis would 
explore the difference between animals who had same feed type (example 
formula feeds) but differed in maternal nutrition.   
Application of two-way or three-way mixed ANOVA testing method is 
conditional upon confirmation of data characteristics such as normal 
distribution, sphericity, homogeneity of variance and absence of large 
outliers [415]. Appropriate transformations to the data as described in 
Section 2.11.2 can be attempted to make the data fit the required data 
characteristics. Post hoc correction for multiple comparisons is required if 
the number of subgroups in a factorial analysis are three or greater. 
However, in a two by two comparison, such post hoc testing is neither 
required nor possible [412, 413] 
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3 The effect of prenatal nutrient restriction and 
obesity on the cell stress response and metabolic 
inflammation in liver and adipose tissue 
 
3.1 Introduction and hypothesis 
This chapter describes the outcome of an investigation performed to study 
the following two questions: 
1. does obesity promote cell stress and inflammation in the liver and 
adipose tissue? 
2. does late gestational nutrient restriction (NR-LG) of the mother 
enhance the effects of cell stress in the liver and adipose tissue in the 
young adult offspring?  
In addition to being important in the body’s metabolic functions, adipose 
tissue and the liver are organs capable of initiating and modulating a 
cellular stress response and metabolic inflammation in response to a 
stressful environment [39, 212]. Interventional experiments in small 
animal models [40] and descriptive studies in humans [41, 387] have 
demonstrated the role of cell stress responses and metabolic inflammation 
in both liver [163, 416] and adipose tissue [21] in the development of 
obesity related insulin resistance. Studies of the Dutch Famine cohort 
described in Section 1.6.2.1 revealed that, in comparison to a control 
group of individuals not exposed to in utero undernutrition, offspring of 
women experiencing severe undernutrition in the third trimester had 
reduced birth weight [258] and impaired glucose tolerance at a mean age 
of 50 years [261], a finding which was confirmed when the glucose 
tolerance testing was repeated at the age of 58 years [417]. This cohort 
also had abnormal lipid profiles [418]. 
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As discussed in Section 1.6.2.1, animal experiments in sheep models of 
NR-LG have demonstrated compromised glucose and insulin profiles when 
compared to offspring of sheep fed to requirements [315]. Sharkey et al. 
demonstrated increased gene expression for CD68 and  TLR4 in the 
visceral adipose tissue of juvenile sheep who had experienced NR-LG 
[275]. In another study, early gestational nutrient restriction led to 
differential alteration of the ER stress response and inflammation in 
visceral (perirenal) adipose tissue and kidney associated with increased 
CLS in adipose tissue following juvenile onset obesity [68]. There have 
been no large animal interventional studies to characterise the cell stress 
response to obesity in the liver or other adipose tissue depots or which 
have examined the potential of developmental programming of this cell 
stress response pathways as pathogenic mechanisms for the metabolic 
morbidity of individuals exposed to in utero NR-LG. 
The experiments described in this chapter investigate the following 
hypotheses (summarised in Figure 3.1). 
1. It is hypothesised that increased fat deposition in liver and features 
of non-alcoholic fatty liver disease in obesity would be associated 
with increased gene expression of the regulators and components 
of the cell stress response. 
2. It is hypothesised that obesity would lead to increased adipocyte 
size in the visceral fat depot located around the omentum, greater 
abundance of macrophage infiltration and CLS and raised gene 
expression of components of cell stress response and metabolic 
inflammatory pathways as compared to non-obese animals.  
It is hypothesised that NR-LG would, by the process of developmental 
programming, promote cell stress within the liver and adipose tissue, 
thereby exacerbating metabolic inflammation. It is predicted that this 
would manifest as further augmentation in the gene expression of 
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pathways of cell stress response and metabolic inflammation. Ultimately, 
this would further compromise metabolic homeostasis and decreased 
insulin sensitivity in the offspring born to nutrient restricted mothers. 
 
 
  
Figure 3.1 Schematic flow chart summarising the study hypothesis and expected 
outcomes of the investigation.  
Offspring of pregnant sheep allowed to feed to appetite during late gestation were 
either raised in an environment allowing physical activity resulting in a lean 
phenotype (A-L) or were raised in a restricted obesogenic environment leading to 
an obese phenotype (A-O). Offspring of ewes nutrient restricted during late 
gestation were either raised in an environment allowing physical activity resulting 
in a lean phenotype (N-L) or were raised in a restricted environment resulting in 
an obese phenotype (N-O). The various experiments performed are marked next to 
the stage in the proposed pathogenic process in the experimental hypotheses. 
NAFLD, Non-Alcoholic Fatty Liver Disease; IHC, Immunohistochemistry. 
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3.2 Methods 
The design of the study, animal interventions and all experimental 
methods used to establish the results described in this chapter are 
described in detail in the Chapter 2. Briefly, after confirmation of twin 
gestation by ultrasound scanning, twin bearing ewes were randomised to 
either nutrient restriction (N) from gestational day 110 until term (145±2 
days) or fed to appetite (A) during the same period. After birth, twin 
offspring were all reared by their mother until weaning at 90 days of age 
when they were separated to be reared in an environment restricting 
physical activity leading to obesity (O) or an environment allowing normal 
physical activity in which they remained lean (L). The combination of 
prenatal (A and N) and postnatal factors (L and O) develops a factorial 
experimental design of four groups (A-L, A-O, N-L and N-O) as depicted in 
Figure 3.2. The control group for the experiments described in this study is 
the A-L group.  
During pregnancy, blood sampling was performed from the ewe at 130 
days gestational age and plasma was analysed for concentrations of 
glucose, insulin, non-esterified fatty acids (NEFA) and triglycerides. 
Following delivery of the lambs, birth weight was recorded followed by 
regular body weight measurements; physical activity was measured using 
accelerometers at age 1.5 months and 15 months; glucose tolerance tests 
and blood sampling was performed at age 7 months and 16 months 
respectively; body composition analysis was performed by DXA scanning 
at 16 months of age. All the animals were humanely euthanased at 17 
months of age and, after weighing organs, representative samples from 
liver and adipose tissue were taken, snap frozen in liquid nitrogen and 
stored at -80°C until further processing.  
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The output of laboratory experiments, which were performed in duplicate, 
was only accepted for analyses if the coefficient of variation between the 
experimental replicates was less than 5%. The statistical analyses has 
been described in Chapter 2. Briefly, for the factorial study design, the 
data were first interrogated with two-way analysis of variance (2-way 
ANOVA). Upon identification of a significant effect or interaction in the 2-
way ANOVA, a hypothesis driven simple main effects analysis was 
performed for comparison between groups differing in only one factor 
(prenatal nutrient restriction or environment of rearing). Although the 2-
way ANOVA is considered robust for analyses of data which are not 
Figure 3.2 Schematic diagram depicting the factorial experimental design for study 
of interaction of prenatal nutrient restriction and postweaning rearing environment.  
From 110 days gestational age (dGA) to term, twin bearing ewes were fed to 
appetite (A) and, following the suckling period (birth - 90 days), twin offspring were 
separated either to rearing in an environment restricting physical activity leading to 
obesity (A-O) or to an environment allowing physical activity where they remained 
lean (A-L). Twin bearing ewes were nutrient restricted to 60% of their caloric 
requirements during late gestation (N) and, after weaning, one of the twin offspring 
was reared either in an environment restricting physical activity leading to obesity 
(N-O) or in an environment allowing physical activity where they remained lean (N-
L). During the suckling period, the offspring were reared together with their mother 
in all groups. DXA, dual-energy X-ray absorptiometry; GTT, glucose tolerance test; 
dGA, days gestational age. 
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normally distributed [414], non-parametric testing using Kruskal-Wallis 
test followed by Mann Whitney was performed for any such data for 
confirmation of the ANOVA findings. Outcome for GTT and body weight 
measurements produced data with repeated measures in same animal 
over time. Analyses for such data with repeated measures were performed 
with two way or three way mixed ANOVA. Time was analysed as within 
subject factor to assess for interaction between time and experimental 
conditions (between-subject factors). For sake of uniformity of 
presentation and in keeping with standard practice, data have been 
expressed as means and standard error of the means for all the 
experimental output irrespective of the distribution of the data.   
The inequality of numbers in the final experimental groups, as depicted in 
Figure 3.2 is the result of offspring death at various ages. A total of 4 
offspring died or were lost to follow-up. This represents 10% loss in the 
overall experiment and is in keeping with standard mortality rates in sheep 
experimental studies [329, 330].  
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3.3 Results 
3.3.1 Maternal and offspring metabolic profile 
3.3.1.1 Weight gain and metabolic parameters of pregnant 
ewes 
At the time of randomisation at 110 days of gestation, the body weight of 
ewes randomised to nutrient restriction (N, n=10, 73.2 ±1.8 kg; mean ± 
SEM) or to feeding to appetite (A, n=10, 71.9 ± 1.7 kg) was not 
statistically different (p=0.87). Two-way mixed ANOVA was performed and 
time (dGA) was included as a within subject factor to account for repeated 
measures. There was a statistically significant interaction between the 
maternal nutrition and time on body weight expressed as percentage of 
weight at the beginning of intervention (p<0.001). Upon simple effects 
analysis, the ewes randomised to nutrient restriction were identified to 
have significantly lower body weight at 120dGA, 130 dGA and at delivery 
(Figure 3.3). 
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Figure 3.3 Maternal weight gain during late gestation, expressed as percentage 
gain over the weight at 110 days of gestation (dGA). 
Ewes were fed a diet delivering 60% of caloric requirements (N, red, n=10) or were 
allowed to feed to appetite (A, blue, n=10) between 110 – 145 dGA. Two-way mixed 
ANOVA was performed with time (dGA) as within subject factor to account for 
repeated measures.  **p<0.001 for N versus A simple main effect comparison. Data 
are means with error bars representing SEM. 
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At 130 dGA, 20 days into the nutritional intervention, the N ewes had 
lower plasma insulin and glucose concentrations and higher plasma NEFA 
as compared to A ewes (Figure 3.4 A, B and C). Plasma cortisol 
concentrations at 130 days gestational age did not differ between N 
(26.9± 5.4 nmol/L) and A (18.0 ± 4.8 nmol/L) ewes. 
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Figure 3.4 Fasting plasma insulin (A), glucose (B), non-esterified fatty acids (NEFA, 
C) and triglyceride (D) concentration measured from plasma taken at 130 days of 
gestational age from ewes randomised as described to nutrient restriction (N, red, 
n=9) or allowed to feed to appetite (A, blue, n=10) between 110 – 145 days 
gestational age. Data are means with error bars representing SEM *p<0.05 and 
**p<0.001 for N versus A comparison. Data analysed by Mann-Whitney U test for 
plasma insulin and glucose concentrations. 
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3.3.1.2 Offspring birth weight and weight gain and physical 
activity phenotype during the suckling period 
The birth weight of twin offspring of ewes randomised to restricted 
nutrition (N) during late gestation was lower as compared to offspring of 
the A ewes (N: 4.07 ± 0.14 kg; A: 4.63 ± 0.16 kg; p=0.02).  The mean z-
score of the birth weight of N offspring was -3 in comparison to the birth 
weight of the A group. Two-way mixed ANOVA to account for repeated 
measures with time (age) as within subject factor analysis did not identify 
a significant interaction between the experimental groups and time 
(p=0.19). Pairwise comparison demonstrated that the N offspring 
remained lighter in body weight as compared to the A offspring during for 
the main effect of prenatal intervention (p=0.024, Figure 3.5). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  178 
 
 
 
  
0
5
10
15
20
25
30
0 30 60 90
W
e
ig
h
t 
(k
g
)
Postnatal age (days) A N
Figure 3.5 Weight gain during the suckling period (birth to 90 days) in offspring of 
ewes randomised as described to nutrient restriction (N, red, n=16) or allowed to 
feed to appetite (A, blue, n=19) between 110 – 145 days gestational age. Data are 
means with error bars representing SEM. Two-way mixed ANOVA was performed 
with time (age) as within subject factor to account for repeated measures. p=0.19 
for interaction between prenatal intervention and time.  p=0.024 for overall main 
effect of prenatal nutrition. 
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Body weight gain relative to birth weight (relative weight gain) was not 
different between the N and R groups (Figure 3.6) 
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Figure 3.6 Body weight fold change relative to birth weight (i.e. relative weight 
gain) in offspring of ewes randomised as described to nutrient restriction (N, red, 
n=16) or allowed to feed to appetite (A, blue, n=19) during late gestation. Data are 
means with error bars representing SEM. 
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Physical activity measurements were recorded using accelerometers and 
expressed as unit counts and analysed as mean activity over a 24 hour 
period. Mean activity, duration of activity and maximum intensity of 
activity did not differ in the offspring of N and A ewes at age 45 days 
(Table 3.1). 
 
 
Physical activity parameter 
 
A N 
 
Mean activity  
(counts) 
 
160 ± 14 173 ± 11 
 
Duration mobile in 24 hours 
(minutes) 
 
931 ± 64 963 ± 51 
 
Maximum intensity of physical 
activity (counts) 
 
2972 ± 183 3148 ± 347 
  
Table 3.1 Physical activity parameters at 45 days of age in offspring of ewes 
randomised as described to nutrient restriction (N, n=18) or allowed to feed to 
appetite (A, n=19) during late gestation. Data are displayed as means ± SEM. 
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3.3.1.3 Effect of the environment of rearing on the body 
weight, physical activity parameters and the adipose tissue 
depots 
Statistical analysis was performed using three-way mixed factorial ANOVA 
to account for witnin subject factor of time as a repeated measure. The 
three-way interaction between age, prenatal nutrition and rearing 
environment were not statistically significant (p=0.41). There was a 
significant two-way interaction between environment of rearing and age 
(p=0.001). There were statistically significant simple main effects of 
obesity on weight on measurements after age 12 month (p=0.001, Figure 
3.7). 
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Figure 3.7 Effect of the post-weaning environment on body weight in offspring of 
sheep fed to appetite during late gestation and reared for a lean phenotype (A-L; 
n=9) or obese phenotype (A-O; n=10) and offspring of sheep nutrient restricted 
during late gestation reared for a lean phenotype (N-L; n=9) or obese phenotype 
(N-O; n=7). A three-way ANOVA was performed to account for repeated 
measurement of weight at different timepoints. *p<0.05 for obese versus lean 
simple main effects following a significant two-way interaction between 
environment of rearing and time.  Data are expressed as means with error bars 
representing SEM. 
  182 
 
Physical activity quantified using accelerometer demonstrated decreased 
physical activity in both groups raised in obesogenic environment (A-O and 
N-O) in comparison to their lean comparison groups (A-L and N-L 
respectively). The duration of mobility was not different in any 
comparisons and the measurements for the maximum intensity of physical 
activity were higher in N-L group as compared to the N-O group (Table 
3.2). 
 
Physical  
activity 
parameter 
Maternal  
nutrition 
Phenotype Prenatal 
Nutrition 
Obesity Inter-
action 
 Lean Obese p value p value p value 
        
Mean 
activity 
(counts) 
A 471±67c 150± 13d 0.91 <0.001 0.21 
N 536±69c 74±33d    
       
Duration 
mobile in 24 
hours 
(minutes)  
A 1018±52 940±68 0.62 0.68 0.87 
N 984±54 541±199    
       
Maximum 
intensity of 
activity 
(counts)  
A 1670±149 1553±131 0.45 <0.01 0.20 
N 1956±168a 1221±77b    
  
Table 3.2 Physical activity parameters at 12 months of age for offspring of sheep 
fed to appetite during late gestation and reared for a lean phenotype (A-L; n=9) or 
obese phenotype (A-O; n=10) and offspring of sheep nutrient restricted during late 
gestation reared for a lean phenotype (N-L; n=9) or obese phenotype (N-O; n=7). 
Data are displayed as means ± SEM. Non parametric Kruskal-Wallis tests followed 
by Mann-Whitney test performed for all comparisons for confirmation of ANOVA 
outcome. Statistical difference denoted by superscripts a versus b, p<0.05; c versus 
d, p<0.001  
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The weights of visceral adipose tissue depots of omental, pericardial and 
perirenal adipose tissue sampled following euthanasia at 17 months of age 
were significantly increased in offspring raised in obesogenic environment 
as compared to the respective comparative groups. Prenatal nutrient 
restriction had no impact on the adipose tissue weight (Table 3.3)  
Adipose 
depot 
(g) 
Maternal 
nutrition 
Phenotype Prenatal 
nutrition 
Obesity Interaction 
  Lean Obese p value p value p value 
 Omental 
A 313±65c 1526±163d 0.87 <0.001 0.39 
N 224±56c 1655±151d    
 Pericardial 
A 66±10a 101±9b 0.73 <0.001 0.24 
N 59±16c 116±14d    
 Perirenal 
A 279±43c 1003±119d 0.84 <0.001 0.62 
N 252±37c 1014±104d    
  
Table 3.3 Weight of omental, pericardial and perirenal adipose tissue depots at age 
17 months for offspring of sheep fed to appetite during late gestation and reared 
for a lean phenotype (A-L; n=9) or obese phenotype (A-O; n=10) and offspring of 
sheep nutrient restricted during late gestation reared for a lean phenotype (N-L; 
n=9) or obese phenotype (N-O; n=7). Data are displayed as means ± SEM. 
Statistical difference denoted by superscripts a versus b, p<0.05; c versus d, 
p<0.001 for simple effects analysis following 2-way ANOVA. 
  184 
The fat free and total fat mass was calculated from DXA scan at 16 months 
of age and demonstrated an increase in the calculated total body fat 
content when the offspring were reared in an obesogenic environment as 
compared to the respective lean groups. Prenatal NR-LG had no impact on 
the calculated total fat content. To calculate the relative proportion of 
visceral and non-visceral adipose tissue, the known quantity of visceral fat 
depots (omental+pericardial+perirenal fat) were used to calculate the 
relative proportion of visceral and non-visceral fat content of the body 
(Figure 3.8).  
 
  
Figure 3.8 Relative proportion of visceral and non visceral adipose tissue weight at 
age 17 months for offspring of ewes allowed to feed to appetite during late 
gestation (blue) and reared to a lean phenotype (n=9) or to an obese phenotype 
(n=10). Offspring of ewes nutrient restricted during late gestation (red) were 
raised to a lean phenotype (n=9) or to an obese phenotype (n=7). The grey area of 
the histogram represents proportion of non visceral fat mass. **p<0.001 for simple 
effects analysis following 2-way ANOVA. 
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Expressed as a percentage of the total fat content, the proportion of 
visceral fat was significantly increased in the offspring raised in an 
obesogenic environment as compared to the respective lean comparison 
groups, demonstrating a predisposition to increased visceral fat deposition 
as a response to rearing in an obesogenic environment (Table 3.4). 
 
 Maternal 
nutrition 
Phenotype Prenatal 
Nutrition 
Obesity Interaction 
 Lean Obese p value p value p value 
       
Body 
weight at 
DXA (kg) 
A 59.6±3.2a 75.6±4.5b 0.13 <0.001 0.86 
N 52.7±1.3a 70.1±5.7b    
       
Total FAT 
mass from 
DXA (kg)  
A 4.4±0.6c 10.3±1.1d 0.60 <0.001 0.97 
N 3.9±0.5a 9.9±0.7b    
       
Relative 
fat mass 
from DXA 
(%)  
A 7.3±0.7c 13.6±1.2d 0.87 <0.001 0.39 
N 7.5±0.9c 14.4±1.0d    
 
Visceral 
fat as % 
of total fat 
(%) 
      
A 14.8±0.7c 26.1±1.3d 0.82 <0.001 0.60 
N 13.4±1.2c 28.1±1.8d    
      
      
  
Table 3.4 Body weight and fat content parameters calculated and extrapolated from 
DXA measurements for offspring of ewes fed to appetite during late gestation (A) 
were either reared to a lean phenotype (n=9) or to an obese phenotype (n=10). 
Lambs born to ewes given nutrient restricted diet during late gestation (N) were 
either reared to a lean phenotype (n=8) or to obese phenotype (n=7). Data are 
displayed as means ± SEM. Statistical difference denoted by superscripts a versus 
b, p<0.05; c versus d, p<0.001 for simple effects analysis following 2-way ANOVA. 
DXA, dual-energy X-ray absorptiometry. 
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3.3.1.4 Plasma metabolic profile at the age of 7 months 
The glucose measurements were analysed using three-way mixed ANOVA 
to account for repeated measures of glucose at different timepoints. There 
was a significant three-way interaction between the prenatal nutrition, 
environment of rearing and time (p=0.019). There was no statistically 
significant two-way interaction of prenatal nutrition and environment of 
rearing at any timepoint (Figure 3.9 A). NR-LG had no impact on the 
glucose measurements taken in offspring at 7 months of age.  For the 
plasma insulin concentrations (Figure 3.9 B), the statistical analyses was 
not significant for a three-way interaction between experimental conditions 
and time (p=0.39). Further analysis did not identify a two-way interaction 
between the prenatal nutrition and time (p=0.32) or environment of 
rearing and time (p=0.52). Simple main effect test for two-way interaction 
between prenatal nutrition and environment of rearing was also not 
significant (p=0.32). 
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Figure 3.9 Plasma glucose (A) and insulin (B) concentrations during a glucose 
tolerance test performed at the age of 7 months.  
Offspring of ewes allowed to feed to appetite during late gestation were either 
raised to a lean phenotype (A-L, blue diamond, dashed line, n=7) or to obese 
phenotype (A-O, blue circle, continuous line, n=9). Offspring of ewes nutrient 
restricted during late gestation were either raised to a lean phenotype (N-L, purple 
square, dashed line, n=5 for glucose and 7 for insulin) or to obese phenotype (N-
O, red square, continuous line, n=7).  *p<0.05 for A-L versus A-O comparison; 
#p<0.05 for N-L versus N-O comparison. Data are expressed as means with error 
bars representing SEM. 
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At 7 months of age, the raised glucose for obese animals during the GTT 
were reflected in the increased area under the curve (AUC) for glucose 
(Table 3.5), but the calculation of the surrogate marker for insulin 
sensitivity measured by homeostatic index-IR (HOMA-IR) was not 
increased by any experimental intervention.  
 
 
Maternal 
nutrition 
Phenotype 
Prenatal 
nutrition 
Obesity Interaction 
 Lean Obese p value p value p value 
       
Area under the 
curve glucose 
(mmol/L) 
A 1370±67a 1593±61b 0.90 <0.01 0.69 
N 1377±64a 1549±44b    
       
Area under the 
curve insulin 
(ng/ml) 
      
A 49.1±6.9 51.6±6.1 0.95 0.23 0.40 
N 43.2±5.2 56.7±7.9    
      
       
HOMA-IR  
A 5.57±0.2 5.54±0.6 0.27 0.61 0.64 
N 6.89±1.8 6.07±0.4    
       
  
Table 3.5 Markers of insulin sensitivity expressed as area under the curve and 
HOMA-IR calculated from glucose tolerance test performed at age 7 months. Lambs 
born to ewes fed to appetite during late gestation (A) were either reared to a lean 
phenotype (n=7) or obese phenotype as described (n=9). Lambs born to ewes 
given nutrient restricted diet during late gestation (N) were either reared to a lean 
phenotype in (n=7 for area under the curve and 5 for HOMA-IR) or obese phenotype 
(n=7). Data are displayed as means ± SEM. Statistical difference denoted by 
superscripts a versus b, p<0.05; simple effects analysis following 2-way ANOVA. 
HOMA-IR, homeostatic index- insulin resistance. 
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The plasma triglyceride and the plasma non esterified fatty acids (NEFA) 
concentrations were similar in all groups (Table 3.6). As expected, plasma 
leptin was increased in obese animals in comparison to their respective 
lean comparison groups, although the comparison between the N-L and N-
O groups did not achieve statistical significance. The morning plasma 
cortisol samples did not differ between any experimental groups. 
 
 
Prenatal 
nutrition 
Phenotype 
Prenatal 
nutrition 
Obesity Interaction 
 Lean Obese p value p value p value 
       
Plasma 
triglyceride 
(mg/dL) 
A 0.20±0.02 0.14±0.02 0.84 0.36 0.92 
N 0.20±0.03 0.14±0.02    
       
Plasma 
NEFA 
(mmol/L)  
A 1.32±0.11 1.34±0.18 0.79 0.55 0.48 
N 1.39±0.21 1.18±0.13    
       
Plasma 
cortisol 
(nmol/L)  
A 48.7±11.7 92.7±24.5 0.27 0.14 0.24 
N 50.1±11.7 55.1±7.8    
       
Plasma 
leptin 
(ng/ml) 
A 1.18±0.12c 1.98±0.19d 0.36 <0.01 0.36 
N 1.55±0.26 1.98±0.15    
      
  
Table 3.6 Plasma metabolic profile in the fasted state at the age of 7 months 
Lambs born to ewes fed to appetite during late gestation (A) were either reared to 
a lean phenotype (n=7) or obese phenotype as described (n=9). Lambs born to 
ewes given nutrient restricted diet during late gestation (N) were either reared to 
a lean phenotype in (n=7) or obese phenotype (n=7). Data are displayed as means 
± SEM. Statistical difference denoted by superscripts c versus d, p<0.001; simple 
effects analysis following 2-way ANOVA. NEFA. Non esterified fatty acids. 
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3.3.1.5 Plasma metabolic profile at the age of 16 months 
During the GTT at 16 months, the plasma glucose and insulin 
measurements were analysed using three-way mixed ANOVA to account 
for repeated measurements. The analysis for three-way interaction 
between prenatal nutrition, environment of rearing and time was not 
statistically significant (p=0.765). Further analyses for two-way interaction 
did not demonstrate a significant interaction between prenatal nutrition 
and time (p=0.74), environment of rearing and time (p=0.45) or between 
prenatal nutrition and environment of rearing (p=0.79). The plasma insulin 
concentrations did not demonstrate a significant three-way interaction 
between prenatal nutrition, environment of rearing and time (p=0.874). 
Analysis for 2 way interaction also did not demonstration between prenatal 
nutrition and environment of rearing (p=0.221) or for environment of 
rearing and time (p=0.12). The interaction between prenatal nutrition and 
time approached statistical significance (p=0.058, Figure 3.10 B).  
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Figure 3.10 Plasma glucose (A) and insulin (B) concentrations during a glucose 
tolerance test performed at the age of 16 months. 
Lambs born to ewes fed to appetite during late gestation were either reared to a 
lean phenotype (A-L, blue diamond, dashed line, n=7) or obese phenotype as 
described (A-O, blue circles, continuous line, n=8). Lambs born to ewes given 
nutrient restricted diet during late gestation were either reared to a lean phenotype 
(N-L, red diamond, dashed line, n=8) or obese phenotype (N-O, red circles, 
continuous line, n=6 for glucose and 5 for insulin). Statistical analysis performed 
using three-way mixed ANOVA to account for repeated measures. Data are 
expressed as means with error bars representing SEM. 
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The AUC for insulin response to GTT was significantly increased in obese 
offspring as compared to their lean counterparts. This finding, suggestive 
of insulin resistance, is supported by the values of HOMA-IR for sheep at 
age 16 months where the A-O group had significantly higher values 
compared to the A-L group (Table 3.7). 
 
 Prenatal 
nutrition 
Phenotype Prenatal 
nutrition 
Obesity Interaction 
 Lean Obese p value p value p value 
AUC glucose 
(mmol/L) 
      
A 1403±52 1402±40 0.17 0.73 0.71 
N 1455±39 1491±69    
      
AUC insulin  
(ng/ml) 
      
A 31.7±14.8a 67.7±9.1b 0.60 <0.001 0.60 
N 15.7±3.9a 49.8±14.5b    
HOMA-IR  
      
A 2.8±0.1c 4.3±0.4d 0.31 <0.001 0.90 
N 3.0±0.1 3.6±0.3    
      
 
  
Table 3.7 Markers of insulin sensitivity expressed as area under the curve insulin 
and HOMA-IR calculated from glucose tolerance test performed at age 16 months.  
Lambs born to ewes fed to appetite during late gestation (A) were either reared to 
a lean phenotype (n=9) or obese phenotype as described (n=8). Lambs born to 
ewes given nutrient restricted diet during late gestation (N) were either reared to 
a lean phenotype in (n=8) or obese phenotype (n=5). Data are displayed as means 
± SEM. Statistical difference denoted by superscripts a versus b, p<0.05; c versus 
d, p<0.001 (simple effects analysis following 2-way ANOVA). HOMA-IR, 
homeostatic index- insulin resistance. 
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Plasma leptin concentrations at 16 months of age were higher than the 
measurements performed at 7 months age in all groups. Furthermore, 
similar to the findings at 7 months of age, the A-O group had significantly 
higher plasma leptin concentrations as compared to the A-L group. There 
was no difference in the concentrations of plasma triglycerides, plasma 
NEFA or early morning plasma cortisol measurements (Table 3.8) 
 
 
Prenatal 
nutrition 
Phenotype 
Prenatal 
nutrition 
Obesity Interaction 
 Lean Obese p value p value p value 
Plasma 
triglyceride 
(mg/dL) 
      
A 0.13±0.01 0.14±0.01 0.91 0.48 0.14 
N 0.16±0.01 0.12±0.02    
Plasma 
NEFA 
(mmol/L) 
      
A 0.36±0.05 0.42±0.06 0.18 0.23 0.71 
N 0.43±0.07 0.53±0.06    
Plasma 
Cortisol 
(nmol/L) 
      
A 26.3±4.7 47.3±15 0.63 0.08 0.70 
N 21.9±3.8 41.9±11.6    
Plasma 
leptin 
(ng/mL) 
      
A 2.6±0.3c 4.5±0.4d 0.83 <0.01 0.14 
N 3.1±0.2 3.8±0.5    
      
  
Table 3.8 Plasma metabolic profiles in the fasted state at the age of 16 months.  
Lambs born to ewes fed to appetite during late gestation (A) were either reared to 
a lean phenotype (n=9) or obese phenotype as described (n=8). Lambs born to 
ewes given nutrient restricted diet during late gestation (N) were either reared to 
a lean phenotype in (n=8) or obese phenotype (n=5). Data are displayed as means 
± SEM. Statistical difference denoted by superscripts c versus d, p<0.001 (simple 
effects analysis following 2-way ANOVA). NEFA, Non esterified fatty acids 
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3.3.2 Liver weight and triglyceride deposition 
The liver weight at dissection was significantly greater in animals reared in 
obesogenic environment (p=0.004) and simple effects analysis reached 
significance in in the N-O offspring in comparison to the N-L group 
(p=0.007). When expressed as proportion of body weight, the lean 
animals had similar values for the relative liver weight irrespective of 
prenatal maternal nutrition. However, when expressed as liver weight 
relative to total body weight, the relative weight of liver in the A-O group 
was significantly lower in comparison to the N-O group (Figure 3.11). 
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Figure 3.11 Organ weight of the offspring liver in grams (A) and relative (B) to the 
body weight in grams/kg.  
Offspring of ewes allowed to feed to appetite during late gestation (blue) were 
either raised for a lean phenotype (n=9) or for obese phenotype (n=10). Offspring 
of ewes nutrient restricted during late gestation (red) were either raised for a lean 
phenotype (n=9) or for obese phenotype (n=7). *p<0.05 and **p<0.001 for simple 
effects analysis following significant two-way ANOVA. Non parametric statistical 
tests performed to confirm the ANOVA findings for data displayed in the Figure 
3.11B   
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Furthermore, measured liver tissue triglyceride concentrations were 
significantly increased in N-O offspring as compared to the N-L offspring 
which was also reflected in the relative total liver triglyceride content, 
calculated from the known liver weight and the relative concentrations 
(Table 3.9). This suggests that the increase in liver weight in the N-O 
group was related to increased triglyceride deposition in the liver.  
 
 Prenatal 
nutrition 
Phenotype Prenatal 
Nutrition 
Obesity Inter-
action 
 Lean Obese p value p value p value 
       
Liver 
weight (g) 
A 649±26 716±34 0.89 <0.01 0.23 
N 600±23c 755±59d    
       
       
Liver 
triglyceride 
(mg/g liver 
tissue)  
A 32.2±6.6 37.0±6.1 0.41 0.04 0.26 
N 28.6±3.78a 48.3±7.8b    
       
Total liver 
triglyceride 
(g) 
A 21.2±0.44a 27.0±0.55b 0.55 0.02 0.18 
N 17.0±0.26c 37.8±0.85d    
      
Table 3.9 Liver triglyceride concentrations and total triglyceride content in 
different experimental groups.  
Lambs born to ewes fed to appetite during late gestation (A) were either reared to 
a lean phenotype (n=9) or obese phenotype as described (n=8). Lambs born to 
ewes given nutrient restricted diet during late gestation (N) were either reared to 
a lean phenotype in (n=8) or obese phenotype (n=5). Data are displayed as means 
± SEM. Statistical difference denoted by superscripts a versus b, p<0.05; c versus 
d, p<0.001 (simple effects analysis following 2-way ANOVA).  
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Correlation analysis between triglyceride concentration and liver weight 
demonstrated a stronger relationship between these variables in obese 
animals as compared to those from the lean groups. This was also 
reflected in the correlation between liver triglyceride content and the liver 
weight (Figure 3.12). These findings also support the proposal that the 
increased in liver weight in obese animals was due, at least in part, to 
triglyceride deposition within the liver.  
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Figure 3.12 Correlation analysis of weight of liver at 17 months of age against 
measured liver triglyceride concentrations (A) and calculated total liver triglyceride 
content (B) respectively.  
Lambs born to sheep undergoing nutritional interventions as described werereared 
in environment leading to development of lean phenotype (n=17) or obese 
phenotype (n=16). Data presented as Pearson’s correlation coefficient and two-
tailed significance testing. The trendline in both figures depict the statistically 
significant correlation in values from obese animals 
r=0.662 
p=<0.001 
r=0.165 
p=0.26 
r=0.435 
p=0.002 
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Correlation analysis of total body weight at the age of 17 months 
performed against total liver weight and against total liver triglyceride 
content respectively demonstrated a linear relationship (Table 3.10) 
 
 
 
Variable 1 
 
 
Variable 2 
 
 
Pearson’s  
 coefficient (r) 
 
 
p value 
(two tailed) 
 
Body weight at 17 months 
(kg) 
 
 
Liver weight  
(g) 
 
0.804 
 
<0.001 
 
Body weight at 17 months 
(kg) 
 
 
Liver triglyceride 
(g) 
 
0.489 
 
0.004 
  
Table 3.10 Correlation of body weight at 17 months of age (kg) against liver 
weight (kg) at dissection and total liver triglyceride content (g) respectively for 
all animals (n=35).  
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3.3.3 Liver histology 
Liver samples from representative animals from both obese and lean 
groups were stained with H&E and with Masson’s Trichrome stains to 
identify features of liver ultrastructure (Figure 3.13). 
 
  
Figure 3.13 Liver tissue stained with H&E (A) and Masson’s Trichrome (B) stains 
visualised at 10x magnification demonstrating the structure of liver lobules. 
A liver lobule consists of a central vein surrounded by radially arranged rows of 
liver cells (hepatocytes). At the perimeter of these lobules are branches of hepatic 
artery, hepatic portal vein and bile ducts clustered together in a structure called 
portal triad. The collagenous structures of portal triad are stained blue with 
Masson’s trichrome stain.  
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Masson’s Trichrome stained liver sections were qualitatively analysed to 
identify features of NAFLD characterised by the presence of inflammatory 
infiltrate, macrovesicular steatosis and the severity of pericellular and 
periportal fibrosis. The hepatic tissue from obese animals did not 
demonstrate any inflammatory infiltrate and, whilst scattered lipid droplets 
were visible in tissues from both the lean and obese sheep, the distribution 
and content of the steatosis and fibrosis was not different between the 
experimental groups (Figure 3.14).  
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Figure 3.14 Representative histological sections of sheep liver from lean and obese 
offspring stained with Masson’s Trichrome and visualised at 20x magnification.  
A, Periportal region from lean offspring (100X); B, periportal region from obese 
offspring (100X); C, central vein draining zone from lean offspring (100X); D, 
central vein region from obese offspring (100X); E, sinusoidal area from lean 
offspring visualised at high magnification (200X); F, sinusoidal area of liver from 
obese offspring visualised at high magnification (200X). Tissue sections were 
visualised to identify features of periportal fibrosis identified by blue staining in the 
periportal area (white arrows) and also faint blue lines in the perisinusoidal region. 
Steatosis is identified as intracellular lipid droplets large enough to displace the 
nucleus to the periphery were scattered and infrequent (black arrows). 
A B 
C D 
E F 
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3.3.4 Hepatic gene expression 
3.3.4.1 Gene expression of modulators and effectors of 
metabolic inflammation in liver 
Gene expression studies for 11β-hydroxysteroid dehydrogenase type 1 
(11βHSD1), cluster of differentiation 95 (CD95), TLR4 showed resilience to 
change in response to the experimental interventions. Neither obesity nor 
NR-LG impacted upon the gene expression as shown in Table 3.11. 
 
 
Gene 
Prenatal 
nutrition 
Phenotype Prenatal 
Nutrition 
Obesity Interaction 
 Lean Obese p value p value p value 
       
11βHSD1 
 
A 1.00±0.06 0.92±0.03 0.06 0.42 0.99 
N 1.19±0.18 1.11±0.10    
       
       
Leptin 
receptor 
 
A 1.00±0.07 0.91±0.12 0.29 0.82 0.29 
N 0.98±0.04 1.11±0.13    
       
CD95 
 
A 1.00±0.18 0.86±0.16 0.43 0.21 0.59 
N 0.95±0.27 0.61±0.13    
      
       
TLR4 A 1.00±0.09 1.05±0.11 0.84 0.26 0.60 
N 0.93±0.07 1.09±0.08    
      
  
Table 3.11 Normalised gene expression of genes involved in regulation of 
metabolic inflammation expressed in arbitrary units relative to the A-L group. 
Lambs born to ewes fed to appetite during late gestation (A) were either reared to 
a lean phenotype (n=9) or obese phenotype as described (n=10). Lambs born to 
ewes given nutrient restricted diet during late gestation (N) were either reared to 
a lean phenotype in (n=7) or obese phenotype (n=7). Data are displayed as means 
± SEM. Data were analysed using 2-way ANOVA. 11βHSD1, 11β-hydroxysteroid 
dehydrogenase type 1; CD95, cluster of differentiation 95; TLR4, toll-like receptor-
4. 
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3.3.4.2 Gene expression for the components of the unfolded 
protein response in the liver 
Obesity led to increased gene expression for ER stress degradation 
enhancer molecule-1 (EDEM1) and glucose-regulated protein 78 (GRP78). 
However, the subgroup analysis reached statistical significance only for 
GRP78 in the nutrient restricted animals. The gene expression for 
activating transcription factor-6 (ATF6) did not change with the 
experimental interventions (Table 3.12).  
 
 Prenatal 
nutrition 
Phenotype Prenatal 
Nutrition 
Obesity Interaction 
 Lean Obese p value p value p value 
       
ATF4 A 1.00±0.05a 0.86±0.04 0.14 0.86 0.01 
N 0.76±0.03b 0.93±0.10    
       
       
EDEM1  A 1.00±0.01 1.03±0.02 0.99 0.02 0.23 
N 0.97±0.00 1.06±0.05    
       
       
GRP78 A 1.00±0.08 1.09±0.09 0.88 0.04 0.21 
N 0.86±0.08a 1.21±0.16b    
       
       
ATF6  
 
A 1.00±0.09 0.94±0.05 0.14 0.43 0.99 
N 0.88±0.04 0.81±0.13    
      
There was a significant interaction between the prenatal intervention and 
obesogenic environment on the gene expression for activating 
transcription factor-4 (ATF4). Within the offspring randomised to A 
treatment, the gene expression tended towards decrease with obesity 
Table 3.12 Normalised gene expression for components of the unfolded protein 
response: ATF4, ATF6, EDEM1 and GRP78, in liver of 17 month old offspring 
expressed as arbitrary units relative to A-L group.  
Lambs born to ewes fed to appetite during late gestation (A) were either reared to 
a lean phenotype (n=9) or obese phenotype as described (n=10). Lambs born to 
ewes given nutrient restricted diet during late gestation (N) were either reared to 
a lean phenotype in (n=7) or obese phenotype (n=7). Data are displayed as means 
± SEM. Statistical difference denoted by superscripts a versus b, p<0.05 (simple 
effects analysis following 2-way ANOVA). ATF4, activating transcription factor-4; 
ATF6, activating transcription factor-6; EDEM1- ER stress degradation enhancer 
molecule-1; GRP78, glucose-regulated protein 78. 
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(p=0.06) whereas in the N group, the gene expression was tending to an 
increase (p=0.07) with obesity. The simple main effect for subgroups 
reached statistical significance only in the A-L versus N-L comparison 
(Table 3.12). 
3.3.4.3 Gene expression for the components of autophagy in 
the liver 
Obesity led to increased hepatic gene expression for both BECN1 and 
ATG12 (Figure 3.15). Furthermore, the gene expression for BECN1 
demonstrated a significant interaction (p=0.04) between NR-LG and 
obesity demonstrating significantly increased BECN1 in obese offspring of 
NR-LG sheep.  
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Figure 3.15 Normalised gene of hepatic ATG12 and BECN1 expressed as arbitrary 
units relative to A-L group.  
Offspring of ewes allowed to feed to appetite during late gestation (blue) were 
either raised for a lean phenotype (n=9) or for obese phenotype (n=10). Offspring 
of ewes nutrient restricted during late gestation (red) were either raised for a lean 
phenotype (n=9) or for obese phenotype (n=7). Data are expressed as means with 
error bars representing SEM.*p<0.05 and **p<0.001 for simple effects analysis 
following significant two-way ANOVA. Non parametric statistical tests performed 
for gene expression for BECN1 to confirm the findings of the 2-way ANOVA. ATG12, 
autophagy related gene 12; BECN1, gene encoding Beclin1. 
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The gene expression of the mTOR, known to inhibit autophagy, showed no 
difference with experimental interventions (Table 3.13) 
 
 
Gene 
Prenatal 
nutrition 
Phenotype Prenatal 
nutrition 
Obesity Interaction 
 Lean Obese p value p value p value 
       
mTOR 
 
A 1.00±0.09 1.16±0.06 0.54 0.19 0.49 
N 1.01±0.05 1.06±0.11    
       
  
 
Table 3.13 Normalised gene expression of hepatic mTOR expressed in arbitrary 
units relative to the A-L group.  
Lambs born to ewes fed to appetite during late gestation (A) were either reared to 
a lean phenotype (n=9) or obese phenotype as described (n=10). Lambs born to 
ewes given nutrient restricted diet during late gestation (N) were either reared to 
a lean phenotype in (n=7) or obese phenotype (n=7). Data are displayed as means 
± SEM. Data were analysed using 2-way ANOVA.  mTOR, Mammalian target of 
rapamycin. 
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3.3.5 Histological characteristics of omental adipose tissue 
3.3.5.1 Adipocyte cell size. 
H&E staining of the omental adipose tissue demonstrated adipocytes 
incorporating unilocular lipid droplets in their centres surrounded by 
nuclear and cytoplasmic contents (Figure 3.16). The stromal cell content 
was scant and appeared to be concentrated around fibrous septae 
traversing through the tissue.  
 
 
  
Figure 3.16 Representative images of haematoxylin and eosin stained omental 
adipose tissue sections from Lean (A) and Obese animals (B) viewed at 20x 
magnification.  
Adipocytes, the predominant cell type in adipose tissue consist of a rim of 
cytoplasm and cell membrane surrounding empty spaces representing the location 
of the unilocular lipid droplet. The lipid is not visible in the histological section as it 
gets removed during histological processing. The other tissue types present in 
adipose tissues include loose connective tissue, blood vessels and cells of 
haematogenous origin.   
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Adipocyte size was significantly increased with obesity. However, there 
was no effect of NR-LG on the cell size (Figure 3.17). 
 
 
 
A significant correlation was identified between the mean adipocyte size 
with animal bodyweight at 17 months (Figure 3.18 A). The correlation 
remained significant for subgroup analysis of A offspring (r=0.489; 
p=0.016). Correlation of body weight and adipocyte size on N offspring 
was not statistically significant (r=0.10; p=0.09). A statistically significant  
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Figure 3.17 Mean adipocyte area in µm2 calculated from the histological sections of 
omental adipose tissue of 17 month old offspring.  
Offspring of ewes allowed to feed to appetite during late gestation (blue) were 
either raised for a lean phenotype (n=7) or for obese phenotype (n=10). Offspring 
of ewes nutrient restricted during late gestation (red) were either raised for a lean 
phenotype (n=8) or for obese phenotype (n=7). Data are expressed as means with 
error bars representing SEM.  **p<0.001 for simple effects analysis following 
significant two-way ANOVA. 
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correlation was present between the mean adipocyte size and weight of 
the omental adipose tissue (Figure 3.18 B.) The significant correlation was 
also present on subgroup analysis of the A offspring (r=0.801; p<0.001) 
and of N offspring (r=0.94; p<0.001). 
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Figure 3.18 Correlation analysis of adipocyte size with adult body weight (A) and 
weight of the omental adipose tissue at dissection (B) in all offspring.  
Offspring born to sheep fed to appetite (A, n=19) are demonstrated with blue 
circles and offspring born to sheep restricted to 60% nutrition (N, n=17) during 
late gestation identified with red squares. Pearson correlation coefficient r and p 
values of significance as indicated in the figure. The trendline and values of r and p 
depicts correlation analysis of all animals.   
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3.3.5.2 GRP78, pJNK and IBA1 staining 
GRP78 staining was localised to cytoplasmic content present at the 
periphery of the adipocytes. In images of adipose tissue of lean animals 
with relatively small adipocytes, such staining was easily identified all 
along the adipocyte periphery. In the adipocyte from obese animals, the 
cytoplasm and the cell organelles were located as a thin rim on the 
periphery while the lipid form majority of the cellular content.  As a result, 
staining in the adipocyte in tissues from obese animals was either spread 
thinly along the wall or was concentrated in pockets of perinuclear 
cytoplasmic content (Figure 3.19).   
 
 
  
Figure 3.19 Representative images demonstrating distribution of staining for 
GRP78 in adipose tissue from  lean (A) and obese (B) animals at 17 months of age. 
GRP78 can be identified by brown DAB staining.  
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Expressed as area stained per adipocyte, the stained area was measured 
by computerised quantification. Greater GRP78 staining was present in 
obese animals, with no interaction identified with prenatal intervention 
Table 3.14.  
 Prenatal 
nutrition 
Phenotype Prenatal 
nutrition 
Obesity Interaction 
 Lean Obese p value p value p value 
       
GRP 78 
(µm2/cell) 
A 35.9±21.6 79.8±24.2 0.51 0.02 0.83 
N 30.4±11.0 70.9±21.8    
       
       
pJNK 
(µm2/cell) 
A 29.6±12.7 53.1±6.3 0.50 0.36 0.18 
N 55.5±17.5 44.2±12.7    
       
Staining for the phosphorylated c-Jun N-terminal kinase (pJNK) was 
mostly restricted to nucleus and the perinuclear areas (Figure 3.20). 
Obesity or NR-LG did not lead to any difference in the area of pJNK 
staining per cell (Table 3.14). 
 
Table 3.14 Quantitative analysis of GRP78 and pJNK stain expressed as area 
stained in µm2/ adipocyte.  
Lambs born to ewes fed to appetite during late gestation (A) were either reared to 
a lean phenotype (n=7) or obese phenotype as described (n=7). Lambs born to 
ewes given nutrient restricted diet during late gestation (N) were either reared to 
a lean phenotype in (n=6) or obese phenotype (n=7). Data are displayed as means 
± SEM. Data were analysed using 2-way ANOVA. GRP78 Glucose regulated protein- 
78; pJNK, phosphorylated c-Jun N-terminal kinase. 
Figure 3.20 Representative images demonstrating pJNK staining visible in the 
perinuclear areas in the omental adipose tissue from lean (A) and obese (B) sheep. 
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Iba1 staining for macrophages identified macrophage infiltration in 
isolation and in clusters consistent with appearance of CLS and milky 
spots. Macrophage staining in the omental adipose tissue from the lean 
animals was relatively infrequent, the CLS tended to be present singly and 
on occasions the adipocytes were not fully surrounded by the macrophages 
on all sides. In contrast, the staining for adipose tissue macrophages was 
subjectively more abundant in the obese animals and, along with scattered 
CLS, remarkable clusters of Iba1 stained cells surrounding necrotic 
adipocytes were present (Figure 3.21). Some of these clusters of 
macrophages surrounding dead adipocytes were present in proximity to 
the blood vessels and connective tissue septae traversing through the 
adipose tissue. Such clusters were consistent with the described 
appearance of milky spots. Accurate quantification of Iba1 staining was not 
possible due to confounding factors including non-homogenous distribution 
in clusters in obese animals and the unintended uptake of DAB stain by 
necrotic adipocytes (Figure 3.21 D).   
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Figure 3.21 Representative images of Iba1 staining of adipose tissue of lean (A and 
B) and obese (C and D) sheep visualised at 10x magnification.  
Iba1 staining identifies macrophages which were present through the tissue in a 
non-homogenous distribution. The infiltrating macrophage were presented in 
isolated clusters or around necrotic adipocytes in pattern described as crown like 
structures in omental adipose tissue visualised at 10x magnification.  
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3.3.6 Omental adipose tissue gene expression analysis  
3.3.6.1 Genes expression of modulators and effectors of 
metabolic inflammation in the omental adipose tissue. 
The experimental factors, obesity and NR-LG, had no impact on the 
omental adipose tissue gene expression of 11βHSD1 and GCR (Table 
3.15). Gene expression for CD68, leptin and TLR4 was increased with 
obesity whereas the expression was not affected by NR-LG (Table 3.15). 
  
 
Gene 
Prenatal 
nutrition 
Phenotype Prenatal 
nutrition 
Obesity Interaction 
 Lean Obese p value p value p value 
11βHSD1 
A 1.00±0.25 0.69±0.04 0.54 0.51 0.17 
N 0.66±0.06 0.78±0.09    
GCR 
A 1.00±0.15 1.11±0.09 0.60 0.21 0.71 
N 0.89±0.13 1.10±0.11    
Leptin 
A 1.00±0.23a 5.42±1.52b 0.82 <0.001 0.96 
N 0.69±0.13a 5.51±1.37b    
TLR4 
A 1.00±0.05 1.33±0.20 0.51 0.01 0.99 
N 0.92±0.11a 1.25±0.07b    
CD68 
A 1.00±0.18a 3.53±1.03b 0.19 <0.001 0.85 
N 0.65±0.07a 3.03±1.56b    
  
Table 3.15 GeNorm normalised gene expression for regulators of metabolic 
inflammation in the omental adipose tissue of 17 month old offspring.  
Lambs born to ewes fed to appetite during late gestation (A) were either reared to 
a lean phenotype (n=7) or obese phenotype as described (n=8). Lambs born to 
ewes given nutrient restricted diet during late gestation (N) were either reared to 
a lean phenotype in (n=9) or obese phenotype (n=7). Data are displayed as means 
± SEM. Statistical difference denoted by superscripts a versus b, p<0.05 (simple 
effects analysis following 2-way ANOVA). 11βHSD1, 11β-hydroxysteroid 
dehydrogenase type 1; GCR, glucocorticoid receptor CD95, cluster of differentiation 
95; TLR4, toll-like receptor-4e. 
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Correlations between leptin gene expression and plasma leptin 
concentrations performed at 16 months of age were statistically significant 
for all animals and for obese animals. Upon analysis of lean subgroups, 
there was no correlation between the gene expression for leptin and 
plasma leptin concentrations (Table 3.16) 
 
Variable 1 Variable 2 
Pearson’s  
coefficient 
(r) 
p value  
(two tailed) 
Plasma leptin all 
animals (ng/ml) 
Leptin gene expression 
all animals 
0.478 <0.001 
Plasma leptin all 
obese animals 
(ng/ml) 
Leptin gene expression 
all obese animals 
0.356 0.019 
Plasma leptin all lean 
animals (ng/ml) 
Leptin gene expression 
all lean animals 
0.044 0.871 
  
Table 3.16 Correlation analysis between gene expression and plasma concentration 
of leptin in all animals and subgroup analysis of obese and lean animals.  
Sheep were either reared in an unrestricted environment for a lean phenotype 
(n=17) or were reared in a restricted environment as described to decrease 
physical activity leading to obese phenotype (n=16). Plasma leptin quantification 
was performed by the laboratory of Professor Keisler at the Department of Animal 
Science of the University of Missouri using radioimmunoassay method. 
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3.3.6.2 Gene expression for the components of the unfolded 
protein response in the omental adipose tissue  
Obesity led to increased gene expression for all the tested components of 
the UPR (Table 3.17). Subgroup analysis demonstrated increased gene 
expression for ATF6, GRP78 and EDEM1 in the obese offspring as 
compared to the lean offspring of sheep experiencing NR-LG. The gene 
expression of ATF4 was increased in obese offspring irrespective of 
maternal prenatal nutrition (Figure 3.22).   
 
 
Gene 
Prenatal 
nutrition 
Phenotype Prenatal 
nutrition 
Obesity Interaction 
 Lean Obese p value p value p value 
ATF4 
A 1.00±0.10a 1.53±0.20b 0.12 0.001 0.82 
N 0.82±0.06c 1.32±0.11d    
ATF6 
A 1.00±0.09 1.16±0.07 0.12 0.01 0.37 
N 0.81±0.09a 1.13±0.08b    
GRP78 
A 1.00±0.16 1.14±0.10 0.04 0.04 0.31 
N 0.69±0.10a 1.05±0.12b    
EDEM1 
A 1.00±0.06 1.05±0.08 0.36 0.01 0.23 
N 0.82±0.06a 1.05±0.05b    
  
Table 3.17 GeNorm normalised gene expression for components of the unfolded 
protein response in the omental adipose tissue. 
Lambs born to ewes fed to appetite during late gestation (A) were either reared to 
a lean phenotype (n=7) or obese phenotype as described (n=8). Lambs born to 
ewes given nutrient restricted diet during late gestation (N) were either reared to 
a lean phenotype in (n=9) or obese phenotype (n=7). Data are displayed as means 
± SEM. Superscripts denote statistical difference for simple effects analysis 
following 2-way ANOVA a versus b, p<0.05; c versus d, p<0.001. ATF4, activating 
transcription factor-4; ATF6, activating transcription factor-6; GRP78, glucose-
regulated protein 78; EDEM1, ER stress degradation enhancer molecule-1 
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Figure 3.22  Relative gene expression in omental adipose tissue for unfolded 
protein response components: A, ATF4; B, ATF6; C, GRP78; D, EDEM1.  
Offspring of ewes allowed to feed to appetite during late gestation (blue) were 
either raised for a lean phenotype (n=7) or for obese phenotype (n=8). Offspring 
of ewes nutrient restricted during late gestation (red) were either raised for a lean 
phenotype (n=9) or for obese phenotype (n=7). Data are expressed as means with 
error bars representing SEM.  *p<0.05 and **p<0.001 for simple effects analysis 
following significant two-way ANOVA. ATF4, activating transcription factor-4; 
ATF6, activating transcription factor-6; GRP78, glucose-regulated protein 78; 
EDEM1, ER stress degradation enhancer molecule-1. 
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3.3.6.3 Gene expression for autophagy in the omental adipose 
tissue 
Obesity led to increased gene expression for both the genes, ATG12 and 
BECN1. This result was significant in subgroup analysis irrespective of the 
prenatal nutrition (Figure 3.23) 
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Figure 3.23 Relative gene expression in omental adipose tissue for (A) ATG12 and 
(B) BECN1. Offspring of ewes allowed to feed to appetite during late gestation 
(blue) were either raised for a lean phenotype (n=7) or for obese phenotype (n=8). 
Offspring of ewes nutrient restricted during late gestation (red) were either raised 
for a lean phenotype (n=9) or for obese phenotype (n=7). Data are expressed as 
means with error bars representing SEM.  **p<0.001 for simple effects analysis 
following significant two-way ANOVA. ATG12, autophagy related gene 12; BECN1, 
gene encoding Beclin1. 
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The gene expression in the omental adipose tissue for both AMPK and 
mTOR were increased with obesity. This difference achieved statistical 
significance in comparisons between A-O to A-L group in both genes. In 
addition, AMPK was also increased in the N-O group as compared to the N-
L group (Figure 3.24 A and B). 
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Figure 3.24 Normalised gene expression of AMPK (A) and mTOR (B) in omental 
adipose tissue of 17 month old offspring expressed in arbitrary units relative to A-
L group.  
Offspring of ewes allowed to feed to appetite during late gestation (blue) were 
either raised for a lean phenotype (n=7) or for obese phenotype (n=8). Offspring 
of ewes nutrient restricted during late gestation (red) were either raised for a lean 
phenotype (n=9) or for obese phenotype (n=7). Data are expressed as means with 
error bars representing SEM. *p<0.05 and **p<0.001 for simple effects analysis 
following significant two-way ANOVA. AMPK, 5' adenosine monophosphate 
activated protein kinase; mTOR, mammalian target of rapamycin. 
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3.4 Discussion 
The main objectives of the experiments described in this chapter were to: 
 establish a study design, in a sheep model, to investigate the 
interaction between maternal NR-LG during pregnancy and offspring 
obesity on offspring health.  
 describe the characteristics of the cell stress response in liver and 
omental adipose tissue of obese and lean sheep. 
 identify any programming influence of maternal NR-LG on offspring 
cell stress response to obesity.  
Restriction of physical activity in sheep led to development of obesity 
which was characterised by selective increase in visceral adipose tissue 
deposition, increased plasma leptin and increased gene expression for 
leptin from omental adipose tissue. This was associated with features 
consistent with insulin resistance. The increase in the weight of the 
omental adipose tissue depot in obese sheep was in direct correlation with 
omental adipocyte size. In addition, adipose tissue histology identified 
patterns of distribution of CLS and of Iba1 stained macrophage infiltration 
in adipose tissue from obese and lean offspring.  
Restriction of maternal nutrition to 60% of metabolisable energy during 
late gestation led to significantly decreased maternal weight gain, lower 
maternal plasma glucose and higher maternal plasma NEFA concentrations 
and decreased offspring birth weight as compared to the sheep allowed to 
feed to appetite during the same period. 
In the offspring liver at 17 months of age, obesity led to increased gene 
expression for UPR genes EDEM1 and GRP78 and autophagy genes BECN1 
and ATG12. The obese offspring of sheep who underwent NR-LG, had 
increased relative liver weight as compared to obese offspring of sheep fed 
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to appetite. The former also had increased gene expression for BECN1 
expression as compared to the latter.  
In the omental adipose tissue of offspring, obesity was associated with 
increased gene expression for leptin, macrophage marker CD68 and 
autophagy genes. The obese offspring of nutrient restricted mothers had 
increased UPR genes ATF6, GRP78 and EDEM1 as compared to the lean 
offspring. The UPR gene ATF4 was increased in all obese sheep irrespective 
of prenatal nutrition. These results are discussed in detail in the following 
sections. 
3.4.1 NR-LG in twin bearing sheep leads to a state of energy deficit 
and growth restriction of the developing offspring 
Metabolite analysis of plasma samples taken from sheep at 130dGA 
demonstrated that, in comparison with ewes which fed to appetite, 
nutrient restriction to 60% of energy requirements led to decreased 
plasma insulin and glucose along with increased NEFA concentrations. In 
the state of energy deficit, the initial physiological response of the body 
involves mobilisation of glucose from hepatic glycogen stores. This is 
followed by lipolysis of triglycerides in adipose tissue, which results in 
release of glycerol and NEFA into circulation [419]. NEFA, through the 
process of beta oxidation, acts as a source of energy and also provides 
ketone bodies, an important source of fuel for glucose deficient vital 
organs [419].  In addition, the catabolic state [420] of energy deficit is 
associated with a decreased plasma insulin and increased glucocorticoid 
and glucagon concentrations in non-pregnant animals [421]. Plasma 
biochemistry of the twin bearing N mothers during late gestation was 
characterised by increased NEFA concentrations and low blood glucose 
despite decreased insulin and, therefore, conforms to the patterns 
expected in the state of energy deficit. 
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Late gestation is a stage of the maximum rate of fetal growth associated 
with a high requirement of nutrition as indicated by a 14 fold increase in 
fetal glucose demand [422]. Increased fetal number, by itself, is known to 
lead to lower birth weight [268, 423]. In a study which had a mixture of 
singleton and twin bearing ewes, 50% nutrient restriction from gestational 
day 110 to term in comparison to 100% metabolisable energy 
consumption did not result in a decreased birth weight [315]. Whereas, 
twin bearing pregnancies undergoing NR-LG results in lower birth weight of 
twins in comparison to singletons [268, 423]. The compensatory responses 
to any decrease in the availability of nutrients at this stage include 
decreased fetal insulin secretion [424, 425] , increased newborn offspring 
insulin sensitivity [426] and placental nutritional partitioning [427, 428]. 
In sheep with twin pregnancies, the placental compensatory mechanisms 
to decreased nutrition are less effective [429]. Furthermore, growing twin 
fetuses impose relatively increased nutritional demand in comparison to 
singletons [430] exacerbating the deficit in nutrient availability for the 
fetus, leading to the decreased birth weight in the offspring of the twin 
bearing ewes in the nutrient restricted group. The lower birth weight in N 
offspring in this study is likely to be the outcome of nutrient deficit during 
a period of increased nutritional requirements brought about by timing of 
late gestation and requirements of a twin fetuses.  
The sample mean z-score of the birth weight of N offspring was -3 in 
comparison to the birth weight of the A group. There is no definition of 
sheep intrauterine growth restriction (IUGR). However, the sample mean 
birth weight z-score of -3 in N offspring indicates a significant difference 
from the population mean. Assuming that the mean fetal growth prior to 
randomisation was the same in both groups, the significant decrease in 
birth weight is likely to be an outcome of IUGR.  
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The presence of a plasma metabolic profile consistent with energy deficit, 
the relatively lower maternal weight gain during the intervention period in 
the N group and the decreased birth weight of the offspring demonstrate 
exposure of the mother and the growing fetus to an environment of 
relative macronutrient deficiency. The animal model described in this 
study, therefore, is well suited for a study of potential fetal programming 
in IUGR secondary to relative macronutrient deficiency during the late 
gestation. 
3.4.2 Body weight and metabolic parameters of the offspring 
3.4.2.1 Establishment of a model of mild to moderate obesity.  
From birth to 90 days postnatal age, all twin offspring fed on their 
mother’s milk. The offspring of sheep in N group, which had been lighter at 
birth, remained lighter for the first four weeks following which their body 
weights became similar to the offspring sheep in A group. The absence of 
rapid postnatal growth over the suckling period in this group is also 
demonstrated by the similar values for the fold change in body weight. 
This experimental model, therefore, avoids the significant potential 
confounding factor of rapid weight gain soon after birth. Such accelerated 
postnatal growth has been proposed to programme predisposition to 
adverse metabolic outcomes in later life [286, 431].  
When measured at 45 days of age, there was no difference in physical 
activity parameters between any groups ruling out selective programming 
of the offspring physical activity with prenatal nutrition.  The restricted 
area of the rearing environment for N-O and A-O offspring led to 
decreased physical activity measured by accelerometer at 15 months of 
age in comparison to N-L and A-L groups respectively. 
The increased body weight of the offspring randomised to the obesogenic 
environment as compared to unrestricted environment did not reach 
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statistical significance for the first 9 months after randomisation to 
restricted physical activity, differing only after the age of 12 months. Basal 
metabolic rate, which constitutes the largest component of the energy 
expenditure, is maximal during the period of body growth [432] and is also 
increased with raised body mass [433]. As studies of sheep growth curves 
have identified, the first nine months of age coincide with the period of 
maximal growth rate [434]. It is plausible that the high basal metabolic 
rate during the rapid growth period [432, 435] compensated for the 
excess energy balance during the first half of the intervention and that the 
difference in body weight of obese and lean sheep became apparent only 
once the rate of body growth decreased in adulthood with the consequent 
proportional decrease in basal metabolic rate. Previous studies of sheep 
reared in a similar restricted environment from the age 15 months until 20 
months resulted in a larger difference of 1.5 fold change in absolute weight 
as compared to lean animals [264].  However, along with restricted 
physical activity, the animals in that study also experienced increased 
intake of calories and dietary fat using palm kernel oil.  
There is no precise definition of obesity in sheep. In an experiment 
describing the phases of dietary obesity in sheep, prior to reaching a static 
phase after 42 weeks of high calorie dietary intake, the weight of animals 
increased at an accelerated rate until it plateaued at 2.1 fold in comparison 
to the group fed to metabolic requirements [436]. Existing models of 
sheep obesity include relative weight increase between 1.5 [264] and 
more than 2 fold [223, 436]. A model of severe obesity is likely to 
significantly affect the baseline cellular physiology even at an early age 
[223], thereby potentially masking any effect of late gestation nutrient 
restriction in the pathogenesis of obesity related morbidity. For example, if 
excess obesity led to a substantial adipokine secretion, metabolic 
inflammation and associated cell stress response in all obese animals, any 
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modulation of these pathways, of relatively smaller quantity, brought 
about by the developmental programming would be masked and its 
demonstration would require a very large sample size.  In contrast, the 
1.35 fold relative weight gain resulting from this model of physical 
inactivity-induced obesity can be designated as mild to moderate obesity 
and such a model is less likely to mask any modulation of obesity 
associated cell stress response following maternal NR-LG. 
3.4.2.2 NR-LG does not predispose offspring to obesity or 
adiposity.  
NR-LG did not lead to any difference in the body weight and adipose 
deposition in N-L versus A-L and N-O versus A-O comparisons, findings 
consistent with other sheep studies of NR-LG [264]. This outcome is also 
in accord with the outcome of the Dutch Famine birth cohort studies which 
demonstrated that offspring of mothers exposed to famine in the third 
trimester were of similar body weight at age of 19 years [437] and 
adiposity at 50 [438] and 58 [418] years as those unexposed.  
3.4.2.3 Obesity associated decreased glucose disposal at 7 
months and insulin resistance at age of 16 months were not 
exacerbated with NR-LG. 
GTT performed at 7 months showed a significantly higher glucose response 
in the A-O and N-O groups in comparison with A-L and N-L groups 
respectively. The values for plasma insulin concentrations in all the groups 
were similar during the GTT, demonstrating a state of decreased glucose 
disposal in the animals reared in an obesogenic environment. 
Interestingly, the body weights of all the animals at this stage were not 
different, irrespective of the rearing environment. It is already known that 
physical activity associated morphological changes in muscles are 
associated with improved glucose tolerance [439] and this increased 
insulin-stimulated glucose disposal in physically active individuals is 
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present irrespective of body weight [440]. It is also plausible that despite 
there being no change in body weight, changes in tissue composition were 
already established by this age, a possibility which is supported by the 
finding of increased plasma leptin concentrations at this age in A-O in 
comparison to the A-L offspring, whilst the smaller difference in plasma 
leptin in N-O (2.31±0.44 ng/mL) as compared to N-L (1.54±0.26 ng/mL) 
offspring did not reach statistical significance.  
During the GTT performed at 16 months of age, although there were no 
differences in the glucose concentrations at any of the standard time 
points, obesity led to increased plasma insulin with higher values in both 
obese groups. This finding was also confirmed by the raised area under the 
curve for insulin and HOMA-IR for obese sheep. NR-LG did not have any 
impact on glucose and insulin measured in the GTT in the obese and lean 
offspring.  
The obese animals, therefore, demonstrated enhanced insulin secretion in 
order to achieve a plasma glucose comparable to lean animals. This 
signifies the presence of peripheral insulin resistance requiring a 
compensatory increase in insulin secretion in this model of mild to 
moderate obesity.  Human studies have also demonstrated development of 
obesity related peripheral insulin resistance secondary to obesity as early 
as the age of 6-12 years [42]. 
NR-LG did not exacerbate the insulin resistance as determined by the GTT 
in both lean and obese groups. The follow up cohort of the offspring of 
mothers exposed to the Dutch famine during late gestation had higher 
insulin resistance in GTT and also higher fasting plasma proinsulin [261]. 
The absence of features of insulin resistance in our experiment is 
inconsistent with the Dutch Cohort findings in humans at age 50 years. 
The age of 16 months in sheep is considered equivalent to young 
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adulthood and it is plausible that, by this age, the programming 
mechanisms of NR-LG may not yet have contributed significantly to the 
progression of insulin resistance. Previous sheep studies of NR-LG either 
employed a more severe nutritional challenge (50%) [274]  or studied the 
glucose-insulin axis at older ages as seen in the abnormal glucose-insulin 
homeostasis apparent in obese offspring at the age of 2 years, but not at 
18 months postnatal age [264]. The experiments do not demonstrate any 
difference in measured markers of insulin resistance between N-O as 
compared to A-O group at age of 16 months. Any modifications to the 
biochemical and cellular processes in the N-O as compared to the A-O 
group would signify programming changes instead of being the outcome of 
established insulin resistance.  
Plasma triglyceride and NEFA did not differ between any of the groups. In 
the metabolic syndrome, dyslipidaemia, signified by raised plasma 
triglycerides and decreased high density lipoproteins, is a component of 
the diagnostic criterion [1]. Such dyslipidaemia is the outcome of insulin 
resistance which leads to decreased activation of lipoprotein lipase in the 
endothelial lining of blood vessels [187]. This prevents breakdown of 
circulating plasma triglycerides and the subsequent uptake of fatty acids 
by adipocytes, liver or muscle tissue [441]. At the same time, triglycerides 
continue to be manufactured in the liver, packed up into very low density 
lipoproteins (VLDL) and released into the circulation. This imbalance 
between triglyceride released into circulation and disposal by the body 
leads to raised triglyceride concentrations. In this study, such raised 
plasma triglyceride concentrations would have indicated a state of insulin 
resistance and metabolic syndrome.  
Lipid metabolism in ruminants is significantly different as compared to 
humans [442]. In ruminants, the liver contributes little to fatty acid 
synthesis whilst adipose tissue is the primary site for this [443]. 
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Furthermore, the substrates utilised are mainly glucose and acetate [444] 
although this does vary between depots [445]. It is plausible that 
ruminants are more resistant to plasma lipid abnormalities brought about 
by insulin resistance because of the relatively low contribution of the liver 
to ovine fatty acid and subsequent triglyceride production. The absence of 
any differences in plasma triglyceride concentrations in previously 
published sheep studies, despite the presence of abnormal glucose-insulin 
homeostasis [264, 274] supports such a proposal. This factor, along with 
relatively younger age of the animals in the experimental model, may 
explain the absence of abnormal lipid profile following NR-LG as would 
have been predicted from the Dutch Famine cohort studies [418] . 
3.4.3 The characteristics of liver fat deposition and cell stress 
response to obesity with and without prenatal NR-LG.  
3.4.3.1 Increased hepatic fat deposition in obese sheep is 
associated with upregulated autophagy and ER stress.  
The increased liver weight of obese sheep correlated strongly with the 
increased hepatic triglyceride content. The values of absolute liver weight 
at dissection were comparable to previously published literature in ovine 
model [315, 446] as were hepatic triglyceride content in lean animals 
(3%) in both sheep [279] and humans [447].  
Obesity related ectopic accumulation of fat in the liver can range from 
asymptomatic steatosis (NAFLD), to more severe non-alcoholic 
steatohepatitis (NASH) [208], both of which are associated with the 
presence of the metabolic syndrome [448]. Histological examination of the 
liver was performed to identify and quantify the features of NASH and 
steatosis by performing H&E and Masson’s Trichrome staining. However, 
despite multiple attempts at optimising the staining protocol for formalin 
fixed paraffin embedded histological sections prepared from gradually 
thawed frozen liver tissue, the staining and quality of histological sections 
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were unsuitable for reliable analysis. This precluded a confident 
morphometric confirmation of features of NAFLD or NASH as suggested by 
the above findings of higher liver weight along with increased triglyceride 
concentrations in the hepatic tissue. 
Oil red O staining of frozen sections of liver has previously been used to 
identify hepatic steatosis [279]. However, this procedure does not provide 
any more information regarding hepatic fibrosis, inflammatory infiltrate or 
other known features of NAFLD-NASH spectrum as described in validated 
diagnostic methods [377]. Whilst the presence of increased triglyceride 
with obesity in this model has already been demonstrated, oil red O 
staining would have only confirmed the increased lipid deposition. In light 
of the above and time constraints, oil red O staining was not undertaken. 
The upregulated ER stress response to obesity as indicated by increased 
EDEM and GRP78 is in agreement with previous human [105] and animal 
model studies [99]. The relationship between ER stress and obesity 
associated NAFLD has been demonstrated to be bidirectional [228]. 
Furthermore, activated UPR in response to ER stress is capable of 
promoting other cell stress response pathways such as autophagy. For 
example, ATF4 activation via the PERK pathway of the ER stress response 
has been demonstrated to activate autophagy [95].  
As previously reported in studies of NAFLD patients and murine models 
[449, 450], the gene expression of autophagy components was increased 
with obesity. The accepted role of hepatocyte autophagy is that of lipid 
disposal preventing the development of hepatic lipid accumulation by 
promoting lipid metabolism [130], insulin sensitivity [234] and promoting 
cell survival by maintaining cellular homeostasis (Figure 3.25 A). However, 
the obese sheep in this study had increased liver tissue triglyceride content 
despite having similar plasma triglycerides as lean animals. If the 
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increased gene expression reflected an increase in autophagic function of 
the hepatocytes, it would predict more efficient lipid disposal by the 
hepatocytes. It has been demonstrated that this increased gene 
expression of autophagy in obesity is paradoxically associated with an 
impaired autophagic flux [234, 450] which correlates with progressive 
NAFLD [451]. Such a defect in normal functioning of autophagy would 
promote additional lipid deposition in the liver along with compromising 
the normal homeostasis of cellular functioning (Figure 3.25 B). The 
ensuing cell stress, including activation of UPR would activate a state of 
metabolic inflammation. Increased gene expression for autophagy, in such 
a scenario, would be a consequence of upregulated cell stress response to 
obesity (Figure 3.25 B). However, in the absence of additional evidence 
demonstrating a defect in the autophagic functioning, such explanations 
for the increased gene expression for autophagy components in this study 
remain speculative. 
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The other known regulators of autophagic pathways include energy 
sensing and leptin action. Autophagy is known to be activated during a 
state of energy deficit through activation of AMPK which then inhibits 
mTOR and also increases autophagic gene expression via activation of the 
transcriptional factor forkhead boxO1 (FoxO1) [452, 453]. The gene 
expression of hepatic mTOR was not altered in response to any of the 
experimental interventions. 
Another explanation for increased autophagy in the obese offspring is the 
possibility of hepatic insulin resistance. Insulin action is known to lead to 
transcriptional downregulation of autophagy through phosphatidylinositide 
3-kinase (Pi3K) - protein kinase B (Akt/PkB) signalling pathway leading to 
inactivation of transcriptional factor FoxO3 [130]. A state of insulin 
resistance would lead to activation of FoxO3 transcription factors leading 
Figure 3.25 Schematic diagram depicting (A) the role of constitutive autophagy and 
UPR maintainence of liver homeostasis  and (B) obesity induced defective 
autophagy and ER stress response leading to hepatocellular damage and 
inflammation.  Normal functioning of autophagy is important for lipid metabolism 
and, in conjunction with ER stress response, for cell survival in the hepatocytes. A 
defect in the functioning of hepatic autophagic processes, as proposed, would 
promote intrahepatic lipid accumulation and activation of the cell stress response. 
Along with obesity induced ER stress response, the resultant cell stress response 
is capable of promoting an increase in gene expression of components of 
autophagy. 
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to increased expression of autophagic genes (Figure 3.26). It is, therefore, 
plausible that hepatic insulin resistance resulting from obesity associated 
hepatic steatosis could contribute to the increased autophagy gene 
expression.  
 
 
 
In conclusion, the increased hepatic triglyceride accumulation in sheep 
secondary to decreased post weaning physical activity is associated with 
increased gene expression of hepatic autophagy and ER stress indicating a 
state of increased hepatic cell stress response. This was not associated 
with changes in gene expression of hepatic energy sensing regulators 
AMPK, mTOR and hepatic leptin receptors.  
Figure 3.26 Schematic diagram depicting the mechanism of increased transcription 
of autophagy genes in the state of insulin resistance. The transcriptional factor 
FoxO3 is maintained in the state of inhibition with normal insulin action. During a 
state of insulin resistance, as seen secondary to hepatosteatosis, inhibition of 
FoxO3 transcription factors would be lost, thereby promoting transcription of 
autophagy genes. 
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3.4.3.2 NR-LG leads to exaggerated hepatic triglyceride 
deposition in obesity associated and upregulated gene 
expression of hepatic autophagy.  
The hepatic triglyceride concentrations and organ weights at dissection 
were significantly greater in N-O in comparison to N-L offspring. 
Furthermore, when expressed relative to body weight, the N-O offspring 
had higher relative liver weight in comparison to A-O offspring. The 
findings of increased hepatic triglyceride content along with higher liver 
weight indicate that exaggerated triglyceride deposition may be the source 
of the increase in liver weight in N-O offspring.  
The association of low birth weight with NAFLD [454] and abnormal liver 
function [277] has been demonstrated in epidemiological studies. A 
previous sheep study by Hyatt et al. of 50% nutrient restriction from 30 
days to 80 days gestation demonstrated increased hepatic triglyceride 
deposition in the offspring at 1 year of age, in the absence of any change 
in birth weight [279]. This was associated with elevated hepatic gene 
expression for peroxisome proliferator-activated receptor γ (PPARG) and 
its co-activator PGC1α, thereby indicating a decrease in hepatic fatty acid 
oxidation. Such decreased fatty acid oxidation, could be a mechanism of 
the observed increase in the hepatic triglyceride content.  This mechanism 
is supported by the findings of a study performed in offspring of Wistar 
rats subject to gestational nutrient restriction to 65% of metabolic 
requirements during late gestation (day 14 until birth), and then fed a high 
fat diet [238]. The offspring of nutrient restricted rats developed insulin 
resistance, liver steatosis and ER stress. In association, high fat diet 
feeding in offspring of rats fed to appetite during pregnancy showed 
enhanced autophagic activity in liver whereas, the comparison group of 
IUGR rats maintained lower levels of Atg7 and LC3B II despite the high fat 
diet. The defective autophagy in the IUGR offspring was demonstrable as 
early as 6 hours of age. Developmentally, such an adaptation of defective 
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hepatic autophagy in a fetus would be consistent with a predictive-
adaptive response of the fetal liver towards accumulation of glycogen in 
the short term and paradoxically, lipids in the long term in response to 
suboptimal nutrition during late gestation. Indeed, increased hepatic 
glycogen in IUGR sheep fetuses has been demonstrated [455, 456] and is 
a subject of mammalian investigation. This type of defective hepatic 
autophagy, when individuals are exposed to the relative nutrient excess of 
obesogenic environment, would result in less effective hepatic lipid 
mobilisation, leading to hepatosteatosis, associated ER stress and 
eventually, insulin resistance. 
In obese humans, defective hepatic autophagy secondary to obesity has 
been associated with paradoxically increased gene expression of 
autophagy [450].  In this study, the gene expression of autophagy 
component BECN1 was maximum in the N-O group and was significantly 
increased in comparison to A-O and N-L groups. Furthermore, the gene 
expression of transcription factor ATG4, was increased with obesity in 
offspring of NR-LG sheep and decreased with obesity in offspring of sheep 
fed to appetite. ATF4, through its encoded protein also known as cAMP-
response element binding protein 2 (CREB-2), promotes autophagy gene 
expression [95, 457]. Raised gene expression for ATF4, in association with 
the increased gene expression for BECN1 in the N-O offspring, indicates 
that, in comparison to obese offspring of sheep fed to appetite, the liver of 
the obese offspring of NR-LG sheep had activated UPR further enhancing 
autophagy gene expression. In the absence of any further indicators of 
autophagic flux, the interpretation of increased gene expression of BECN1 
remains speculative. Any further interpretation of the isolated changes in 
gene expression of autophagy will require study of markers of autophagy 
function and should form part of any future investigation of this 
mechanism.  
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This is the first experimental study performed in a large animal model 
demonstrating the potential role of autophagy in the pathogenesis of 
hepatic steatosis in the subgroup of population exposed to in utero 
undernutrition. 
3.4.4 The characteristics of sheep omental adipose tissue in 
obesity and effect of prenatal NR-LG 
3.4.4.1 Obesity related changes in adipose tissue depot weight, 
distribution and adipocyte size are not affected by NR-LG. 
As a risk factor for metabolic complications, visceral adiposity is known to 
be more predictive of adverse outcomes [29]. In this study, DXA scanning 
of 16 month old offspring demonstrated that fat mass constituted 14% of 
body weight of obese offspring as compared to 7.5% of body weight in the 
lean counterparts. These values of percentage fat mass measured by DXA 
scan are similar to previous experiments in 18 month old sheep raised in 
obesogenic environment [264]. The visceral depot weight was calculated 
as the sum of omental, pericardial and perirenal depots. When calculated 
as proportion of total predicted fat (from DXA scan performed at 16 
months age), obese offspring had significantly increased visceral to total 
fat depot ratio as compared to the lean offspring. Prenatal NR-LG did not 
affect this preferential deposition of fat in visceral depots.  
Obesity lead to a threefold increase in adipocyte size in the omental 
adipose tissue whereas NR-LG had no effect on the size of adipocytes in 
either the lean or obese offspring at 17 months of age. A strong correlation 
was evident between adipocyte size and the weight of the omental adipose 
tissue depot (r=0.84). As mature adipocytes do not divide in vivo, 
adipocyte hypertrophy is considered as the primary mechanism for 
expansion of white adipose tissue depot in obesity whilst dead cells are 
replaced by adipocyte precursors present in the stromal vascular fraction 
[458]. The strong correlation between adipocyte size and the weight of 
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adipose tissue depot demonstrated in this study supports this proposed 
mechanism. Spalding and colleagues have previously demonstrated this in 
experiments using the incorporation of 14C as tracer and calculated that 
human adipocytes have a half-life of 8.3 years and, upon adipocyte death, 
new adipocytes replace old dead adipocytes [34]. The adipocyte number in 
an adult is tightly regulated irrespective of energy balance and in the state 
of excess energy, the excess lipid deposition is accommodated by increase 
in cell size. 
Apart from storing reserve fuel, this process of adipocyte hypertrophy 
serves to protect the individual from adverse effects of circulating lipids. 
However, the metabolic and secretory demands of these hypertrophic 
adipocytes in obesity puts the cellular functioning under stress [459] 
leading to activation of the various cell stress response pathways. 
Exploration of such metabolic inflammation and cell stress response, 
therefore, is the natural next step in describing the features of obesity 
associated adipose tissue changes. 
3.4.4.2 Obesity is associated with increased macrophage 
infiltration, the presence of CLS and activated milky spots in 
omental adipose tissue.  
CLS were identified in omental adipose tissue from obese as well as lean 
animals. This is in contrast to the subcutaneous adipose tissue from the 
same animals where no CLS were identified from adipose tissue from lean 
or obese offspring [460]. Furthermore, in the obese animals, two distinct 
patterns, consistent with previously described CLS [68] and milky spots 
[461], were evident. In the omental adipose tissue from obese animals, 
the macrophages tended to be in clusters of CLS or as milky spots 
surrounding adjacent necrotic cells, whereas in the lean animals the CLS 
were infrequent and diffuse amongst adipocytes. Milky spots, which are a 
feature unique to omentum, develop in late gestation and are identifiable 
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as a large collection of immune cells, predominantly macrophages present 
in clusters and are considered to be an important source of macrophages 
for the peritoneal immune response [69]. Such milky spots were more 
abundantly present in omental adipose tissue from obese animals. 
However, despite analysing slides containing a minimum of 350 adipocytes 
per animal, accurate quantification of abundance of macrophage or CLS 
structures was not possible due to non-homogenous scatter of such 
structures throughout the adipose tissue sections. Increased abundance of 
Iba1 stained macrophages with obesity is supported by the finding of a 4-5 
fold increase in CD68 gene expression with obesity (Section 3.4.4.3), 
indicating increased number and activation state with obesity.  
3.4.4.3 Obesity associated upregulation of gene expression of 
adipokines and inflammation in omental adipose tissue is 
not exacerbated by NR-LG.  
As expected, the omental adipose tissue from obese animals had a 
significantly higher gene expression for leptin which was increased 5 fold in 
A-O compared to the A-L offspring and increased 8 fold in N-O compared 
to the N-L offspring. The gene expression for leptin correlated strongly 
with plasma leptin levels at 16 months of age. Whilst the main function of 
leptin is in the regulation of appetite, its pro-inflammatory role is well 
recognised [52].  Elevated plasma leptin has been demonstrated to 
correlate with severity of metabolic dysfunction [47]. Cytokines of 
macrophage origin are known to be increased with obesity [462]. 
Accordingly, the omental adipose tissue from the obese offspring 
demonstrated significantly greater expression of CD68, indicating an 
increased number, and activation state, of the macrophages. Gene 
expression of TLR4, a membrane bound receptor known to be present on 
adipose tissue cells and capable of activating intracellular inflammatory 
pathways (JNK) and stimulating release of cytokines [57] was also 
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increased with obesity. The obesity associated increase in gene expression 
of leptin, CD68 and TLR4 is in agreement with the study hypothesis. 
The lack of a further increase in the gene expression for CD68, TLR4 and 
leptin in offspring of nutrient restricted sheep fails to support the 
hypothesised worsened metabolic inflammation in omental adipose tissue. 
The findings are in contrast to a sheep study of 50% NR-LG (days 110-
147) which demonstrated increased gene expression of perirenal adipose 
tissue CD68 and TLR4 at one year of age [68]. The differences between 
these findings may reflect the differential mechanisms of development of 
perirenal and omental adipose tissue. At birth, perirenal adipose tissue is 
relatively abundant, forming approximately 80% of total adipose tissue of 
sheep [463] as compared to omental adipose tissue which undergoes all of 
its lipid deposition after birth [322]. Furthermore, omental adipose tissue 
is distinctive due to presence of its own immune cell deposits, similar to 
lymphoid organs known as milky spots. These milky spots develop during 
the late gestation in humans [69]. The differential developmental 
processes of the two visceral adipose tissues depots, perirenal and 
omental, could explain the variance in the gene expression of components 
of metabolic inflammation CD68 and TLR4 in response to NR-LG. It is also 
plausible that the severity of nutrient restriction (60% of metabolisable 
energy) in this study was not severe enough to modify these components 
of the cell stress response. The age at the time of sampling of tissue may 
also be an important determinant of the difference in results. It is plausible 
that, by 17 months of age, the upregulated gene expression for cellular 
inflammatory pathways masks the relatively subtle impact of the NR-LG on 
these pathways. However, in the absence of larger studies focusing on 
depot specific differential gene expression at various stages of 
development and growth, such explanations are speculative. However, 
mechanisms of cell stress response intrinsic to the cell, such as autophagy 
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or ER stress [464], may influence the metabolic inflammation irrespective 
of lack of further increase in gene expression of extrinsic factors such as 
macrophage marker CD68 and pattern recognition receptors TLR4. Such 
intrinsic factors were the focus of further experiments described in this 
thesis. 
3.4.4.4 Obesity associated upregulation of gene expression for 
autophagy and its energy sensing regulators in omental 
adipose tissue is not exacerbated by NR-LG.  
In line with the study hypothesis, and as previously identified in human 
descriptive studies of omental adipose tissues of individuals with visceral 
adiposity [134], obesity led to upregulation of the gene expression for 
components of the autophagic pathway (ATG12 and BECN1) in omental 
adipose tissue. Similar to its role in the liver, autophagy contributes to 
adipose tissue homeostasis by regulating lipid metabolism and adipocyte 
development. Inhibition, or knockout, of autophagy related proteins ATG5 
and ATG7 [131, 132]  results in mice with a lean phenotype with 
decreased white adipose tissue mass and enhanced insulin sensitivity. In 
addition, autophagy has been closely linked to control of innate and 
acquired immunity [465]. AMPK, which is activated in a nutrient depleted 
state, is known to directly upregulate autophagy through phosphorylation. 
In contrast, mTOR inhibits autophagy. The upregulated gene expression of 
ATG12, BECN1 and AMPK with obesity, therefore, indicates that obesity 
enhances autophagy in adipose tissue as has been previously proposed 
[134].  
The direction of relationship and specific role of autophagy in obesity has 
not been clearly identified. It has been proposed that increased autophagy 
in obese adipose tissue is a cell survival response to obesity induced 
metabolic and inflammatory stress and insulin resistance [107]. However, 
as a process which interacts at multiple nodes with other cell stress 
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response pathways, activated autophagy has been shown to degrade 
insulin receptors [466] and promote survival of anti-inflammatory (M2) 
monocytes. A persistent increase in autophagy also has the potential to 
promote cell death, a feature of obese adipose tissue microstructure.  
NR-LG did not result in the hypothesised accentuation of gene expression 
for autophagy in omental fat. In conjunction with the previously described 
findings of increased gene expression of leptin, TLR4 and CD68, these 
results suggest that whilst autophagy and inflammation are associated 
with obesity, these pathways may not be a target of nutritional 
programming during late gestational undernutrition.  
3.4.4.5 Omental adipose tissue from obese sheep exposed to 
NR-LG demonstrates upregulated UPR. 
It was predicted in the study hypothesis that obesity would lead to 
upregulation of gene expression of UPR [99, 103, 105]. In this model of 
young adult sheep experiencing moderate obesity, upregulation of UPR 
components ATF6, EDEM1 and GRP78 was limited to obese offspring of 
NR-LG sheep, in comparison to the lean offspring of the NR-LG sheep. 
Adipose tissue ATF4 gene expression was uniformly increased in obese 
offspring in comparison to lean offspring, irrespective of prenatal 
intervention. Therefore, the tendency for upregulation of UPR in obesity, as 
evident by increased ATF4, was enhanced by the prenatal undernutrition in 
the offspring of NR-LG sheep. 
The three genes, ATF6, EDEM1 and GRP78, share the same transcriptional 
regulators (Figure 3.27) called ER Stress Response Element-II (ERSE-II) 
and UPRE (Unfolded Protein Response Element). Upon activation of UPR, 
the canonical pathways ATF6 and IRE1 activate these transcription factors 
leading to increased gene expression of UPR genes [467]. 
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Figure 3.27 Schematic diagram of canonical pathways of ER stress demonstrating 
the common transcription factor known to upregulate gene expression for GRP78, 
ATF6 and EDEM (encircled in red). 
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The adipocyte endoplasmic reticulum plays an important role in 
maintaining cell homeostasis by contributing to protein folding, secretion 
of adipokines [112], lipid droplet formation [468] and lipid metabolism 
[469]. ER stress not only affects the adipocyte protein and lipid 
metabolism but also leads to upregulation of inflammation and consequent 
insulin resistance [99].  
Upregulated UPR in perirenal adipose tissue of obese sheep has previously 
been demonstrated in a model of prenatal nutrient restriction to 50% of 
requirements during early gestation [68]. Sharkey et al. then proposed 
that suboptimal nutrition during adipocyte development programmes a 
reduced total adipocyte number. When subject to the nutritional 
abundance of obesity, the fewer adipocytes in the visceral depots would 
reach their lipid storage capacity sooner. These expanding adipocytes 
would, therefore, reach the threshold of activation of ER stress response at 
a lower level of obesity. The activated ER stress response, while initially 
attempting to restore the cellular homeostasis and survival, can eventually 
lead to activation of inflammatory pathways, cell death pathways and 
development of insulin resistance. In such a scenario, the upregulated 
gene expression of UPR components is the consequence of the expanding 
adipocyte reaching the threshold of ER stress response sooner.  
Omental serosa and omental adipose tissue share the same developmental 
source of mesodermal stem cells [314]. In humans and sheep, before 
birth, the omentum is predominantly comprised of serosal tissue and milky 
spots and there is very little recognisable adipose tissue. During the late 
gestation, the sheep omentum rapidly increases in size from 90mm2 at 50 
days gestational age to 21,000mm2 by term gestation [69]. Following 
birth, the omental adipose tissue depot rapidly expands and since mature 
adipocytes do not divide, this occurs from differentiation of preadipocytes 
of mesodermal origin present in the omentum [470]. Any suboptimal 
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nutrition during late gestation could affect the adipocyte precursors 
making the omentum vulnerable to programming of adipocyte number, 
and thereafter, to rapid expansion of adipocyte size following birth in a 
similar fashion as proposed by Sharkey et al. for perirenal adipose tissue 
(Figure 3.28). 
Another explanation could be a resetting of such threshold of activation of 
ER stress response in the offspring of NR-LG sheep. Models of various 
activation states of the UPR [471] have been proposed. Modulation of UPR 
activation has been proposed to be mediated by mechanisms such as 
variation in the concentrations of intra-organelle chaperone proteins [472], 
alterations in the inactivating binding of such chaparones or turnover rates 
of the individual components of the UPR[473]. ER is sensitive to nutrient 
supply as it uses considerable energy for protein processing steps such as 
protein folding, chaperone functioning and vesicle formation [155]. 
Furthermore, glucose deficiency by itself has been proposed to cause 
inefficient protein folding adding to the ER stress load [474, 475]. Indeed, 
glucose regulated proteins were so named because they were regulated by 
the glucose concentration in the culture medium [476]. Upregulation of the 
ER stress response in response to hypoglycaemia has been demonstrated 
in in vitro experiments in tumour cells [477], pancreatic β cells [477], 
myocytes and adipocyte cell cultures [478]. Apart from the rapid increase 
in the size of omental serosa containing adipocyte precursors and 
macrophage collections during late gestation [69], this period also 
coincides with dynamic nutritional and endocrine changes in other 
established adipose tissue depots [479] with active protein synthesis in the 
adipocyte. Any suboptimal nutrient restriction during this period of 
increased metabolic demand of rapidly growing and developing omental 
adipocyte precursors would activate an ER stress response. Adipocytes and 
developing precursors with lower threshold for ER stress response in such 
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a scenario are more likely to survive and potentially prepare the organ to a 
poor postnatal environment, as proposed in the predictive adaptive 
response hypothesis [480]. When this subgroup of animals are further 
subjected to post-weaning obesity, the ensuing ER stress in the adipocyte, 
would achieve the threshold of activation of UPR sooner. After the initial 
pro-survival actions, prolonged UPR in these offspring would initiate 
inflammation and cell death pathways (Figure 3.28).  
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Figure 3.28 Schematic diagram depicting the two proposed mechanisms leading to 
increased vulnerability of adipose tissue of offspring of nutrient restricted sheep to 
obesity induced cell stress. 
Exposure to undernutrition during late gestation may decrease the number of total 
adipocytes. When subject to relative nutrient excess of obesity, the adipocytes 
expand by hypertrophy, thereby predisposing the cells to ER stress and activation 
of cell stress pathways and inflammation. Alternatively, during the period of 
prenatal undernutrition, cells capable of instituting UPR at a lower threshold, are 
selectively able to survive the period of undernutrition. When exposed to 
hypertrophy and the cell stress of the obesogenic environment, the lower threshold 
of UPR activation leads to a prolonged UPR which then redirects the cellular 
response towards inflammation and cell death pathways. 
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3.4.4.6 Protein abundance of GRP78 was increased with 
obesity and is not modified by NR-LG. 
IHC staining for GRP78 demonstrated localisation of this protein in the 
cytoplasmic fraction of adipocytes in contrast to pJNK, which was present 
in the perinuclear area. Adipocyte number was used as a denominator 
because of the variance in adipocyte size with increasing obesity [68]. 
Obesity was associated with increased GRP78 staining per adipocyte. NR-
LG did not lead to any difference in the quantity of the staining. This fails 
to confirm the outcome predicted by the gene expression analysis where 
NR-LG followed by offspring obesity was associated with increased gene 
expression as compared to the offspring of mothers fed to appetite during 
late gestation. It is known that the relationship between gene expression 
and protein expression is not linear as the latter is the outcome of multiple 
post-transcriptional processes including mRNA processing, postranslational 
modifications, misfolding and ER associated protein degradation, negative 
feedback and, most importantly, the sensitivity of the quantifying assay 
[481]. The increased staining for the protein in obese offspring in 
comparison to the lean animals suggests that the increase in UPR genes in 
offspring of NR-LG sheep is in a background of increased ER stress 
response to obesity as suggested by increased gene expression of ATF4 
genes. Increased adipose tissue UPR with obesity is a well-documented 
phenomenon which is confirmed by this study [112]. 
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3.5 Conclusion 
The first objective of this study was to establish a large animal model of 
obesity and to describe the characteristics of cell stress response to 
obesity in two metabolically vital organs, liver and omental adipose tissue. 
Restriction of physical activity, instituted after weaning from mother’s 
feeding at 90 days of age, established a model of obesity with 1.35 fold 
weight gain in comparison to sheep in an unrestricted environment. In 
contrast to other sheep studies, such relative weight gain can be 
designated as mild to moderate obesity. In this study, such a degree of 
obesity was associated with alterations of glucose homeostasis which were 
demonstrated by the GTT results of decreased glucose disposal at 7 
months of age and insulin resistance at 16 months of age.  
The adipose tissue from obese sheep demonstrated preferential lipid 
deposition in visceral depots as compared to lean animals and omental 
adipose depot weight was strongly correlated with adipocyte size. A 
correlation was also demonstrated between plasma leptin concentrations 
and the gene expression of omental adipose tissue leptin in obese sheep. 
In omental adipose tissue, obesity was associated with a generalised 
increased gene expression of components of metabolic inflammation and 
the cell stress response including autophagy and some components of 
UPR. Furthermore, obese adipose tissue demonstrated increased 
abundance structures consistent with activated milky spots and crown like 
structures as compared to adipose tissue from lean sheep.  
In the liver from obese sheep, increased liver weight correlated with 
hepatic triglyceride content. The study was unable to identify histological 
features of evolving non-alcoholic fatty liver disease in this sheep model. 
There was a generalised increase in gene expression for autophagy and ER 
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stress in association with the increased hepatic lipid deposition 
demonstrated with obesity in this sheep model in comparison to the lean 
animals.  
The metabolic derangements associated with obesity and the ensuing 
metabolic syndrome have been proposed to be the outcome of active 
metabolic inflammation in adipose tissue and liver, leading to cellular 
dysfunction, death and insulin resistance. This study is unique as it 
confirms the presence of the activated cell stress response and metabolic 
inflammation in the adipose tissue and liver and describes their 
characteristics in a large animal model of physical inactivity induced 
obesity at young adult age equivalence. This establishes a baseline for 
investigation of the interactions of obesity with other risk factors such as 
developmental programming on the cell stress response and metabolic 
inflammation with the potential to accentuate an individual’s risk of worse 
metabolic outcomes.  
Suboptimal maternal nutrition during late gestation is one such risk factor 
and the second objective of this study was to investigate the 
developmental programming impact of such poor nutrition on the cell 
stress response and inflammation at young adult equivalent age. Twin 
bearing sheep subject to NR-LG to 60% of maternal metabolic 
requirements had decreased plasma insulin and glucose and increased 
plasma NEFA in comparison to sheep fed to appetite signifying a state of 
energy deficit in the environment of the growing fetus. This resulted in 
lower maternal weight and decreased offspring birth weight in comparison 
to sheep fed to appetite. NR-LG did not exacerbate markers of obesity 
induced decreased glucose disposal or insulin resistance as measured 
during GTT performed at 7 months and 16 months respectively. 
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Adipose tissue distribution and relative adipose depot weight was not 
affected by prenatal nutrition. Following NR-LG, obese offspring 
demonstrated upregulation of all four UPR genes in comparison to lean 
offspring. The gene expression for UPR component ATF4 was upregulated 
in all obese offspring irrespective of prenatal nutrition group. Prenatal 
suboptimal nutrition did not exacerbate obesity induced upregulated 
omental adipose tissue autophagy and increased gene expression for CD68 
and leptin. 
Obesity associated increased hepatic weight was exaggerated in offspring 
of NR-LG sheep in comparison to offspring of sheep fed to appetite, a 
result similar to a previous study of prenatal nutrient restriction during 
early gestation [279] which was proposed to be an outcome of decrease in 
hepatic fatty acid oxidation. Developmentally, such a process would 
indicate a response of a nutrient deprived fetus leading to a phenotype 
maladapted to the relative nutrient excess of obesogenic postnatal 
environment. The obesity associated increased gene expression of hepatic 
autophagy marker BECN1 was exaggerated with prenatal NR-LG. Obesity 
is associated with a defective autophagy [234] which can promote hepatic 
lipid accumulation associated with increased compensatory gene 
expression. Such defective autophagy has also been identified in offspring 
of nutrient restricted rats, in association with increased hepatosteatosis 
[238]. Future studies in this regard should focus of demonstrating the 
characteristics of the hepatic autophagic function in the obese offspring of 
NR-LG sheep. 
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Figure 3.29 Schematic flowchart summarising the overall findings of the study described in 
this chapter.  
Obesity leads to increased liver triglyceride, and increase in UPR and autophagy genes. If 
obesity is preceded by nutrient restriction during late gestation, the increase in liver 
triglyceride and BECN1 autophagy gene is further enhanced. In the omental adipose tissue, 
obesity leads to increased adipocyte size and macrophage infiltration in association to 
increase in gene expression for UPR and autophagy. If preceded by nutrient restriction during 
late gestation, the adipose tissue UPR is further enhanced.  
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In conclusion, the results described in this chapter describe the 
characteristics of upregulated gene expression of omental adipose tissue 
UPR and hepatic autophagy in the obese offspring of NR-LG sheep (Figure 
3.29). On the background of obesity associated enhanced hepatic and 
adipose cell stress response and adipose metabolic inflammation in a large 
animal model described in this chapter, such findings establish a direction 
for potential future studies. 
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4 Interaction of prenatal nutrient restriction and 
formula feeding during early life on the cell stress 
response and metabolic inflammation in liver and 
adipose tissue. 
 
4.1 Introduction and hypothesis 
Nutrient supply during early infancy has the potential to influence long 
term health of an individual [281, 344]. Several meta-analyses [299, 300, 
482] have demonstrated both a dose response and a categorical 
relationship between breastfeeding and decreased risk of obesity in later 
life as compared to feeding with infant formula milk. However, studies 
investigating the development of metabolic syndrome and its relationship 
to the type of feeding during infancy are sparse and not conclusive [301]. 
A recent meta-analysis of breast fed infants (n=76,744) identified a 
decreased risk of later type 2 diabetes as adults (pooled odds ratio: 0.61; 
95% CI: 0.44–0.85; p=0.003) [301, 305]. In contrast, other studies have 
reported an absence of any association between infant feeding type on the 
components of metabolic syndrome in adulthood [306].   
Experimental studies investigating the mechanisms of the impact of 
feeding type on development of later obesity and adverse metabolic health 
have primarily focussed on appetite regulation [307, 308]. However, 
published literature investigating the effects of the type of infant feeding 
on the liver and adipose tissue is limited to one observational study 
demonstrating increased likelihood of developing NAFLD in childhood in 
formula fed infants [309] and one longitudinal study which demonstrated 
no difference in hepatic lipid content or adiposity of breast fed in 
comparison to formula fed infants at 13 and 63 days median age [310]. 
Both, liver and adipose tissue have a vital role in the pathogenesis of 
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obesity associated metabolic dysfunction [21, 239]. Therefore, any 
investigation of mechanisms of increased predisposition to obesity and 
adverse metabolic outcomes due to formula feeding should focus on 
describing the hepatic and adipose tissue characteristics and investigate 
the pathogenic processes in these organs. There are no published 
experimental studies which investigate the cumulative effect of prenatal 
undernutrition and formula feeding during early life on the development of 
obesity and metabolic syndrome. 
In the absence of such experimental studies, there is a need for a 
randomised experimental study performed in a suitable large animal model 
which compares type of milk used for feeding during early postnatal life 
and reports the adult outcomes of such groups. The study described in this 
chapter utilises a sheep model to investigate the impact of formula feeding 
in comparison to being fed by mother, on the mechanisms influencing long 
term metabolic health of an individual. In addition, through the use of a 2 
by 2 factorial design, this study also investigates if suboptimal maternal 
nutrition during late gestation interacts with postnatal diet to influence the 
the long term metabolic health of the offspring. This experimental model 
aims to reflect individuals who were fed with formula milk after being born 
growth restricted due to reduced maternal nutrition and then who become 
obese in later life and compare with individuals fed on the mother’s milk.  
The results in Chapter 3 describe the characteristics of liver and adipose 
tissue metabolic inflammation in sheep due to obesity with, or without, a 
background of prenatal nutrient restriction. The study now described in 
this Chapter builds on these findings by incorporation of an additional 
stimulus of formula feeding which has the potential to exacerbate obesity 
and associated adverse metabolic outcomes [299, 305].  Such outcome 
measures of adiposity, state of metabolic inflammation in liver and adipose 
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tissue and overall metabolic health have not been previously described in a 
large animal model.  
In light of findings described in Chapter 3 and the limited evidence 
summarised above, the experiments described in this chapter investigate 
the following experimental hypotheses: 
1. Formula fed lambs, in comparison to lambs fed by their mother, 
would experience greater adiposity and visceral fat deposition in 
young adult age. It is predicted that this will be associated with 
decreased insulin sensitivity and increased gene expression of 
components of metabolic inflammation in liver and omental adipose 
tissue.  
2. Formula fed offspring born to mothers exposed to nutrient 
restriction in late gestation (NR-LG), in comparison to the group not 
exposed to in utero undernutrition, will demonstrate a greater 
increase in hepatic and adipose tissue metabolic inflammation and 
an exaggerated cell stress response to obesity. It is predicted that 
this would manifest as augmented gene expression of pathways of 
metabolic inflammation and the cell stress response, worsening of 
metabolic parameters and decreased insulin sensitivity in the 
formula fed offspring of the nutrient restricted group in comparison 
to the group not exposed to in utero undernutrition. 
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4.2 Methods 
The design of the study, animal interventions and all experimental 
methods used to establish the results described in this Chapter are 
described in detail in Chapter 2 and summarised in Figure 4.1. Briefly, 
after confirmation of twin gestation by ultrasound scanning, twin bearing 
ewes were randomised to either nutrient restriction (N) to 60% of 
metabolic requirements from gestational day 110 until term (145±2 days) 
or fed to 100% of metabolic requirements (R) through the entire 
gestation. After birth, the twin offspring were separated during the 
suckling period (birth to 90 days): one twin was formula fed (F) whilst the 
other was fed by their mother (M). The resulting combination of prenatal 
(R and N) and postnatal factors (M and F) render a factorial experimental 
design with four groups (R-M, R-F, N-M and N-F). Post-weaning, the 
offspring were all raised in a barn with a stocking rate of 6 sheep per 
19m2. 
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All the animals were humanely euthanased at 17 months of age and, after 
weighing organs, representative samples from liver and adipose tissue 
were snap frozen in liquid nitrogen and stored at -80°C until further 
processing for analyses such as gene expression analysis, histological and 
immunohistochemical analysis and hepatic triglyceride content and 
thiobarbituric acid reactive substances (TBARS) analyses. The animal 
experiments were performed at the joint animal breeding unit, Sutton 
Bonington Campus of the University of Nottingham (Nottingham, UK), by 
Dr S. Sebert under supervision of Professor M.E. Symonds and Dr D. 
Gardner. The results presented in this thesis were derived from analysis of 
raw data by the author. 
 
Figure 4.1 Schematic diagram depicting the experimental study design 
investigating effect of late gestation maternal nutrient restriction and type of 
feeding during suckling period (birth to 90 days age) on obesity and metabolic 
health of 17 month old sheep.  
From 110 days gestational age (dGA) to term, ewes were fed a diet meeting 
requirements (R, n=10) or a nutrient restricted diet (N, n=9). During the suckling 
period, twin offspring were separated where one twin was reared by mother (M) 
and the sibling was separated from their mother and fed with formula milk. DXA, 
dual-energy X-ray absorptiometry; GTT, glucose tolerance test; dGA, days 
gestational age. 
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The statistical analyses are described in detail in Chapter 2. Briefly, for the 
factorial study design, the data were first interrogated with two-way 
analysis of variance (2-way ANOVA). Upon identification of a significant 
effect or interaction on the 2-way ANOVA, a hypothesis driven simple main 
effects analysis was performed for comparison between groups differing in 
only one factor (prenatal nutrient restriction or environment of rearing). If 
required, non-parametric testing was performed using Kruskal-Wallis test 
followed by Mann Whitney. Outcome for GTT and body weight 
measurements produced results with repeated measures in same animal 
over time. Analyses for such data with repeated measures were performed 
with two way or three way mixed ANOVA and time was included as a 
within-subject factor to assess for interaction between time and 
experimental conditions. For sake of uniformity of presentation and in 
keeping with standard practice, data have been expressed as mean and 
standard error of the mean for all the experimental output irrespective of 
the type of distribution of the data. 
The final animal numbers in the experimental groups, as depicted in Figure 
4.1 excludes the 4 offspring, one in each of the four experimental groups 
that died unexpectedly prior to the studies’ end. The specific causes of 
animal deaths are not known. The deaths were not concentrated in any 
specific experimental group and are fewer than 10% reported natural 
death rate in similar populations [329].  
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4.3 Results 
4.3.1 Maternal and offspring metabolic profile 
4.3.1.1 Weight gain and metabolic profile of pregnant ewes. 
The body weight of sheep randomised to NRLG (N, n=9, 72± 1.9 kg) did 
not significantly differ (p=0.78) from sheep randomised to a diet meeting 
metabolic requirements (R, n=10, 69.7±1.8 kg).  Two-way mixed ANOVA 
was performed with time (dGA) as within-subject factor to account for 
repeated measures. There was a statistically significant interaction 
between the maternal nutrition and time on body weight expressed as 
percentage of weight at the beginning of intervention (p=0.008). Sheep 
undergoing NR-LG to 60% of ME gained significantly less weight during the 
late gestation (Figure 4.2).  
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Figure 4.2 Weight gain during late gestation (110 -145 days), expressed as 
percentage gain over the weight at 110 days of gestation in ewes fed a diet meeting 
requirements (R, yellow, n=10) or a nutrient restricted diet (N, red, n=9) during 
late. Data are means with error bars representing SEM. Two-way mixed ANOVA was 
performed with time (dGA) as within subject factor to account for repeated 
measures.  *p<0.05 and **p<0.001 for N versus R simple main effects comparison. 
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At 130dGA, ewes in the nutrient restricted group had a lower plasma 
glucose and higher plasma NEFA concentrations. There was no difference 
in plasma insulin and plasma triglyceride levels (Figure 4.3). The fasting 
early morning plasma cortisol was also not different between the N (mean 
±SEM; 26.8±5.4 nmol/L, n=9) and R (17.7±2.5 nmol/L, n=10) groups.   
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Figure 4.3 Fasting plasma insulin (A), glucose (B), NEFA(C) and triglyceride (D) 
concentration on 130 days of gestation in ewes fed a diet meeting requirements (R, 
yellow, n=10) or a nutrient restricted (N, red, n=9) between 110–145 days of 
gestation. Data are means with error bars representing SEM. **p<0.001 for N 
versus R comparison identified by independent sample t tests. NEFA, non-esterified 
fatty acids.  
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4.3.1.2 Offspring birth weight, weight gain and physical 
activity phenotype during the suckling period 
The birth weight of the twin offspring of ewes in N group (3.75±0.11 kg, 
n=18) was significantly lower than the offspring of the ewes in R group 
(4.86±0.14 kg, n=17; p<0.001).   
One of each twin pair of offspring was randomised to being fed by the 
mother whilst the sibling was randomised to being fed on formula milk. 
There was no difference in the mean birth weight measurements of the 
offspring randomised to feeding on formula milk or on their mother’s milk 
as detailed in Table 4.1. 
 
 Prenatal 
nutrition 
Feeding method Prenatal 
nutrition 
Feeding 
method 
Interaction 
Mother fed Formula fed p value p value p value 
Birth 
weight (kg) 
R 4.96±0.27c 4.78±0.17d <0.001 0.87 N/A 
N 3.69±0.17c 3.81±0.16d    
Table 4.1 Birth weight measurements in offspring of ewes fed to requirement 
during pregnancy randomised to formula feeding (R-F, n=9) or being fed by 
mother (R-M, n=9) and offspring or ewes nutrient restricted during late gestation 
randomised to formula feeding N-F, n=9) or to being fed by mother (N-M, n=9). 
Data presented as means ± SEM. Statistical significance denoted by superscripts c 
versus d, p<0.001 for simple effects analysis of 2-way ANOVA  
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To account for repeated measurement of weight at different timepoints 
and factorial study design, a three-way mixed ANOVA was performed with 
weight at different timepoints as the within-subject factor. The analysis 
was not significant for a three-way interaction. However, a significant 
(p=0.003) two-way interaction was present between feeding method and 
weight at different timepoints. The simple main effects analysis 
demonstrated difference between weight of formula fed and mother fed 
offspring at all measurements during the suckling period (Figure 4.4) 
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Figure 4.4 Weight gain during the suckling period for the N-F (red squares, 
continuous red line, n=9), R-F (yellow square, continuous line , n=9), N-M (red 
circles, dashed red line, n=9) and R-M (yellow circles, dashed line, n=9) offspring. 
Three-way mixed ANOVA accounting for repeated measures across time was 
performed. **p<0.05 for main effect analysis between formula fed and mother fed 
offspring. Data presented as means with error bars representing SEM 
  261 
The relative rate of growth, expressed as fold change from birth to 30, 60 
and 90 days of age was greatest in the N-M group in comparison to N-F 
and R-M offspring respectively (Figure 4.5). 
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Figure 4.5 Relative weight gain during the suckling period in offspring of ewes fed 
to requirement during pregnancy randomised to formula feeding (R-F, n=9) or 
being fed by mother (R-M, n=9) and offspring or ewes nutrient restricted during 
late gestation randomised to formula feeding N-F, n=9) or to being fed by mother 
(N-M, n=9). Data presented as means with error bars representing SEM.*p<0.05, 
**p<0.001 for simple effects analysis following 2-way ANOVA. 
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The recordings of physical activity performed at 45 days of age identified 
that formula fed offspring were less active in comparison to the offspring 
fed by their mother. The duration of mobility during a 24 hour period also 
approached statistical significance with a trend towards decreased activity 
in formula fed offspring irrespective of the prenatal nutrition (Table 4.2). 
 
  Prenatal 
nutrition 
Feeding method Prenatal 
Nutrition 
Feeding 
method 
Interaction 
 Mother fed Formula 
fed 
p value p value p value 
       
Mean activity 
(counts) 
R 155±5a 105±10b 0.90 <0.001 0.71 
N 158±14c 99±13d    
       
Duration 
mobile in 24 
hours 
(minutes)  
      
R 972±60 944±57 0.76 0.08 0.16 
N 1049±55 826±88    
      
Maximum 
intensity of 
physical 
activity 
(counts) 
      
R 2042±171 2188±247 0.03 0.22 0.37 
N 2627±449 3543±635    
      
 
  
Table 4.2 Physical activity parameters at 45 days of age in offspring of ewes fed to 
requirement during pregnancy randomised to formula feeding (R-F, n=9) or being 
fed by mother (R-M, n=9) and offspring or ewes nutrient restricted during late 
gestation randomised to formula feeding N-F, n=9) or to being fed by mother (N-
M, n=9). Data presented as means ± SEM. Statistical significance denoted by 
superscripts a versus b, p<0.05; c versus d, p<0.001 for simple effects analysis of 
2-way ANOVA  
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4.3.1.3 Plasma metabolic profile at the age of 7 months 
Offspring feeding method or maternal nutrient restriction during late 
gestation had no significant impact on fasting blood glucose or insulin at 7 
months of age (Table 4.3). The analysis was performed using three-way 
mixed ANOVA to account for repeated plasma glucose measurements at 
different time points. There was no significant three-way interaction 
between prenatal nutrition, feeding method and time (p=0.66, Figure 
4.6A).  The analysis also demonstrated lack of two-way interaction 
between prenatal nutrition and time (p=0.38) and feeding method and 
time (p=0.51). Simple main effect test for two-way interaction between 
prenatal nutrition and feeding method was also not significant (p=0.80). 
The plasma insulin concentrations (Figure 4.6) did not demonstrate a 
statistically significant three-way interaction between the experimental 
groups and time (p=0.62). Analysis for two-way interactions also did not 
identify an interaction between prenatal nutrition and time (p=0.82) or 
feeding method and time (p=0.52) Simple main effect test for two-way 
interaction between prenatal nutrition and feeding method was also not 
significant (p=0.34).  
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Figure 4.6 Plasma glucose (A) and insulin (B) concentrations during a glucose 
tolerance test performed at the age of 7 months from lambs randomised as 
described to formula feeding (R-F, n=8; N-F, n=7) or being fed on their mother’s 
milk (R-M, n=9; N-M, n=9). Data presented as means with error bars representing 
SEM. Statistical analysis performed with three-way mixed ANOVA.  
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The area under the curve for glucose and insulin measurements during the 
GTT was calculated and did not differ between the groups (Table 4.3). 
Analysis of HOMA-IR index calculated using the baseline glucose and 
insulin concentrations demonstrated a significant interaction between the 
experimental measures. However, there was no statistical difference on 
subgroup analysis for simple effects.  
 
 Prenatal 
nutrition 
Feeding method Prenatal 
nutrition 
Feeding 
method 
Interaction 
Mother fed Formula fed p value p value p value 
AUC 
glucose 
(mmol/L) 
R 1585±45 1452±51 0.10 0.07 0.84 
N 1462±90 1355±71    
AUC insulin  
(ng/ml) 
R 42.8±11.3 56.0±17.0 0.97 0.99 0.30 
N 55.5±9.57 40.1±9.49    
HOMA-IR R 6.0±0.4 6.4±0.7 0.12 0.82 0.03 
N 7.4±0.6 5.2±0.3    
  
Table 4.3 Markers of insulin sensitivity expressed as area under the curve and 
HOMA-IR calculated from glucose tolerance test performed at age 7 months of age 
in offspring of ewes fed to requirement during pregnancy randomised to formula 
feeding (R-F, n=9) or being fed by mother (R-M, n=9) and offspring or ewes 
nutrient restricted during late gestation randomised to formula feeding N-F, n=9) 
or to being fed by mother (N-M, n=9). Data presented as means ± SEM. Data were 
analysed using 2-way ANOVA 
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Comparison of the plasma metabolic profile which consisted of plasma 
triglyceride, plasma NEFA, plasma leptin and plasma cortisol 
concentrations showed no effect of either formula feeding or maternal 
nutrient restriction (Table 4.4).   
 
 Prenatal 
nutrition 
Feeding method Prenatal 
nutrition 
Feeding 
method 
Interaction 
Mother fed Formula fed p value p value p value 
Plasma 
triglyceride 
(mg/dl) 
R 0.16±0.01 0.18±0.02 0.54 0.53 0.58 
N 0.16±0.01 0.16±0.02    
Plasma 
NEFA 
(mmol/L) 
R 1.32±0.07 1.12±0.16 0.36 0.36 0.56 
N 1.11±0.08 1.07±0.15    
Plasma 
cortisol 
(nmol/L 
R 74.4±19.0 63.3±12.3 0.69 0.30 0.39 
N 60.5±40.2 61.2±9.2    
Plasma 
leptin  
(ng/ml) 
R 1.80±0.23 2.2±0.38 0.72 0.58 0.68 
N 2.45±0.45 2.29±0.22    
 
  
Table 4.4 Plasma metabolic profile in fasted state at the age of 7 months in offspring 
of ewes fed to requirement during pregnancy randomised to formula feeding (R-F, 
n=9) or being fed by mother (R-M, n=9) and offspring or ewes nutrient restricted 
during late gestation randomised to formula feeding N-F, n=9) or to being fed by 
mother (N-M, n=9). NEFA, Non-esterified fatty acids. Data presented as means with 
error bars representing SEM. Statistical analysis performed with 2-way ANOVA.  
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4.3.1.4 Adult weight, adipose tissue depots and physical 
activity parameters of the offspring. 
Analysis of body weight measurements after weaning, performed using a 
three-way mixed ANOVA using weight measurements at different 
timepoints as repeated measures, did not demonstrate a three-way 
interaction between measurements (p=0.057). Analysis for main effects of 
prenatal nutrition (p=0.76) and feeding method (p=0.65) also did not 
identify a significant effect of these interventions (Figure 4.7). 
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Figure 4.7 Offspring body weight measurements following weaning from milk feeds 
at 90 days of age until the culmination of experimental intervention at the age of 
17 in offspring of ewes fed to requirement during pregnancy randomised to formula 
feeding (R-F, n=9) or being fed by mother (R-M, n=9) and offspring or ewes 
nutrient restricted during late gestation randomised to formula feeding N-F, n=9) 
or to being fed by mother (N-M, n=9). Data presented as means with error bars 
representing SEM. The statistical analysis was performed using a three-way mixed 
ANOVA to account for repeated measurements of weight over time.  
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The weight of visceral adipose tissue depots of omental, pericardial and 
perirenal adipose tissue sampled following euthanasia at 17 months of age 
did not differ with the experimental interventions. The calculated non-fat 
and total fat mass extrapolated from DXA scan at 16 months of age 
demonstrated that the gross adult body fat content and distribution was 
not affected by maternal nutrient restriction or by feeding method during 
early life. There was a non-significant trend towards decreased adiposity in 
N-F offspring as compared to N-M offspring. Similarly, the proportion of 
visceral fat (calculated as sum of omental, perirenal and pericardial fat) to 
total fat also did not differ between experimental groups (Table 4.5).  
 Prenatal 
nutrition 
Feeding  
method 
Prenatal 
nutrition 
Feeding 
method 
Interaction 
 Mother fed Formula fed p value p value p value 
Weight of 
omental 
adipose 
depot (g) 
R 1451±174 1173±90 0.33 0.13 0.72 
N 1563±381 1045±203    
Weight of 
pericardial 
adipose 
tissue (g) 
R 109±8 100±12 0.95 0.67 0.18 
N 96±8 114±10    
Weight of 
perirenal 
adipose 
tissue (g) 
R 1016±149 1130±201 0.44 0.64 0.28 
N 1073±239 787±99    
Relative 
fat mass  
(% of 
body wt.) 
R 13.1±2.2 14.8±2.1 0.90 0.43 0.11 
N 17.1±2.8 11.3±1.4    
Visceral 
fat (% of 
total body 
fat) 
R 25.6±2.2 25.1±2.1 0.65 0.64 0.52 
N 22.7±2.3 25.5±3.6    
 
  
Table 4.5 Body weight and adipose tissue deposit details in offspring of ewes fed 
to requirement during pregnancy randomised to formula feeding (R-F, n=9) or 
being fed by mother (R-M, n=9) and offspring or ewes nutrient restricted during 
late gestation randomised to formula feeding N-F, n=9) or to being ed by mother 
(N-M, n=9). Data presented as means ± SEM. Statistical analysis performed with 2-
way ANOVA.  
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At 15 months of age, physical activity indices measured for 24 hour period 
using an accelerometer did not reach statistical significance for difference 
between experimental conditions. There was a trend towards decreased 
activity in the mother fed offspring (p=0.07) as compared toformula fed 
offspring (Table 4.6). 
 Prenatal 
nutrition 
Feeding method Prenatal 
nutrition 
Feeding 
method 
Interaction 
 Mother  
fed 
Formula 
fed 
p value p value p value 
Mean 
activity at 
15 months 
(counts) 
R 117±14 128±14 0.05 0.68 0.75 
N 149±22 164±12    
Duration 
mobile/ 
day at 15 
months 
(minutes) 
R 834±94 933±88 0.45 0.07 0.72 
N 892±79 1045±58    
Maximum 
intensity 
at 15 
months 
(counts) 
R 1781±247 1415±82 0.43 0.75 0.13 
N 1579±131 1727±105    
  
Table 4.6 Physical activity parameters at the age of 15 months in offspring of ewes 
fed to requirement during pregnancy randomised to formula feeding (R-F, n=9) or 
being fed by mother (R-M, n=9) and offspring or ewes nutrient restricted during 
late gestation randomised to formula feeding N-F, n=9) or to being fed by mother 
(N-M, n=9). Data presented as means ± SEM. Statistical analysis performed with 2-
way ANOVA.  
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In order to analyse if the physical activity phenotype of decreased physical 
activity in formula fed animals persists post-weaning, a correlation analysis 
was performed between mean 24 hours’ physical activity counts measured 
at age of 45 days and at 15 months. Measurements from lambs from 
formula fed and mother fed groups demonstrated a significant linear 
correlation between physical activity measurements at age of 45 days with 
the measurements at age of 15 months in lambs (Figure 4.8). 
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Figure 4.8 Correlation analysis of mean 24 hour physical activity measurements 
performed at the age of 45 days and at 15 months. 
Lambs fed on formula milk during the suckling period are represented by black 
squares (n=14) and lambs fed by their mother are represented as open circle 
(n=14). Data presented as Pearson’s correlation coefficient (r) and p value from 
two tailed significance testing. 
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4.3.1.5 Plasma metabolic profile at the age of 16 months 
The plasma glucose and insulin concentrations during GTT were analysed 
using three-way mixed ANOVA to account for repeated measurements at 
different time points. For glucose (Figure 4.9), there was no significant 
three-way interaction between prenatal nutrition, feeding method and time 
(p=0.67). Analysis of glucose concentrations for two-way interactions also 
did not identify an interaction between prenatal nutrition and time 
(p=0.78) or feeding method and time (p=0.10). Simple main effect test 
for two-way interaction between prenatal nutrition and feeding method 
was also not significant (p=0.67). 
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Figure 4.9 Plasma glucose concentrations during a glucose tolerance test 
performed at the age of 16 months in offspring of ewes fed to requirement during 
pregnancy randomised to formula feeding (R-F, n=9) or being fed by mother (R-M, 
n=9) and offspring or ewes nutrient restricted during late gestation randomised to 
formula feeding N-F, n=9) or to being fed by mother (N-M, n=9). Data presented 
as means with error bars representing SEM. Statistical analysis performed with 
three-way mixed ANOVA to account for repeated measures over time. 
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The plasma insulin concentrations (Figure 4.10) also did not demonstrate a 
three-way interaction between experimental groups and time (p=0.85). 
Analysis for a two-way interaction also did not demonstrate a significant 
interaction between prenatal nutrition and time (p=0.36) or feeding 
method and time (p=0.39). Simple main effect test for two-way 
interaction between prenatal nutrition and feeding method was also not 
significant (p=0.65) 
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Figure 4.10 Plasma insulin concentrations during a glucose tolerance test 
performed at the age of 16 months in offspring of ewes fed to requirement during 
pregnancy randomised to formula feeding (R-F, n=9) or being fed by mother (R-M, 
n=9) and offspring or ewes nutrient restricted during late gestation randomised to 
formula feeding N-F, n=9) or to being fed by mother (N-M, n=9). Data presented 
as means with error bars representing SEM. Statistical analysis performed with 
three-way mixed ANOVA.  
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Fasting blood glucose concentrations at 16 months in the R-F offspring 
were higher than those of the R-M group (Table 4.7). The area under the 
curve for glucose and insulin measurements during the GTT were 
compared and did not differ between the groups (Table 4.3). Analysis of 
HOMA-IR index calculated using the baseline glucose and insulin 
concentrations demonstrated a significant interaction between the 
experimental measures. However, there was no statistical difference on 
subgroup analysis for simple effects.   
 
 Prenatal 
nutrition 
Feeding method Prenatal 
nutrition 
Feeding 
method 
Interaction 
Mother fed Formula fed p value p value p value 
Fasting 
glucose 
(mmol/L) 
R 2.9±0.2a 3.5±0.2b 0.53 0.02 0.13 
N 
3.2±0.1 3.3±0.1 
   
AUC 
glucose 
(mmol/L) 
R 1572±32 1434±41 0.45 0.09 0.44 
N 1515±64 1434±42    
AUC insulin  
(ng/ml) 
R 55.7±12.8 64.9±10.3 0.59 0.98 0.44 
N 71.9±11.6 61.9±14.1    
HOMA-IR R 3.2±0.3 4.6±0.6 0.73 0.15 <0.01 
N 4.6±0.4 3.4±0.1    
  
Table 4.7 Markers of insulin sensitivity expressed as area under the curve and 
HOMA-IR calculated from glucose tolerance test performed at the age of 16 months 
in offspring of ewes fed to requirement during pregnancy randomised to formula 
feeding (R-F, n=9) or being fed by mother (R-M, n=9) and offspring or ewes 
nutrient restricted during late gestation randomised to formula feeding N-F, n=9) 
or to being fed by mother (N-M, n=9). Data presented as means ± SEM. Data were 
analysed with 2-way ANOVA. superscript a vs b, p<0.05 for simple effects analysis 
of 2-way ANOVA.  
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The experimental groups did not differ in the plasma concentrations for 
NEFA or cortisol. Offspring of sheep undergoing late gestation nutrient 
restriction had lower plasma triglyceride concentration but was unaffected 
by formula feeding (Table 4.8). A statistically significant interaction was 
present between prenatal intervention and feeding type for the plasma 
leptin concentrations. Subgroup analyses demonstrated lower leptin 
measurements in N-F offspring in comparison to N-M group.  
 
 Prenatal 
nutrition 
Feeding method Prenatal 
nutrition 
Feeding 
method 
Interaction 
 Mother fed Formula fed p value p value p value 
Plasma 
triglyceride
(mg/dL) 
R 0.18±0.02 0.19±0.03 0.03 0.96 0.75 
N 0.13±0.03 0.13±0.01    
Plasma 
NEFA 
(mmol/L) 
R 0.39±0.06 0.55±0.08 0.74 0.19 0.37 
N 0.43±0.09 0.46±0.04    
Plasma 
cortisol 
(nmol/L) 
R 40.8±9.3 33.1±13.9 0.36 0.26 0.65 
N 56.1±13.9 38.4±5.0    
Plasma 
leptin  
(ng/mL) 
R 4.1±0.6 5.2±0.9 0.71 0.36 0.03 
N 6.2±0.7a 3.7±0.5b    
  
Table 4.8 Plasma metabolic profile in the fasted state at the age of 16 months in 
offspring of ewes fed to requirement during pregnancy randomised to formula 
feeding (R-F, n=9) or being fed by mother (R-M, n=9) and offspring or ewes 
nutrient restricted during late gestation randomised to formula feeding N-F, n=9) 
or to being fed by mother (N-M, n=9). Data presented as means ± SEM. Statistical 
significance denoted by superscripts a versus b, p<0.001 for simple effects analysis 
of 2-way ANOVA. NEFA, Non-esterified fatty acids 
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4.3.2 Liver weight, triglyceride deposition and oxidative stress. 
Neither liver weight, triglyceride or malondialdehyde (MDA) concentrations 
(the latter as a marker for thiobarbituric acid reactive substances (TBARS)) 
differed between experimental groups (Table 4.9). There was a trend 
towards increased triglyceride concentrations (p=0.05) and liver TBARS 
concentration (p=0.05) in formula formula fed offspring as compared to 
offspring fed by their mother. 
 
 Prenatal 
nutrition 
Feeding 
method 
Prenatal 
nutrition 
Feeding 
method 
Interaction 
 Mother 
fed 
Formula 
fed 
p value p value p value 
Liver weight 
(g) 
R 717±33 695±33 0.21 0.75 0.78 
N 660±39 658±38    
Liver 
triglyceride 
(mg/g liver) 
R 29.8±1.7 36.8±5.4 0.519 0.05 0.68 
N 30.8±1.5 41.5±7.4    
Total liver 
triglycerides 
(g) 
R 37.8±8.5 20.3±1.5 0.817 0.10 0.83 
N 20.4±1.6 28.5±6.2    
Liver TBARS 
(MDA μM/ 
protein 
μg/μl) 
R 1.02±0.08 0.79±0.06 0.60 0.05 0.37 
N 0.90±0.08 0.82±0.08    
  
Table 4.9 Liver weight, triglyceride concentrations, calculated total liver 
triglycerides and hepatic TBARS assay at the age of 17 months in offspring of ewes 
fed to requirement during pregnancy randomised to formula feeding (R-F, n=9) or 
being fed by mother (R-M, n=9) and offspring or ewes nutrient restricted during 
late gestation randomised to formula feeding N-F, n=9) or to being fed by mother 
(N-M, n=9). Data presented as means ± SEM. Statistical analyses performed using 
2-way ANOVA 
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Correlation between liver weight and triglyceride content varied depending 
upon the type of feeding. There was no correlation between the above two 
variables for offspring fed on their mother’s milk, whereas, for formula fed 
offspring, liver weight was positively correlated with the triglyceride 
concentrations (Figure 4.11). 
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Figure 4.11 Correlation analysis of weight of liver at 17 months of age against 
measured liver triglyceride relative concentrations for lambs randomised to 
formula feeding (n=16) or to being fed by their mother (n=16). Data presented as 
Pearson’s correlation coefficient (r) and two tailed significance testing. The 
trendline depicts the statistically significant linear relationship between the 
variables of formula fed animals only.  
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The correlation between liver TBARS and triglyceride concentrations for 
the offspring fed on formula milk was weakly positive (r=0.543) but 
statistically significant (p=0.03), whereas, no such correlation was present 
in the offspring fed on mother’s milk (Figure 4.12). There was no 
correlation between liver TBARS concentration and liver weight for formula 
fed (p=0.81; r=0.06) and mother fed (p=0.13; r=0.418). 
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Figure 4.12 Correlation analysis of relative triglyceride concentration in the liver 
tissue at 17 months of age against measured liver TBARS for lambs randomised to 
formula feeding (n=12) or to being fed by their mother (n=12). Data presented as 
Pearson’s correlation coefficient (r) and two-tailed significance testing. TBARS, 
Thiobarbituric acid reactive substances; MDA, malondialdehyde. The trendline 
depicts the linear relationship between the two variables from formula fed 
offspring only. 
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4.3.3 Liver histology 
Histological images were analysed for appearance of steatosis and 
steatohepatitis (Figure 4.13). There was no difference in appearances of 
macrovesicular steatosis or cellular infiltration with experimental 
intervention which was similar to findings described in detail in Section 
3.3.3. Quantification was performed for periportal fibrosis in Masson’s 
Trichrome stained areas of liver tissue using volocity software which did 
not show any difference in fibrosis with experimental interventions (Table 
4.10). 
 
 Prenatal 
nutrition 
Feeding  
method 
Prenatal 
nutrition 
Feeding 
method 
Interaction 
 Mother  
fed 
Formula 
fed 
p value p value p value 
Periportal 
fibrosis area  
(X100µm2) 
R 56±08 67±05 0.22 0.65 0.18 
N 78±13 79±14    
 
  
Table 4.10 Periportal fibrosis area quantified from Masson’s Trichrome stained 
histological sections and standardised by dividing by portal vein perimeter in 
offspring of ewes fed to requirement during pregnancy randomised to formula 
feeding (R-F, n=9) or being fed by mother (R-M, n=9) and offspring or ewes 
nutrient restricted during late gestation randomised to formula feeding N-F, n=9) 
or to being fed by mother (N-M, n=9).  Data presented as means ± SEM. Statistical 
analyses performed using 2-way ANOVA.  
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Figure 4.13 Representative histological sections of hepatic periportal area from sheep 
from (A) R-M offspring, (B) R-F offspring, (C) N-M offspring and (D) N-F offspring 
demonstrating staining of periportal area with Masson’s Trichrome and visualised at 
20x magnification. 
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4.3.4 Hepatic gene expression 
4.3.4.1 Gene expression for modulators and effectors of 
metabolic inflammation in liver 
The gene expression for leptin receptor, toll-like receptor-4 (TLR4), cluster 
of differentiation-95 (CD95), and cluster of differentiation-68 (CD68) did 
not differ with experimental interventions (Table 4.11). There was a trend 
towards decreased CD95 expression with prenatal nutrient restriction 
(p=0.06) as compared to offspring of sheep fed to requirement. 
 
Gene 
expression 
 
Prenatal 
nutrition 
Feeding  
method 
Prenatal 
Nutrition 
Feeding 
method 
Interaction 
 Mother fed Formula fed p value p value p value 
Leptin 
receptor 
R 1.00±0.17 0.98±0.17 0.22 0.93 0.95 
N 1.20±0.16  1.19±0.17     
TLR4 
R 1.00±0.23 1.26±0.34 0.10 0.66 0.61 
N 1.59±0.29 1.57±0.23     
CD95 
 
R 1.00±0.03 0.98±0.02 0.06 0.38 0.47 
N 0.93±0.01  0.95±0.03     
CD68 
 
R 1.00±0.11 1.20±0.21 0.26 0.42 0.73 
N 0.89±0.09  0.98±0.13     
  
Table 4.11 Gene expression for regulatory factors of inflammation and cell stress 
response (leptin receptor, TLR4, CD95 and CD68) in offspring of ewes fed to 
requirement during pregnancy randomised to formula feeding (R-F, n=9) or being 
fed by mother (R-M, n=9) and offspring or ewes nutrient restricted during late 
gestation randomised to formula feeding N-F, n=9) or to being fed by mother (N-
M, n=9). Data presented as means ± SEM. Statistical analyses performed using 2-
way ANOVA. TLR4, toll like receptor 4; CD95, cluster of differentiation 95; CD68, 
cluster of differentiation 68.  
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4.3.4.2 Gene expression for the components of the unfolded 
protein response in the liver 
The unfolded protein response was investigated by analysing the gene 
expression for ATF4, ATF6, EDEM1 and GRP78, none of which 
demonstrated any influence of the experimental intervention (Table 4.12). 
 
 Prenatal 
nutrition 
Feeding  
method 
Prenatal 
nutrition 
Feeding 
method 
Interaction 
 Mother  
fed 
Formula fed p value p value p value 
ATF4 
R 1.00±0.10 0.95±0.05 0.33 0.86 0.61 
N 0.89±0.06  0.91±0.07     
ATF6 
R 1.00±0.09 0.88±0.05 0.68 0.26 0.63 
N 0.93±0.08  0.89±0.04     
EDEM1 
R 1.00±0.07 0.99±0.07 0.24 0.15 0.40 
N 0.97±0.05  0.83±0.08     
GRP78 
R 1.00±0.15 0.91±0.09 0.21 0.45 0.89 
N 0.85±0.10  0.79±0.04     
  
Table 4.12 Gene expression analysis for components of unfolded protein response 
in offspring of ewes fed to requirement during pregnancy randomised to formula 
feeding (R-F, n=9) or being fed by mother (R-M, n=9) and offspring or ewes 
nutrient restricted during late gestation randomised to formula feeding N-F, n=9) 
or to being fed by mother (N-M, n=9). Data presented as means ± SEM. Statistical 
analysis performed with 2-way ANOVA.ATF4, activating transcription factor-4; 
ATF6, activating transcription factor-6; EDEM1- ER stress degradation enhancer 
molecule-1; GRP78, glucose-regulated protein 78. 
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4.3.4.3 Gene expression for the components of the autophagy 
in the liver  
Prenatal nutrient restriction followed by formula feeding was associated 
with increased gene expression for mTOR in comparison to formula fed 
offspring of sheep fed to requirements. The experimental interventions, 
however, did not induce any change on the gene expression of AMPK, 
ATG12 or for BECN1 (Table 4.13). 
 
 Prenatal 
nutrition 
Feeding  
method 
Prenatal 
nutrition 
Feeding 
method 
Interaction 
 Mother fed Formula fed p value p value p value 
mTOR 
R 1.00±0.13 1.14±0.12a 0.03 0.10 0.34 
N 1.24±0.16  1.74±0.28b    
AMPK 
R 1.00±0.11 1.06±0.07 0.617 0.32 0.88 
N 0.95±0.05  1.00±0.07     
ATG12 
R 1.00±0.05 0.98±0.03 0.06 0.38 0.70 
N 0.93±0.03  0.88±0.44     
BECN1 
 
R 1.00±0.10 0.95±0.10 0.22 0.41 0.82 
N 0.83±0.15  0.81±0.09     
  
Table 4.13 Gene expression for the components of autophagy in the liver tissue 
from offspring of ewes fed to requirement during pregnancy randomised to formula 
feeding (R-F, n=9) or being fed by mother (R-M, n=9) and offspring or ewes 
nutrient restricted during late gestation randomised to formula feeding N-F, n=9) 
or to being fed by mother (N-M, n=9). Data presented as means ± SEM. Statistical 
analyses performed using 2-way ANOVA. mTOR, mammalian target of rapamycin; 
AMPK, 5' adenosine monophosphate-activated protein kinase; ATG12, autophagy 
related gene 12; BECN1, gene encoding Beclin1. superscripts a versus b denote 
p<0.05 for simple effects analysis. 
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4.3.5 Omental adipose tissue histological characteristics 
4.3.5.1 Adipocyte cell size and characteristics.  
Histological observation (Figure 4.14) of omental adipose tissue 
demonstrated adipocytes containing unilocular lipid droplets, scant stromal 
connective tissue and non-homogenously dispersed clusters of IBA1 
positive macrophages present within crown like structures and milky spots. 
Mean adipocyte area in the omental adipose tissue was not affected by 
nutrient restriction during late gestation or by feeding method during the 
suckling period (Table 4.14).  
 
 Prenatal 
nutrition 
Feeding  
method 
Prenatal 
nutrition 
Feeding 
method 
Interaction 
 Mother fed Formula fed p value p value p value 
Adipocyte 
area (µm2) 
R 3762±545 3825±273 0.76 0.76 0.67 
N 4116±546 3767±373    
 
  
Table 4.14 Mean adipocyte area in µm2 calculated from the histological sections of 
omental adipose tissue from offspring of ewes fed to requirement during pregnancy 
randomised to formula feeding (R-F, n=9) or being fed by mother (R-M, n=9) and 
offspring or ewes nutrient restricted during late gestation randomised to formula 
feeding N-F, n=9) or to being fed by mother (N-M, n=9). Data presented as means 
± SEM. Statistical analyses performed using 2-way ANOVA 
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Figure 4.14 Representative H&E stained histological sections of omental 
adipose tissue from sheep from (A) R-M offspring, (B) R-F offspring, (C) 
N-M offspring and (D) N-F offspring visualised at 20X magnification. 
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4.3.5.2 GRP78 and pJNK staining of adipose tissue 
As previously demonstrated in Section 3.3.5.2, glucose-regulated protein 
78 (GRP78) staining was localised to the cytoplasm whereas 
phosphorylated c-Jun N-terminal kinase (pJNK) was concentrated in the 
perinuclear region. There was no difference in the quantified stained area 
per adipocyte with the experimental interventions (Table 4.15). There was 
a statistical trend towards increased pJNK staining (p=0.06) in omental 
adipose tissue of nutrient restricted offspring as compared to offspring of 
sheep fed to requirement.  
 
 Prenatal 
nutrition 
Feeding  
method 
Prenatal 
Nutrition 
Feeding 
method 
Interaction 
 Mother fed Formula fed p value p value p value 
GRP78 
(µm2/cell) 
R 42.2±14.7 55.2±26.0 0.51 0.29 0.46 
N 65.1±29.5 27.1±14.4    
pJNK 
(µm2/cell) 
R 39.4±15.0 27.5±9.2 0.06 0.93 0.75 
N 50.1±8.8 93.6±54.7    
 
  
Table 4.15 Quantitative analysis of GRP78 and pJNK stain expressed as area stained 
in µm2/ adipocyte from omental adipose tissue in offspring of ewes fed to 
requirement during pregnancy randomised to formula feeding (R-F, n=9) or being 
fed by mother (R-M, n=9) and offspring or ewes nutrient restricted during late 
gestation randomised to formula feeding N-F, n=9) or to being fed by mother (N-
M, n=9).  Data presented as means ± SEM. Statistical analyses performed using 2-
way ANOVA. GRP78, glucose-regulated protein 78; pJNK, phosphorylated c-Jun N-
terminal kinase 
  286 
4.3.6 Omental adipose tissue gene expression analysis 
4.3.6.1 Gene expression of regulatory factors of metabolic 
inflammation  
The experimental interventions of late gestation nutrient restriction with, 
or without, formula feeding did not result in any direct change in the gene 
expression of CD68, leptin or adiponectin. The statistical analysis 
demonstrated a significant interaction between prenatal nutrition and 
feeding choice for the gene expression for TLR4. The simple effects 
analysis, however, did not reach statistical significance (Table 4.16).  
 
 Prenatal 
nutrition 
Feeding  
method 
Prenatal 
nutrition 
Feeding 
method 
Interaction 
 Mother  
fed 
Formula 
fed 
p value p value p value 
Leptin 
R 1.00±0.18 2.07±0.57 0.35 0.62 0.33 
N 1.92.±0.50 1.80±0.73    
Adiponectin R 1.00±0.12  0.80±0.13  0.09 0.75 0.66 
N 1.12±0.18 0.78±0.16     
CD68 
R 1.00±0.14 1.48±0.57 0.46 0.48 0.09 
N 1.75±0.51 0.90±0.18    
TLR4 
R 1.00±0.09 1.35±0.12 0.98 0.29 0.04 
N 1.24±0.08 1.06±0.10    
  
Table 4.16 Gene expression analysis of leptin, adiponectin, CD68 and TLR4 in 
omental adipose tissue from offspring of ewes fed to requirement during pregnancy 
randomised to formula feeding (R-F, n=9) or being fed by mother (R-M, n=9) and 
offspring or ewes nutrient restricted during late gestation randomised to formula 
feeding N-F, n=9) or to being fed by mother (N-M, n=9). Data presented as means 
± SEM. Statistical analyses performed using 2-way ANOVA. TLR4, toll like receptor 
4; CD95, cluster of differentiation 95; CD68, cluster of differentiation 68. 
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4.3.6.2 Gene expression of components of UPR in omental 
adipose tissue 
The experimental interventions did not have any consistent impact on 
relative gene expression of the components of the UPR, namely ATF4, 
ATF6, GRP78 and EDEM1, in omental adipose tissue (Table 4.17).  
 
Gene  Prenatal 
nutrition 
Feeding  
method 
Prenatal 
nutrition 
Feeding 
method 
Interaction 
 Mother fed Formula fed p value p value p value 
ATF4 R 1.00±0.05 0.97±0.04 0.16 0.07 0.18 
N 1.00±0.06 0.83±0.04    
ATF6 R 1.00±0.09  1.05±0.05  0.60 0.77 0.12 
N 1.19±0.11  1.01±0.07    
GRP78 
R 1.00±0.09 1.00±0.09 0.71 0.93 0.97 
N 0.96±0.11 0.96±0.11    
EDEM1 
R 1.00±0.09  1.35±0.12  0.41 0.83 0.01 
N 1.24±0.08  1.06±0.10     
  
Table 4.17 Relative gene expression ATF4, ATF6, GRP78 and EDEM1 in omental 
adipose tissue of in offspring of ewes fed to requirement during pregnancy 
randomised to formula feeding (R-F, n=9) or being fed by mother (R-M, n=9) and 
offspring or ewes nutrient restricted during late gestation randomised to formula 
feeding N-F, n=9) or to being fed by mother (N-M, n=9).  Data presented as means 
± SEM. Statistical analyses performed using 2-way ANOVA. ATF4, activating 
transcription factor-4; ATF6, activating transcription factor-6; EDEM1, ER 
degradation enhancer, mannosidase alpha-like 1; GRP78, glucose-regulated 
protein-78. 
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4.3.6.3 Gene expression of the components of autophagy in the 
omental adipose tissue 
The gene expression for mTOR demonstrated interaction between prenatal 
nutrition and feeding type during ANOVA testing prompting a simple 
effects analysis. R-F offspring had increased mTOR gene expression as 
compared to N-F and R-M offspring. The gene expression for AMPK, ATG12 
and BECN1 was not significantly affected by the interventions (Figure 
4.15). 
 
  
  289 
 
  
  
 
  
0.0
0.5
1.0
1.5
2.0
2.5
Mother fed Formula fed
m
T
O
R
 g
e
n
e
 e
x
p
re
s
s
io
n
 (
G
e
N
o
rm
)
R N
*
*
A
0.0
0.5
1.0
1.5
2.0
2.5
Mother fed Formula fed
A
M
P
K
 g
e
n
e
 e
x
p
re
s
s
io
n
 (
G
e
N
o
rm
)
R N
B
0.0
0.5
1.0
1.5
2.0
Mother fed Formula fed
A
T
G
1
2
 g
e
n
e
 e
x
p
re
s
s
io
n
 (
G
e
N
o
rm
) 
R N
C
0.0
0.5
1.0
1.5
2.0
Mother fed Formula fed
B
E
C
N
1
 g
e
n
e
 e
x
p
re
s
s
io
n
 (
G
e
N
o
rm
) 
R N
D
Figure 4.15 Relative gene expression of A, mTOR; B, AMPK; C, ATG12; D, BECN1 in 
omental adipose tissue of in offspring of ewes fed to requirement during pregnancy 
randomised to formula feeding (R-F, n=9) or being fed by mother (R-M, n=9) and 
offspring or ewes nutrient restricted during late gestation randomised to formula 
feeding N-F, n=9) or to being fed by mother (N-M, n=9). Data presented as means 
with error bars representing SEM. *p<0.05 for simple effects following a significant 
2-way ANOVA. AMPK, 5' adenosine monophosphate-activated protein kinase; 
mTOR, mammalian target of rapamycin; ATG12, autophagy related gene 12; BECN1, 
gene encoding Beclin1. 
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4.4 Discussion 
The experiments described in this chapter aimed to examine the potential 
effects of formula feeding with, or without, prenatal undernutrition upon 
the liver and adipose tissue in a sheep model of juvenile onset obesity. 
Following intrauterine growth restriction mediated by maternal nutrient 
restriction, mother fed offspring gained weight faster than formula fed 
offspring. When physical activity was quantified during the pre-weaning 
stage at 45 days of age, formula feeding was associated with decreased 
activity, a finding which was not present when the physical activity was 
again measured at 15 months of age. There were no significant differences 
in metabolic parameters and GTT results in tests performed at 7 and 16 
months of age respectively.  
In keeping with findings described in Chapter 3, prenatal undernutrition 
was not associated with histological features of hepatic steatohepatitis nor 
with increases in the expression of components of inflammation and cell 
stress response. Furthermore, the add-on intervention of formula feeding 
during infancy was not associated with exacerbation of the above outcome 
parameter in liver. 
Adipocyte size and mediators of inflammation in omental adipose tissue 
were not consistently increased with prenatal nutrient restriction with, or 
without, formula feeding. There was no consistent difference in gene 
expression for components of UPR and autophagy with the experimental 
interventions. The above findings are discussed in the following sections. 
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4.4.1 Maternal and offspring metabolic profiles 
4.4.1.1 Maternal weight gain, plasma metabolic profile and 
offspring birth weight and weight gain during the suckling 
period. 
The twin bearing sheep restricted to a diet providing 60% of ME 
demonstrated relatively decreased weight gain, had lower plasma glucose 
concentrations, higher NEFA concentrations and delivered offspring that 
were significantly lighter at birth. The above results confirm the findings of 
maternal weight gain and metabolic profile of the twin bearing sheep 
undergoing late gestation NR described in Chapter 3. All these parameters 
confirm the development of a sheep model of relative macronutrient 
insufficiency during late gestation. Such an animal model, with a control 
group of offspring of sheep fed to requirements, therefore, is well suited 
for the study of fetal programming.  
At birth, the weight of the N offspring was 23% lower than the birth weight 
of the R offspring. During the 90 days suckling period, the N-F offspring 
remained significantly lighter than R-F offspring whereas, the N-M 
offspring gained weight relatively faster and their body weight 
measurements were similar to the R-M offspring after 38 days. Such a 
weight gain profile of N-F offspring was different from the rapid growth 
described in formula fed human infants [483]. However, in sheep, such 
relatively slower weight gain following formula feeding has previously been 
described [484]. The sheep formula used in the study was a commercially 
available formula which differs in relative micronutrient composition from 
the known composition of sheep mother’s milk (Table 4.18). Overall, the 
sheep formula contains 20% less fat and 14% less carbohydrates as 
compared to the sheep mother’s milk. Such differences in the relative 
composition and overall lower calorific value may not make this equivalent 
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to human formula milk, which is designed to closely replicate the 
macronutrient composition of milk consumed by breastfed infants.  
 Sheep milk# Formula milk* 
Protein (%) ~5 4.8 
Fat (%) ~6 4.8 
Carbohydrate (%) ~4.8 4.1 
Energetic value (MJ/kg) 4.5 4.1 
Appetite may be another factor contributing to the variation in growth 
identified in formula fed lambs compared with those reared by their 
mother using a shared feeding system. One contributory factor is that 
rearing the lamb away from the mother clearly removes any interaction 
between them. In humans, maternal deprivation during early infancy has 
been known to affect neuroendocrine function and behaviour in infants 
with the potential to affect offspring appetite and growth [485, 486]. In 
sheep, maternal deprivation during early life has also been shown to be 
associated with changes to neuroendocrine axis with potential effects on 
hypothalamic nuclei important for appetite regulation [487, 488]. In order 
to differentiate the independent impact of maternal deprivation or type of 
feed on the offspring, a much larger study would be required with 
independent arms of a maternally deprived lamb who is fed on age 
appropriate sheep milk with a bottle or feeder as appropriate. At the onset 
of the study design, the impact of maternal deprivation was not the 
primary focus of our study. Furthermore, the addition of such an arm 
would have significant financial and logistical implications on an already 
elaborate large animal study design. The results described in this study 
demonstrate the need for independent scrutiny of relative impact of 
Table 4.18 Macronutrient and calorific content in sheep milk and formula milk used 
in the study.  
#As reported by Park et. al. and Dove et. al. [327, 328];  *as reported in information 
sheet provided by the manufacturer (Volac International, Royston, UK).  
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maternal deprivation and type of milk feed on offspring growth and 
physiology in future studies. 
In addition to the variation in the macronutrient composition of the sheep 
formula milk as compared to the sheep mothers’ milk, it has also been 
proposed that formula milk lacks hormonal and growth factors present in 
sheep mother’s milk [484], all of which could account for the relatively 
slower weight gain in formula fed sheep offspring. Late gestation 
undernutrition is known to affect the composition of sheep milk [489]. It is 
plausible that the resultant milk composition either affects offspring 
appetite, metabolism or macronutrient intake during the suckling period 
enabling the N-M offspring to achieve a much faster growth rate. Further 
investigation of this aspect would require a study of monitoring of milk 
intake and composition in all groups and was not in the scope of these 
experiments.  
When analysed as fold change of birth weight (Figure 4.6, Section 
4.3.1.2), it becomes apparent that, whilst the N-M offspring experience a 
rapid weight gain enabling them to ‘catch up’ with the R-M, N-F offspring 
gain weight at a rate comparable to the R-F offspring. The resulting 
absence of ‘catch-up’ growth ensures that they remain lighter in body 
weight as compared to R-F offspring. In human terms, this may be similar 
to a small for gestational age (SGA) infant who maintain their weight gain 
along the birth percentiles. Rapid weight gain following a SGA birth, by 
itself, has been proposed to be a factor increasing the likelihood of later 
cardiovascular and metabolic morbidity [286, 293]. However, the absence 
of such rapid early growth in the N-F subgroup, whilst inadvertent, 
eliminates this potentially important contributory factor’s impact on the 
outcome.  
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4.4.1.2 Decreased physical activity in formula fed offspring at 
age 45 days correlates with physical activity phenotype in 
young adolescence.  
Physical activity, by itself, has been investigated as a target of nutritional 
programming [490]. Offspring of undernourished rats (fed 30% of ad 
libitum intake) were permanently less physically active than offspring of ad 
libitum fed rats [490]. Furthermore, analysis of the Dutch famine birth 
cohort found that individuals who were prenatally exposed to famine were 
less physically active as adults according to a physical activity 
questionnaire and self-rating scale [491]. A previous sheep study has 
reported that physical activity level varies amongst individual animals and 
persists from early life to adulthood [492]. Persistence of a phenotype of 
decreased physical activity confirms the presence of a proposed centrally 
regulated physical activity phenotype [490] which is amenable to 
programming. 
During the accelerometer recordings of physical activity performed over 24 
hour period at 45 days of age, the formula fed offspring were significantly 
less active as compared to the lambs reared with their mothers, a result 
which was consistent in offspring of N and R sheep and was also not 
affected by the diurnal variation in physical activity. When the same 
measurements were made at 15 months of age, prenatal nutrient 
restriction or postnatal feeding type was not associated with any 
statistically significant difference in physical activity. However, a significant 
correlation was present between the recordings at 45 days and at 15 
months of age for the mean physical activity measurements during the 24 
hour study period. This suggests that a physical activity phenotype is set 
in response to environmental measures such as rearing or feeding method 
and persists during later life. It is plausible that the increased physical 
activity of the mother fed offspring at 45 days of age was a reflection of 
their environmental factors such as proximity to their mother and they 
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were following the movements of the mother. However, programming of a 
physical activity phenotype was not a primary objective for this study. It is 
plausible that the identified correlation of physical activity phenotype in 
this study did not reflect into a statistically significant difference in the 15 
months measurements due to the large variance in the outcome 
measures. A retrospective sample size calculation identified that to 
demonstrate a mean difference of 10%, a sample size of 156 would be 
required in each group. A definitive determination of presence or absence 
of a physical activity phenotype determined by early life factors would 
therefore require a study powered and specifically designed to investigate 
this in a systematic fashion. 
4.4.1.3 Formula feeding did not exacerbate obesity, adiposity 
or markers of metabolic derangement.  
Post weaning, the measurements for body weight including the final adult 
weight and the size of adipose tissue depots did not differ between the 
experimental groups. The absence of a change in final body weight as a 
result of prenatal nutrient restriction conforms to the results described in 
Chapter 3 and other sheep studies of NR-LG [264]. For this study, it was 
hypothesised that that formula feeding would lead to exacerbation in 
obesity which would present as increased body weight and increase in size 
of adipose depots. However, the study findings do not conform these 
hypotheses. Similarly, formula feeding did not lead to the predicted 
worsening of markers of metabolic profile (including GTT, plasma 
triglycerides, NEFA, cortisol and leptin) at the age of 7 months and at 16 
months.   
After the first 90 days, all the study animals were kept in a restricted 
environment designed to encourage obesity. As described in Chapter 3, 
sheep reared in obesogenic environment, when compared to lean animals, 
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demonstrate GTT results consistent with insulin resistance at 16 months of 
age. 
It is possible that the effects of obesogenic environment on the 
development of adiposity and insulin resistance is proportionately much 
larger so that a relatively smaller effect of formula feeding is masked as a 
result. Such a phenomenon is called effect modification [493]. 
Identification of a relatively small effect size would require a much larger 
study and this should include lean comparison groups and a large sample 
size. However, on basis of the presented results, it can be concluded that 
even if such an independent effect was present, it would likely be of 
relatively small effect size. 
As described previously, the rate of weight gain during formula feeding is 
another factor which is significantly different between our study model and 
the human epidemiological data. Human infants fed on formula milk have 
a much higher growth rate in comparison to breast fed infants [483], a 
factor that has been considered significant enough to prompt changes in 
the WHO growth charts [292]. Such early weight gain is strongly 
associated with the development of later obesity [289, 494] and adverse 
metabolic outcomes [495], whereas a relatively slower growth rate has 
been proposed to have a protective effect [496]. The N-F animals in this 
study had a relatively decreased growth rate which is in contrast to the 
rapid early growth of formula fed infants. It is plausible that the 
obesogenic effect and adverse metabolic outcomes known to be associated 
with formula feeding is a consequence of the programming influence of 
rapid weight gain and, in absence of the latter, the impact was not 
apparent in this study. Such an independent effect of growth rate is the 
focus of investigation in the study described in Chapter 5.  
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4.4.2 Hepatic fat deposition and cell stress response in formula 
feeding with, or without, pre-existing NR-LG.  
The measurements for liver weight and triglyceride deposition were 
comparable to the results described in Chapter 3 and in previously 
published studies [279, 315, 446]. In the formula fed offspring, the liver 
weight was positively correlated with the measured liver triglyceride 
concentrations and TBARS, whereas no such correlation was evident in 
offspring fed on mother’s milk. However, features of NAFLD including 
intrahepatocyte lipid droplets, cellular infiltrate or quantification for 
periportal fibrosis were not increased with formula feeding.  
Currently, very little research has been performed to investigate the effect 
of type of feed on development of steatohepatitis. Nobili et al. reported 
decreased odds (OR 0.04, 95% CI 0.01 to 0.10) for developing 
steatohepatitis at a median age of 12 years in individuals who were breast 
fed as compared to formula fed during infancy [309]. Such a difference 
was, however, not evident when investigated during early infancy (age 6-
12 weeks) [310]. In the study described in this chapter, there was a trend 
towards increasing liver triglyceride concentrations with formula feeding 
(p=0.058). Furthermore, similar to the results described in Section 3.3.2, 
there was a positive correlation between liver weight and hepatic 
triglyceride concentrations, specifically in formula fed animals. It is 
plausible that formula feeding during early life brings about alteration in 
mechanisms of hepatic lipid deposition and disposal which, over time, 
present as hepatic steatosis as indicated by the trend towards increased 
hepatic triglycerides in formula fed offspring in this study. Inflammation 
and the cell stress response associated with such hepatic fat deposition 
have been proposed as factors in development of the metabolic syndrome 
(discussed in Section 1.5.3.2). However, formula feeding with, or without, 
a background of prenatal nutrient restriction was not associated with any 
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change in gene expression for components of metabolic inflammation, UPR 
and autophagy. The current study model, therefore, does not confirm the 
hypothesised increase in metabolic inflammation and cell stress response 
in formula fed offspring.  
This is the first such study in a large animal model of formula feeding and 
provides baseline data for future investigations, including data which can 
be used to inform sample size calculations for well powered studies. The 
absence of the predicted inflammation and cell stress response could be an 
outcome of the characteristics of the study model. Formula fed offspring 
demonstrated a slower rate of weight gain, which is potentially protective 
effect against development of insulin resistance [286] and obesity 
associated metabolic complications [495]. It is also plausible that the 
relatively modest effect of formula feeding are masked by effects of 
obesity as described in Chapter 3.  For example, if obesity led to 
substantial changes in the gene expression of pathways of cell stress 
response in all obese animals, any modulation of these pathways, of 
relatively smaller quantity, brought about by formula feeding would be 
masked and its demonstration would require a very large sample size or a 
lean comparison group with interventions of formula feeding.  
The age of offspring at the study endpoint (17 months age) is equivalent 
to young adulthood in human counterparts. Studies of the association of 
hepatosteatitis with formula feeding have demonstrated that, whilst there 
is no difference at young ages [310], such an association is present when 
tested in older children (median age 12 years, range 3-18 years). 
Increasing age is a known independent risk factor for development of both 
NAFLD [497] and the metabolic syndrome [498] even in the paediatric 
population. It is plausible that, with age, the demonstrated trend towards 
increased hepatic triglycerides in formula fed offspring, would continue to 
increase eventually reaching a significant level, not just in statistical terms 
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but also in terms of affecting metabolic inflammation at a later age. Any 
future studies of the impact of formula feeding would ideally include 
testing at different endpoints to identify progressive stages in natural 
developmental process of metabolic syndrome. Another option would be to 
perform biopsies (similar to needle biopsy) of liver tissue in individual 
animals at different ages paired with a select combination of plasma 
biomarkers such as alanine aminotransferase. Research in hepatic 
biomarkers is rapidly advancing with report of 1500 new publications 
within a 6 month period [499]. The choice of biomarkers studied should 
therefore be made depending upon the latest data and availability of a 
reliable assay in sheep population at the time such study is performed.  
4.4.3 Omental adipose tissue characteristics and cell stress 
response in formula feeding with or without pre-existing NR-
LG 
4.4.3.1 Formula feeding was not associated with adipocyte 
characteristics or gene expression for inflammation 
The mean area of omental adipocytes measured in histological sections 
from sheep, all reared in obesogenic environment, was similar to 
measured adipocyte area of the obese offspring described in Chapter 3 (~ 
4000 µm2). In keeping with lack of any change to the weight of omental 
adipose depot, formula feeding or prenatal nutrient restriction did not 
affect the adipocyte size. Immunohistological and gene expression studies 
did not demonstrate the predicted increase in inflammation and UPR. The 
gene expression for the components of autophagy were also not increased 
with formula feeding or prenatal nutrient restriction. However, the gene 
expression for mTOR demonstrated a significant interaction with R-F 
offspring demonstrating maximal gene expression, significantly increased 
in comparison to N-F and R-M offspring respectively. mTOR is a nodal 
regulator for multiple cellular functions including autophagy, adipogenesis, 
mitochondrial metabolism and cell survival. As a component of cellular 
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energy sensing mechanism, a change in gene expression for mTOR has the 
potential for affecting downstream cellular homeostasis and survival. 
However, in absence of any evidence for a significant difference in adipose 
tissue structure, inflammation or related gene expression, the isolated 
finding of mTOR gene expression change cannot be interpreted.  
 
4.5 Conclusion 
The experiments described in this chapter had set out to establish a sheep 
model of formula feeding in a background of prenatal undernutrition with 
respective control groups. A standard restricted postweaning environment 
promoting development of obesity was established with the intention to 
amplify any programming effect of the experimental interventions.  
Unlike human equivalents, formula fed offspring of nutrient restricted 
sheep did not demonstrate a rapid weight gain during the entire period 
before they were weaned. Such a deviation from the observed pattern in 
human studies has the potential to make this sheep model not 
representative of the mechanisms underlying increased predisposition to 
obesity and adverse metabolic outcomes witnessed in human studies.  
When tested at age of 45 days, the formula fed offspring were less active 
than the offspring fed by their mother. Furthermore, a significant 
correlation was evident between the physical activity measurements at age 
45 days and 15 months indicating presence of an environmentally 
programmable physical activity phenotype as previously proposed [490, 
492] which persists until young adult age. Further investigation of this 
aspect would require targeted experimental studies to confirm and 
describe the possibility of such a programmable physical activity 
phenotype.  
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Formula feeding was not associated with exacerbation of obesity, insulin 
resistance or hepatic and adipose tissue metabolic inflammation.  
The liver of formula fed offspring demonstrated a positive correlation 
between liver weight and measured triglyceride and TBARS assay. It is 
plausible that at the age of 17 months, when the sheep were euthanased, 
hepatic triglyceride accumulation and associated oxidative stress was at an 
early stage and would have become evident at a later age. However, in 
absence of any features of metabolic inflammation, or modification of cell 
stress response, such a proposition remains speculative.  Formula feeding 
with, and without, a background of late gestation nutrient restriction in the 
obese sheep model did not lead to a consistent pattern of increase in 
metabolic inflammation or altered cell stress response.  
The results described in this chapter also underline the need for further 
studies to explore the potential impact on interaction between maternal 
deprivation on offspring growth and physiology and also to explore the 
potential setting of physical activity phenotype in response to early life 
environmental factors such as formula feeding. 
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5 Effect of prenatal nutrient restriction followed by 
accelerated postnatal growth on the cell stress 
response and metabolic inflammation in liver and 
adipose tissue. 
 
5.1 Introduction and hypothesis 
The studies described in Chapter 4 investigated the longer term impact of 
formula feeding during the early postnatal period which brings about 
qualitative changes to nutrition. However, quantitative nutrient availability 
during early life with its effect on rate of early postnatal growth has been a 
subject of investigation for its association with glucose tolerance and 
obesity in later life [280]. The growth acceleration hypothesis [281], 
formulated in 2004, proposed that the increased risk of adult metabolic 
and cardiovascular morbidity associated with being born small for 
gestational age (SGA) is a consequence of accelerated early growth. A 
meta-analysis [289] of 10 cohort studies (n=47661) investigating obesity 
as an outcome of rapid early growth during infancy, demonstrated that for 
each unit increase in weight SD scores of an infant between 0 and 1 year 
age, the adjusted risk for childhood obesity increased two fold and the 
adjusted risk for adult obesity increased by 23%. However, such results 
have been contradicted by other more recent studies [290] and remain a 
subject of further investigation [293]. 
A prospective birth cohort study of 851 children investigated insulin 
sensitivity as an outcome measure [285] and demonstrated that greater 
weight gain between birth to 3 years of age predicted lower insulin 
sensitivity. In another randomised controlled trial of preterm infants [286], 
children randomised to receiving lower nutrition had lower fasting plasma 
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split proinsulin as compared to those children receiving a nutrient enriched 
diet.  
Animal experiments using rodent models have demonstrated that rapid 
early growth results in adult offspring with increased adiposity, raised 
systolic blood pressure, hyperinsulinaemia [296] and alteration of adipose 
tissue insulin signalling [136]. Whilst these experiments showed increased 
adiposity and modulation of insulin sensitivity due to early postnatal 
growth, it is well recognised that rodent development differs significantly 
from that of large animals and humans including substantial differences in 
fetal organ growth rate and metabolic rate [297] and maturity of the 
hypothalamic pituitary adrenal axis [298]. There is, therefore, a need for 
experiments in a large animal model which explore the later metabolic 
consequences of accelerated early growth.   
Infant nutrition, especially during the first 30 days after birth, is the 
primary determinant of growth [283] along with genetic, environmental 
and endocrine factors [282, 283]. Manipulation of macronutrient 
availability during early life as a means of modulating early growth is, 
therefore, a potential target of controlled experiments in a large animal 
model. The outcome of such nutritional management of early growth may 
be significant to public health and has the potential to influence longer 
term health. This is particularly relevant in children born with intrauterine 
growth restriction (IUGR) who experience rapid early growth during the 
early postnatal period. As described in previous chapters, the pathways of 
the cell stress response and metabolic inflammation in the liver and 
adipose tissue, with their influence on metabolic health, are important 
targets of such investigations. The experiments described in this chapter, 
therefore, attempt to build upon the epidemiological and rodent studies 
which have indicated that modulation of adiposity and insulin sensitivity 
occur in response to early accelerated postnatal growth. In light of the 
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limited evidence described above, and the need for such a study in a large 
animal model, the experiments in the study described in this chapter 
investigate the following experimental hypotheses: 
1. IUGR, generated as an outcome of late gestational nutrient 
restriction followed by relative acceleration of early postnatal growth 
in twin offspring reared as singletons on their mother’s milk in 
comparison to offspring reared as twins, will lead to development of 
adult obesity.  
2. Such accelerated early growth in offspring following IUGR will be 
associated with decreased insulin sensitivity and increased 
expression of components of metabolic inflammation and altered cell 
stress response in liver and omental adipose tissue.  
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5.2 Methods 
The design of the study, animal interventions and all experimental 
methods used to establish the results described in this chapter are 
described in detail in the Chapter 2. Briefly, after confirmation of twin 
gestation by ultrasound scanning, twin bearing ewes were fed with a diet 
meeting 60% of metabolic requirements from gestational day 110 until 
term (145±2 days). After birth, the offspring were randomised to achieve 
two growth rates during suckling period (birth to 90 days). The offspring 
randomised to achieve standard growth (St) for a twin offspring were both 
kept with, and were fed by, their mother. In the comparison group, one 
twin offspring was fed on its mother’s milk without competition from its 
sibling in order to achieve relatively accelerated (Ac) growth, whilst the 
other twin was not part of this comparison and was removed to be raised 
and fed separately on formula milk. Post-weaning, all the offspring 
included in this study were raised in a barn with a stocking rate of 6 sheep 
per 19m2. In line with the principles of the reduction of the use of animals 
in experimental paradigms [500], for maximal utilisation of resources and 
standardisation of experimental conditions, there is overlap in animals 
used in the study described in this chapter and the previous chapters 
(Figure 5.1). The Ac offspring described in this chapter are the same as 
mother fed (M) offspring described in Chapter 4 and the St offspring in this 
study were one of the experimental groups described in Chapter 3. 
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During pregnancy, blood sampling was performed from the ewe at 130 
days gestational age and plasma was analysed for concentrations of 
glucose, insulin, non-esterified fatty acids (NEFA) and for triglyceride 
content. Following delivery of the lambs, birth weight and regular body 
weight measurements were recorded; physical activity was measured 
using accelerometers when offspring were aged 1.5 months and 15 
months; glucose tolerance tests and blood sampling was performed at age 
7 months and 16 months respectively; body composition analysis was 
performed by dual X-ray absorptiometry (DXA) scanning at 16 months of 
age. The randomisation and investigations are summarised in Figure 5.2. 
The animal experiments were performed at the joint animal breeding unit, 
Sutton Bonington Campus of the University of Nottingham (Nottingham, 
UK), by Dr S. Sebert under supervision of Professor M.E. Symonds and Dr 
D. Gardner. 
Figure 5.1 Schematic diagram depicting the overlap between studies described in 
Chapters 3, 4 and 5 achieved for maximal utilisation of resources and 
standardisation of experimental conditions.   
In Study 2, twin offspring of ewes restricted to 60% nutrient restriction (N) during 
late gestation (NR-LG) were either separated and only one offspring fed to mother’s 
milk without competition achieving an accelerated rate of growth (Ac) or were both 
fed by the ewes achieving a standard rate of growth for a twin (St). All offspring 
were raised in obesogenic environment of restricted activity. The offspring 
randomised to lean experimental group (N-L) and formula feeding (N-F) were 
included in studies described in Chapters 3 and 4 respectively.  
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The statistical analyses are described in detail in Chapter 2. Briefly, 
between-group differences were analysed using independent sample t-
tests. If required, non-parametric testing was performed by Mann Whitney 
test. Outcome for GTT and body weight measurements produced data of 
repeated measures in same animal over time. Analyses for such data with 
repeated measures were performed with two way mixed ANOVA and time 
was included as within-subject factor to assess for interaction between 
time and feeding method. For sake of uniformity of presentation and in 
keeping with standard practice, data have been expressed as mean and 
standard error of the mean for all the experimental output irrespective of 
the type of distribution of the data. 
 
 
  
Figure 5.2 Schematic diagram demonstrating the randomisation and timing 
of blood sampling and DXA scan investigations in the experimental study.  
Offspring of twin bearing sheep fed to 60% of metabolic requirements were 
randomised to be fed by their mother as twins, achieving standard growth 
for a twin offspring (St) or, after removal of one offspring, to be the 
remaining offspring fed by mother without competition for milk and 
achieving accelerated (Ac) growth for a twin offspring. Blood sampling were 
performed from the twin bearing sheep at 130 days gestational age (dGA) 
and offspring had glucose tolerance test (GTT) and blood sampling 
performed at age 7 and 16 months. Dual X ray absorptiometry (DXA) 
analysis was performed in the offspring at age 16 months. 
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5.3 Results 
5.3.1 Maternal and offspring metabolic and endocrine profile 
5.3.1.1 Effect of rearing as a singleton or twin on the weight 
gain of the offspring 
The birth weight of offspring randomised to the Ac (mean±SEM; 
3.76±0.18 kg, n=9) and St (4.07±0.14 kg, n=9) groups was comparable 
(p=0.116). The serial weight measurements from birth to the end of the 
suckling period at 90 days was analysed using a two-way mixed ANOVA to 
account repeated measures of weight at different timepoints. The analysis 
was significant for interaction between experimental groups and time 
(p=0.017). During the suckling period (birth to 90 days), the St offspring 
were significantly lighter than the Ac offspring in all the bodyweight 
measurements between age of 21 days until the age of 90 days (Figure 
5.3).  
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Figure 5.3  Offspring weight gain from birth to age of 90 days for lambs randomized 
to rearing as described to achieve a standard growth rate for a twin (St, red circle, 
dotted line, n=9) or to accelerated rate of growth (Ac, blue squares, solid line, n=9) 
during the sucking period. Two-way mixed ANOVA to account repeated measures 
of weight at different timepoints was significant for interaction between 
experimental groups and time (p=0.017). Data points depict mean with error bars 
depicting SEM. * p<0.05 for Ac versus St simple main effects comparison. 
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Accelerated early growth did not lead to any difference in the final body 
weight of the offspring as measured at 17 months of age. In addition, 
measurements of physical activity using an accelerometer performed 
during the suckling period (i.e. at 45 days of age) and at age 15 months 
did not differ between the two groups (Table 5.1).  
 
 St Ac 
Body weight at 17 months (kg) 69.6±5 68.0±3.1 
Mean physical activity at age 45 
days (counts) 
158.6±21.6 157.7±14.1 
Duration mobile in 24 hours at 
age 45 days (minutes) 
916±95 1048±55 
Mean physical activity at age 15 
months (counts) 
74±33 149±22 
Duration mobile in 24 hours at 
age 15 months (minutes) 
541±199 892±79 
 
  
Table 5.1 Body weight and physical activity parameters at the age of 45 days and 
15 months for lambs randomized to rearing as described to achieve a standard 
growth rate for a twin (St, n=6) or to accelerated rate of growth (Ac, n=9) during 
the sucking period. Data presented as means ± SEM. Statistical analysis performed 
with independent sample t test.  
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5.3.1.2 Effect of accelerated early growth on the body 
composition and liver weight at 17 months of age 
The total body and relative fat mass measurements obtained from DXA 
scan and from weighing of adipose depots at dissection did not 
demonstrate any difference in overall adiposity between the two groups 
(Table 5.2). The absolute weight of the omental adipose tissue was not 
different between the two groups. However, relative omental adipose 
tissue weight (percentage of total body fat mass) of Ac offspring was 
significantly less than the St offspring. The absolute and relative weights of 
other adipose depots and the liver were not different between the two 
groups. 
 St Ac 
Total fat mass from DXA (%) 14.4±1.0  17.1±2.8  
Total fat mass from DXA (kg) 9.9±0.6 11.7±2.1 
Omental fat mass at dissection (kg) 1.66±0.15 1.56±0.38 
Omentum, relative to total fat mass (%) 16.8±1.1a 12.7±1.5b 
Pericardial fat mass at dissection (kg) 0.12±0.01 0.96±0.07 
Pericardial fat, relative to total fat mass (%) 0.14±0.01 0.17±0.02 
Perirenal fat mass at dissection (kg) 1.01±0.10 1.07±0.25 
Perirenal fat, relative to total fat mass (%) 1.48±0.16 1.57±0.34 
Total visceral fat depots at dissection (kg) 2.78±0.26  2.73±0.62  
Visceral fat depots, relative to total fat (%) 28.1±1.8 22.7±2.3 
Liver weight at dissection (kg) 0.76±0.06 0.67±0.04 
Liver, relative to total body weight (%) 1.08±0.04 0.96±0.02 
Table 5.2 Body composition and organ weight of the offspring for lambs randomized 
to rearing as described to achieve a standard growth rate for a twin (St, n=9) or to 
accelerated rate of growth (Ac, n=9) during the sucking period. Data are presented 
as mean±SEM. a versus b, p=0.03 (independent sample t-test). DXA, dual X-ray 
absorptiometry 
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5.3.1.3 Effect of accelerated early growth on plasma metabolic 
and endocrine profile. 
Analyses of the plasma glucose and insulin samples from the GTT (Figure 
5.4) were performed using two-way mixed ANOVA to account for repeated 
measurements.  
For GTT at 7 months age, the statistical test was significant for interaction 
between early growth and time (p=0.02). Univariate analysis at individual 
time points did not demonstrate a statistically significant difference except 
for the marginal difference in measurement at 120 minutes (p=0.048). 
Statistical analysis of the plasma insulin concentrations at 7 months age 
did not demonstrate a significant interaction between early growth and 
time (p=0.37) or for the main effect of early growth (p=0.16)  
At 16 months of age, the glucose concentrations did not show a significant 
two-way interaction between early growth and time (p=0.36) or for the 
main effects of early growth (p=0.63). The plasma insulin concentrations 
did not demonstrate a significant interaction between early growth and 
time (p=0.88) or for the main effects of early growth (p=0.37).  
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Figure 5.4 Plasma glucose and insulin measurements during glucose tolerance test 
performed at 7 months (A and B respectively) and 16 months (C and D respectively) 
for lambs randomized to rearing as described to achieve a standard growth rate for 
a twin (St, n=6) or to accelerated rate of growth (Ac, n=9) during the sucking 
period. Statistical analysis performed using two-way mixed ANOVA. * p<0.05 for 
simple main effects analysis. Data are displayed as mean with error bars depicting 
SEM.  
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The measurements of glucose and insulin concentrations during the GTT 
were used to calculate the AUC. The calculated AUC values did not differ 
between the experimental groups for glucose and insulin measured at 7 
and 16 months respectively. The absence of differences in insulin 
sensitivity was confirmed on calculation of the HOMA-IR for sheep. Plasma 
cortisol, triglyceride and NEFA measurements also did not differ between 
the two groups (Table 5.3). Although they were similar at the age of 7 
months, plasma leptin measurements at 16 months were increased in the 
Ac as compared to the St growth group. 
 
 
 
Age 
(months) 
St Ac 
AUC glucose (mmol/L) 
7 1549±44 1462±90 
16 1491±69 1504±64 
AUC insulin (ng/ml) 
7 55.4±9.6 36±7.6 
16 49.8±14.5 71.9±11.6 
HOMA-IR 
7 0.60±0.04 0.75±0.06 
16 0.36±0.03 0.47±0.04 
Plasma leptin (ng/mL) 
7 2.31±0.45 2.45±0.45 
16 3.81±0.52a 6.16±0.94b 
Plasma cortisol (nmol/L) 
7 55.1±7.8 60.5±14.2 
16 41.9±11.6 56.1±13.9 
Plasma triglycerides (mg/dL) 
7 0.14±0.02 0.16±0.01 
16 0.12±0.02 0.13±0.03 
Plasma NEFA (mmol/L) 
7 1.18±0.13 1.11±0.08 
16 0.54±0.07 0.43±0.09 
  
Table 5.3 Plasma metabolic and endocrine profile of offspring at age 7 and 16 
months for lambs randomized to rearing as described to achieve a standard growth 
rate for a twin (St, n=9) or to accelerated rate of growth (Ac, n=9) during the 
sucking period. Data presented as means ± SEM. Statistical analysis performed with 
independent sample t test. A versus b <0.05. HOMA-IR, homeostatic model 
assessment – insulin resistance. NEFA, Non-esterified fatty acids. 
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5.3.2 Liver weight, triglyceride deposition and oxidative stress.  
Liver weight, triglyceride concentrations and malondialdehyde (MDA) 
concentrations (as a marker for thiobarbituric acid reactive substances 
(TBARS)) did not differ between the experimental groups (Table 5.4). 
 
 St Ac 
Liver weight (g) 755±59 660±39 
Liver triglyceride (mg/g liver) 48.3±7.8 30.8±1.5 
Total liver triglyceride (g) 27.8±4.5 20.4±1.6 
Liver TBARS (MDA μM/protein μg/μl) 0.98±0.09 0.90±0.08 
  
Table 5.4  Liver organ weight, triglyceride content and TBARS measurements for 
lambs randomized to rearing as described to achieve a standard growth rate for a 
twin (St, n=9) or to accelerated rate of growth (Ac, n=9) during the sucking period. 
Data presented as means ± SEM. Statistical analysis performed with independent 
sample t test . TBARS, Thiobarbituric acid reactive substances.  
  315 
5.3.3 Liver histology 
Histological images could not be quantified for appearance of steatosis and 
steatohepatitis (Figure 5.5). There was no difference in appearances of 
macrovesicular steatosis or cellular infiltration with experimental 
intervention which was similar to findings described in Section 3.3.3. 
 
 
 
  
Figure 5.5 Representative images of histological sections of liver from (A) 
St and (B) Ac offspring stained with Masson’s Trichrome demonstrating 
components of hepatic lobules at 10x magnification. 
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5.3.4 Hepatic gene expression 
5.3.4.1 Gene expression for modulators and effectors of 
metabolic inflammation in liver 
The gene expression for leptin receptor and TLR4 were significantly 
increased in the Ac group as compared to the St group (Figure 5.6).  
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Figure 5.6 Gene expression for liver TLR4 (A) and leptin receptor (B) for lambs 
randomized to rearing as described to achieve a standard growth rate for a twin 
(St, n=7) or to accelerated rate of growth (Ac, n=9) during the sucking period. Data 
presented as means with error bars depicting SEM. *p<0.05 (independent sample 
t test). CD95, cluster of differentiation 95; TLR4, toll-like receptor 4. 
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There was no difference in the gene expression for hepatic cluster of 
differentiation 95 (CD95), cluster of differentiation 68 (CD68), 
glucocorticoid receptor and 11β-hydroxysteroid dehydrogenase isoform 1 
(11βHSD1) (Table 5.5). 
 
 
 
St Ac 
CD68 1.00±0.09 1.00±0.10 
CD95 1.00±0.03 0.99±0.10 
11βHSD1 1.00±0.06 1.01±0.07 
  
Table 5.5 Relative gene expression of liver CD68, CD95 and 11 βHSD1 for lambs 
randomized to rearing as described to achieve a standard growth rate for a twin 
(St, n=7) or to accelerated rate of growth (Ac, n=9) during the sucking period. Data 
presented as means ± SEM. Statistical analysis performed with independent sample 
t test. CD68, cluster of differentiation 68; CD95, cluster of differentiation 95, 
11βHSD1, 11β-hydroxysteroid dehydrogenase isoform 1. 
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5.3.4.2 Gene expression for the components of the unfolded 
protein response in the liver 
Analysis of the components of unfolded protein response by comparing the 
gene expression for ATF4, ATF6, EDEM1 and GRP78 did not demonstrate 
any modification by the experimental intervention (Table 5.6). 
 
 St Ac 
ATF4 1.00±0.09 0.88±0.06 
ATF6 1.00±0.02 1.02±0.09 
EDEM1 1.00±0.04 1.02±0.05 
GRP78 1.00±0.12 0.99±0.11 
  
Table 5.6 Relative gene expression for the components of the UPR (ATF4, ATF6, 
EDEM1 and GRP78) for lambs randomized to rearing as described to achieve a 
standard growth rate for a twin (St, n=7) or to accelerated rate of growth (Ac, n=9) 
during the sucking period. Data presented as means ± SEM. Statistical analysis 
performed with independent sample t test. ATF4, Activating transcription factor 4; 
ATF6, Activating transcription factor 6; ER degradation-enhancing alpha-
mannosidase-like 1; GRP78, glucose-regulated protein 78. 
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5.3.4.3 Gene expression for the components of the autophagy 
in the liver. 
The gene expression for mTOR was significantly increased in Ac group as 
compared to the St group. However, this was not associated with any 
changes in the gene expression of AMPK (Figure 5.7) or ATG12 Ac 
(1.00±0.03, n=9) and St (1.05± 0.04, n=7).  
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Figure 5.7 Relative gene expression in liver for mTOR (A) and AMPK (B) for lambs 
randomized to rearing as described to achieve a standard growth rate for a twin 
(St, n=7) or to accelerated rate of growth (Ac, n=9) during the sucking period. Data 
presented as means ± SEM. Statistical analysis performed with independent sample 
t test. mTOR, mammalian target of rapamycin; AMPK, 5' adenosine 
monophosphate-activated protein kinase. 
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5.3.5 Omental adipose tissue histological characteristics 
5.3.5.1 Cell size, GRP78 and pJNK staining in omental adipose 
tissue 
There was no difference in the measured area of omental adipocytes and 
the microscopic characteristics of the adipose tissue were consistent with 
the description of omental adipose tissue from obese offspring given in 
Chapters 3 and 4 including unilocular lipid droplets, scant stromal 
connective tissue and non-homogenously dispersed clusters of IBA1 
positive macrophages present within crown like structures and milky spots.  
There was no difference in measured quantities of GRP78 staining which 
was localised to the cytoplasmic content or of the phosphorylated c-Jun N-
terminal kinase (pJNK) staining concentrated in the perinuclear region 
(Table 5.7 and Figure 5.8). 
 
 St Ac 
Adipocyte area (µm2) 4429±445 4116±545 
GRP78 (µm2/cell) 70±21 65±29 
pJNK (µm2/cell) 44±13 50±9 
 
 
 
 
Table 5.7 Mean adipocyte area in µm2 and quantification of GRP78 and pJNK 
calculated from the histological sections of omental adipose tissue of 17 month old 
lambs randomized during the sucking period to rearing as described to achieve a 
standard growth rate for a twin (St, n=7) or to accelerated rate of growth (Ac, 
n=9). Data presented as means ± SEM. Statistical analysis performed with 
independent sample t test. GRP78 Glucose regulated protein-78; pJNK, 
phosphorylated c-Jun N-terminal kinase 
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Figure 5.8 Representative images demonstrating distribution of staining in omental 
adipose tissue for GRP in (A) St and (B) Ac offspring and staining for Iba1 in (C) St 
and (D) Ac offspring, Location of GRP and pJNK staining can be identified by brown 
DAB staining 
A B 
C D 
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5.3.6 Omental adipose tissue gene expression analysis 
5.3.6.1 Gene expression of regulatory factors of metabolic 
inflammation and components of UPR. 
There was no difference in the gene expression of omental adipose tissue 
leptin, adiponectin, CD68, TLR4 and 11βHSD1 (Table 5.8). 
 
 St Ac 
Leptin  1.00±0.27 1.01±0.28 
Adiponectin 1.00±0.15 1.17±0.10 
CD68 1.00±0.52 0.78±0.23 
TLR4 1.00±0.06 1.05±0.11 
11βHSD1 1.00±0.11 0.88±0.14 
  
Table 5.8 Gene expression for leptin, adiponectin, CD68, TLR4 and 11βHSD1 in the 
omental adipose tissue of lambs randomized as described during the sucking period 
to achieve a standard growth rate for a twin (St, n=7) or to accelerated rate of 
growth (Ac, n=9). Data presented as means ± SEM. Statistical analysis performed 
with independent sample t test. Data are presented as mean±SEM. CD68, cluster of 
differentiation 68; 11βHSD1, 11β-hydroxysteroid dehydrogenase isoform 1; TLR4, 
toll-like receptor 4. 
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5.3.6.2 Gene expression of components of UPR in omental 
adipose tissue. 
The experimental intervention did not lead to any change in the gene 
expression of the UPR genes, ATF4, ATF6, GRP78 and EDEM1 (Table 5.9).  
 
 St Ac 
ATF4 1.00±0.08 0.95±0.06 
ATF6 1.00±0.07 1.03±0.09 
EDEM1 1.00±0.05 1.03±0.07 
GRP78 1.00±0.11 0.98±0.12 
  
Table 5.9 Expression of genes responsible for UPR in the omental adipose tissue of 
lambs randomized as described during the sucking period to achieve a standard 
growth rate for a twin (St, n=7) or to accelerated rate of growth (Ac, n=9). Data 
presented as means ± SEM. Statistical analysis performed with independent sample 
t test. ATF4, activating transcription factor 4; ATF6, activating transcription factor 
6; ER degradation-enhancing alpha-mannosidase-like 1; GRP78, glucose-regulated 
protein 78.  
  324 
 
5.3.6.3 Gene expression of the components of autophagy in the 
omental adipose issue. 
The gene expression for regulators and components of autophagy, AMPK, 
mTOR, ATG12 and BECN1 did not differ between the experimental groups 
(Table 5.10).  
 
 St Ac 
AMPK 1.00±0.14 1.09±0.10 
mTOR 1.00±0.24 0.96±0.16 
ATG 1.00±0.06 1.04±0.06 
BECN1 1.00±0.08 0.99±0.05 
  
Table 5.10 Gene expression of regulators and components of autophagy in omental 
adipose tissue of randomized as described during the sucking period to achieve a 
standard growth rate for a twin (St, n=7) or to accelerated rate of growth (Ac, 
n=9). Data presented as means ± SEM. Statistical analysis performed with 
independent sample t test. mTOR, mammalian target of rapamycin; AMPK, 5' 
adenosine monophosphate-activated protein kinase; Autophagy-related protein 
12; BECN1, gene encoding Beclin1. 
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5.4 Discussion 
 
Nutritional intake during early life is known to be the primary determinant 
of infant growth. The experiments described in this chapter were designed 
to investigate the impact of accelerated early postnatal growth rate in 
IUGR animals upon development of later obesity, insulin resistance or on 
metabolic inflammation and cell stress response. Sheep offspring fed by 
their mother as a singleton grew at a faster rate as compared to the twin 
offspring, both feeding on their mother’s milk. This was not associated 
with any difference in final adult weight or adiposity. Testing for GTT, 
plasma triglycerides, NEFA or plasma cortisol did not identify any 
differences in the carbohydrate or lipid metabolism of the offspring. 
Offspring in the accelerated early growth rate group had significantly 
higher plasma leptin levels as compared to the offspring experiencing 
standard growth for a twin.  
Hepatic weight, triglyceride content and TBARS as a marker of oxidative 
stress were comparable between the two groups. Ac offspring 
demonstrated increased gene expression for hepatic TLR4 and leptin 
receptors. However, this was not associated with any change in gene 
expression of hepatic inflammatory markers, components of UPR or 
autophagy.  
Ac offspring had increased circulating leptin at 16 months of age, however 
this was not associated with differential adipose tissue deposition, change 
in adipocyte size or with a consistent pattern of change to gene expression 
of metabolic inflammation and adipocyte cell stress response.  
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5.4.1 Accelerated early growth in sheep is not associated with 
development of adult obesity, insulin resistance or altered 
cell stress response.  
Offspring of nutrient restricted twin bearing sheep demonstrated increased 
growth rate when one of the twins was removed from feeding from their 
mother’s milk as compared to the offspring which were both fed on their 
mother’s milk. As early growth rate is primarily determined by food intake, 
offspring’s milk intake, although not measured in this study, can be 
assumed to be higher in the Ac offspring as compared to the St offspring. 
However, when reared in similar postweaning environment, the adult Ac 
offspring were not heavier than the St offspring, indicating the increased 
nutritional intake and the rapid early weight gain during early life did not 
predispose the Ac offspring to increased obesity or adipose tissue 
deposition.  
The stimulus for research of the programming potential of nutritional 
intake during early life [501, 502] arises from evidence from early 
epidemiological [289] and rodent animal studies [269] indicating potential 
deleterious effect of rapid early growth. This is particularly important as 
many infants born SGA subsequently experience rapid postnatal growth in 
early infancy.  
Whilst the associations between early weight gain and adult obesity and 
adiposity identified in epidemiological studies have been contradicted in 
more recent studies [289, 290], rodent studies of nutritionally mediated 
rapid early postnatal growth have demonstrated its association with 
obesity in adulthood [296]. Rodent organ development, maturity of 
endocrine axis, milk composition are some of the potentially significant 
factors which differ from large mammals such as sheep [247]. The inability 
to replicate the increased obesity in response to rapid early postnatal 
growth in this study as predicted from the rodent studies could be due to 
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relatively underdeveloped rodent endocrine axes [298] or differences in 
the characteristics of adipocyte depots [503] during early postnatal life. It 
is plausible that such factors make early postnatal life in rodents a critical 
window of development susceptible to programming through nutrition 
intake and rapid growth whereas sheep, with relatively mature endocrine 
and differing adipocyte profile are relatively resistant to such 
programming. 
Metabolic syndrome and insulin resistance can occur independent of 
obesity [7] and, therefore, it was important to investigate if the offspring 
were predisposed to these potentially deleterious phenomena irrespective 
of a difference in final adult weight or adiposity. However, in conjunction 
with no change in predisposition to obesity, insulin sensitivity measured 
using GTT and metabolic parameters, NEFA and plasma triglyceride 
concentrations did not differ between Ac and St offspring. The circulating 
leptin concentrations at 16 months of age were higher in Ac than in Sc 
despite similar body fat mass indicating that the adipose tissue in the Ac 
animals may have a different phenotype and inflammatory profile. 
However, leptin gene expression in omental adipose tissue was not 
significantly increased in the Ac sheep. Hyperleptinaemia has been 
associated with development of insulin resistance, suggesting a role in the 
metabolic syndrome [504]. It is plausible that the increased baseline 
plasma leptin concentration is an outcome of production from another 
adipose depot such as perirenal or subcutaneous adipose tissue or an 
outcome of selective post translational modifications of the product. It is 
thought that the chronic exposure of higher leptin levels observed in obese 
subjects leads to leptin desensitisation and development of leptin 
resistance. The raised plasma leptin concentrations in the Ac offspring 
could also indicate a compensatory response to a leptin resistance at 
tissue level. The gene expression for leptin receptors in the adipose tissue 
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was below the detectable limits of the PCR assay and the gene expression 
for hepatic leptin receptor was increased in the Ac offspring. This was not 
associated with a consistent increase in gene expression of any markers of 
inflammation apart from increase in hepatic TLR4 receptor gene expression 
in the AC offspring. The effect of such isolated gene expression changes is 
difficult to interpret and would be speculative at best.  
Circulating leptin is known to be associated with modulaton of the immune 
system [505]. However, the adipocyte size, structure and 
immunohistochemistry for components of GRP78 and pJNK did not identify 
any such difference. Omental adipose tissue gene expression of 
inflammatory markers and cell stress response also was not increased with 
accelerated postnatal growth.  Along with modulator of metabolic 
inflammation, leptin is known to have an effect on appetite regulation. 
Such possibility of leptin action and leptin resistance in this setting of early 
postnatal nutritional programming is already being investigated [506].  
The results from the experiments do not confirm the predictions of the 
study hypotheses. As with any scientific experimental study, the 
interpretations of results are restricted to the limitations of the scientific 
model being used.  Notably, this model is not able to determine if the 
relatively faster rate of growth in the Ac offspring as compared to the St 
offspring is a reflection of overnutrition in the Ac group or relative 
undernutrition in the St group. The study was designed to bring about a 
nutritionally mediated alteration in the rate of early growth following IUGR. 
The nutritional intake and growth rate of the twin offspring in the St group 
would match the naturally occurring parameters of this population of twin 
offspring. Therefore the St offspring were designated as the control group 
and Ac offspring represent the experimental intervention.  
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The experiments investigated whether IUGR offspring followed by 
relatively accelerated postnatal growth would exacerbate obesity induced 
insulin resistance and worsen hepatic and adipose tissue inflammation and 
cell stress response. Whilst, there is no definition of sheep IUGR, the 
offspring of sheep undergoing nutrient restriction with the z-score of 
sample mean of -3 as compared to the entire population indicates a 
significant difference from the population mean (Chapter 3). This was 
interpreted as an indicator of significant IUGR. It is plausible that nutrient 
restriction mediated IUGR developed in this sheep model is not entirely 
representative of the IUGR in humans which is an outcome of the multiple 
mutually interacting maternal and fetal factors such as placental health, 
intrauterine infections, maternal micronutrient intake and genetic factors 
[423, 507].  Such differing intrauterine mechanisms could still differentially 
regulate the predisposition of a growth restricted offspring to the 
programming effect of postnatal growth. It is also plausible that a more 
severe maternal nutrient restriction with, or without, a relatively faster 
postnatal growth would have demonstrated development of severe 
metabolic outcome. However, such an extreme nutrient restriction during 
pregnancy or forced acceleration of postnatal growth during early 
postnatal life is unlikely to reflect human equivalence or to have a public 
health implication. Future efforts of research into metabolic impact of the 
interaction of IUGR and postnatal growth should instead focus on a 
different model of sheep IUGR [507] followed by postnatal accelerated 
growth. The data presented in this thesis can serve to be a reference 
measure and for power calculations while designing any such study.  
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5.5 Conclusion 
Accelerated postnatal growth following development of IUGR brought 
about by maternal nutrient restriction in a sheep model did not predispose 
the offspring to worsening of adult adiposity, insulin resistance, metabolic 
inflammation or altered hepatic and adipose tissue cell stress response. 
Whilst the circulating plasma leptin is increased in adult sheep who 
experienced accelerated postnatal growth, this did not lead to a difference 
in the metabolic inflammatory profile or in the cell stress response of the 
offspring in adulthood. The data presented in this unique study lay a 
background and reference point for future investigations in this topic which 
has potentially significant public health implications.  
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6 Conclusions 
 
6.1 Aims 
The studies described in this thesis investigate the developmental 
programming effects of nutrition during early life on the obesity associated 
hepatic and omental adipose tissue cell stress response. Obesity is known 
to be associated with a state of chronic metabolic inflammation [508] and 
cell stress response pathways [112] in organs such as liver and adipose 
tissue. The ability of the organ cell stress response to alleviate the adverse 
effects of such inflammation determines, in part, the cellular and organ 
dysfunction of the derangements associated with metabolic syndrome 
[459]. The state of metabolic health in this study was described using the 
parameters of body weight, adiposity, glucose tolerance, plasma 
metabolite concentrations, endocrine parameters, hepatic oxidative stress 
and histological characteristics of adipose and hepatic tissue. Gene 
expression and immunohistochemistry studies were performed to describe 
the hepatic and omental adipose tissue cell stress response in adult sheep. 
Three different studies were performed to analyse combinations of early 
life nutrition influences on the outcome measures. The first study (Chapter 
3) established the baseline metabolic and cell stress characteristics in 
obese and lean sheep and compared them to obese and lean sheep that 
had experienced intrauterine growth restriction (IUGR) secondary to 
maternal nutrient restriction during late gestation (NR-LG). The study 
described in Chapter 5 investigated the effect of accelerated early 
postnatal growth in IUGR lambs fed by mother on the same outcome 
measures in adult sheep. Formula feeding as a programming mechanism 
was investigated in Chapter 4 which described the outcome measures in 
offspring of sheep undergoing NR-LG or of sheep fed to requirements who 
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had been randomised to formula feeding or to being fed on their mother’s 
milk. 
6.2  Summary of findings 
Table 6.1 summarises the findings of the studies described in this thesis 
which are described in the following subsections. 
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Experimental 
intervention 
Obesity  
Prenatal nutrient restriction 
+ 
Obesity 
 
Prenatal nutrient restriction 
+ 
Formula Feeding 
+ 
Obesity 
Prenatal nutrient restriction 
+ 
Accelerated early growth 
+Obesity 
Physiological 
characteristics of 
offspring 
 1.35 fold increased adult 
weight 
 Weight gain apparent after 
12 months 
 Raised insulin on 16 month 
GTT 
 Increased plasma leptin 
 Birth weight z-score -3 
 No effect on adult body 
weight or endocrine 
parameters 
 Relatively slow early growth 
(0-90 days) in IUGR formula 
fed offspring. 
 Decreased physical activity 
 No difference in adult body 
weight or endocrine 
parameters 
 Singleton rearing of twin 
offspring resulted in increased 
weight gain during suckling 
(0-90 days) 
 No difference in adult body 
weight. 
 Increased plasma leptin 
 
 Increased liver weight 
 Increased hepatic 
triglyceride 
 Increased relative liver 
weight 
 Further increase in hepatic 
triglycerides 
 No exacerbation of lipid 
deposition. 
 No exacerbation of lipid 
deposition. 
 Increased hepatic UPR gene 
expression 
 
 Increased autophagy gene 
(BECN1) 
 No change in hepatic gene 
expression of inflammation or 
cell stress response 
 Increased hepatic TLR4 and 
leptin gene expression. 
 No change to UPR gene 
expression 
  Preferential deposition to 
visceral adipose depots 
 Adipocyte hypertrophy 
 Increased macrophages, 
crown-like structures and 
milky spots 
 No change  No change in adiposity or 
histological characteristics.  
 No change in adiposity or 
histological characteristics. 
 Increased gene expression 
for leptin, TLR4 and CD68 
 Increased autophagy gene 
expression (ATG12 and 
Beclin1) 
 Increased omental UPR 
response gene expression 
(ATF6, GRP78 and EDEM1)  
 No change in omental adipose 
gene expression for 
inflammation or cell stress 
 No change in omental adipose 
gene expression for 
inflammation or cell stress 
Table 6.1 Summary of the findings of studies described in this thesis listed in a tabular format.  
UPR, unfolded protein response; GTT, glucose tolerance test, TLR4, toll like receptors-4; CD68, cluster of differentiation 68; ATG12, 
autophagy related protein-12; ATF, activating transcription factor 6; EDEM1, ER stress degradation enhancer molecule-1; BECN1, gene 
encoding Beclin1.
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6.2.1 Effects of obesity in young adult sheep 
Sheep reared in a restricted environment of decreased physical activity 
demonstrated a 1.35 fold weight gain compared to controls. This is modest in 
contrast to other studies with a 1.5 fold [264] or 2 fold [223, 436] weight gain 
induced in the obese sheep compared to the control animals.  
Rearing in an obesogenic environment was associated with development of 
peripheral insulin resistance. As hypothesised, obesity was associated with 
increased gene expression of unfolded protein response (UPR) components 
which is in consensus with observational human studies [105] and small animal 
experiments [99]. In addition, upregulated gene expression of hepatic 
autophagy components, increased hepatic triglyceride deposition without 
increase in plasma triglyceride concentrations indicate defective autophagy 
contributing further to hepatic cell stress. Upregulated gene expression of 
hepatic autophagy, by itself, is insufficient to conclusively reveal the state of 
hepatic autophagic flux [237]  since upregulation of the gene expression can be 
a reflection of either increased, or defective, autophagy. Ongoing studies of the 
relationship between hepatic autophagy and development of NAFLD [235] are 
important for improving the knowledge of the pathogenesis of metabolic 
syndrome. However, the focus of this component of the studies was to establish 
the baseline state of the gene expression. In the interest of time and resources, 
further efforts were not made to perform further analysis of the autophagic flux.  
 
6.2.2 Effects of maternal nutrient restriction followed by obesity in 
offspring 
Maternal NR-LG during late pregnancy to 60% of maternal nutrient requirements 
caused maternal hypoglycaemia, higher plasma non-esterified fatty acids (NEFA) 
concentrations and gave birth to IUGR offspring of nutrient restricted sheep (N) 
had sample mean birth weight z-score of -3 as compared to the offspring of the 
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sheep fed to appetite (A). In concurrence with other studies of sheep nutrition 
during late gestation, [264] nutrient restriction did not predispose the offspring 
to increased obesity or adiposity. However, the relative liver weight and hepatic 
triglyceride concentration of the N-O offspring was significantly increased as 
compared to obese offspring of sheep fed to appetite (A-O) which is similar to 
the outcome of a sheep study applying a 50% nutrient restriction in mid-
gestation paired with increased expression of PPARϒ and PGC1α suggesting a 
decrease in beta-oxidation [279]. The increased hepatic triglyceride in N-O 
animals was associated with increased hepatic autophagy gene expression for 
BECN1. It has been proposed that a defective autophagy in nutritionally 
mediated IUGR predisposes to hepatic triglyceride accumulation. Confirmation of 
such a mechanism will require study of markers of autophagy function and 
should form part of any future investigation of this mechanism.  
In the omental adipose tissue, NR-LG did not exacerbate obesity related changes 
in adipose depots, adipocyte size, macrophage infiltration or gene expression for 
adipokines. Gene expression for UPR components demonstrated obesity related 
increased expression limited to N-O versus N-L. Enhanced UPR with prenatal 
nutrient restriction, targeted between early-to-mid gestation, has previously 
been shown in perirenal adipose tissue of sheep at 1 year of age [68].  
Late gestation in sheep coincides with rapid expansion of the fetal omental 
serosa [69] which contains adipocyte precursors. A state of energy deficit, as 
seen during the late gestation undernutrition, is known to cause ER stress and 
activate UPR [477, 478]. Preadipocytes are vulnerable to external stress [509, 
510], and will survive to develop into mature adipocytes in this scenario if they 
have effective ER stress response. The selective survival of such adipocytes, 
would potentially prepare the organ to a postnatal environment of 
undernourishment. The contrasting nutrient replete state of obesity, which is 
also known to induce ER stress in adipocytes [91], would lead to sustained 
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activation of UPR. After the initial pro-survival actions, prolonged UPR in these 
offspring would initiate inflammation and cell death pathways [25].  
Another possible explanation for the exaggerated UPR in the nutrient restricted 
offspring could be through resetting of total adipocyte number in the depot. It 
has been shown that the maximal adipocyte number in adipose depots of an 
adult is set in early life and does not further increase with adult obesity [34]. 
However, the timing of such determination of preadipocyte destination has not 
yet been precisely established [511].  If the late gestational undernutrition 
programmes the developing organism to possess fewer adipocytes, lipid storage 
with obesity during later life would require a greater degree of hypertrophy. The 
ensuing cell stress would potentially activate a greater degree of UPR [36] in 
response to hypertrophy as compared to cells in adipose depots with more 
abundant adipocytes which would undergo a relatively less degree of 
hypertrophy while accommodating the excess lipid. 
The selective increase in gene expression of UPR components was not supported 
by immunohistochemistry for GRP78 which was consistently increased with 
obesity irrespective of prenatal intervention. Moreover, the study did not confirm 
the hypothesised predisposition to insulin resistance and metabolic syndrome 
due to prenatal undernutrition as compared to offspring of sheep fed to appetite. 
The age of 17 months in sheep is considered equivalent to young adulthood and 
it is plausible that, by this age, the programming mechanisms of NR-LG may not 
yet have contributed significantly to the progression of insulin resistance. 
Previous sheep studies of NR-LG either employed a more severe nutritional 
challenge (50%) [274]  or studied the glucose-insulin axis at older age [264]. 
Additional work is necessary to determine if the upregulated UPR gene 
expression in obese offspring of sheep undergoing NR-LG would contribute to a 
worse metabolic outcome at either a later age or following a more severe in 
utero nutritional challenge.  
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6.2.3 Interaction of prenatal nutrient restriction and formula feeding 
during the suckling period.  
During the 90 day suckling period, the IUGR formula fed offspring of NR-LG 
sheep (N-F) remained significantly lighter than formula fed offspring of sheep 
fed to requirement (R-F). This is in contrast to the pattern of increased growth 
described in some formula fed human infants [483]. This could reflect better 
proximity of human formula micronutrient composition to breast milk or could be 
the outcome of maternal deprivation [485, 486], which is known to result in 
growth failure [512]. In addition, in this study, the formula fed offspring were 
noted to be significantly less active as compared to offspring of mother fed 
sheep at 45 days of age. The physical activity counts at the age of 45 days 
correlated with physical activity measurements performed at 15 months 
indicating that early environmental influences lead to establishment of a physical 
activity phenotype which persists during adolescence.  
There was a trend towards increasing liver triglyceride concentrations with 
formula feeding (p=0.058). However, this was not associated with the studied 
histological features characteristic of NAFLD.  Formula feeding with, or without, a 
background of prenatal nutrient restriction was not associated with any change 
in gene expression for components of metabolic inflammation, UPR or 
autophagy. The current study model, therefore, does not confirm the 
hypothesised increase in the cell stress response and metabolic inflammation in 
formula fed offspring. It is plausible that, with age, the demonstrated trend 
towards increased hepatic triglycerides in formula fed offspring would reach a 
level consistent with hepatic steatosis and contribute to development of the 
metabolic inflammation. Future studies would ideally include testing at different 
endpoints using hepatic biomarkers or liver biopsies to identify progressive 
stages in natural history of the disease with a final endpoint at a much older 
age.  
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mTOR, a component of cellular energy sensing mechanism, was significantly 
increased in R-F offspring as compared to both N-F and R-M groups respectively. 
In the absence of evidence for a significant difference in adipose tissue 
structure, inflammation or cell stress response gene expression, the relevance of 
an isolated finding of mTOR gene expression change cannot be fully interpreted.  
The results described in this study, therefore, do not support the hypothesised 
interaction between formula feeding and prenatal undernutrition leading to 
development of a phenotype with insulin resistance and exaggerated cell stress 
response. This is the first large animal model experimental study that has 
attempted to describe the potential interaction of formula feeding and prenatal 
undernutrition. The failure to support the hypothesised outcome measures are 
applicable to the study model and there is a need for further studies in large and 
small animal models to identify the potential mechanisms of adverse metabolic 
outcomes witnessed in formula fed infants. 
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6.2.4 Effects of rate of weight gain during suckling period following 
nutrient restriction in a twin pregnancy.  
Offspring of twin bearing sheep who had undergone NR-LG demonstrated 
increased growth (Ac - accelerated growth) when one of the twins was removed 
from the mother as compared to the group of twin offspring which were both fed 
on their mother’s milk (St – standard growth for a twin offspring). The rapid 
weight gain in the former is a reflection of increased nutritional intake, the 
primary determinant of postnatal growth. Such rapid early weight gain did not 
lead to an increase in final adult weight or adiposity. Early human 
epidemiological data exploring the relationship between early weight gain and 
risk for obesity had used BMI as outcome measure whereas recent studies 
evaluating the former’s association with adiposity demonstrated lack of an 
association (Table 6.2). Rodent experimental studies [269, 296], in contrast, 
have demonstrated hyperphagia and increased adiposity as an outcome of rapid 
early growth. However, the significant differences in intrauterine and postnatal 
organ development between rodents and a large animals and in their maturity of 
endocrine axis at birth and milk composition are all potentially significant factors 
influencing the plasticity of a developing organism, highlighting the need for 
experimental studies in the latter.  
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Study Method Outcome 
Druet et al. 
2005[289] 
 Meta analysis; n=47661 
 SD scores of body weight at birth 
and age 1 year. 
 Outcome measure: Risk of adult 
obesity (BMI>30) 
 1 unit increase in SD score of 
weight from birth to 1 year 
increases risk of obesity as adult 
OR 1.23 (1.16,1.30) 
Bann et al. 
2014[290] 
 Cohort study; n=1558 
 SD scores of body weight at birth 
and regular measurements until 
20y. 
 Outcome measure: Lean mass 
and fat mass from DXA scans at 
mean age 63y. 
 Increased weight gain from birth 
to 2 years associated with 
increased lean mass. 
 Increased weight gain from 2-20 
years associated with increased fat 
and lean mass. 
Wells et al. 
2012 [513] 
 Cohort study; n=425 
 Weight gain from birth to 2y. 
 Outcome measure: Body 
composition at age 14 y. 
 Rapid weight gain associated with 
larger size and lean mass but not 
with adiposity. 
Stettler et al. 
2005[287] 
 Cohort study; n=653 
 Weight gain during the first week 
after birth 
 Outcome measure: Risk for adult 
overweight (BMI>25) 
 For each 100 g increase in weight 
gain from birth to age 8d OR for 
adult overweight 1.28 ( 1.08,1.52) 
 
No differences were apparent in the insulin sensitivity or metabolic profiles of the 
two groups at 6 and 16 months of age. The Ac animals had increased plasma 
leptin at 16 months of age as compared to St offspring. This was not associated 
with a consistent increase in gene expression of any markers of inflammation 
apart from increase in hepatic TLR4 receptor gene expression in the Ac offspring. 
The effect of such isolated gene expression change is difficult to interpret and 
would be speculative, at best. Along with modulation of metabolic inflammation, 
leptin is known to regulate appetite and is the subject of ongoing investigations 
[506].  
Table 6.2 Summary of methodology and relevant outcomes of major epidemiological 
studies investigating association between early postnatal growth with obesity and 
adiposity. 
B.M.I, body mass index; y, years; g, gram; OR, odds ratio; DXA, dual-energy x-ray 
absorptiometry; SD, standard deviation. 
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It was hypothesised that rapid early weight gain in nutritionally mediated IUGR 
would predispose the offspring to a greater adverse outcome of obesity 
manifesting as decreased insulin sensitivity and metabolic inflammation. The 
results do not support this hypothesis. Maternal nutrition is just one of many 
mutually interacting mechanisms which determine the development of IUGR. 
Different models of sheep IUGR obtained secondary to methods such as 
carunclectomy, hyperthermia, embolisation and single umbilical artery ligation of 
adolescent overfeeding have differing intrauterine physiological profiles [514]. 
Fetal hypoxia, hypoglycaemia and acidemia, amongst other endocrine and 
physiological changes, are all known to be present in human IUGR, which has 
not been replicated in its entirety by any of the known sheep models [514]. It is 
plausible that the nutritionally mediated sheep IUGR, in an otherwise healthy 
animal, was a relatively insignificant stimulus in comparison to the multiple 
mutually interacting causative factors of IUGR. It is, however, important to 
systematically elucidate the impact of individual components of the aetiology of 
IUGR as a programming stimulus. The outcomes of this study demonstrate the 
absence of exaggerated metabolic inflammation or metabolic outcome secondary 
to accelerated postnatal growth following nutritionally mediated IUGR. 
6.3 Limitations of the model 
6.3.1 The sheep as a model of obesity and metabolic syndrome 
Distinct differences between the sheep model and human physiology have the 
potential to confound the programming effect of early life environmental 
influences. As discussed, ruminants have a distinctly different digestive system 
and dietary requirements from humans. This model, however, was an 
investigation into intrauterine undernutrition, postnatal growth rate and physical 
inactivity induced obesity on the later metabolic health. Developmental 
programming in both liver and adipose tissue in association with predisposition 
of obesity and insulin resistance has previously been demonstrated in other 
sheep studies of nutrition during early life and decreased physical activity [68, 
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264, 279] with experimental interventions performed at varying timings and of 
differing magnitude.   
There has not been any large animal model which has manifested all the 
components of metabolic syndrome secondary to obesity. Age, an independent 
risk factor for development of metabolic syndrome, is an important aspect 
precluding development of such a model in a research setting. A large animal 
study which permits the experimental intervention to last through the longer 
lifespan of a large animal would be logistically and financially very difficult to 
organise. The focus of this study was to identify the presence of alterations of 
metabolic inflammation preceding the development of metabolic derangement of 
metabolic syndrome. The timing of the end point of this study was, therefore, 
not expected to demonstrate the full complement of metabolic derangements. In 
addition, there are no defined criterion for sheep metabolic syndrome or insulin 
resistance. The outcome of endocrine and metabolic parameters were, therefore, 
studied with comparison to a control group.  
 
6.3.2 The sheep as a model of IUGR secondary to maternal 
undernutrition. 
IUGR is an outcome of multiple factors intrinsic and extrinsic to the mother and 
fetus such as umbilical blood flow, placental function, adverse maternal and fetal 
endocrine profiles and pathogen exposure along with maternal nutrition. The 
results of this study would be applicable to individuals with low birth weight 
secondary to late gestation undernutrition. An alternative approach could be to 
divide offspring at birth to cohorts of low birth weight and normal weight. 
However, such an approach would have some limitations including an inability to 
differentiate healthy small for gestation age (SGA) individuals from those who 
genuinely suffer from IUGR. Furthermore, in order to elucidate the mammalian 
processes behind any pathogenesis would require an extremely large cohort to 
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account for all the confounding factors potentially contributing to the 
development of IUGR. In contrast, the interventions described in this thesis were 
performed systematically in a randomly selected population with the 
experimental groups differing only in the amount of macronutrient availability 
during the late gestation, enabling a focussed study of this specific model.  
There is no standard for sheep birth weight which makes it difficult to determine 
if a certain birth weight qualifies a birth weight value to meet SGA or IUGR 
criterion.  A birth weight z-score of -2 in human studies is conventionally used to 
represent IUGR [515]. The z-score for offspring in the NR-LG group was >3 
below the values for the control animals and, in the absence of any other 
differences in experimental conditions, this outcome was deemed to be 
secondary to IUGR. It is plausible that, despite a large difference in birth weight 
in comparison to the control group, the nutrient restriction to 60% during late 
gestation was not a severe enough stimulus. Furthermore, twin pregnancies in 
sheep are known to be inherently different from singleton in terms of fetal 
growth, postnatal growth and offspring adiposity [516].  It has been proposed 
that the relatively lower birth weight in twin sheep as compared to singleton are 
a reflection of IUGR in twin pregnancies [517]. The nature of hypothalamic 
pituitary adrenal axis in twins has also been shown to be different as compared 
to singletons. In twin fetal sheep, basal cortisol and ACTH concentrations are 
lower than in singletons [518] and differences persist even in young adult sheep 
[519]. Ideally a study of offspring of twin pregnancy as subject would have a 
singleton control group. This may, therefore, not be a directly transferrable 
model of IUGR in which the fetuses experience hypoinsulinaemia with the 
potential to programme later insulin sensitivity. However, the phenotype 
displayed by the offspring is consistent with findings in human cohorts of 
nutrient restriction during late gestation. 
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6.3.3 The sheep as a model for formula feeding. 
The study of long term metabolic effects of formula feeding aimed to replicate 
the growth patterns of human IUGR offspring fed with formula milk. However, 
these formula fed IUGR offspring grew at a slower rate from the comparison 
groups and the IUGR offspring fed by their mother. This did not replicate the 
pattern of enhanced postnatal growth in formula fed IUGR human infants [483]. 
It is plausible that this could be the outcome of one or more factors such as 
isolation from the mother and the difference in milk nutrient composition. The 
impact of maternal deprivation on offspring growth and health was not the 
primary focus of this study and would require an independent study for such 
investigation. The absence of excessive postnatal growth in formula fed IUGR 
offspring in this study provides an opportunity to investigate the independent 
effect of formula feeding independent of rapid postnatal growth which was the 
subject of investigation in the study described in Chapter 5.  
 
6.3.4 The sheep model of rapid postnatal growth 
The unique model of using offspring of twin bearing sheep to alter the postnatal 
growth provides an excellent opportunity to study the programming effect of 
growth and nutrition in early postnatal life. Offspring of twin pregnancies in 
sheep are known to be inherently different from singleton in terms of fetal 
growth, postnatal growth and adiposity [516]. It is not possible to ascertain 
whether similar alterations of postnatal growth rates would lead to identical 
outcomes in singleton offspring. 
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6.3.5 Effect of gender 
The impact of gender on differential programming of adult health has not been 
addressed in the study described in this thesis. Where possible, efforts were 
made to maintain a homogenous distribution of animals of both sexes in each 
group. However, due to unbalanced gender distribution of offspring birth and 
death, an even distribution of males and females in all groups was not achieved. 
Developmental programming is a phenomenon known to occur in both males 
and females. Nevertheless, gender may have an influence in modulating an 
individual’s risk of developing adverse health outcomes (reviewed in [520]). 
Notably, in the Dutch famine follow up study, the association of maternal 
undernutrition during the first trimester with higher BMI and waist circumference 
was demonstrated in 50 year old women and not in men. Male offspring of sheep 
fed low methionine and vitamin B diet in periconceptual period demonstrate a 
more marked hypertensive effect as compared to female ovine offspring [521].  
The studies described in this thesis are unable to measure gender specific effects 
due to lack of adequate statistical power to address this question. It would have 
been desirable to have a greater number of animals in each group so that an 
independent effect of gender of such programming could be analysed.   
6.3.6 Technical challenges 
Commercial assays for sheep are not readily available owing to infrequent use of 
the species for experimental research. A wider availability of reliable biomarkers 
and antibodies would have permitted a wider and more robust examination of 
the phenotype and underlying mechanisms. For example, TLR4 protein 
expression, to corroborate the gene expression findings or quantification of 
plasma cytokines, was attempted but was not reliably reproducible. Similarly, 
the absence of fully described sheep genome at the time of these experiments 
limited the number of genes which could be analysed. For example, attempts to 
design primers for important ER stress response components X-box binding 
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protein 1(XBP1) and homocysteine-inducible endoplasmic reticulum stress 
protein1 (HERP1) using cow (Bos Taurus) genome were not successful.  
The absence of a standardised criterion for NAFLD definitions in sheep means 
some aspects of NAFLD could not be fully identified. In addition, the clusters of 
immune system cells consistent with crown-like structures and milky spots in the 
omental adipose tissue were non-homogenously distributed which prevented 
reliable quantification of the distribution. The analysis was, therefore, limited to 
assessments of the tissue performed by observers blinded to experimental group 
allocation.  
6.4 Future work 
The research described in this thesis could be further elucidated by modified 
study models and advanced analysis of the model described.  
6.4.1 Elucidation of metabolic inflammation in obesity, its effects on 
organism and developmental programming. 
As demonstrated, the gene expression of UPR and autophagy was pliable to 
obesity and to NR-LG in both hepatic and omental adipose tissue. Advance 
lipidomic analysis of hepatic and adipose tissue in this model could provide 
valuable information regarding the impact of such modified gene expression on 
the organ. As more antibodies with reliable action become available, further 
elucidation of the state of autophagy could also facilitate in defining the role 
played by autophagy in pathogenesis of metabolic derangements. This would 
ideally be done by quantification of the protein contents if the components of 
autophagy.  
Glucose tolerance test was performed in the studies to describe the state of 
insulin resistance. At the tissue level, future work may focus on insulin signalling 
pathways with a focus on describing the expression of insulin receptors, insulin 
sensing mechanisms, the state of phosphorylation of insulin receptor and the 
expression of insulin mediated glucose transporters. Insulin receptor and glucose 
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transporters have been shown to be amenable to developmental programming 
[522] and description of the state of tissue insulin sensitivity would help describe 
the phenotype in more detail.  
The international sheep genome consortium [523] is actively working to describe 
the full genome. Newer technologies, such as, transciptome analysis [524], 
followed by gene cluster mapping [525] with focus upon the cell stress response, 
has the potential of demonstrating a robust confirmation of the results described 
in the thesis. In absence of a fully described sheep genome, whole transcriptome 
analysis was performed using SOLiDTM sequencing technique available at the 
University of Nottingham with bos taurus as reference genome on mRNA from a 
small number of representative animals. However, the results from such 
modified analysis were not replicated in gene expression of specific genes using 
polymerase chain reaction when all animals were subsequently analysed. With 
the availability of the complete sheep genome in the future, and further 
development of sequencing methodologies and data processing, such an analysis 
should be revisited.  
Epigenetic modification of the gene expression has also been proposed as a 
potential mechanism of developmental programming [526] and has been the 
focus of ongoing investigations [527]. However, as the technology matures, the 
current concerns regarding inconsistencies [528] will need to be addressed 
before it can be reliably applied for analysis.  
The important question of sexual dimorphism in pathogenesis of metabolic 
syndrome and specifically in metabolic inflammation needs to be addressed 
using focused models of larger studies of animals [364] designed to identify and 
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describe such a dimorphism and relate it to endocrine and phenotypic 
differences in males and females.    
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6.5 Final remarks 
As the first large animal model to demonstrate characteristics of obesity 
associated metabolic inflammation and the cell stress response in liver and 
omental adipose tissue, this study provides an important baseline for 
investigation of programming of these cellular processes. Investigations into 
mutual interaction of three different programming influences, maternal 
undernutrition during late gestation, formula feeding and postnatal growth rate 
identified that the prenatal intervention exacerbated the gene expression of the 
UPR in the omental adipose tissue and autophagy in liver. Formula feeding and 
accelerated postnatal growth did not programme the hepatic and adipose tissue 
cell stress response. 
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